courseId,chapterId,lessonId,topicId,questionId,question,options,correct
course_1,ch_1_01,les_1_01_01,topic_1_01_01_01,quiz_1_01_01_1,What are the four critical elements that a Quality Management System (QMS) coordinates in an organization?,"A) Planning, execution, monitoring, and reporting. |
B) Quality standards, procedures, roles, and corrective actions. |
C) Documentation, training, auditing, and compliance. |
D) Policies, processes, people, and performance.",B
course_1,ch_1_01,les_1_01_01,topic_1_01_01_01,quiz_1_01_01_2,"In the hospital analogy, what does operating without QMS resemble?","A) A well-organized military unit | 
B) A disciplined army with clear command structure | 
C) A military unit without command structure | 
D) A strategic command center",C
course_1,ch_1_01,les_1_01_01,topic_1_01_01_01,quiz_1_01_01_3,"What is the primary difference between SOPs (Standard Operating Procedures) and Work Instructions in a QMS framework?
","A) SOPs are more important than Work Instructions |
B) SOPs are manuals; Work Instructions are step-by-step guides |
C) Work Instructions are strategic; SOPs are tactical |
D) There is no difference between them.",B
course_1,ch_1_01,les_1_01_01,topic_1_01_01_01,quiz_1_01_01_4,What are the three systematic steps involved in SOP gap analysis?,"A) Plan, implement, and review |
B) Identify, analyze, and document |
C) Compare, find gaps, and update |
D) Audit, correct, and prevent ",C
course_1,ch_1_01,les_1_01_01,topic_1_01_01_01,quiz_1_01_01_5,"According to the lesson, what question should quality professionals always ask themselves regarding documentation?","A) Is this documentation complete? | 
B) Would my documentation protect this organization in regulatory scrutiny? | 
C) Does this follow company policy? | 
D) Is this the most efficient process?",B
course_1,ch_1_01,les_1_01_02,topic_1_01_02_01,quiz_1_01_02_1,what are the three critical outcomes guaranteed by a sophisticated document control system?,"A) Cost reduction, efficiency improvement, and staff training |
B) Universal adherence to instructions, elimination of obsolete versions, and perpetual audit readiness |
C) Document creation, approval processes, and storage management |
D) Version tracking, change management, and regulatory compliance",B
course_1,ch_1_01,les_1_01_02,topic_1_01_02_01,quiz_1_01_02_2,What is the complete document lifecycle trajectory mentioned in the lesson?,"A) Create → Approve → Release → Archive |
B) Plan → Write → Review → Distribute |
C) Creation → Review → Approval → Release → Revision → Obsolescence |
D) Draft → Edit → Validate → Implement → Update",C
course_1,ch_1_01,les_1_01_02,topic_1_01_02_01,quiz_1_01_02_3,"In the document numbering format QA-SOP-012 v2.0, what does each component represent?","A) QA=Quality Audit, SOP=Standard Process, 012=Date code, v2.0=Second draft |
B) QA=Quality Assurance Department, SOP=Standard Operating Procedure, 012=Serial number, v2.0=Second major revision |
C) QA=Quality Analysis, SOP=System Operating Protocol, 012=Priority level, v2.0=Version 2.0 |
D) QA=Quick Access, SOP=Safety Operating Procedure, 012=Classification code, v2.0=Final version",B
course_1,ch_1_01,les_1_01_02,topic_1_01_02_01,quiz_1_01_02_4,What is the key difference between version changes and revision changes?,"A) Version changes are approved by management, revision changes are not |
B) Version changes are major procedural alterations, revision changes are minor editorial corrections |
C) Version changes cost more money than revision changes |
D) There is no difference between version and revision changes",B
course_1,ch_1_01,les_1_01_02,topic_1_01_02_01,quiz_1_01_02_5,What was the consequence of the pharmaceutical company's document control failure mentioned in the real-world example?,"A) Loss of one employee and minor production delays |
B) Equipment malfunction and temporary shutdown |
C) Two million tablets recalled, FDA warning letter, and millions in losses |
D) Customer complaints and quality audit failure",C
course_1,ch_1_01,les_1_01_03,topic_1_01_03_01,quiz_1_01_03_1,what is the definition of a deviation in quality assurance?,"A) A planned change to improve processes |
B) Any unexpected event that causes a process, document, or product to drift from approved standards, SOPs, or regulations |
C) A minor mistake that doesn't affect quality |
D) An intentional modification approved by management",B
course_1,ch_1_01,les_1_01_03,topic_1_01_03_01,quiz_1_01_03_2,What are the four critical organizational functions served by deviation detection?,"A) Cost reduction, time management, staff training, and compliance |
B) Documentation, investigation, reporting, and prevention |
C) Protects product quality, maintains regulatory compliance, provides cost containment, and preserves stakeholder trust |
D) Identification, classification, notification, and resolution",B
course_1,ch_1_01,les_1_01_03,topic_1_01_03_01,quiz_1_01_03_3,What is the correct sequence of the five-step rapid response protocol for deviation management?,"A) Notify,  Document evidence, Classify, Contain, Investigate |
B) Record instantly, Classify severity, Notify QA immediately, Contain impact, Document evidence |
C) Identify, Report, Analyze, Correct, Prevent |
D) Observe, Classify severity,Record, Escalate, Investigate, Close",B
course_1,ch_1_01,les_1_01_03,topic_1_01_03_01,quiz_1_01_03_4,"In the pharmaceutical case study, what was the root cause of the tablet batch having lower active ingredient content?","A) Wrong raw materials were used |
B) Temperature control failure |
C) Miscalibrated weighing balance |
D) Operator training deficiency",C
course_1,ch_1_01,les_1_01_03,topic_1_01_03_01,quiz_1_01_03_5,Which principle emphasizes that speed is more important than completeness in deviation reporting?,"A) ""If uncertain, report immediately"" |
B) ""Speed beats perfection – A quick, incomplete report is better than a perfect one submitted late"" |
C) ""Documentation is organizational protection"" |
D) ""Prevention is better than correction""",B
course_1,ch_1_01,les_1_01_04,topic_1_01_04_01,quiz_1_01_04_1,What is the fundamental difference between Root Cause Analysis (RCA) and treating symptoms?,"A) RCA quickly and efficiently solves problems at their source. |
B) RCA identifies and resolves the root cause, not just surface symptoms. |
C) RCA reduces long-term costs by preventing repeat issues. |
D) RCA uses fewer resources than ongoing symptom management.
",B
course_1,ch_1_01,les_1_01_04,topic_1_01_04_01,quiz_1_01_04_2,"In the Five Whys technique example, what was identified as the root cause of the machine stoppage?","A) Fuse failure |
B) Electrical overload |
C) Motor maintenance issues |
D) Absence of systematic maintenance scheduling",D
course_1,ch_1_01,les_1_01_04,topic_1_01_04_01,quiz_1_01_04_3,What are the six sequential phases of the CAPA workflow?,"A) Identify, Analyze, Plan, Implement, Monitor, Close |
B) Identify problem, Investigate, Plan action, Implement, Verify, Document |
C) Detect issue, Investigate, Correct, Prevent, Verify, Record |
D) Define, Measure, Analyze, Improve, Control, Document",B
course_1,ch_1_01,les_1_01_04,topic_1_01_04_01,quiz_1_01_04_4,What is the key difference between Corrective Action and Preventive Action?,"A) Corrective Action is more expensive than Preventive Action |
B) Corrective Action fixes current issues, Preventive Action stops future recurrence |
C) Corrective Action is required, Preventive Action is optional |
D) Corrective Action involves management, Preventive Action involves operators",B
course_1,ch_1_01,les_1_01_04,topic_1_01_04_01,quiz_1_01_04_5,"In the tablet dissolution testing case study, what were the corrective and preventive actions taken?","A) Corrective: Replace equipment; Preventive: Train more staff |
B) Corrective: Operator retraining and monitoring; Preventive: Automated timers and alarms |
C) Corrective: Change SOPs; Preventive: Hire new operators |
D) Corrective: Stop production; Preventive: Buy new equipment",B
course_1,ch_1_01,les_1_01_05,topic_1_01_05_01,quiz_1_01_05_1,What are the three strategic functions served by internal audits?,"A) Identifying opportunities for cost reduction, improving operational efficiency, and evaluating staff performance effectiveness |
B) Providing early warning systems for risks, verifying performance against objectives, and facilitating continuous improvement initiatives |
C) Conducting detailed documentation reviews, observing processes for accuracy, and preparing structured reporting of findings |
D) Checking compliance with standards, delivering relevant training when required, and supporting structured problem-solving efforts",B
course_1,ch_1_01,les_1_01_05,topic_1_01_05_01,quiz_1_01_05_2,What are the three distinct categories of internal audits?,"A) Routine, special, and regulatory audits |
B) System audits, process audits, and product audits |
C) Document, personnel, and equipment audits |
D) Compliance, quality, and safety audits",B
course_1,ch_1_01,les_1_01_05,topic_1_01_05_01,quiz_1_01_05_3,"
When discovering missing calibration logs for temperature-controlled equipment, what is the proper investigative approach according to the lesson?","A) Record that the logs are missing, acknowledge the gap, and then proceed without further checks |
B) Check systematically: Was monitoring done, is integrity at risk, and who holds accountability? |
C) Assume the equipment continues to function correctly, without additional verification or follow-up |
D) Report the issue only in cases where other related problems are also identified ",B
course_1,ch_1_01,les_1_01_05,topic_1_01_05_01,quiz_1_01_05_4,What are the four critical areas of focus in document inspection?,"A) Content, format, distribution, and storage |
B) Creation, review, approval, and implementation |
C) Completeness, legibility, traceability, and version control |
D) Accuracy, timeliness, accessibility, and security",C
course_1,ch_1_01,les_1_01_05,topic_1_01_05_01,quiz_1_01_05_5,"In the hospital laboratory case study, what three systematic responses were implemented after discovering the missing temperature logs?","A) Implementation of CAPA, retraining staff on deviation reporting, and installing a backup thermometer|
B) Replacement of faulty equipment, revision of existing policies, and delivery of targeted staff training |
C) Upgrading systems, adjusting work schedules, and performing vendor performance evaluations |
D) Issuing written warnings, conducting process reviews, and formally notifying management",A
course_1,ch_1_01,les_1_01_06,topic_1_01_06_01,quiz_1_01_06_1,What is the definition of an Out-of-Specification (OOS) result?,"A) A test outcome that indicates an unusual or unexpected trend developing over time |
B) An analytical result that falls outside the officially defined acceptance specifications or criteria |
C) A reported value that demands immediate retesting to confirm its accuracy |
D) A measurement that shows a noticeable difference compared with the prior result",B
course_1,ch_1_01,les_1_01_06,topic_1_01_06_01,quiz_1_01_06_2,How does an Out-of-Trend (OOT) result differ from an Out-of-Specification (OOS) result?,"A) OOT findings are considered more serious than OOS deviations |
B) OOT stays within limits but shows unusual trend shifts, while OOS falls fully outside specification criteria |
C) OOT must be acted on immediately, whereas OOS issues can be delayed |
D) No meaningful difference exists between OOT and OOS outcomes",B
course_1,ch_1_01,les_1_01_06,topic_1_01_06_01,quiz_1_01_06_3,What are the six sequential steps of first-line investigation protocol?,"A) Analyze the issue, document findings, report deviations, investigate cause, apply corrections, and plan prevention |
B) Quarantine material, verify data, check calibration, interview analyst, confirm reagent status, and review documentation |
C) Identify the problem, isolate the source, investigate thoroughly, implement actions, verify outcomes, and close record |
D) Stop the process, look for errors, listen to staff, analyze details, take action, and record results",B
course_1,ch_1_01,les_1_01_06,topic_1_01_06_01,quiz_1_01_06_4,"In the capsule dissolution testing case study, what was identified as the root cause of the failure?","A) Analyst error in following SOP |
B) Instrument calibration problems |
C) Omitted blending step during manufacturing |
D) Contaminated reagents",C
course_1,ch_1_01,les_1_01_06,topic_1_01_06_01,quiz_1_01_06_5,"According to the lesson, what is the professional quality mindset approach to unusual analytical results?","A) Investigate only if the result is clearly wrong |
B) Wait to see if the pattern continues before acting |
C) Focus on whether the result meets specifications |
D) Treat every unusual result as a potential patient safety threat",D
course_1,ch_1_01,les_1_01_07,topic_1_01_07_01,quiz_1_01_07_1,"What does the acronym ALCOA stand for, and what is each component's meaning?","A) Accurate, Legal, Complete, Original, Available |
B) Attributable, Legible, Contemporaneous, Original, Accurate |
C) Accessible, Logical, Consistent, Objective, Authentic |
D) Authorized, Listed, Controlled, Official, Auditable",B
course_1,ch_1_01,les_1_01_07,topic_1_01_07_01,quiz_1_01_07_2,What are the five critical areas of focus in systematic data integrity auditing?,"A) Planning activities, executing tasks, documenting results, reviewing findings, and granting approvals |
B) Verifying metadata, matching source data, reviewing change controls, assessing security, and confirming archival integrity |
C) Creating data, storing information, retrieving records, analyzing content, and disposing of materials |
D) Managing input, handling processing, producing output, gathering feedback, and applying control measures",B
course_1,ch_1_01,les_1_01_07,topic_1_01_07_01,quiz_1_01_07_3,"What are the four additional pillars represented by the ""+"" in ALCOA+?","A) Protected, Permanent, Proven, Professional |
B) Complete, Consistent, Enduring, Available |
C) Controlled, Certified, Electronic, Archived |
D) Validated, Verified, Visible, Valuable",B
course_1,ch_1_01,les_1_01_07,topic_1_01_07_01,quiz_1_01_07_4,"According to the lesson, what constitutes ""Contemporaneous"" data recording?","A) Data recorded within 24 hours of the activity |
B) Data recorded at the end of each shift |
C) Data recorded simultaneously with operational activities, not hours afterward |
D) Data recorded whenever convenient for the analyst",C
course_1,ch_1_01,les_1_01_07,topic_1_01_07_01,quiz_1_01_07_5,"How is backdating of results typically detected during audits, and what are the consequences?","A) Identified by statistical analysis methods, leading mainly to regulatory warning letters |
B) Revealed through employee self-reporting, leading to follow-up sessions and additional staff training |
C) Spotted by trend or pattern recognition techniques, resulting primarily in process improvement steps |
D) Detected through mismatched audit trail timestamps, causing data invalidation and mandatory retesting",D
course_1,ch_1_01,les_1_01_08,topic_1_01_08_01,quiz_1_01_08_1,"According to the lesson, what are the three critical outcomes ensured by the Deviation to CAPA lifecycle?","A) Identifying the true root cause, neutralizing risks immediately, and reinforcing systems to prevent recurrence |
B) Achieving cost reduction, improving efficiency, and maintaining basic compliance standards |
C) Completing documentation, delivering required training, and preparing for future audit readiness |
D) Driving process improvement, allocating resources effectively, and measuring overall performance levels",A
course_1,ch_1_01,les_1_01_08,topic_1_01_08_01,quiz_1_01_08_2,What are the three risk stratification categories used in Stage Two (Initial Assessment)?,"A) Low, Medium, High |
B) Minor, Major, Critical |
C) Simple, Complex, Severe |
D) Internal, External, Regulatory",B
course_1,ch_1_01,les_1_01_08,topic_1_01_08_01,quiz_1_01_08_3,What is the key difference between containment actions and permanent solutions?,"A) Containment approaches usually cost more compared with permanent solutions |
B) There is no difference between containment and solutions |
C) Containment efforts need management approval, whereas permanent solutions can be applied directly |
D) Containment actions are temporary steps to stabilize and prevent further harm, not lasting resolutions",D
course_1,ch_1_01,les_1_01_08,topic_1_01_08_01,quiz_1_01_08_4,What are the three characteristics that effective CAPA must demonstrate?,"A) Fast, cheap, and simple |
B) Approved, documented, and monitored |
C) Specificity, Measurability, and Time boundaries |
D) Corrective, preventive, and verified",C
course_1,ch_1_01,les_1_01_08,topic_1_01_08_01,quiz_1_01_08_5,What is the fundamental principle regarding documentation in Stage One (Detection and Logging)?,"A) Documentation should be completed within 24 hours |
B) Documentation is only required for major deviations |
C) Undocumented events possess no regulatory existence |
D) Documentation can be completed after the issue is resolved",C
course_1,ch_1_01,les_1_01_09,topic_1_01_09_01,quiz_1_01_09_1,what are the three critical competencies demanded by high-pressure crisis environments?,"A) Planning, execution, and monitoring |
B) Speed, accuracy, and leadership |
C) Documentation, investigation, and resolution |
D) Communication, coordination, and control",B
course_1,ch_1_01,les_1_01_09,topic_1_01_09_01,quiz_1_01_09_2,What are the four primary trigger categories for comprehensive QA/QC crises?,"A) Failures involving equipment, personnel, documentation practices, or environmental conditions |
B) Overlapping deviations, OOS findings during audits, compromised data integrity, and supplier breakdowns | 
C) Issues arising internally, externally, through regulators, or from customer-related concerns |
D) Events classified as minor, major, critical, or catastrophic in impact levels",B
course_1,ch_1_01,les_1_01_09,topic_1_01_09_01,quiz_1_01_09_3,What are the seven phases of the Integrated Response Framework (IRF)?,"A) Identify the event, assess potential impact, contain immediate risks, investigate thoroughly, document findings, implement resolution, and formally close the case |
B) Triage situation, assemble crisis team, contain breach, assign investigation, document actions, plan recovery, and capture learning |
C) Plan systematically, organize resources, assign and staff roles, direct critical activities, coordinate responses, generate detailed reports, and manage budgeting considerations |
D) Detect early signals, analyze the event, respond with mitigation, recover operations, communicate to stakeholders, evaluate effectiveness, and apply continuous improvement",B
course_1,ch_1_01,les_1_01_09,topic_1_01_09_01,quiz_1_01_09_4,"In the 2018 Asian pharmaceutical manufacturing case study, what were the three simultaneous crises that occurred?","A) Equipment failure, power outage, and supplier delay |
B) Product recall, audit failure, and system breakdown |
C) Contamination, documentation error, and staff shortage |
D) Sterility failure, missing training records, and unannounced FDA inspection",D
course_1,ch_1_01,les_1_01_09,topic_1_01_09_01,quiz_1_01_09_5,What are the three strategic mindset components required for integrated crisis management?,"A) Preparation, execution, and evaluation |
B) Strategic thinking, systemic awareness, and narrative leadership |
C) Technical expertise, communication skills, and decision-making ability |
D) Risk assessment, resource allocation, and performance measurement",B
course_1,ch_1_01,les_1_01_10,topic_1_01_10_01,quiz_1_01_10_1,"What does the acronym ALCOA stand for, and what is each component's meaning?","A) Accurate, Legal, Complete, Original, Available |
B) Attributable, Legible, Contemporaneous, Original, Accurate |
C) Accessible, Logical, Consistent, Objective, Authentic |
D) Authorized, Listed, Controlled, Official, Auditable",B
course_1,ch_1_01,les_1_01_10,topic_1_01_10_01,quiz_1_01_10_2,"In the hospital laboratory case study, what three systematic responses were implemented after discovering the missing temperature logs?","A) Implementation of CAPA, retraining staff on deviation reporting, and installing a backup thermometer|
B) Replacement of faulty equipment, revision of existing policies, and delivery of targeted staff training |
C) Upgrading systems, adjusting work schedules, and performing vendor performance evaluations |
D) Issuing written warnings, conducting process reviews, and formally notifying management",A
course_1,ch_1_01,les_1_01_10,topic_1_01_10_01,quiz_1_01_10_3,"How is backdating of results typically detected during audits, and what are the consequences?","A) Identified by statistical analysis methods, leading mainly to regulatory warning letters |
B) Revealed through employee self-reporting, leading to follow-up sessions and additional staff training |
C) Spotted by trend or pattern recognition techniques, resulting primarily in process improvement steps |
D) Detected through mismatched audit trail timestamps, causing data invalidation and mandatory retesting",D
course_1,ch_1_01,les_1_01_10,topic_1_01_10_01,quiz_1_01_10_4,what are the three critical outcomes guaranteed by a sophisticated document control system?,"A) Cost reduction, efficiency improvement, and staff training |
B) Universal adherence to instructions, elimination of obsolete versions, and perpetual audit readiness |
C) Document creation, approval processes, and storage management |
D) Version tracking, change management, and regulatory compliance",B
course_1,ch_1_01,les_1_01_10,topic_1_01_10_01,quiz_1_01_10_5,What are the six sequential phases of the CAPA workflow?,"A) Identify, Analyze, Plan, Implement, Monitor, Close |
B) Identify problem, Investigate, Plan action, Implement, Verify, Document |
C) Detect issue, Investigate, Correct, Prevent, Verify, Record |
D) Define, Measure, Analyze, Improve, Control, Document",B
course_1,ch_1_02,les_1_02_01,topic_1_02_01_01,quiz_1_02_01_1,What is the primary function of a hospital’s Quality Management System (QMS)?,"A) To schedule staff shifts and ward assignments |
B) To document processes, responsibilities, and procedures for quality care and patient safety |
C) To manage hospital finances and budgets |
D) To market the hospital to new patients",B
course_1,ch_1_02,les_1_02_01,topic_1_02_01_01,quiz_1_02_01_2,Which of the following is a core pillar of a hospital QMS?,"A) Public relations campaigns |
B) Social media engagement |
C) Document Control |
D) Patient transportation services ",C
course_1,ch_1_02,les_1_02_01,topic_1_02_01_01,quiz_1_02_01_3,What should a QA/QC officer do first when entering a ward to ensure compliance with accreditation standards?,"A) Conduct a staff meeting |
B) Reorganize patient charts |
C) Immediately correct staff errors |
D) Check the latest NABH or JCI standards",D
course_1,ch_1_02,les_1_02_01,topic_1_02_01_01,quiz_1_02_01_4,Which of the following is a common fail point in hospital wards that a QA/QC officer should monitor?,"A) Too many patient satisfaction surveys |
B) Outdated SOPs in use |
C) Overstaffing during night shifts |
D) Excessive use of hand sanitizers ",B
course_1,ch_1_02,les_1_02_01,topic_1_02_01_01,quiz_1_02_01_5,"During an NABH audit, a ward is flagged for poor compliance with infection control protocols due to inconsistent hand hygiene during night shifts. As a QA/QC officer, which of the following sequences best represents a comprehensive approach to address this issue, incorporating root cause analysis and corrective actions?","A) Change ward leadership, reduce hand hygiene checks, and focus on other compliance areas |
B) Reprimand night shift staff, update SOPs without analysis, and conduct a single follow-up audit |
C) Identify the issue, analyze root causes, implement automated hand sanitizer sensors linked to EMR, and monitor compliance improvements |
D) Install new hand sanitizers, ignore night shift data, and retrain all staff annually",C
course_1,ch_1_02,les_1_02_02,topic_1_02_02_01,quiz_1_02_02_1,A hospital’s pharmacy fails an NABH audit due to unauthorized SOP edits by a staff member no longer in the QA role. What is the best corrective action to prevent recurrence?,"A) Train all staff on SOP editing |
B) Allow photocopies of SOPs |
C) Implement role-based access controls and audit access logs regularly |
D) Delete all digital SOPs  and create a new SOPs",C
course_1,ch_1_02,les_1_02_02,topic_1_02_02_01,quiz_1_02_02_2,What triggers the initiation of a new SOP in a hospital?,"A) Routine staff promotions |
B) An incident or new regulation |
C) Patient feedback surveys |
D) Annual budget reviews ",B
course_1,ch_1_02,les_1_02_02,topic_1_02_02_01,quiz_1_02_02_3,Who is typically responsible for approving a hospital SOP?,"A) Ward nurses |
B) External consultants |
C) QA Head or Medical Director |
D) IT department",C
course_1,ch_1_02,les_1_02_02,topic_1_02_02_01,quiz_1_02_02_4,Why is an access log critical for SOP control?,"A) To track staff vacation days |
B) To monitor who accessed SOPs and why |
C) To record patient admissions |
D) To schedule training sessions",B
course_1,ch_1_02,les_1_02_02,topic_1_02_02_01,quiz_1_02_02_5,What happens if a staff member’s role changes in a hospital?,"A) They retain all previous SOP access |
B) Their access authority is automatically revoked |
C) They gain override authority |
D) Their access level adjusts to their new role ",D
course_1,ch_1_02,les_1_02_03,topic_1_02_03_01,quiz_1_02_03_1,What is the primary role of Patient Safety Indicators (PSIs) in a hospital?,"A) To track staff attendance |
B) To monitor complications and adverse events |
C) To manage hospital budgets |
D) To schedule patient appointments ",B
course_1,ch_1_02,les_1_02_03,topic_1_02_03_01,quiz_1_02_03_2,Which of the following is a core PSI monitored in hospitals?,"A) Patient satisfaction scores |
B) Central Line-Associated Bloodstream Infection (CLABSI) |
C) Staff training hours |
D) Equipment maintenance costs ",B
course_1,ch_1_02,les_1_02_03,topic_1_02_03_01,quiz_1_02_03_3,"A hospital’s ICU shows a spike in CAUTI cases due to inconsistent catheter care. As a QA/QC officer, which approach best addresses this issue using PSI monitoring and risk flagging?","A) Ignore the spike and focus on other PSIs |
B) Retrain all staff without tracking compliance |
C) Implement digital catheter care logs with nurse ID tracking and monitor PSI trends |
D) Remove all catheters from ICU ",C
course_1,ch_1_02,les_1_02_03,topic_1_02_03_01,quiz_1_02_03_4,What should a QA/QC officer do if a PSI crosses a safety threshold?,"A) Ignore it until the next audit |
B) Update patient charts |
C) Trigger a Corrective and Preventive Action |
D) Reorganize ward supplies ",C
course_1,ch_1_02,les_1_02_03,topic_1_02_03_01,quiz_1_02_03_5,What is a key method for risk flagging in a hospital ward?,"A) Scheduling staff meetings |
B) Using bedside signs like “Fall Risk” tags |
C) Updating hospital brochures |
D) Tracking visitor logs ",B
course_1,ch_1_02,les_1_02_04,topic_1_02_04_01,quiz_1_02_04_1,What qualifies as an incident in a hospital QA/QC context?,"A) Routine staff scheduling |
B) Unexpected events causing or risking harm |
C) Patient feedback surveys |
D) Planned equipment upgrades ",B
course_1,ch_1_02,les_1_02_04,topic_1_02_04_01,quiz_1_02_04_2,"A surgical ward reports a near-miss incident where a wrong medication was nearly administered due to a labeling error. As a QA/QC officer, which escalation and corrective action pathway best ensures compliance and prevention?","A) Escalate to department head, update SOPs, and retrain staff |
B) Escalate to QA head, revise labeling protocol, and monitor compliance |
C) Escalate to ward nurse, redesign medication labels, and audit logs |
D) Escalate to Medical Director, implement digital alerts, and track recurrence",B
course_1,ch_1_02,les_1_02_04,topic_1_02_04_01,quiz_1_02_04_3,What is the first step in the incident reporting lifecycle?,"A) Conduct root cause analysis |
B) Make the area safe and start documenting |
C) File a closure report |
D) Train staff on new SOPs ",B
course_1,ch_1_02,les_1_02_04,topic_1_02_04_01,quiz_1_02_04_4,Who should be contacted first for a low-severity incident?,"A) Hospital CEO |
B) Ward nurse or department head |
C) Legal team |
D) External auditors",B
course_1,ch_1_02,les_1_02_04,topic_1_02_04_01,quiz_1_02_04_5,What is a common failure point in incident reporting?,"A) Excessive staff training |
B) Delayed reporting  |
C) Overuse of digital forms |
D) frequent audits",B
course_1,ch_1_02,les_1_02_05,topic_1_02_05_01,quiz_1_02_05_1,Which of the following best describes the core learning objective of this module?,"A) To focus solely on administrative tasks in QAQC |
B) To master the IPC framework, explain protocols, apply isolation measures, and audit ward readiness |
C) To train on financial compliance only |
D) To review general hospital housekeeping routines",B
course_1,ch_1_02,les_1_02_05,topic_1_02_05_01,quiz_1_02_05_2,"According to the module, what is a key reason infection control is crucial in QAQC?","A) To improve staff morale through cleaning schedules |
B) To prevent HAIs, avoid NABH/JCI/WHO penalties, and maintain patient trust |
C) To reduce equipment costs via waste recycling |
D) To schedule routine maintenance without disruptions",B
course_1,ch_1_02,les_1_02_05,topic_1_02_05_01,quiz_1_02_05_3,Which standard precaution involves following the WHO’s 5 Moments and is essential for all patients?,"A) Hand Hygiene |
B) Sharps Safety |
C) Airborne Precautions |
D) Waste Segregation",A
course_1,ch_1_02,les_1_02_05,topic_1_02_05_01,quiz_1_02_05_4,What is a frequent infection control failure point in hospitals?,"A) Missing PPE usage logs |
B) Incomplete waste segregation logs |
C) Inconsistent hand hygiene logs |
D) Unverified isolation room logs",B
course_1,ch_1_02,les_1_02_05,topic_1_02_05_01,quiz_1_02_05_5,What is one of the five steps in the QAQC officer’s field protocol for IPC oversight?,"A) Schedule annual vacations for staff |
B) Update hospital website content |
C) Review patient meal plans |
D) Conduct at least two unannounced IPC audits per month ",D
course_1,ch_1_02,les_1_02_06,topic_1_02_06_01,quiz_1_02_06_1,Which of the following best describes the core learning objective of this module?,"A) To focus on general hospital financial audits and budgeting |
B) To train on patient admission procedures and bed allocation |
C) To review equipment maintenance schedules and vendor contracts |
D) To master EMR/EHR security, detect breaches, and audit access logs for compliance",D
course_1,ch_1_02,les_1_02_06,topic_1_02_06_01,quiz_1_02_06_2,"According to the module, what is a primary consequence of an EMR/EHR data breach in a hospital?","A) Enhanced marketing opportunities via patient data sharing |
B) Simplified inventory tracking for medical supplies |
C) Loss of accreditation from NABH/JCI and legal penalties under HIPAA/PDPB/GDPR |
D) Improved staff efficiency through faster data entry",C
course_1,ch_1_02,les_1_02_06,topic_1_02_06_01,quiz_1_02_06_3,Which ALCOA+ principle ensures that data is recorded at the time of the activity and remains readable?,"A) Original and Available |
B) Accurate and Consistent |
C) Attributable and Enduring |
D) Legible and Contemporaneous",D
course_1,ch_1_02,les_1_02_06,topic_1_02_06_01,quiz_1_02_06_4,What is the key difference in scope between EMR and EHR as outlined in the comparison table?,"A) EMR focuses on billing records only, while EHR includes clinical notes exclusively |
B) EMR requires external provider access, while EHR limits it to internal staff |
C) EMR is shared across multiple facilities for coordinated care |
D) EMR is facility-specific like a hospital's internal chart, while EHR enables broader sharing",D
course_1,ch_1_02,les_1_02_06,topic_1_02_06_01,quiz_1_02_06_5,"In the QAQC officer’s field protocol, what is a required weekly task for maintaining EMR/EHR security?","A) Schedule routine staff performance evaluations |
B) Update hospital marketing brochures and flyers |
C) Review patient meal preferences and dietary logs |
D) Audit EMR/EHR access logs for unauthorized activity",D
course_1,ch_1_02,les_1_02_07,topic_1_02_07_01,quiz_1_02_07_1,"During a compliance sweep, a ward is found with expired drugs in a crash cart and missing sterilization logs. As a QA/QC officer, which approach best addresses these issues to ensure compliance and patient safety?","A) Remove expired drugs, update sterilization SOPs, and audit logs regularly |
B) Replace crash cart drugs, revise sterilization protocols, and monitor weekly |
C) Discard expired drugs, train staff on sterilization, and check logs monthly |
D) Eliminate expired drugs, implement sterilization log checks, and retrain staff",A
course_1,ch_1_02,les_1_02_07,topic_1_02_07_01,quiz_1_02_07_2,What defines a critical non-compliance issue in a ward?,"A) Direct risk to patient safety, like expired drugs in crash cart |
B) Missing signage on doors |
C) Incomplete staff training records |
D) Uncalibrated non-critical equipment",A
course_1,ch_1_02,les_1_02_07,topic_1_02_07_01,quiz_1_02_07_3,How must biomedical waste be handled in a hospital?,"A) Transported in puncture-proof, closed containers without spillage |
B) Disposed along with municipal/general waste after basic disinfection |
C) Segregated at the point of generation into designated color-coded containers |
D) Stored temporarily in utility rooms without proper labeling until collection",A
course_1,ch_1_02,les_1_02_07,topic_1_02_07_01,quiz_1_02_07_4,Which practice is essential for maintaining ward hygiene and preventing healthcare-associated infections?,"A) Routine use of non-sterile equipment if visibly clean |
B) Disinfection of high-touch surfaces only during outbreak situations |
C) Scheduled cleaning and disinfection of critical areas with strict adherence to PPE protocols |
D) Skipping sterilization records provided disinfection is visibly adequate",C
course_1,ch_1_02,les_1_02_07,topic_1_02_07_01,quiz_1_02_07_5,What is the primary goal of a hospital compliance sweep?,"A) Check that wards and facilities meet hygiene and regulatory standards |
B) Evaluate staff performance and appraisals |
C) Revise patient care and treatment protocols |
D) Review hospital budgeting and financial planning",A
course_1,ch_1_02,les_1_02_08,topic_1_02_08_01,quiz_1_02_08_1,What is QA/QC’s primary role within the first 3 minutes of a Code Blue emergency?,"A) Lead the medical team response |
B) Document patient outcomes |
C) Confirm emergency protocol initiation |
D) Conduct root cause analysis",C
course_1,ch_1_02,les_1_02_08,topic_1_02_08_01,quiz_1_02_08_2,What must QA/QC verify before an emergency to ensure readiness?,"A) Patient admission records |
B) Emergency cart and staff training compliance |
C) Staff vacation schedules |
D) Hospital marketing plans",C
course_1,ch_1_02,les_1_02_08,topic_1_02_08_01,quiz_1_02_08_3,Which action is part of the post-incident phase in an emergency response?,"A) Deploy initial response team |
B) Conduct root cause analysis |
C) Initiate alarm systems |
D) Stabilize patient conditions",B
course_1,ch_1_02,les_1_02_08,topic_1_02_08_01,quiz_1_02_08_4,What is a key QA/QC practice for emergency preparedness?,"A) Train staff on non-emergency tasks |
B) Monitor visitor logs weekly |
C) Audit alarm systems monthly |
D) Update patient charts daily",C
course_1,ch_1_02,les_1_02_08,topic_1_02_08_01,quiz_1_02_08_5,"During a biohazard spill, a hospital’s isolation measures fail due to improper PPE usage. As a QA/QC officer, which approach best ensures compliance and prevents recurrence?","A) Revise PPE protocols and audit compliance post-incident |
B) Conduct PPE spot checks during drills and enforce compliance protocols |
C) Implement PPE training sessions and monitor usage during emergencies |
D) Mandate PPE checks and document adherence after each drill",C
course_1,ch_1_02,les_1_02_09,topic_1_02_09_01,quiz_1_02_09_1,What is a primary goal of QA/QC in multi-department coordination?,"A) Align departments to shared compliance goals |
B) Focus only on high-risk departments |
C) Ensure department-specific SOPs are independent |
D) Limit inter-department communication",A
course_1,ch_1_02,les_1_02_09,topic_1_02_09_01,quiz_1_02_09_2,What is the first step in the multi-department QA/QC coordination process?,"A) Schedule department-specific audits |
B) Conduct root cause analysis for incidents |
C) Centralize all SOPs without mapping |
D) Map departments and their QA focal points",D
course_1,ch_1_02,les_1_02_09,topic_1_02_09_01,quiz_1_02_09_3,Which tool supports effective multi-department QA/QC coordination?,"A) Non-standardized department reports |
B) Manual incident logs without integration |
C) Centralized QA/QC dashboard for data integration |
D) Department-isolated audit checklists",C
course_1,ch_1_02,les_1_02_09,topic_1_02_09_01,quiz_1_02_09_4,What is a common pitfall in multi-department QA/QC coordination?,"A) Excessive inter-department shadowing |
B) Overuse of cross-department audits |
C) Departments hiding errors to avoid blame |
D) Over-centralized SOP versions",C
course_1,ch_1_02,les_1_02_09,topic_1_02_09_01,quiz_1_02_09_5,"A pharmacy mislabeling error leads to a medication error in the ICU. As a QA/QC officer, which approach best ensures coordinated resolution and prevents recurrence across departments?","A) Perform RCA with pharmacy only, update SOPs, and track via department logs |
B) Implement cross-department training, revise protocols, and monitor with weekly audits |
C) Lead multi-team huddle with ICU and pharmacy, align SOPs, and audit compliance |
D) Conduct joint RCA with pharmacy and ICU, revise SOPs, and monitor via QA dashboard",D
course_1,ch_1_02,les_1_02_10,topic_1_02_10_01,quiz_1_02_10_1,What is the primary purpose of a QA/QC Command Debrief?,"A) Review non-conformities, verify root causes, and redesign processes |
B) Conduct informal staff meetings |
C) Update patient records |
D) Discuss hospital budgets",A
course_1,ch_1_02,les_1_02_10,topic_1_02_10_01,quiz_1_02_10_2,What is a key element of the findings review in a Command Debrief?,"A) Reviewing hospital marketing plans |
B) Ignoring frontline staff feedback |
C) Categorizing deviations and incidents |
D) Accepting verbal reports without data",C
course_1,ch_1_02,les_1_02_10,topic_1_02_10_01,quiz_1_02_10_3,What is the first step in the strategy redesign process?,"A) Consolidate findings by category |
B) Test new designs hospital-wide |
C) Define KPIs without stakeholder input |
D) Prioritize low-risk issues",A
course_1,ch_1_02,les_1_02_10,topic_1_02_10_01,quiz_1_02_10_4,Which tool helps track improvements after a Command Debrief?,"A) Patient satisfaction surveys  tracker |
B) Staff training schedules  tracker |
C) Corrective and preventive actions  tracker |
D) General meeting minutes  tracker",C
course_1,ch_1_02,les_1_02_10,topic_1_02_10_01,quiz_1_02_10_5,"An ICU oxygen supply interruption occurs due to a faulty regulator. As a QA/QC officer, which redesign strategy best addresses this issue and ensures long-term prevention?","A) Update SOPs with daily regulator checks, install pressure alarms, and cross-train staff |
B) Revise SOPs for weekly regulator checks, add alarms, and train only technicians |
C) Implement daily regulator checks, use manual overrides, and train nursing staff |
D) Install pressure alarms, update SOPs for monthly checks, and retrain all staff",A
course_1,ch_1_03,les_1_03_01,topic_1_03_01_01,quiz_1_03_01_1,What is the primary purpose of Good Manufacturing Practices (GMP) in pharmaceutical production?,"A) To reduce production costs by streamlining processes |
B) To ensure products are safe, pure, and effective |
C) To speed up the manufacturing process for faster delivery |
D) To allow flexibility in production without regulatory oversight",B
course_1,ch_1_03,les_1_03_01,topic_1_03_01_01,quiz_1_03_01_2,Which historical event significantly influenced the development of GMP regulations?,"A) The introduction of biologics in the 1980s |
B) The 1938 sulfathiazole disaster |
C) The 1963 WHO global health initiative |
D) The establishment of the USFDA in 1906",B
course_1,ch_1_03,les_1_03_01,topic_1_03_01_01,quiz_1_03_01_3,Which of the following is NOT one of the five pillars of GMP?,"A) Procedures |
B) Premises |
C) Profits |
D) People",C
course_1,ch_1_03,les_1_03_01,topic_1_03_01_01,quiz_1_03_01_4,What is a key requirement of GMP to prevent contamination in manufacturing?,"A) Reducing the number of staff in the facility |
B) Environmental monitoring and equipment validation |
C) Using unvalidated processes for flexibility |
D) Limiting documentation to simplify audits",B
course_1,ch_1_03,les_1_03_01,topic_1_03_01_01,quiz_1_03_01_5,Why is documentation critical in GMP compliance?,"A) It reduces the need for staff training |
B) It ensures processes are auditable and traceable |
C) It allows manufacturers to skip quality control |
D) It is only required for non-regulated products",B
course_1,ch_1_03,les_1_03_02,topic_1_03_02_01,quiz_1_03_02_1,What is the primary function of a cleanroom in pharmaceutical manufacturing?,"A) To speed up production processes |
B) To maintain low levels of contaminants like dust and microbes |
C) To store raw materials for easy access |
D) To reduce the need for quality control testing",B
course_1,ch_1_03,les_1_03_02,topic_1_03_02_01,quiz_1_03_02_2,Which ISO cleanroom classification is typically used for sterile processes like injectable drug production?,"A) ISO 8 |
B) ISO 7 |
C) ISO 5 |
D) ISO 9",C
course_1,ch_1_03,les_1_03_02,topic_1_03_02_01,quiz_1_03_02_3,What role do HEPA filters play in cleanroom environmental controls?,"A) They regulate temperature to prevent microbial growth |
B) They remove 99.97% of particles ≥0.3 μm from the air |
C) They create negative pressure to pull in clean air |
D) They monitor particle counts in real-time",B
course_1,ch_1_03,les_1_03_02,topic_1_03_02_01,quiz_1_03_02_4,Why might a cleanroom fail a GMP audit?,"A) Using laminar airflow to sweep contaminants away |
B) Maintaining positive pressure in cleaner areas |
C) Exceeding particle count limits due to a clogged HEPA filter |
D) Keeping humidity levels between 40-60%",C
course_1,ch_1_03,les_1_03_02,topic_1_03_02_01,quiz_1_03_02_5,What is the purpose of positive pressure differentials in a cleanroom?,"A) To increase humidity for better product stability |
B) To prevent dirty air from entering cleaner areas |
C) To reduce the need for regular maintenance |
D) To allow higher particle counts in sterile zones",B
course_1,ch_1_03,les_1_03_03,topic_1_03_03_01,quiz_1_03_03_1,What is the primary role of personnel in ensuring GMP compliance?,"A) To operate machinery without training to speed up production |
B) To follow strict protocols to prevent human-borne contamination |
C) To handle raw materials without hygiene checks |
D) To reduce documentation for faster audits",B
course_1,ch_1_03,les_1_03_03,topic_1_03_03_01,quiz_1_03_03_2,"In an ISO 5 cleanroom, why are sterile gloves donned last in the gowning sequence?","A) To allow workers to touch non-sterile surfaces |
B) To simplify the gowning process for speed |
C) To avoid contamination from touching non-sterile surfaces |
D) To reduce the need for handwashing",C
course_1,ch_1_03,les_1_03_03,topic_1_03_03_01,quiz_1_03_03_3,Which hygiene practice is explicitly prohibited in GMP production areas to minimize contamination?,"A) Wearing sterile gloves during production |
B) Using specific soaps for handwashing |
C) Conducting regular health screenings |
D) Wearing cosmetics or nail polish",D
course_1,ch_1_03,les_1_03_03,topic_1_03_03_01,quiz_1_03_03_4,How do physical barriers help prevent cross-contamination in pharmaceutical manufacturing?,"A) They allow shared equipment between batches |
B) They separate products using dedicated cleanrooms or airlocks |
C) They reduce the need for personnel training |
D) They permit mixing of raw materials for efficiency",B
course_1,ch_1_03,les_1_03_03,topic_1_03_03_01,quiz_1_03_03_5,What is a common consequence of improper gowning in a cleanroom?,"A) Improved product quality due to flexibility |
B) Faster production cycles |
C) Introduction of contaminants like microbes or skin cells |
D) Reduced need for airlock systems",C
course_1,ch_1_03,les_1_03_04,topic_1_03_04_01,quiz_1_03_04_1,What is the main purpose of controlled documentation in GMP compliance?,"A) To reduce the need for quality control testing |
B) To ensure traceability and verify manufacturing processes |
C) To allow flexibility in production without oversight |
D) To simplify audits by minimizing record-keeping",B
course_1,ch_1_03,les_1_03_04,topic_1_03_04_01,quiz_1_03_04_2,What must be done when correcting an error in a batch record?,"A) Erase the mistake completely to maintain clarity |
B) Ignore the error to avoid audit complications |
C) Use a single line-through, initial, and date the correction |
D) Rewrite the entire record to ensure accuracy",C
course_1,ch_1_03,les_1_03_04,topic_1_03_04_01,quiz_1_03_04_3,What is the role of logbooks in a GMP-compliant facility?,"A) To reduce documentation for faster production |
B) To store raw materials securely |
C) To track equipment use, cleaning, and environmental conditions |
D) To replace batch records during audits",C
course_1,ch_1_03,les_1_03_04,topic_1_03_04_01,quiz_1_03_04_4,Why might a pharma company fail an audit due to document control issues?,"A) Using real-time documentation for batch records |
B) Archiving obsolete SOP versions properly |
C) Maintaining secure electronic document systems |
D) Using an outdated SOP leading to incorrect processing",D
course_1,ch_1_03,les_1_03_04,topic_1_03_04_01,quiz_1_03_04_5,What is a key feature of batch records to ensure GMP compliance?,"A) They are completed after production to save time |
B) They document every step of a product batch in real-time |
C) They exclude quality control test results |
D) They allow unsigned entries for flexibility",B
course_1,ch_1_03,les_1_03_05,topic_1_03_05_01,quiz_1_03_05_1,Why is raw material gatekeeping critical in GMP-compliant pharmaceutical production?,"A) To reduce production costs by using untested materials |
B) To ensure raw materials meet quality standards for safe drugs |
C) To speed up manufacturing by skipping supplier audits |
D) To allow storage without controlled conditions",B
course_1,ch_1_03,les_1_03_05,topic_1_03_05_01,quiz_1_03_05_2,What is a key requirement for sampling raw materials under GMP standards?,"A) Testing all containers in a shipment for accuracy |
B) Using non-sterile tools to simplify the process |
C) Following statistically valid sampling plans like square root of N+1 |
D) Conducting sampling outside cleanrooms to save time",C
course_1,ch_1_03,les_1_03_05,topic_1_03_05_01,quiz_1_03_05_3,What is the purpose of storing raw materials in quarantine before approval?,"A) To mix them with approved materials for efficiency |
B) To allow degradation testing under uncontrolled conditions |
C) To prevent use until quality is verified |
D) To reduce the need for supplier qualification",C
course_1,ch_1_03,les_1_03_05,topic_1_03_05_01,quiz_1_03_05_4,Why might a supplier be rejected during qualification for GMP compliance?,"A) Providing materials with clear labeling |
B) Maintaining detailed quality agreements |
C) Having reliable third-party certifications |
D) Poor documentation found during an audit",D
course_1,ch_1_03,les_1_03_05,topic_1_03_05_01,quiz_1_03_05_5,"What can happen if raw materials are stored improperly, such as above specified temperatures?","A) Improved material stability for longer shelf life |
B) Degradation leading to formulation failures |
C) Reduced need for environmental monitoring |
D) Faster approval during GMP audits",B
course_1,ch_1_03,les_1_03_06,topic_1_03_06_01,quiz_1_03_06_1,What is the purpose of equipment validation in GMP-compliant pharmaceutical production?,"A) To reduce equipment costs by skipping maintenance |
B) To prove machines consistently deliver expected results |
C) To allow uncalibrated equipment for faster production |
D) To simplify audits by minimizing documentation",B
course_1,ch_1_03,les_1_03_06,topic_1_03_06_01,quiz_1_03_06_2,Which step of equipment validation confirms that a machine operates as intended?,"A) Performance Qualification (PQ) |
B) Cleaning Validation |
C) Installation Qualification (IQ) |
D) Operational Qualification (OQ)",D
course_1,ch_1_03,les_1_03_06,topic_1_03_06_01,quiz_1_03_06_3,What is the primary goal of cleaning validation for pharmaceutical equipment?,"A) To reduce cleaning frequency between batches |
B) To confirm no residues remain after cleaning |
C) To allow shared equipment without SOPs |
D) To replace preventive maintenance cycles",B
course_1,ch_1_03,les_1_03_06,topic_1_03_06_01,quiz_1_03_06_4,Why might a facility fail a GMP audit related to equipment management?,"A) Maintaining smooth, non-reactive equipment surfaces |
B) Logging all cleaning and maintenance activities |
C) Completing IQ, OQ, and PQ for new equipment |
D) Using a rusted machine part that contaminates a batch",D
course_1,ch_1_03,les_1_03_06,topic_1_03_06_01,quiz_1_03_06_5,How does regular calibration of equipment contribute to GMP compliance?,"A) It reduces the need for cleaning validation |
B) It ensures accurate measurements like temperature or pressure |
C) It allows unlogged repairs for flexibility |
D) It eliminates the need for preventive maintenance",B
course_1,ch_1_03,les_1_03_07,topic_1_03_07_01,quiz_1_03_07_1,What is the primary goal of process validation in GMP-compliant manufacturing?,"A) To reduce production time by simplifying processes |
B) To ensure processes consistently produce quality products |
C) To eliminate the need for change control systems |
D) To allow untested processes for flexibility",B
course_1,ch_1_03,les_1_03_07,topic_1_03_07_01,quiz_1_03_07_2,Which stage of process validation involves testing the process under real production conditions?,"A) Continued Process Verification |
B) Process Design |
C) Process Qualification |
D) Change Control",C
course_1,ch_1_03,les_1_03_07,topic_1_03_07_01,quiz_1_03_07_3,What is a key requirement of a GMP-compliant change control system?,"A) Allowing changes without documentation for efficiency |
B) Conducting risk assessments and documenting all changes |
C) Bypassing validation for minor process tweaks |
D) Avoiding audits to speed up production",B
course_1,ch_1_03,les_1_03_07,topic_1_03_07_01,quiz_1_03_07_4,Why might a pharmaceutical company face a product recall due to process changes?,"A) Implementing a validated process change |
B) Maintaining detailed change control logs |
C) Conducting thorough risk assessments |
D) Making an unapproved process change",D
course_1,ch_1_03,les_1_03_07,topic_1_03_07_01,quiz_1_03_07_5,What is the purpose of Continued Process Verification in process validation?,"A) To develop the initial process design |
B) To monitor ongoing production for consistency |
C) To replace change control systems |
D) To skip process qualification for efficiency",B
course_1,ch_1_03,les_1_03_08,topic_1_03_08_01,quiz_1_03_08_1,What is the primary purpose of in-process controls in pharmaceutical manufacturing?,"A) To reduce production time by skipping quality checks |
B) To monitor critical quality parameters during production |
C) To replace batch release protocols |
D) To allow deviations without investigation",B
course_1,ch_1_03,les_1_03_08,topic_1_03_08_01,quiz_1_03_08_2,Which type of in-process control is used to verify the correct dose in a vaccine filling line?,"A) Environmental monitoring |
B) Chemical assay |
C) Physical check |
D) Packaging inspection",C
course_1,ch_1_03,les_1_03_08,topic_1_03_08_01,quiz_1_03_08_3,What is a key requirement for batch release under GMP standards?,"A) Skipping final product testing for faster release |
B) Reviewing complete batch records and test results |
C) Releasing batches without QP approval |
D) Ignoring out-of-specification results",B
course_1,ch_1_03,les_1_03_08,topic_1_03_08_01,quiz_1_03_08_4,Why might a batch of injectables be rejected during the batch release process?,"A) Complete documentation and passing sterility tests |
B) Thorough QP review and approval |
C) Meeting all critical quality attributes |
D) Incomplete documentation found by the QP",D
course_1,ch_1_03,les_1_03_08,topic_1_03_08_01,quiz_1_03_08_5,What happens if out-of-specification (OOS) results are ignored during in-process controls?,"A) Improved batch consistency |
B) Potential release of defective products |
C) Reduced need for batch release checks |
D) Faster audit approvals",B
course_1,ch_1_03,les_1_03_09,topic_1_03_09_01,quiz_1_03_09_1,"What is the primary purpose of GMP codes across WHO, USFDA, EU, and Indian regulations?","A) To reduce manufacturing costs for faster production |
B) To ensure pharmaceutical products are safe and effective |
C) To eliminate the need for regulatory audits |
D) To allow flexibility without documentation",B
course_1,ch_1_03,les_1_03_09,topic_1_03_09_01,quiz_1_03_09_2,Which GMP standard is specifically designed as a global baseline for developing countries?,"A) EU GMP (EudraLex Vol. 4) |
B) USFDA GMP (21 CFR Part 211) |
C) Indian GMP (Schedule M) |
D) WHO GMP",D
course_1,ch_1_03,les_1_03_09,topic_1_03_09_01,quiz_1_03_09_3,What is a key focus of USFDA GMP (21 CFR Part 211) compared to other GMP codes?,"A) Flexible cleanroom standards |
B) Data integrity and detailed documentation |
C) Local manufacturing adaptations |
D) Minimal regulatory inspections",B
course_1,ch_1_03,les_1_03_09,topic_1_03_09_01,quiz_1_03_09_4,Why might a company exporting to the EU face compliance issues if only following Indian GMP?,"A) Indian GMP has stricter cleanroom standards |
B) EU GMP requires less documentation |
C) EU GMP demands stricter requirements like QP oversight |
D) Indian GMP bans exports to the EU",C
course_1,ch_1_03,les_1_03_09,topic_1_03_09_01,quiz_1_03_09_5,What is a common reason for penalties during a USFDA GMP audit?,"A) Using WHO-aligned cleanroom standards |
B) Poor data integrity in documentation |
C) Implementing risk-based approaches |
D) Conducting frequent inspections",B
course_1,ch_1_03,les_1_03_10,topic_1_03_10_01,quiz_1_03_10_1,What is the primary goal of a GMP compliance simulation in a production floor setting?,"A) To reduce production costs by skipping validation |
B) To test adherence to GMP principles across all stages |
C) To eliminate the need for regulatory audits |
D) To simplify documentation for faster batch release",B
course_1,ch_1_03,les_1_03_10,topic_1_03_10_01,quiz_1_03_10_2,Which GMP element from Module 3 ensures that raw materials are verified before use in the simulation?,"A) Batch release protocols |
B) Equipment maintenance cycles |
C) Process validation |
D) Raw material sampling and storage",D
course_1,ch_1_03,les_1_03_10,topic_1_03_10_01,quiz_1_03_10_3,"How should a deviation, such as an incomplete batch record, be handled during a GMP war game?","A) Ignore it to maintain production speed |
B) Perform a root cause analysis and implement CAPA |
C) Skip documentation to avoid audit scrutiny |
D) Retrain staff without investigating the issue",B
course_1,ch_1_03,les_1_03_10,topic_1_03_10_01,quiz_1_03_10_4,Why might a facility fail a mock EU GMP audit in the simulation?,"A) Maintaining ISO 5 cleanroom standards |
B) Completing all in-process controls accurately |
C) Following proper gowning protocols |
D) Missing records in the change control log",D
course_1,ch_1_03,les_1_03_10,topic_1_03_10_01,quiz_1_03_10_5,What is a key factor for success in a GMP compliance simulation?,"A) Focusing only on batch release to save time |
B) Coordinating across departments to integrate all GMP elements |
C) Avoiding deviations by skipping in-process controls |
D) Using unvalidated equipment for flexibility",B
course_1,ch_1_04,les_1_04_01,topic_1_04_01_01,quiz_1_04_01_1,What is the primary purpose of Standard Operating Procedures (SOPs) in GMP compliance?,"A) To allow flexibility in manufacturing processes |
B) To standardize processes for consistency and quality |
C) To reduce the need for regulatory audits |
D) To simplify documentation by omitting details",B
course_1,ch_1_04,les_1_04_01,topic_1_04_01_01,quiz_1_04_01_2,Which section of an SOP defines what the procedure covers and excludes?,"A) Procedure |
B) References |
C) Scope |
D) Title",C
course_1,ch_1_04,les_1_04_01,topic_1_04_01_01,quiz_1_04_01_3,Why might a facility face penalties during a USFDA audit related to SOPs?,"A) Using clear, approved SOPs for all processes |
B) Missing an SOP for a critical process like change control |
C) Training staff on SOP implementation |
D) Maintaining version-controlled SOPs",B
course_1,ch_1_04,les_1_04_01,topic_1_04_01_01,quiz_1_04_01_4,What is a key regulatory mandate for SOPs under GMP standards?,"A) SOPs can be informal to allow operator flexibility |
B) SOPs must be approved, version-controlled, and accessible |
C) SOPs are optional for non-critical processes |
D) SOPs should avoid detailed procedures for simplicity",B
course_1,ch_1_04,les_1_04_01,topic_1_04_01_01,quiz_1_04_01_5,What is a common risk of poorly designed SOPs in a GMP environment?,"A) Improved process consistency across batches |
B) Inconsistent processes leading to audit failures |
C) Reduced need for staff training |
D) Faster regulatory approvals",B
course_1,ch_1_04,les_1_04_02,topic_1_04_02_01,quiz_1_04_02_1,Why is clarity critical in writing SOPs for GMP compliance?,"A) To allow operators to interpret steps freely |
B) To ensure all personnel can follow instructions without confusion |
C) To reduce the need for detailed documentation |
D) To simplify audits by using vague language",B
course_1,ch_1_04,les_1_04_02,topic_1_04_02_01,quiz_1_04_02_2,What does precision in SOP writing involve?,"A) Using vague terms like “some” for flexibility |
B) Providing exact details like measurements and times |
C) Avoiding active voice to simplify instructions |
D) Omitting decision points for brevity",B
course_1,ch_1_04,les_1_04_02,topic_1_04_02_01,quiz_1_04_02_3,How do zero-ambiguity rules help prevent errors in SOP execution?,"A) By allowing vague terms like “adequate” |
B) By using complex sentences for detail |
C) By defining terms and including decision points |
D) By excluding step-by-step instructions",C
course_1,ch_1_04,les_1_04_02,topic_1_04_02_01,quiz_1_04_02_4,Why might an SOP lead to an EU GMP audit failure?,"A) Including clear cleaning validation steps |
B) Lacking clear instructions for critical processes |
C) Using numbered steps for clarity |
D) Being approved by quality assurance",B
course_1,ch_1_04,les_1_04_02,topic_1_04_02_01,quiz_1_04_02_5,What is a recommended practice to ensure an SOP is clear and effective?,"A) Use jargon to keep instructions concise |
B) Test the SOP with a new employee for clarity |
C) Avoid visuals like diagrams to save space |
D) Use vague terms to allow flexibility",B
course_1,ch_1_04,les_1_04_03,topic_1_04_03_01,quiz_1_04_03_1,What is the primary purpose of version control in managing SOPs for GMP compliance?,"A) To allow multiple SOP versions to be used simultaneously |
B) To ensure only the latest, approved SOP version is used |
C) To reduce the need for change logs |
D) To simplify audits by skipping approvals",B
course_1,ch_1_04,les_1_04_03,topic_1_04_03_01,quiz_1_04_03_2,When are SOP review cycles typically conducted to maintain GMP compliance?,"A) Only when a new regulation is introduced |
B) After every batch production |
C) Annually or after process changes |
D) During equipment maintenance",C
course_1,ch_1_04,les_1_04_03,topic_1_04_03_01,quiz_1_04_03_3,What is a key function of a change log in SOP management?,"A) To replace the need for version control |
B) To document all SOP revisions for traceability |
C) To allow unapproved changes for flexibility |
D) To archive current SOP versions",B
course_1,ch_1_04,les_1_04_03,topic_1_04_03_01,quiz_1_04_03_4,Why might a facility face a citation during a GMP audit related to SOP management?,"A) Archiving obsolete SOP versions properly |
B) Using an unapproved SOP version |
C) Maintaining detailed change logs |
D) Conducting regular review cycles",B
course_1,ch_1_04,les_1_04_03,topic_1_04_03_01,quiz_1_04_03_5,What is a recommended practice to ensure audit-readiness for SOPs?,"A) Skip minor changes in the change log |
B) Include all changes, even minor ones, in the change log |
C) Avoid archiving old SOP versions |
D) Use unapproved SOPs for minor processes",B
course_1,ch_1_04,les_1_04_04,topic_1_04_04_01,quiz_1_04_04_1,What is the primary purpose of system validation in GMP-compliant pharmaceutical production?,"A) To reduce equipment maintenance costs |
B) To confirm equipment consistently meets quality standards |
C) To allow untested systems for faster production |
D) To simplify audits by skipping documentation",B
course_1,ch_1_04,les_1_04_04,topic_1_04_04_01,quiz_1_04_04_2,Which validation stage verifies that equipment is installed according to specifications?,"A) Performance Qualification (PQ) |
B) Operational Qualification (OQ) |
C) Installation Qualification (IQ) |
D) System Monitoring",C
course_1,ch_1_04,les_1_04_04,topic_1_04_04_01,quiz_1_04_04_3,What does Operational Qualification (OQ) focus on during equipment validation?,"A) Testing equipment under real-world production conditions |
B) Confirming equipment operates within specified conditions |
C) Verifying installation matches manufacturer guidelines |
D) Ensuring long-term maintenance schedules",B
course_1,ch_1_04,les_1_04_04,topic_1_04_04_01,quiz_1_04_04_4,Why might a facility fail an EU GMP audit related to equipment validation?,"A) Completing detailed IQ, OQ, and PQ reports |
B) Lacking a PQ report for a new autoclave |
C) Conducting real-time validation documentation |
D) Using validated equipment for production",B
course_1,ch_1_04,les_1_04_04,topic_1_04_04_01,quiz_1_04_04_5,What is a key practice to ensure successful Performance Qualification (PQ)?,"A) Skipping OQ to speed up validation |
B) Using production-like conditions to mimic real-world challenges |
C) Avoiding detailed documentation for flexibility |
D) Testing equipment without production materials",B
course_1,ch_1_04,les_1_04_05,topic_1_04_05_01,quiz_1_04_05_1,What is the main objective of cleaning SOPs in GMP-compliant manufacturing?,"A) To reduce cleaning frequency for efficiency |
B) To eliminate residues and prevent cross-contamination |
C) To simplify equipment operation procedures |
D) To bypass validation for faster production",B
course_1,ch_1_04,les_1_04_05,topic_1_04_05_01,quiz_1_04_05_2,What does an equipment SOP typically specify to ensure consistent performance?,"A) Optional calibration schedules for flexibility |
B) Operating parameters and maintenance schedules |
C) Unvalidated startup procedures |
D) Skipping preventive maintenance checks",B
course_1,ch_1_04,les_1_04_05,topic_1_04_05_01,quiz_1_04_05_3,How do safety SOPs contribute to GMP compliance?,"A) By allowing optional PPE use for hazardous materials |
B) By providing protocols for handling hazards and emergencies |
C) By reducing the need for staff training |
D) By ignoring occupational safety regulations",B
course_1,ch_1_04,les_1_04_05,topic_1_04_05_01,quiz_1_04_05_4,Why might a facility face a WHO GMP audit failure related to cleaning SOPs?,"A) Using validated swab testing for residues |
B) Following detailed cleaning procedures |
C) Maintaining auditable cleaning records |
D) Having an incomplete cleaning SOP",D
course_1,ch_1_04,les_1_04_05,topic_1_04_05_01,quiz_1_04_05_5,What is a recommended practice to ensure effective equipment SOPs?,"A) Using complex instructions for detailed execution |
B) Breaking operations into numbered steps for clarity |
C) Avoiding calibration to save time |
D) Skipping validation for non-critical equipment",B
course_1,ch_1_04,les_1_04_06,topic_1_04_06_01,quiz_1_04_06_1,"According to the study material, what is a primary risk associated with untrained staff or poor compliance tracking in a GMP environment?","A) Improved product quality | B) Reduced regulatory penalties | C) Errors, deviations, or audit failures | D) Faster production speeds",C
course_1,ch_1_04,les_1_04_06,topic_1_04_06_01,quiz_1_04_06_2,"In the context of competency records, what specific details must be included to provide audit-ready proof of an employee's capability?","A) Only the employee's hire date | B) Training dates, topics, trainers, and assessment results | C) Just the list of SOPs executed | D) Annual salary reviews",B
course_1,ch_1_04,les_1_04_06,topic_1_04_06_01,quiz_1_04_06_3,What does the example in the material illustrate about compliance tracking?,A) Hiring new operators without checks | B) A supervisor verifying batch record SOP adherence via logbooks to catch missed steps | C) Updating records only during audits | D) Skipping refresher sessions for experienced staff,B
course_1,ch_1_04,les_1_04_06,topic_1_04_06_01,quiz_1_04_06_4,"Based on GMP regulations mentioned, such as USFDA 21 CFR Part 211, what consequence is highlighted for non-compliance like using untrained staff?",A) Automatic approval in inspections | B) Risks of audit failures or product recalls | C) Decreased need for documentation | D) Simplified training requirements,B
course_1,ch_1_04,les_1_04_06,topic_1_04_06_01,quiz_1_04_06_5,The training flowchart in the visual aid starts with hiring an employee and ends with which step to maintain a GMP-compliant workforce?,A) Documenting initial assessment only | B) Conducting one-time SOP sessions | C) Ongoing refresher training followed by updating records | D) Monitoring deviations without corrections,C
course_1,ch_1_04,les_1_04_07,topic_1_04_07_01,quiz_1_04_07_1,What characterizes an SOP deviation as per the study material?,"A) A routine update to GMP protocols |
B) Any departure from an SOP risking product quality |
C) An intentional change to improve efficiency |
D) A minor correction with no GMP impact ",B
course_1,ch_1_04,les_1_04_07,topic_1_04_07_01,quiz_1_04_07_2,What is a critical step in the deviation handling process after spotting a deviation?,"A) Halt production immediately for all issues |
B) Conduct root cause analysis to identify causes |
C) Skip documentation to speed up resolution |
D) Retrain entire staff for every deviation",B
course_1,ch_1_04,les_1_04_07,topic_1_04_07_01,quiz_1_04_07_3,How are major deviations managed according to the escalation models?,"A) Handled solely by operators without escalation |
B) Reported to QA for thorough investigation |
C) Ignored if product quality remains unaffected |
D) Logged only after an audit identifies them",B
course_1,ch_1_04,les_1_04_07,topic_1_04_07_01,quiz_1_04_07_4,What risk of poor deviation management is emphasized in the material?,"A) Enhanced batch quality and consistency |
B) Potential for product recalls or penalties |
C) Reduced need for detailed CAPA records |
D) Streamlined audit preparation processes",B
course_1,ch_1_04,les_1_04_07,topic_1_04_07_01,quiz_1_04_07_5,Which tool is suggested for effective root cause analysis in deviation handling?,"A) The “5 Whys” method to find root causes |
B) Yearly performance evaluations for staff |
C) Random checks of SOP compliance logs |
D) Simplified checklists for quick updates",A
course_1,ch_1_04,les_1_04_08,topic_1_04_08_01,quiz_1_04_08_1,What is the primary function of eSOP systems as described in the study material?,"A) Replace paper-based SOPs with digital management |
B) Automate product manufacturing processes |
C) Conduct employee performance reviews |
D) Generate audit reports without user input",A
course_1,ch_1_04,les_1_04_08,topic_1_04_08_01,quiz_1_04_08_2,What role in the access hierarchy is restricted to read-only access to eSOPs?,"A) Editor for updating SOP content |
B) Viewer for accessing SOPs for tasks |
C) Approver for authorizing SOP revisions |
D) Administrator for system maintenance",B
course_1,ch_1_04,les_1_04_08,topic_1_04_08_01,quiz_1_04_08_3,What is a key requirement of 21 CFR Part 11 for eSOP systems?,"A) Allow unrestricted access to all users |
B) Ensure electronic records are secure and traceable |
C) Eliminate the need for paper backups |
D) Simplify SOP content for faster approvals",B
course_1,ch_1_04,les_1_04_08,topic_1_04_08_01,quiz_1_04_08_4,What risk is highlighted in the material for an eSOP system lacking proper access controls?,"A) Improved audit efficiency and compliance |
B) Potential for unauthorized SOP changes |
C) Reduced need for version control systems |
D) Faster distribution of SOPs to users",B
course_1,ch_1_04,les_1_04_08,topic_1_04_08_01,quiz_1_04_08_5,"According to the pro tips, what should be used to enhance eSOP system security?","A) Basic passwords without additional checks |
B) Strong passwords with multi-factor authentication |
C) Single-user access for all system roles |
D) Manual logs instead of digital audit trails",B
course_1,ch_1_04,les_1_04_09,topic_1_04_09_01,quiz_1_04_09_1,What is a primary focus of auditors when reviewing SOPs during a GMP audit?,"A) Checking employee attendance records |
B) Verifying SOP clarity, version control, and adherence |
C) Evaluating the facility’s production speed |
D) Reviewing staff vacation schedules",B
course_1,ch_1_04,les_1_04_09,topic_1_04_09_01,quiz_1_04_09_2,What is a critical step in preparing SOPs for a regulatory audit?,"A) Limiting SOP access to senior management only |
B) Ensuring SOPs are approved and version-controlled |
C) Reducing the number of SOPs to simplify audits |
D) Storing SOPs off-site to protect confidentiality",B
course_1,ch_1_04,les_1_04_09,topic_1_04_09_01,quiz_1_04_09_3,How should staff handle auditor questions about a deviation in a batch record?,"A) Provide vague answers to avoid scrutiny |
B) Show the CAPA log to prove resolution per SOP |
C) Deny the deviation occurred to avoid findings |
D) Refer auditors to unrelated SOPs for clarity",B
course_1,ch_1_04,les_1_04_09,topic_1_04_09_01,quiz_1_04_09_4,What consequence of non-compliant SOPs is highlighted in the study material?,"A) Faster audit approvals and certifications |
B) Risks of recalls, market bans, or sanctions |
C) Simplified staff training requirements |
D) Reduced need for deviation documentation",B
course_1,ch_1_04,les_1_04_09,topic_1_04_09_01,quiz_1_04_09_5,"According to the pro tips, what practice helps identify SOP gaps before a regulatory audit?","A) Conducting mock audits internally |
B) Updating SOPs only after audit findings |
C) Limiting staff training to new hires |
D) Storing records in multiple locations",A
course_1,ch_1_04,les_1_04_10,topic_1_04_10_01,quiz_1_04_10_1,What is the purpose of the Validation Gauntlet drill as described in the study material?,"A) To automate SOP drafting processes |
B) To simulate SOP creation, implementation, and compliance |
C) To reduce the need for staff training |
D) To replace GMP regulations with simpler rules",B
course_1,ch_1_04,les_1_04_10,topic_1_04_10_01,quiz_1_04_10_2,What is a critical requirement when creating effective SOPs for GMP compliance?,"A) Using vague language to allow flexibility |
B) Writing clear, precise, and validated procedures |
C) Limiting SOPs to non-critical processes |
D) Avoiding version control for simplicity",B
course_1,ch_1_04,les_1_04_10,topic_1_04_10_01,quiz_1_04_10_3,How is SOP enforcement primarily achieved according to the material?,"A) By limiting SOP access to auditors only |
B) Through training, compliance tracking, and CAPA |
C) By skipping deviation handling processes |
D) Using paper-based systems without eSOPs",B
course_1,ch_1_04,les_1_04_10,topic_1_04_10_01,quiz_1_04_10_4,What does the Gauntlet Flow include as its final step to ensure GMP compliance?,"A) Drafting an initial SOP without validation |
B) Facing a mock audit to test preparedness |
C) Ignoring deviations to speed up enforcement |
D) Reducing staff training to save time",B
course_1,ch_1_04,les_1_04_10,topic_1_04_10_01,quiz_1_04_10_5,"According to the pro tips, what should be included in the drill to mimic real-world GMP challenges?","A) Simplified SOPs with minimal steps |
B) Audit pressure and deviation scenarios |
C) Exclusion of eSOP system integration |
D) Avoidance of CAPA practice sessions",B
course_1,ch_1_05,les_1_05_01,topic_1_05_01_01,quiz_1_05_01_1,How is a deviation defined in the context of GMP processes?,"A) A routine update to manufacturing SOPs |
B) A departure from approved GMP processes or SOPs |
C) An improvement to product quality standards |
D) A minor change without documentation needs",B
course_1,ch_1_05,les_1_05_01,topic_1_05_01_01,quiz_1_05_01_2,Which type of deviation has a direct threat to product safety or compliance?,"A) Minor deviation, like a missing log signature |
B) Major deviation, like an incorrect material batch |
C) Critical deviation, like a sterility failure |
D) Routine deviation, like a planned SOP revision",C
course_1,ch_1_05,les_1_05_01,topic_1_05_01_01,quiz_1_05_01_3,What is the first step in the first-response protocol when a deviation is spotted?,"A) Notify regulators before documenting |
B) Identify the deviation through checks |
C) Continue production to avoid delays |
D) Retrain staff without containment",B
course_1,ch_1_05,les_1_05_01,topic_1_05_01_01,quiz_1_05_01_4,What risk is highlighted for untreated deviations in the study material?,"A) Streamlined audit processes |
B) Potential product recalls or penalties |
C) Reduced need for staff training |
D) Faster batch release approvals",B
course_1,ch_1_05,les_1_05_01,topic_1_05_01_01,quiz_1_05_01_5,"According to the pro tips, what ensures audit-readiness in deviation reports?","A) Logging only major deviation details |
B) Including who, what, when, and where |
C) Avoiding documentation for minor issues |
D) Delaying reports until audit requests",B
course_1,ch_1_05,les_1_05_02,topic_1_05_02_01,quiz_1_05_02_1,What is the primary goal of immediate containment in response to a GMP deviation?,"A) To accelerate production to meet deadlines |
B) To isolate the deviation and limit its impact |
C) To bypass documentation for quick fixes |
D) To retrain staff without stopping processes",B
course_1,ch_1_05,les_1_05_02,topic_1_05_02_01,quiz_1_05_02_2,Which containment strategy involves isolating affected materials in a designated area?,"A) Process stoppage to halt production |
B) Segregation of approved batches |
C) Quarantine of affected materials |
D) Immediate batch release approval",C
course_1,ch_1_05,les_1_05_02,topic_1_05_02_01,quiz_1_05_02_3,What does an impact assessment evaluate to guide further actions?,"A) The cost of production downtime |
B) The deviation’s effect on quality and safety |
C) The number of staff trained on SOPs |
D) The speed of audit preparation",B
course_1,ch_1_05,les_1_05_02,topic_1_05_02_01,quiz_1_05_02_4,What consequence is highlighted for failing to properly contain or assess deviations?,"A) Faster regulatory approvals |
B) Risks of recalls or regulatory penalties |
C) Simplified compliance documentation |
D) Reduced need for quarantine measures",B
course_1,ch_1_05,les_1_05_02,topic_1_05_02_01,quiz_1_05_02_5,"According to the pro tips, what ensures thorough evaluation during an impact assessment?","A) Using a standardized checklist |
B) Delaying documentation until audits |
C) Ignoring minor deviation details |
D) Relying on verbal reports only",A
course_1,ch_1_05,les_1_05_03,topic_1_05_03_01,quiz_1_05_03_1,What is the primary purpose of deviation registers and logs in a GMP environment?,"A) To summarize production output data |
B) To provide a traceable history of deviations |
C) To replace SOPs with simpler guidelines |
D) To track employee performance metrics",B
course_1,ch_1_05,les_1_05_03,topic_1_05_03_01,quiz_1_05_03_2,What key information must a deviation log include for GMP compliance?,"A) Only the date and process involved |
B) Who, what, when, and corrective actions |
C) General notes without specific details |
D) Production costs and downtime duration",B
course_1,ch_1_05,les_1_05_03,topic_1_05_03_01,quiz_1_05_03_3,What does trending analysis help achieve in deviation management?,"A) Reducing the need for deviation logs |
B) Identifying patterns to prevent recurrence |
C) Simplifying audit preparation processes |
D) Eliminating the need for CAPA actions",B
course_1,ch_1_05,les_1_05_03,topic_1_05_03_01,quiz_1_05_03_4,"What risk is associated with incomplete deviation logs, as per the study material?","A) Faster audit approvals and certifications |
B) Audit failures due to missing details |
C) Reduced need for trending analysis |
D) Simplified regulatory documentation",B
course_1,ch_1_05,les_1_05_03,topic_1_05_03_01,quiz_1_05_03_5,"According to the pro tips, what tool is recommended to spot patterns quickly in trending analysis?","A) Written summaries of deviations |
B) Charts like bar graphs for visualization |
C) Verbal reports during team meetings |
D) Random sampling of log entries",B
course_1,ch_1_05,les_1_05_04,topic_1_05_04_01,quiz_1_05_04_1,What is the primary purpose of root cause analysis (RCA) in GMP deviation management?,"A) To simplify SOP documentation |
B) To identify the true cause of deviations |
C) To bypass audit requirements |
D) To reduce staff training needs",B
course_1,ch_1_05,les_1_05_04,topic_1_05_04_01,quiz_1_05_04_2,"Which tool organizes potential deviation causes into categories like People, Process, and Equipment?","A) 5 Whys Technique |
B) Fault Tree Analysis (FTA) |
C) Fishbone Diagram (Ishikawa) |
D) CAPA Documentation",C
course_1,ch_1_05,les_1_05_04,topic_1_05_04_01,quiz_1_05_04_3,How does the 5 Whys technique help in RCA?,"A) Maps complex causes with logic gates |
B) Asks iterative questions to find the root cause |
C) Categorizes issues into GMP standards |
D) Replaces deviation logs for audits",B
course_1,ch_1_05,les_1_05_04,topic_1_05_04_01,quiz_1_05_04_4,"What is a key requirement of GMP regulations for RCA, as per the material?","A) Avoiding documentation to speed up analysis |
B) Documenting RCA with clear CAPA in reports |
C) Limiting RCA to simple deviations only |
D) Conducting RCA without team involvement",B
course_1,ch_1_05,les_1_05_04,topic_1_05_04_01,quiz_1_05_04_5,"What pitfall should be avoided when using RCA tools like 5 Whys, according to the watch out section?","A) Involving multiple teams in analysis |
B) Stopping at symptoms like “human error” |
C) Combining tools for deeper insights |
D) Documenting findings for audits",B
course_1,ch_1_05,les_1_05_05,topic_1_05_05_01,quiz_1_05_05_1,What is the key difference between a symptom and a root cause in GMP deviation analysis?,"A) Symptoms are underlying issues; root causes are visible effects |
B) Symptoms are observable effects; root causes are underlying reasons |
C) Symptoms require CAPA; root causes do not need investigation |
D) Symptoms are audit findings; root causes are SOP updates",B
course_1,ch_1_05,les_1_05_05,topic_1_05_05_01,quiz_1_05_05_2,Which step is part of the systematic RCA process to identify a deviation’s true origin?,"A) Implement CAPA without data collection |
B) Validate the root cause with evidence |
C) Ignore logs to speed up investigations |
D) Focus only on operator performance",B
course_1,ch_1_05,les_1_05_05,topic_1_05_05_01,quiz_1_05_05_3,Which investigation technique involves asking “Why?” multiple times to uncover a root cause?,"A) Fishbone Diagram |
B) Fault Tree Analysis |
C) 5 Whys Technique |
D) Data Log Review",C
course_1,ch_1_05,les_1_05_05,topic_1_05_05_01,quiz_1_05_05_4,"What risk is highlighted for ineffective RCA, according to the study material?","A) Simplified audit preparation processes |
B) Recurring deviations and regulatory penalties |
C) Reduced need for deviation documentation |
D) Faster product batch release approvals",B
course_1,ch_1_05,les_1_05_05,topic_1_05_05_01,quiz_1_05_05_5,"According to the pro tips, what should be done to ensure accurate RCA findings?","A) Accept “human error” as the final cause |
B) Confirm root causes with data like logs |
C) Limit analysis to a single RCA tool |
D) Skip validation to expedite CAPA",B
course_1,ch_1_05,les_1_05_06,topic_1_05_06_01,quiz_1_05_06_1,What is the key difference between human error and systemic failure in GMP deviations?,"A) Human error is a process flaw; systemic failure is an individual mistake |
B) Human error is an individual mistake; systemic failure is a process flaw |
C) Both are caused by outdated equipment |
D) Both require the same CAPA approach",B
course_1,ch_1_05,les_1_05_06,topic_1_05_06_01,quiz_1_05_06_2,"How can human error typically be addressed, according to the study material?","A) By replacing all equipment involved |
B) Through retraining or improved supervision |
C) By simplifying GMP regulations |
D) By ignoring minor deviations",B
course_1,ch_1_05,les_1_05_06,topic_1_05_06_01,quiz_1_05_06_3,Which tool helps distinguish human error from systemic failure by asking questions like “Was the SOP clear?”,"A) CAPA Documentation |
B) Decision Tree Analysis |
C) Batch Production Log |
D) Employee Performance Review",B
course_1,ch_1_05,les_1_05_06,topic_1_05_06_01,quiz_1_05_06_4,"What risk is associated with misidentifying a deviation’s cause, as per the material?","A) Faster audit approvals |
B) Ineffective solutions and recurring issues |
C) Reduced need for RCA tools |
D) Simplified deviation documentation",B
course_1,ch_1_05,les_1_05_06,topic_1_05_06_01,quiz_1_05_06_5,"According to the pro tips, what should be avoided to ensure accurate cause distinction?","A) Using RCA tools like Fishbone or 5 Whys |
B) Defaulting to human error as the cause |
C) Documenting findings for audit scrutiny |
D) Cross-checking training records",B
course_1,ch_1_05,les_1_05_07,topic_1_05_07_01,quiz_1_05_07_1,What is the primary role of evidence in GMP deviation management?,"A) To simplify SOP creation processes |
B) To provide a verifiable record of deviation resolution |
C) To replace the need for root cause analysis |
D) To track employee performance metrics",B
course_1,ch_1_05,les_1_05_07,topic_1_05_07_01,quiz_1_05_07_2,What must a deviation report include to ensure GMP compliance?,"A) Only the deviation ID and date |
B) Deviation description, impact, and CAPA |
C) General notes without specific actions |
D) Production costs and staff schedules",B
course_1,ch_1_05,les_1_05_07,topic_1_05_07_01,quiz_1_05_07_3,What is the purpose of a witness report in deviation investigations?,"A) To summarize audit findings for regulators |
B) To provide a firsthand account of the deviation |
C) To replace deviation logs with verbal statements |
D) To document unrelated process improvements",B
course_1,ch_1_05,les_1_05_07,topic_1_05_07_01,quiz_1_05_07_4,What consequence is highlighted for missing witness reports in a deviation investigation?,"A) Faster audit approvals and certifications |
B) Undermined investigation credibility and audit failure |
C) Reduced need for proof trail documentation |
D) Simplified CAPA implementation processes",B
course_1,ch_1_05,les_1_05_07,topic_1_05_07_01,quiz_1_05_07_5,"According to the pro tips, what ensures accuracy in deviation documentation?","A) Delaying reports until after audits |
B) Logging deviations in real-time |
C) Limiting details to avoid confusion |
D) Relying on verbal witness accounts",B
course_1,ch_1_05,les_1_05_08,topic_1_05_08_01,quiz_1_05_08_1,What is the purpose of the escalation ladder in GMP deviation management?,"A) To simplify SOP creation processes |
B) To route deviations to appropriate authority levels |
C) To eliminate the need for deviation logs |
D) To reduce staff training requirements",B
course_1,ch_1_05,les_1_05_08,topic_1_05_08_01,quiz_1_05_08_2,"How are minor deviations typically handled, according to the study material?","A) Escalated to senior management immediately |
B) Resolved locally by operators or supervisors |
C) Ignored to avoid audit complications |
D) Reported to regulators without investigation",B
course_1,ch_1_05,les_1_05_08,topic_1_05_08_01,quiz_1_05_08_3,What action is required for a critical deviation like a sterility failure?,"A) Correct locally without documentation |
B) Escalate to management and regulatory teams |
C) Log as a minor issue for supervisor review |
D) Continue production to assess impact later",B
course_1,ch_1_05,les_1_05_08,topic_1_05_08_01,quiz_1_05_08_4,"What risk is associated with under-escalating major or critical deviations, as per the material?","A) Simplified audit preparation processes |
B) Unresolved issues and potential audit findings |
C) Reduced need for CAPA documentation |
D) Faster regulatory approval timelines",B
course_1,ch_1_05,les_1_05_08,topic_1_05_08_01,quiz_1_05_08_5,"According to the pro tips, what ensures swift and accurate deviation handling?","A) Using clear criteria to classify deviations |
B) Delaying escalation until audit requests |
C) Limiting documentation to major issues |
D) Avoiding staff training on escalation",A
course_1,ch_1_05,les_1_05_09,topic_1_05_09_01,quiz_1_05_09_1,What is the primary purpose of a deviation case battle simulation in GMP environments?,"A) To simplify SOP creation processes |
B) To test end-to-end deviation management skills |
C) To reduce the need for deviation logs |
D) To replace real audits with simulations",B
course_1,ch_1_05,les_1_05_09,topic_1_05_09_01,quiz_1_05_09_2,Which Module 5 skill involves using Fishbone or 5 Whys to identify the root cause of a deviation?,"A) Containment and quarantine strategies |
B) Root cause analysis (RCA) application |
C) Logging deviations in registers |
D) Compiling witness reports only",B
course_1,ch_1_05,les_1_05_09,topic_1_05_09_01,quiz_1_05_09_3,What is a critical step in running a deviation case battle simulation?,"A) Ignoring minor deviations to save time |
B) Responding to mock auditor questions with proof trails |
C) Skipping RCA to focus on containment |
D) Limiting documentation to verbal reports",B
course_1,ch_1_05,les_1_05_09,topic_1_05_09_01,quiz_1_05_09_4,What risk is highlighted for skipping steps like containment or RCA in a simulation?,"A) Faster resolution of deviations |
B) Incomplete resolution and audit failures |
C) Reduced need for proof trail evidence |
D) Simplified regulatory compliance checks",B
course_1,ch_1_05,les_1_05_09,topic_1_05_09_01,quiz_1_05_09_5,"According to the pro tips, what should be included in the simulation to mimic real-world stress?","A) Time constraints and mock auditors |
B) Simplified deviation scenarios only |
C) Exclusion of escalation processes |
D) Minimal documentation practice",A
course_1,ch_1_05,les_1_05_10,topic_1_05_10_01,quiz_1_05_10_1,"What risk is associated with misidentifying a deviation’s cause, as per the material?","A) Faster audit approvals |
B) Ineffective solutions and recurring issues |
C) Reduced need for RCA tools |
D) Simplified deviation documentation",B
course_1,ch_1_05,les_1_05_10,topic_1_05_10_01,quiz_1_05_10_2,What action is required for a critical deviation like a sterility failure?,"A) Correct locally without documentation |
B) Escalate to management and regulatory teams |
C) Log as a minor issue for supervisor review |
D) Continue production to assess impact later",B
course_1,ch_1_05,les_1_05_10,topic_1_05_10_01,quiz_1_05_10_3,Which containment strategy involves isolating affected materials in a designated area?,"A) Process stoppage to halt production |
B) Segregation of approved batches |
C) Quarantine of affected materials |
D) Immediate batch release approval",C
course_1,ch_1_05,les_1_05_10,topic_1_05_10_01,quiz_1_05_10_4,What is the purpose of the escalation ladder in GMP deviation management?,"A) To simplify SOP creation processes |
B) To route deviations to appropriate authority levels |
C) To eliminate the need for deviation logs |
D) To reduce staff training requirements",B
course_1,ch_1_05,les_1_05_10,topic_1_05_10_01,quiz_1_05_10_5,What does an impact assessment evaluate to guide further actions?,"A) The cost of production downtime |
B) The deviation’s effect on quality and safety |
C) The number of staff trained on SOPs |
D) The speed of audit preparation",B
course_1,ch_1_06,les_1_06_01,topic_1_06_01_01,quiz_1_06_01_1,What is the primary purpose of CAPA in GMP deviation management?,"A) To simplify SOP documentation processes |
B) To address deviations and prevent recurrence |
C) To reduce the need for deviation logs |
D) To replace root cause analysis tools",B
course_1,ch_1_06,les_1_06_01,topic_1_06_01_01,quiz_1_06_01_2,What is a key component of a corrective action in a CAPA system?,"A) Preventing future deviations |
B) Fixing an existing deviation or issue |
C) Simplifying audit requirements |
D) Updating employee performance records",B
course_1,ch_1_06,les_1_06_01,topic_1_06_01_01,quiz_1_06_01_3,What do GMP regulations require for CAPA systems to ensure audit-readiness?,"A) Evidence of root cause resolution and preventive measures |
B) Minimal documentation to speed up processes |
C) Exclusion of escalation paths for minor issues |
D) Avoidance of effectiveness checks for CAPA",A
course_1,ch_1_06,les_1_06_01,topic_1_06_01_01,quiz_1_06_01_4,"What risk is highlighted for weak CAPA documentation, according to the material?","A) Faster regulatory approvals |
B) Audit failures or production halts |
C) Reduced need for proof trails |
D) Simplified deviation investigations",B
course_1,ch_1_06,les_1_06_01,topic_1_06_01_01,quiz_1_06_01_5,"According to the pro tips, what ensures CAPA prevents deviation recurrence?","A) Skipping follow-up effectiveness checks |
B) Conducting follow-up checks to verify CAPA |
C) Focusing only on corrective actions |
D) Delaying CAPA implementation timelines",B
course_1,ch_1_06,les_1_06_02,topic_1_06_02_01,quiz_1_06_02_1,What is the primary purpose of the CAPA lifecycle in GMP environments?,"A) To simplify deviation documentation processes |
B) To address and prevent quality issues systematically |
C) To reduce the need for audit preparation |
D) To replace root cause analysis with quick fixes",B
course_1,ch_1_06,les_1_06_02,topic_1_06_02_01,quiz_1_06_02_2,What is a key activity during the Identification and Evaluation stage of the CAPA lifecycle?,"A) Implementing corrective actions immediately |
B) Assessing the severity and impact of deviations |
C) Closing the CAPA without verification |
D) Skipping RCA for minor deviations",B
course_1,ch_1_06,les_1_06_02,topic_1_06_02_01,quiz_1_06_02_3,Which tool is used in the Investigation stage to pinpoint the root cause of a deviation?,"A) Deviation log summaries |
B) 5 Whys or Ishikawa diagrams |
C) Employee performance reviews |
D) Production schedule updates",B
course_1,ch_1_06,les_1_06_02,topic_1_06_02_01,quiz_1_06_02_4,"What risk is associated with poor CAPA documentation, as per the study material?","A) Faster regulatory approvals |
B) Failure in WHO or EU GMP inspections |
C) Reduced need for proof trails |
D) Simplified deviation resolution",B
course_1,ch_1_06,les_1_06_02,topic_1_06_02_01,quiz_1_06_02_5,"According to the pro tips, what helps streamline CAPA tracking and reporting?","A) Relying on manual paper records only |
B) Using Quality Management System software |
C) Limiting CAPA to minor deviations |
D) Avoiding cross-functional team involvement",B
course_1,ch_1_06,les_1_06_03,topic_1_06_03_01,quiz_1_06_03_1,What is the primary benefit of using machine learning for deviation detection in GMP environments?,"A) Simplifying SOP documentation |
B) Faster identification of patterns and trends |
C) Replacing manual CAPA processes |
D) Reducing the need for audit trails",B
course_1,ch_1_06,les_1_06_03,topic_1_06_03_01,quiz_1_06_03_2,Which type of ML model is best suited for detecting unknown anomaly patterns in GMP data?,"A) Supervised Learning |
B) Reinforcement Learning |
C) Unsupervised Learning |
D) Manual Data Analysis",C
course_1,ch_1_06,les_1_06_03,topic_1_06_03_01,quiz_1_06_03_3,What is a critical data requirement for effective ML deviation detection in GMP settings?,"A) Incomplete or unstructured data |
B) Accurate and GMP-compliant data |
C) Data limited to employee records |
D) Non-validated data sources",B
course_1,ch_1_06,les_1_06_03,topic_1_06_03_01,quiz_1_06_03_4,What regulatory risk is associated with using unvalidated ML models for deviation detection?,"A) Faster FDA audit approvals |
B) Triggering FDA 483 observations |
C) Eliminating audit trail requirements |
D) Simplifying GMP compliance checks",B
course_1,ch_1_06,les_1_06_03,topic_1_06_03_01,quiz_1_06_03_5,"According to the pro tips, what should be done to ensure ML models meet regulatory standards?","A) Use unvalidated models for quick results |
B) Validate models per GAMP 5 guidelines |
C) Exclude ML outputs from QMS integration |
D) Rely solely on AI without human review",B
course_1,ch_1_06,les_1_06_04,topic_1_06_04_01,quiz_1_06_04_1,What is the primary function of automated alerts in GMP environments?,"A) To replace manual CAPA documentation |
B) To notify teams of deviations in real time |
C) To simplify audit preparation processes |
D) To reduce the need for risk prioritization",B
course_1,ch_1_06,les_1_06_04,topic_1_06_04_01,quiz_1_06_04_2,What is a key benefit of using dashboards for CAPA oversight?,"A) Eliminating the need for QMS integration |
B) Providing real-time visibility into CAPA metrics |
C) Limiting data to non-critical deviations |
D) Replacing RCA with automated analysis",B
course_1,ch_1_06,les_1_06_04,topic_1_06_04_01,quiz_1_06_04_3,How does risk prioritization support CAPA processes in GMP settings?,"A) By ignoring low-risk deviations entirely |
B) By ranking deviations based on severity and impact |
C) By delaying CAPA for high-risk issues |
D) By reducing documentation requirements",B
course_1,ch_1_06,les_1_06_04,topic_1_06_04_01,quiz_1_06_04_4,"What risk is associated with poor system integration in smart trigger tools, according to the material?","A) Faster regulatory approvals |
B) Incomplete CAPA data and audit failures |
C) Reduced need for validated systems |
D) Simplified deviation tracking processes",B
course_1,ch_1_06,les_1_06_04,topic_1_06_04_01,quiz_1_06_04_5,"According to the pro tips, what ensures alert and dashboard tools meet FDA inspection standards?","A) Using unvalidated software for quick setup |
B) Validating systems per GAMP 5 guidelines |
C) Avoiding integration with QMS tools |
D) Setting vague alert thresholds",B
course_1,ch_1_06,les_1_06_05,topic_1_06_05_01,quiz_1_06_05_1,What is the primary difference between local and global CAPA processes in GMP environments?,"A) Local CAPAs address systemic issues; global CAPAs are site-specific |
B) Local CAPAs are site-specific; global CAPAs address multi-site issues |
C) Local CAPAs require no documentation; global CAPAs need QMS |
D) Local CAPAs involve regulators; global CAPAs are internal",B
course_1,ch_1_06,les_1_06_05,topic_1_06_05_01,quiz_1_06_05_2,What triggers the escalation of a deviation from local to global CAPA?,"A) Low-risk, single-site deviations |
B) High-risk or multi-site deviation impact |
C) Routine SOP updates without issues |
D) Minor documentation errors",B
course_1,ch_1_06,les_1_06_05,topic_1_06_05_01,quiz_1_06_05_3,What is a key requirement for GMP-compliant CAPA documentation in escalation pathways?,"A) Recording only local CAPA decisions |
B) Documenting escalation in QMS per 21 CFR Part 11 |
C) Avoiding audit trails for faster processing |
D) Limiting records to verbal agreements",B
course_1,ch_1_06,les_1_06_05,topic_1_06_05_01,quiz_1_06_05_4,"What risk is associated with delayed escalation of high-risk deviations, according to the material?","A) Simplified audit preparation processes |
B) Regulatory violations or product recalls |
C) Reduced need for QMS integration |
D) Faster CAPA implementation timelines",B
course_1,ch_1_06,les_1_06_05,topic_1_06_05_01,quiz_1_06_05_5,"According to the pro tips, what ensures consistency in escalation decisions across sites?","A) Using standardized communication templates |
B) Limiting escalation to minor deviations |
C) Avoiding risk assessment tools like FMEA |
D) Relying on informal team discussions",A
course_1,ch_1_06,les_1_06_06,topic_1_06_06_01,quiz_1_06_06_1,"According to the pro tips, what drives precise corrective and preventive strategies?","A) Avoiding deviation logs entirely |
B) Thorough RCA and trend analysis |
C) Focusing only on corrective fixes |
D) Limiting documentation to audits",B
course_1,ch_1_06,les_1_06_06,topic_1_06_06_01,quiz_1_06_06_2,What risk is associated with misclassifying corrective and preventive actions?,"A) Faster regulatory approvals |
B) Confused auditors and weaker CAPA |
C) Reduced need for trend analysis |
D) Simplified QMS documentation",B
course_1,ch_1_06,les_1_06_06,topic_1_06_06_01,quiz_1_06_06_3,What is a key regulatory requirement for CAPA actions to ensure GMP compliance?,"A) Avoiding documentation for quick fixes |
B) Recording actions in QMS with evidence |
C) Limiting actions to corrective measures |
D) Excluding preventive actions from audits",B
course_1,ch_1_06,les_1_06_06,topic_1_06_06_01,quiz_1_06_06_4,"How does a preventive action differ from a corrective action, according to the material?","A) It addresses existing non-conformances |
B) It proactively mitigates future risks |
C) It eliminates the need for RCA |
D) It focuses on employee performance",B
course_1,ch_1_06,les_1_06_06,topic_1_06_06_01,quiz_1_06_06_5,What is the primary focus of a corrective action in a GMP CAPA system?,"A) Preventing potential deviations |
B) Fixing existing deviations or issues |
C) Simplifying audit documentation |
D) Reducing staff training requirements",B
course_1,ch_1_06,les_1_06_07,topic_1_06_07_01,quiz_1_06_07_1,What is the primary role of AI in root cause analysis (RCA) for GMP deviations?,"A) Simplifying SOP documentation processes |
B) Analyzing data to verify true causes of deviations |
C) Replacing manual CAPA investigations entirely |
D) Reducing the need for audit trail records",B
course_1,ch_1_06,les_1_06_07,topic_1_06_07_01,quiz_1_06_07_2,Which AI tool is best suited for identifying complex patterns in GMP deviation data?,"A) Statistical Models |
B) Machine Learning |
C) Manual Log Reviews |
D) Employee Surveys",B
course_1,ch_1_06,les_1_06_07,topic_1_06_07_01,quiz_1_06_07_3,What is a critical requirement for AI-driven RCA to meet GMP regulatory standards?,"A) Using incomplete or unverified data |
B) Ensuring data integrity per EU GMP Annex 11 |
C) Avoiding integration with QMS or LIMS |
D) Limiting data to single-source inputs",B
course_1,ch_1_06,les_1_06_07,topic_1_06_07_01,quiz_1_06_07_4,"What risk is associated with using unvalidated AI tools for RCA, according to the material?","A) Faster FDA audit approvals |
B) Triggering FDA 483 observations |
C) Eliminating documentation needs |
D) Simplifying CAPA verification",B
course_1,ch_1_06,les_1_06_07,topic_1_06_07_01,quiz_1_06_07_5,"According to the pro tips, what enhances the comprehensiveness of AI-driven RCA verification?","A) Relying solely on AI without human review |
B) Combining QMS, LIMS, and ERP data |
C) Limiting data to batch records only |
D) Skipping GAMP 5 validation steps",B
course_1,ch_1_06,les_1_06_08,topic_1_06_08_01,quiz_1_06_08_1,What is the primary role of QMS in CAPA integration for GMP compliance?,"A) Replacing laboratory test data |
B) Managing CAPA workflows and documentation |
C) Simplifying clinical trial protocols |
D) Reducing the need for audit trails",B
course_1,ch_1_06,les_1_06_08,topic_1_06_08_01,quiz_1_06_08_2,How does LIMS integration support CAPA processes in GMP environments?,"A) By storing regulatory submission documents |
B) By providing lab data for deviation analysis |
C) By eliminating the need for RCA tools |
D) By managing employee training records",B
course_1,ch_1_06,les_1_06_08,topic_1_06_08_01,quiz_1_06_08_3,What is a key benefit of integrating CAPA with eTMF systems?,"A) Enhancing document control for regulatory audits |
B) Automating batch production processes |
C) Reducing the need for data integrity checks |
D) Simplifying equipment maintenance logs",A
course_1,ch_1_06,les_1_06_08,topic_1_06_08_01,quiz_1_06_08_4,"According to the pro tips, what reduces manual errors in CAPA integration?","A) Avoiding data sharing between systems |
B) Setting up real-time data flow automation |
C) Using inconsistent CAPA workflows |
D) Limiting integration to one system",B
course_1,ch_1_06,les_1_06_08,topic_1_06_08_01,quiz_1_06_08_5,"What risk is associated with using unvalidated QMS, LIMS, or eTMF systems for CAPA?","A) Faster FDA audit approvals |
B) Triggering FDA 483 observations |
C) Eliminating documentation requirements |
D) Simplifying CAPA workflow processes",B
course_1,ch_1_06,les_1_06_09,topic_1_06_09_01,quiz_1_06_09_1,"What is a key focus of FDA inspections regarding CAPA processes, per the study material?","A) Simplifying deviation documentation |
B) Evaluating RCA quality and audit trails |
C) Reducing the need for preventive actions |
D) Reviewing employee training schedules",B
course_1,ch_1_06,les_1_06_09,topic_1_06_09_01,quiz_1_06_09_2,What does WHO emphasize in CAPA processes during inspections?,"A) Risk-based prioritization and global consistency |
B) Eliminating the need for audit trails |
C) Focusing only on corrective actions |
D) Simplifying SOP revision processes",A
course_1,ch_1_06,les_1_06_09,topic_1_06_09_01,quiz_1_06_09_3,What characterizes a successful CAPA in an audit scenario?,"A) Addressing symptoms without RCA |
B) Resolving issues with thorough documentation |
C) Ignoring minor deviations for efficiency |
D) Delaying closure until audit completion",B
course_1,ch_1_06,les_1_06_09,topic_1_06_09_01,quiz_1_06_09_4,What risk is associated with incomplete CAPA documentation during audits?,"A) Faster regulatory approvals |
B) Triggering FDA 483 or WHO findings |
C) Reduced need for QMS integration |
D) Simplified CAPA verification processes",B
course_1,ch_1_06,les_1_06_09,topic_1_06_09_01,quiz_1_06_09_5,"According to the pro tips, what helps test CAPA robustness before real audits?","A) Avoiding documentation of RCA steps |
B) Conducting mock FDA/WHO inspections |
C) Limiting CAPA to corrective actions |
D) Skipping verification of CAPA effectiveness",B
course_1,ch_1_06,les_1_06_10,topic_1_06_10_01,quiz_1_06_10_1,What is the primary purpose of the CAPA War Room in GMP environments?,"A) To simplify SOP creation processes |
B) To train teams in deviation response and CAPA execution |
C) To replace real audits with simulations |
D) To reduce the need for QMS documentation",B
course_1,ch_1_06,les_1_06_10,topic_1_06_10_01,quiz_1_06_10_2,How do AI-simulated escalation drills support CAPA processes?,"A) By eliminating the need for root cause analysis |
B) By testing escalation pathways with realistic scenarios |
C) By limiting CAPA to local site issues only |
D) By automating all CAPA closure steps",B
course_1,ch_1_06,les_1_06_10,topic_1_06_10_01,quiz_1_06_10_3,What is a key focus of full CAPA closure drills in the War Room?,"A) Skipping verification to speed up processes |
B) Ensuring timely, audit-ready closure with QMS records |
C) Avoiding cross-functional team involvement |
D) Focusing only on minor deviations",B
course_1,ch_1_06,les_1_06_10,topic_1_06_10_01,quiz_1_06_10_4,"What risk is associated with incomplete documentation in War Room drills, according to the material?","A) Faster FDA audit approvals |
B) Weakened performance in real audits |
C) Reduced need for AI simulations |
D) Simplified CAPA workflow processes",B
course_1,ch_1_06,les_1_06_10,topic_1_06_10_01,quiz_1_06_10_5,"According to the pro tips, what improves the realism of War Room scenarios?","A) Using generic scenarios without data |
B) Feeding historical deviation data into AI |
C) Excluding production team input |
D) Limiting drills to closure steps only",B
course_1,ch_1_07,les_1_07_01,topic_1_07_01_01,quiz_1_07_01_1,,,
course_1,ch_1_07,les_1_07_01,topic_1_07_01_01,quiz_1_07_01_2,,,
course_1,ch_1_07,les_1_07_01,topic_1_07_01_01,quiz_1_07_01_3,,,
course_1,ch_1_07,les_1_07_01,topic_1_07_01_01,quiz_1_07_01_4,,,
course_1,ch_1_07,les_1_07_01,topic_1_07_01_01,quiz_1_07_01_5,,,
course_1,ch_1_07,les_1_07_02,topic_1_07_02_01,quiz_1_07_02_1,,,
course_1,ch_1_07,les_1_07_02,topic_1_07_02_01,quiz_1_07_02_2,,,
course_1,ch_1_07,les_1_07_02,topic_1_07_02_01,quiz_1_07_02_3,,,
course_1,ch_1_07,les_1_07_02,topic_1_07_02_01,quiz_1_07_02_4,,,
course_1,ch_1_07,les_1_07_02,topic_1_07_02_01,quiz_1_07_02_5,,,
course_1,ch_1_07,les_1_07_03,topic_1_07_03_01,quiz_1_07_03_1,,,
course_1,ch_1_07,les_1_07_03,topic_1_07_03_01,quiz_1_07_03_2,,,
course_1,ch_1_07,les_1_07_03,topic_1_07_03_01,quiz_1_07_03_3,,,
course_1,ch_1_07,les_1_07_03,topic_1_07_03_01,quiz_1_07_03_4,,,
course_1,ch_1_07,les_1_07_03,topic_1_07_03_01,quiz_1_07_03_5,,,
course_1,ch_1_07,les_1_07_04,topic_1_07_04_01,quiz_1_07_04_1,,,
course_1,ch_1_07,les_1_07_04,topic_1_07_04_01,quiz_1_07_04_2,,,
course_1,ch_1_07,les_1_07_04,topic_1_07_04_01,quiz_1_07_04_3,,,
course_1,ch_1_07,les_1_07_04,topic_1_07_04_01,quiz_1_07_04_4,,,
course_1,ch_1_07,les_1_07_04,topic_1_07_04_01,quiz_1_07_04_5,,,
course_1,ch_1_07,les_1_07_05,topic_1_07_05_01,quiz_1_07_05_1,,,
course_1,ch_1_07,les_1_07_05,topic_1_07_05_01,quiz_1_07_05_2,,,
course_1,ch_1_07,les_1_07_05,topic_1_07_05_01,quiz_1_07_05_3,,,
course_1,ch_1_07,les_1_07_05,topic_1_07_05_01,quiz_1_07_05_4,,,
course_1,ch_1_07,les_1_07_05,topic_1_07_05_01,quiz_1_07_05_5,,,
course_1,ch_1_07,les_1_07_06,topic_1_07_06_01,quiz_1_07_06_1,,,
course_1,ch_1_07,les_1_07_06,topic_1_07_06_01,quiz_1_07_06_2,,,
course_1,ch_1_07,les_1_07_06,topic_1_07_06_01,quiz_1_07_06_3,,,
course_1,ch_1_07,les_1_07_06,topic_1_07_06_01,quiz_1_07_06_4,,,
course_1,ch_1_07,les_1_07_06,topic_1_07_06_01,quiz_1_07_06_5,,,
course_1,ch_1_07,les_1_07_07,topic_1_07_07_01,quiz_1_07_07_1,,,
course_1,ch_1_07,les_1_07_07,topic_1_07_07_01,quiz_1_07_07_2,,,
course_1,ch_1_07,les_1_07_07,topic_1_07_07_01,quiz_1_07_07_3,,,
course_1,ch_1_07,les_1_07_07,topic_1_07_07_01,quiz_1_07_07_4,,,
course_1,ch_1_07,les_1_07_07,topic_1_07_07_01,quiz_1_07_07_5,,,
course_1,ch_1_07,les_1_07_08,topic_1_07_08_01,quiz_1_07_08_1,,,
course_1,ch_1_07,les_1_07_08,topic_1_07_08_01,quiz_1_07_08_2,,,
course_1,ch_1_07,les_1_07_08,topic_1_07_08_01,quiz_1_07_08_3,,,
course_1,ch_1_07,les_1_07_08,topic_1_07_08_01,quiz_1_07_08_4,,,
course_1,ch_1_07,les_1_07_08,topic_1_07_08_01,quiz_1_07_08_5,,,
course_1,ch_1_07,les_1_07_09,topic_1_07_09_01,quiz_1_07_09_1,,,
course_1,ch_1_07,les_1_07_09,topic_1_07_09_01,quiz_1_07_09_2,,,
course_1,ch_1_07,les_1_07_09,topic_1_07_09_01,quiz_1_07_09_3,,,
course_1,ch_1_07,les_1_07_09,topic_1_07_09_01,quiz_1_07_09_4,,,
course_1,ch_1_07,les_1_07_09,topic_1_07_09_01,quiz_1_07_09_5,,,
course_1,ch_1_07,les_1_07_10,topic_1_07_10_01,quiz_1_07_10_1,,,
course_1,ch_1_07,les_1_07_10,topic_1_07_10_01,quiz_1_07_10_2,,,
course_1,ch_1_07,les_1_07_10,topic_1_07_10_01,quiz_1_07_10_3,,,
course_1,ch_1_07,les_1_07_10,topic_1_07_10_01,quiz_1_07_10_4,,,
course_1,ch_1_07,les_1_07_10,topic_1_07_10_01,quiz_1_07_10_5,,,
course_1,ch_1_08,les_1_08_01,topic_1_08_01_01,quiz_1_08_01_1,,,
course_1,ch_1_08,les_1_08_01,topic_1_08_01_01,quiz_1_08_01_2,,,
course_1,ch_1_08,les_1_08_01,topic_1_08_01_01,quiz_1_08_01_3,,,
course_1,ch_1_08,les_1_08_01,topic_1_08_01_01,quiz_1_08_01_4,,,
course_1,ch_1_08,les_1_08_01,topic_1_08_01_01,quiz_1_08_01_5,,,
course_1,ch_1_08,les_1_08_02,topic_1_08_02_01,quiz_1_08_02_1,,,
course_1,ch_1_08,les_1_08_02,topic_1_08_02_01,quiz_1_08_02_2,,,
course_1,ch_1_08,les_1_08_02,topic_1_08_02_01,quiz_1_08_02_3,,,
course_1,ch_1_08,les_1_08_02,topic_1_08_02_01,quiz_1_08_02_4,,,
course_1,ch_1_08,les_1_08_02,topic_1_08_02_01,quiz_1_08_02_5,,,
course_1,ch_1_08,les_1_08_03,topic_1_08_03_01,quiz_1_08_03_1,,,
course_1,ch_1_08,les_1_08_03,topic_1_08_03_01,quiz_1_08_03_2,,,
course_1,ch_1_08,les_1_08_03,topic_1_08_03_01,quiz_1_08_03_3,,,
course_1,ch_1_08,les_1_08_03,topic_1_08_03_01,quiz_1_08_03_4,,,
course_1,ch_1_08,les_1_08_03,topic_1_08_03_01,quiz_1_08_03_5,,,
course_1,ch_1_08,les_1_08_04,topic_1_08_04_01,quiz_1_08_04_1,,,
course_1,ch_1_08,les_1_08_04,topic_1_08_04_01,quiz_1_08_04_2,,,
course_1,ch_1_08,les_1_08_04,topic_1_08_04_01,quiz_1_08_04_3,,,
course_1,ch_1_08,les_1_08_04,topic_1_08_04_01,quiz_1_08_04_4,,,
course_1,ch_1_08,les_1_08_04,topic_1_08_04_01,quiz_1_08_04_5,,,
course_1,ch_1_08,les_1_08_05,topic_1_08_05_01,quiz_1_08_05_1,,,
course_1,ch_1_08,les_1_08_05,topic_1_08_05_01,quiz_1_08_05_2,,,
course_1,ch_1_08,les_1_08_05,topic_1_08_05_01,quiz_1_08_05_3,,,
course_1,ch_1_08,les_1_08_05,topic_1_08_05_01,quiz_1_08_05_4,,,
course_1,ch_1_08,les_1_08_05,topic_1_08_05_01,quiz_1_08_05_5,,,
course_1,ch_1_08,les_1_08_06,topic_1_08_06_01,quiz_1_08_06_1,,,
course_1,ch_1_08,les_1_08_06,topic_1_08_06_01,quiz_1_08_06_2,,,
course_1,ch_1_08,les_1_08_06,topic_1_08_06_01,quiz_1_08_06_3,,,
course_1,ch_1_08,les_1_08_06,topic_1_08_06_01,quiz_1_08_06_4,,,
course_1,ch_1_08,les_1_08_06,topic_1_08_06_01,quiz_1_08_06_5,,,
course_1,ch_1_08,les_1_08_07,topic_1_08_07_01,quiz_1_08_07_1,,,
course_1,ch_1_08,les_1_08_07,topic_1_08_07_01,quiz_1_08_07_2,,,
course_1,ch_1_08,les_1_08_07,topic_1_08_07_01,quiz_1_08_07_3,,,
course_1,ch_1_08,les_1_08_07,topic_1_08_07_01,quiz_1_08_07_4,,,
course_1,ch_1_08,les_1_08_07,topic_1_08_07_01,quiz_1_08_07_5,,,
course_1,ch_1_08,les_1_08_08,topic_1_08_08_01,quiz_1_08_08_1,,,
course_1,ch_1_08,les_1_08_08,topic_1_08_08_01,quiz_1_08_08_2,,,
course_1,ch_1_08,les_1_08_08,topic_1_08_08_01,quiz_1_08_08_3,,,
course_1,ch_1_08,les_1_08_08,topic_1_08_08_01,quiz_1_08_08_4,,,
course_1,ch_1_08,les_1_08_08,topic_1_08_08_01,quiz_1_08_08_5,,,
course_1,ch_1_08,les_1_08_09,topic_1_08_09_01,quiz_1_08_09_1,,,
course_1,ch_1_08,les_1_08_09,topic_1_08_09_01,quiz_1_08_09_2,,,
course_1,ch_1_08,les_1_08_09,topic_1_08_09_01,quiz_1_08_09_3,,,
course_1,ch_1_08,les_1_08_09,topic_1_08_09_01,quiz_1_08_09_4,,,
course_1,ch_1_08,les_1_08_09,topic_1_08_09_01,quiz_1_08_09_5,,,
course_1,ch_1_08,les_1_08_10,topic_1_08_10_01,quiz_1_08_10_1,,,
course_1,ch_1_08,les_1_08_10,topic_1_08_10_01,quiz_1_08_10_2,,,
course_1,ch_1_08,les_1_08_10,topic_1_08_10_01,quiz_1_08_10_3,,,
course_1,ch_1_08,les_1_08_10,topic_1_08_10_01,quiz_1_08_10_4,,,
course_1,ch_1_08,les_1_08_10,topic_1_08_10_01,quiz_1_08_10_5,,,
course_1,ch_1_09,les_1_09_01,topic_1_09_01_01,quiz_1_09_01_1,,,
course_1,ch_1_09,les_1_09_01,topic_1_09_01_01,quiz_1_09_01_2,,,
course_1,ch_1_09,les_1_09_01,topic_1_09_01_01,quiz_1_09_01_3,,,
course_1,ch_1_09,les_1_09_01,topic_1_09_01_01,quiz_1_09_01_4,,,
course_1,ch_1_09,les_1_09_01,topic_1_09_01_01,quiz_1_09_01_5,,,
course_1,ch_1_09,les_1_09_02,topic_1_09_02_01,quiz_1_09_02_1,,,
course_1,ch_1_09,les_1_09_02,topic_1_09_02_01,quiz_1_09_02_2,,,
course_1,ch_1_09,les_1_09_02,topic_1_09_02_01,quiz_1_09_02_3,,,
course_1,ch_1_09,les_1_09_02,topic_1_09_02_01,quiz_1_09_02_4,,,
course_1,ch_1_09,les_1_09_02,topic_1_09_02_01,quiz_1_09_02_5,,,
course_1,ch_1_09,les_1_09_03,topic_1_09_03_01,quiz_1_09_03_1,,,
course_1,ch_1_09,les_1_09_03,topic_1_09_03_01,quiz_1_09_03_2,,,
course_1,ch_1_09,les_1_09_03,topic_1_09_03_01,quiz_1_09_03_3,,,
course_1,ch_1_09,les_1_09_03,topic_1_09_03_01,quiz_1_09_03_4,,,
course_1,ch_1_09,les_1_09_03,topic_1_09_03_01,quiz_1_09_03_5,,,
course_1,ch_1_09,les_1_09_04,topic_1_09_04_01,quiz_1_09_04_1,,,
course_1,ch_1_09,les_1_09_04,topic_1_09_04_01,quiz_1_09_04_2,,,
course_1,ch_1_09,les_1_09_04,topic_1_09_04_01,quiz_1_09_04_3,,,
course_1,ch_1_09,les_1_09_04,topic_1_09_04_01,quiz_1_09_04_4,,,
course_1,ch_1_09,les_1_09_04,topic_1_09_04_01,quiz_1_09_04_5,,,
course_1,ch_1_09,les_1_09_05,topic_1_09_05_01,quiz_1_09_05_1,,,
course_1,ch_1_09,les_1_09_05,topic_1_09_05_01,quiz_1_09_05_2,,,
course_1,ch_1_09,les_1_09_05,topic_1_09_05_01,quiz_1_09_05_3,,,
course_1,ch_1_09,les_1_09_05,topic_1_09_05_01,quiz_1_09_05_4,,,
course_1,ch_1_09,les_1_09_05,topic_1_09_05_01,quiz_1_09_05_5,,,
course_1,ch_1_09,les_1_09_06,topic_1_09_06_01,quiz_1_09_06_1,,,
course_1,ch_1_09,les_1_09_06,topic_1_09_06_01,quiz_1_09_06_2,,,
course_1,ch_1_09,les_1_09_06,topic_1_09_06_01,quiz_1_09_06_3,,,
course_1,ch_1_09,les_1_09_06,topic_1_09_06_01,quiz_1_09_06_4,,,
course_1,ch_1_09,les_1_09_06,topic_1_09_06_01,quiz_1_09_06_5,,,
course_1,ch_1_09,les_1_09_07,topic_1_09_07_01,quiz_1_09_07_1,,,
course_1,ch_1_09,les_1_09_07,topic_1_09_07_01,quiz_1_09_07_2,,,
course_1,ch_1_09,les_1_09_07,topic_1_09_07_01,quiz_1_09_07_3,,,
course_1,ch_1_09,les_1_09_07,topic_1_09_07_01,quiz_1_09_07_4,,,
course_1,ch_1_09,les_1_09_07,topic_1_09_07_01,quiz_1_09_07_5,,,
course_1,ch_1_09,les_1_09_08,topic_1_09_08_01,quiz_1_09_08_1,,,
course_1,ch_1_09,les_1_09_08,topic_1_09_08_01,quiz_1_09_08_2,,,
course_1,ch_1_09,les_1_09_08,topic_1_09_08_01,quiz_1_09_08_3,,,
course_1,ch_1_09,les_1_09_08,topic_1_09_08_01,quiz_1_09_08_4,,,
course_1,ch_1_09,les_1_09_08,topic_1_09_08_01,quiz_1_09_08_5,,,
course_1,ch_1_09,les_1_09_09,topic_1_09_09_01,quiz_1_09_09_1,,,
course_1,ch_1_09,les_1_09_09,topic_1_09_09_01,quiz_1_09_09_2,,,
course_1,ch_1_09,les_1_09_09,topic_1_09_09_01,quiz_1_09_09_3,,,
course_1,ch_1_09,les_1_09_09,topic_1_09_09_01,quiz_1_09_09_4,,,
course_1,ch_1_09,les_1_09_09,topic_1_09_09_01,quiz_1_09_09_5,,,
course_1,ch_1_09,les_1_09_10,topic_1_09_10_01,quiz_1_09_10_1,,,
course_1,ch_1_09,les_1_09_10,topic_1_09_10_01,quiz_1_09_10_2,,,
course_1,ch_1_09,les_1_09_10,topic_1_09_10_01,quiz_1_09_10_3,,,
course_1,ch_1_09,les_1_09_10,topic_1_09_10_01,quiz_1_09_10_4,,,
course_1,ch_1_09,les_1_09_10,topic_1_09_10_01,quiz_1_09_10_5,,,
course_1,ch_1_10,les_1_10_01,topic_1_10_01_01,quiz_1_10_01_1,,,
course_1,ch_1_10,les_1_10_01,topic_1_10_01_01,quiz_1_10_01_2,,,
course_1,ch_1_10,les_1_10_01,topic_1_10_01_01,quiz_1_10_01_3,,,
course_1,ch_1_10,les_1_10_01,topic_1_10_01_01,quiz_1_10_01_4,,,
course_1,ch_1_10,les_1_10_01,topic_1_10_01_01,quiz_1_10_01_5,,,
course_1,ch_1_10,les_1_10_02,topic_1_10_02_01,quiz_1_10_02_1,,,
course_1,ch_1_10,les_1_10_02,topic_1_10_02_01,quiz_1_10_02_2,,,
course_1,ch_1_10,les_1_10_02,topic_1_10_02_01,quiz_1_10_02_3,,,
course_1,ch_1_10,les_1_10_02,topic_1_10_02_01,quiz_1_10_02_4,,,
course_1,ch_1_10,les_1_10_02,topic_1_10_02_01,quiz_1_10_02_5,,,
course_1,ch_1_10,les_1_10_03,topic_1_10_03_01,quiz_1_10_03_1,,,
course_1,ch_1_10,les_1_10_03,topic_1_10_03_01,quiz_1_10_03_2,,,
course_1,ch_1_10,les_1_10_03,topic_1_10_03_01,quiz_1_10_03_3,,,
course_1,ch_1_10,les_1_10_03,topic_1_10_03_01,quiz_1_10_03_4,,,
course_1,ch_1_10,les_1_10_03,topic_1_10_03_01,quiz_1_10_03_5,,,
course_1,ch_1_10,les_1_10_04,topic_1_10_04_01,quiz_1_10_04_1,,,
course_1,ch_1_10,les_1_10_04,topic_1_10_04_01,quiz_1_10_04_2,,,
course_1,ch_1_10,les_1_10_04,topic_1_10_04_01,quiz_1_10_04_3,,,
course_1,ch_1_10,les_1_10_04,topic_1_10_04_01,quiz_1_10_04_4,,,
course_1,ch_1_10,les_1_10_04,topic_1_10_04_01,quiz_1_10_04_5,,,
course_1,ch_1_10,les_1_10_05,topic_1_10_05_01,quiz_1_10_05_1,,,
course_1,ch_1_10,les_1_10_05,topic_1_10_05_01,quiz_1_10_05_2,,,
course_1,ch_1_10,les_1_10_05,topic_1_10_05_01,quiz_1_10_05_3,,,
course_1,ch_1_10,les_1_10_05,topic_1_10_05_01,quiz_1_10_05_4,,,
course_1,ch_1_10,les_1_10_05,topic_1_10_05_01,quiz_1_10_05_5,,,
course_1,ch_1_10,les_1_10_06,topic_1_10_06_01,quiz_1_10_06_1,,,
course_1,ch_1_10,les_1_10_06,topic_1_10_06_01,quiz_1_10_06_2,,,
course_1,ch_1_10,les_1_10_06,topic_1_10_06_01,quiz_1_10_06_3,,,
course_1,ch_1_10,les_1_10_06,topic_1_10_06_01,quiz_1_10_06_4,,,
course_1,ch_1_10,les_1_10_06,topic_1_10_06_01,quiz_1_10_06_5,,,
course_1,ch_1_10,les_1_10_07,topic_1_10_07_01,quiz_1_10_07_1,,,
course_1,ch_1_10,les_1_10_07,topic_1_10_07_01,quiz_1_10_07_2,,,
course_1,ch_1_10,les_1_10_07,topic_1_10_07_01,quiz_1_10_07_3,,,
course_1,ch_1_10,les_1_10_07,topic_1_10_07_01,quiz_1_10_07_4,,,
course_1,ch_1_10,les_1_10_07,topic_1_10_07_01,quiz_1_10_07_5,,,
course_1,ch_1_10,les_1_10_08,topic_1_10_08_01,quiz_1_10_08_1,,,
course_1,ch_1_10,les_1_10_08,topic_1_10_08_01,quiz_1_10_08_2,,,
course_1,ch_1_10,les_1_10_08,topic_1_10_08_01,quiz_1_10_08_3,,,
course_1,ch_1_10,les_1_10_08,topic_1_10_08_01,quiz_1_10_08_4,,,
course_1,ch_1_10,les_1_10_08,topic_1_10_08_01,quiz_1_10_08_5,,,
course_1,ch_1_10,les_1_10_09,topic_1_10_09_01,quiz_1_10_09_1,,,
course_1,ch_1_10,les_1_10_09,topic_1_10_09_01,quiz_1_10_09_2,,,
course_1,ch_1_10,les_1_10_09,topic_1_10_09_01,quiz_1_10_09_3,,,
course_1,ch_1_10,les_1_10_09,topic_1_10_09_01,quiz_1_10_09_4,,,
course_1,ch_1_10,les_1_10_09,topic_1_10_09_01,quiz_1_10_09_5,,,
course_1,ch_1_10,les_1_10_10,topic_1_10_10_01,quiz_1_10_10_1,,,
course_1,ch_1_10,les_1_10_10,topic_1_10_10_01,quiz_1_10_10_2,,,
course_1,ch_1_10,les_1_10_10,topic_1_10_10_01,quiz_1_10_10_3,,,
course_1,ch_1_10,les_1_10_10,topic_1_10_10_01,quiz_1_10_10_4,,,
course_1,ch_1_10,les_1_10_10,topic_1_10_10_01,quiz_1_10_10_5,,,
course_1,ch_1_11,les_1_11_01,topic_1_11_01_01,quiz_1_11_01_1,,,
course_1,ch_1_11,les_1_11_01,topic_1_11_01_01,quiz_1_11_01_2,,,
course_1,ch_1_11,les_1_11_01,topic_1_11_01_01,quiz_1_11_01_3,,,
course_1,ch_1_11,les_1_11_01,topic_1_11_01_01,quiz_1_11_01_4,,,
course_1,ch_1_11,les_1_11_01,topic_1_11_01_01,quiz_1_11_01_5,,,
course_1,ch_1_11,les_1_11_02,topic_1_11_02_01,quiz_1_11_02_1,,,
course_1,ch_1_11,les_1_11_02,topic_1_11_02_01,quiz_1_11_02_2,,,
course_1,ch_1_11,les_1_11_02,topic_1_11_02_01,quiz_1_11_02_3,,,
course_1,ch_1_11,les_1_11_02,topic_1_11_02_01,quiz_1_11_02_4,,,
course_1,ch_1_11,les_1_11_02,topic_1_11_02_01,quiz_1_11_02_5,,,
course_1,ch_1_11,les_1_11_03,topic_1_11_03_01,quiz_1_11_03_1,,,
course_1,ch_1_11,les_1_11_03,topic_1_11_03_01,quiz_1_11_03_2,,,
course_1,ch_1_11,les_1_11_03,topic_1_11_03_01,quiz_1_11_03_3,,,
course_1,ch_1_11,les_1_11_03,topic_1_11_03_01,quiz_1_11_03_4,,,
course_1,ch_1_11,les_1_11_03,topic_1_11_03_01,quiz_1_11_03_5,,,
course_1,ch_1_11,les_1_11_04,topic_1_11_04_01,quiz_1_11_04_1,,,
course_1,ch_1_11,les_1_11_04,topic_1_11_04_01,quiz_1_11_04_2,,,
course_1,ch_1_11,les_1_11_04,topic_1_11_04_01,quiz_1_11_04_3,,,
course_1,ch_1_11,les_1_11_04,topic_1_11_04_01,quiz_1_11_04_4,,,
course_1,ch_1_11,les_1_11_04,topic_1_11_04_01,quiz_1_11_04_5,,,
course_1,ch_1_11,les_1_11_05,topic_1_11_05_01,quiz_1_11_05_1,,,
course_1,ch_1_11,les_1_11_05,topic_1_11_05_01,quiz_1_11_05_2,,,
course_1,ch_1_11,les_1_11_05,topic_1_11_05_01,quiz_1_11_05_3,,,
course_1,ch_1_11,les_1_11_05,topic_1_11_05_01,quiz_1_11_05_4,,,
course_1,ch_1_11,les_1_11_05,topic_1_11_05_01,quiz_1_11_05_5,,,
course_1,ch_1_11,les_1_11_06,topic_1_11_06_01,quiz_1_11_06_1,,,
course_1,ch_1_11,les_1_11_06,topic_1_11_06_01,quiz_1_11_06_2,,,
course_1,ch_1_11,les_1_11_06,topic_1_11_06_01,quiz_1_11_06_3,,,
course_1,ch_1_11,les_1_11_06,topic_1_11_06_01,quiz_1_11_06_4,,,
course_1,ch_1_11,les_1_11_06,topic_1_11_06_01,quiz_1_11_06_5,,,
course_1,ch_1_11,les_1_11_07,topic_1_11_07_01,quiz_1_11_07_1,,,
course_1,ch_1_11,les_1_11_07,topic_1_11_07_01,quiz_1_11_07_2,,,
course_1,ch_1_11,les_1_11_07,topic_1_11_07_01,quiz_1_11_07_3,,,
course_1,ch_1_11,les_1_11_07,topic_1_11_07_01,quiz_1_11_07_4,,,
course_1,ch_1_11,les_1_11_07,topic_1_11_07_01,quiz_1_11_07_5,,,
course_1,ch_1_11,les_1_11_08,topic_1_11_08_01,quiz_1_11_08_1,,,
course_1,ch_1_11,les_1_11_08,topic_1_11_08_01,quiz_1_11_08_2,,,
course_1,ch_1_11,les_1_11_08,topic_1_11_08_01,quiz_1_11_08_3,,,
course_1,ch_1_11,les_1_11_08,topic_1_11_08_01,quiz_1_11_08_4,,,
course_1,ch_1_11,les_1_11_08,topic_1_11_08_01,quiz_1_11_08_5,,,
course_1,ch_1_11,les_1_11_09,topic_1_11_09_01,quiz_1_11_09_1,,,
course_1,ch_1_11,les_1_11_09,topic_1_11_09_01,quiz_1_11_09_2,,,
course_1,ch_1_11,les_1_11_09,topic_1_11_09_01,quiz_1_11_09_3,,,
course_1,ch_1_11,les_1_11_09,topic_1_11_09_01,quiz_1_11_09_4,,,
course_1,ch_1_11,les_1_11_09,topic_1_11_09_01,quiz_1_11_09_5,,,
course_1,ch_1_11,les_1_11_10,topic_1_11_10_01,quiz_1_11_10_1,,,
course_1,ch_1_11,les_1_11_10,topic_1_11_10_01,quiz_1_11_10_2,,,
course_1,ch_1_11,les_1_11_10,topic_1_11_10_01,quiz_1_11_10_3,,,
course_1,ch_1_11,les_1_11_10,topic_1_11_10_01,quiz_1_11_10_4,,,
course_1,ch_1_11,les_1_11_10,topic_1_11_10_01,quiz_1_11_10_5,,,
course_1,ch_1_12,les_1_12_01,topic_1_12_01_01,quiz_1_12_01_1,,,
course_1,ch_1_12,les_1_12_01,topic_1_12_01_01,quiz_1_12_01_2,,,
course_1,ch_1_12,les_1_12_01,topic_1_12_01_01,quiz_1_12_01_3,, ,
course_1,ch_1_12,les_1_12_01,topic_1_12_01_01,quiz_1_12_01_4,,,
course_1,ch_1_12,les_1_12_01,topic_1_12_01_01,quiz_1_12_01_5,,,
course_1,ch_1_12,les_1_12_02,topic_1_12_02_01,quiz_1_12_02_1,,,
course_1,ch_1_12,les_1_12_02,topic_1_12_02_01,quiz_1_12_02_2,,,
course_1,ch_1_12,les_1_12_02,topic_1_12_02_01,quiz_1_12_02_3,,,
course_1,ch_1_12,les_1_12_02,topic_1_12_02_01,quiz_1_12_02_4,,,
course_1,ch_1_12,les_1_12_02,topic_1_12_02_01,quiz_1_12_02_5,,,
course_1,ch_1_12,les_1_12_03,topic_1_12_03_01,quiz_1_12_03_1,,,
course_1,ch_1_12,les_1_12_03,topic_1_12_03_01,quiz_1_12_03_2,,,
course_1,ch_1_12,les_1_12_03,topic_1_12_03_01,quiz_1_12_03_3,,,
course_1,ch_1_12,les_1_12_03,topic_1_12_03_01,quiz_1_12_03_4,,,
course_1,ch_1_12,les_1_12_03,topic_1_12_03_01,quiz_1_12_03_5,,,
course_1,ch_1_12,les_1_12_04,topic_1_12_04_01,quiz_1_12_04_1,,,
course_1,ch_1_12,les_1_12_04,topic_1_12_04_01,quiz_1_12_04_2,,,
course_1,ch_1_12,les_1_12_04,topic_1_12_04_01,quiz_1_12_04_3,,,
course_1,ch_1_12,les_1_12_04,topic_1_12_04_01,quiz_1_12_04_4,,,
course_1,ch_1_12,les_1_12_04,topic_1_12_04_01,quiz_1_12_04_5,,,
course_1,ch_1_12,les_1_12_05,topic_1_12_05_01,quiz_1_12_05_1,,,
course_1,ch_1_12,les_1_12_05,topic_1_12_05_01,quiz_1_12_05_2,,,
course_1,ch_1_12,les_1_12_05,topic_1_12_05_01,quiz_1_12_05_3,,,
course_1,ch_1_12,les_1_12_05,topic_1_12_05_01,quiz_1_12_05_4,,,
course_1,ch_1_12,les_1_12_05,topic_1_12_05_01,quiz_1_12_05_5,,,
course_1,ch_1_12,les_1_12_06,topic_1_12_06_01,quiz_1_12_06_1,,,
course_1,ch_1_12,les_1_12_06,topic_1_12_06_01,quiz_1_12_06_2,,,
course_1,ch_1_12,les_1_12_06,topic_1_12_06_01,quiz_1_12_06_3,,,
course_1,ch_1_12,les_1_12_06,topic_1_12_06_01,quiz_1_12_06_4,,,
course_1,ch_1_12,les_1_12_06,topic_1_12_06_01,quiz_1_12_06_5,,,
course_1,ch_1_12,les_1_12_07,topic_1_12_07_01,quiz_1_12_07_1,,,
course_1,ch_1_12,les_1_12_07,topic_1_12_07_01,quiz_1_12_07_2,,,
course_1,ch_1_12,les_1_12_07,topic_1_12_07_01,quiz_1_12_07_3,,,
course_1,ch_1_12,les_1_12_07,topic_1_12_07_01,quiz_1_12_07_4,,,
course_1,ch_1_12,les_1_12_07,topic_1_12_07_01,quiz_1_12_07_5,,,
course_1,ch_1_12,les_1_12_08,topic_1_12_08_01,quiz_1_12_08_1,,,
course_1,ch_1_12,les_1_12_08,topic_1_12_08_01,quiz_1_12_08_2,,,
course_1,ch_1_12,les_1_12_08,topic_1_12_08_01,quiz_1_12_08_3,,,
course_1,ch_1_12,les_1_12_08,topic_1_12_08_01,quiz_1_12_08_4,,,
course_1,ch_1_12,les_1_12_08,topic_1_12_08_01,quiz_1_12_08_5,,,
course_1,ch_1_12,les_1_12_09,topic_1_12_09_01,quiz_1_12_09_1,,,
course_1,ch_1_12,les_1_12_09,topic_1_12_09_01,quiz_1_12_09_2,,,
course_1,ch_1_12,les_1_12_09,topic_1_12_09_01,quiz_1_12_09_3,,,
course_1,ch_1_12,les_1_12_09,topic_1_12_09_01,quiz_1_12_09_4,,,
course_1,ch_1_12,les_1_12_09,topic_1_12_09_01,quiz_1_12_09_5,,,
course_1,ch_1_12,les_1_12_10,topic_1_12_10_01,quiz_1_12_10_1,,,
course_1,ch_1_12,les_1_12_10,topic_1_12_10_01,quiz_1_12_10_2,,,
course_1,ch_1_12,les_1_12_10,topic_1_12_10_01,quiz_1_12_10_3,,,
course_1,ch_1_12,les_1_12_10,topic_1_12_10_01,quiz_1_12_10_4,,,
course_1,ch_1_12,les_1_12_10,topic_1_12_10_01,quiz_1_12_10_5,,,
course_2,ch_2_01,les_2_01_01,topic_2_01_01_01,quiz_2_01_01_1,Which statement best describes the main goal of Pharmacovigilance (PV)?,"A) To study the chemical structure of new drugs | B) To detect, assess, and prevent adverse drug effects | C) To promote drug sales globally | D) To monitor drug manufacturing quality",B
course_2,ch_2_01,les_2_01_01,topic_2_01_01_01,quiz_2_01_01_2,Which event directly led to the creation of modern global drug regulations?,A) 1937 Sulfanilamide tragedy | B) 1848 chloroform death | C) 1978 launch of WHO’s VigiBase | D) 1995 establishment of EMA,A
course_2,ch_2_01,les_2_01_01,topic_2_01_01_01,quiz_2_01_01_3,What is the primary limitation of spontaneous reporting in Pharmacovigilance?,A) It is too expensive to maintain | B) Less than 10% of adverse reactions are reported | C) It focuses only on clinical trials | D) It cannot be accessed by patients,B
course_2,ch_2_01,les_2_01_01,topic_2_01_01_01,quiz_2_01_01_4,Which organization manages EudraVigilance and oversees drug safety in the EU?,A) WHO | B) CIOMS | C) EMA | D) FDA,C
course_2,ch_2_01,les_2_01_01,topic_2_01_01_01,quiz_2_01_01_5,What future trend is expected to improve signal detection in Pharmacovigilance?,A) Paper-based record keeping | B) Increased manual data entry | C) Artificial intelligence and real-world data | D) Reduced international collaboration,C
course_2,ch_2_01,les_2_01_02,topic_2_01_02_01,quiz_2_01_02_1,"Which incident led directly to the passage of the Federal Food, Drug, and Cosmetic Act (1938)?",A) The Vioxx withdrawal | B) Thalidomide birth defects | C) The Sulfanilamide Elixir Tragedy | D) Hannah Greener’s chloroform death,C
course_2,ch_2_01,les_2_01_02,topic_2_01_02_01,quiz_2_01_02_2,What was the main outcome of the thalidomide crisis in the 1960s?,A) Creation of WHO’s VigiBase | B) Stricter global drug safety regulations and new monitoring systems | C) Ban on sedatives worldwide | D) Establishment of the ICH,B
course_2,ch_2_01,les_2_01_02,topic_2_01_02_01,quiz_2_01_02_3,What was the purpose of establishing the Uppsala Monitoring Centre (UMC) in 1978?,"A) To manage WHO’s global ADR database, VigiBase | B) To regulate European clinical trials | C) To monitor the safety of herbal medicines | D) To certify pharmaceutical manufacturers",A
course_2,ch_2_01,les_2_01_02,topic_2_01_02_01,quiz_2_01_02_4,Which of the following developments introduced standardized global drug regulations across major regions?,A) EMA formation in 1995 | B) ICH establishment in 1990 | C) FDA’s ADRRS in the 1970s | D) WHO PIDM in 1968,B
course_2,ch_2_01,les_2_01_02,topic_2_01_02_01,quiz_2_01_02_5,What major advancement characterized Pharmacovigilance in the 2010s–2020s?,A) Manual ADR reporting through postal systems | B) AI-driven signal detection and use of big data analytics | C) Exclusive focus on clinical trial data | D) Reduction in international PV collaborations,B
course_2,ch_2_01,les_2_01_03,topic_2_01_03_01,quiz_2_01_03_1,What is the primary function of the World Health Organization (WHO) in Pharmacovigilance?,A) Conducting preclinical drug trials | B) Coordinating global drug marketing | C) Promoting safety monitoring through international collaboration | D) Approving new drug patents,C
course_2,ch_2_01,les_2_01_03,topic_2_01_03_01,quiz_2_01_03_2,Which system serves as the FDA’s central repository for Individual Case Safety Reports (ICSRs)?,A) FAERS | B) EudraVigilance | C) VigiBase | D) DSUR,A
course_2,ch_2_01,les_2_01_03,topic_2_01_03_01,quiz_2_01_03_3,What is the main role of the International Council for Harmonisation (ICH) in Pharmacovigilance?,A) Managing global safety databases | B) Developing harmonized technical PV guidelines across jurisdictions | C) Investigating local drug safety incidents | D) Conducting inspections of manufacturing sites,B
course_2,ch_2_01,les_2_01_03,topic_2_01_03_01,quiz_2_01_03_4,Which national regulatory authority oversees AE collection and PV implementation in India?,A) MHRA | B) PvPI | C) PMDA | D) TGA,B
course_2,ch_2_01,les_2_01_03,topic_2_01_03_01,quiz_2_01_03_5,What technological advancement is increasingly integrated into PV workflows under regulatory supervision?,A) Blockchain-based marketing approval | B) Manual report transcription | C) AI-assisted signal detection and electronic E2B(R3) reporting | D) Paper-based ADR submissions,C
course_2,ch_2_01,les_2_01_04,topic_2_01_04_01,quiz_2_01_04_1,Which statement best defines an Adverse Event (AE)?,"A) Any harmful effect proven to be caused by a drug | B) Any unintended medical occurrence in a patient given a medicinal product, regardless of causality | C) Only life-threatening reactions due to overdose | D) A temporary side effect unrelated to treatment",B
course_2,ch_2_01,les_2_01_04,topic_2_01_04_01,quiz_2_01_04_2,How does an Adverse Drug Reaction (ADR) differ from an Adverse Event (AE)?,"A) ADRs include only psychological effects | B) ADRs imply a causal relationship with the drug, while AEs do not necessarily | C) AEs are limited to post-marketing cases | D) ADRs are not reported to regulatory authorities",B
course_2,ch_2_01,les_2_01_04,topic_2_01_04_01,quiz_2_01_04_3,Which of the following qualifies as a Serious Adverse Event (SAE)?,A) Mild drowsiness after antihistamine use | B) Temporary nausea resolving without treatment | C) Hospitalization following an anaphylactic reaction | D) Dry mouth after antibiotic use,C
course_2,ch_2_01,les_2_01_04,topic_2_01_04_01,quiz_2_01_04_4,Which of the following is NOT part of the EU’s expanded scope of Pharmacovigilance since 2010?,A) Medication errors and misuse | B) Drug exposure during pregnancy | C) Occupational exposure | D) Preclinical animal testing errors,D
course_2,ch_2_01,les_2_01_04,topic_2_01_04_01,quiz_2_01_04_5,What is the main purpose of analyzing Adverse Event data in Pharmacovigilance?,A) To promote drug marketing campaigns | B) To detect safety signals and identify potential causal links between drugs and events | C) To determine drug pricing strategies | D) To eliminate mild side effects from labeling,B
course_2,ch_2_01,les_2_01_05,topic_2_01_05_01,quiz_2_01_05_1,What is the primary purpose of Good Pharmacovigilance Practices (GVP)?,A) To regulate pre-marketing drug approval procedures | B) To ensure post-authorization drug safety through structured monitoring and compliance | C) To evaluate manufacturing efficiency | D) To replace ICH guidelines for all EU drug reviews,B
course_2,ch_2_01,les_2_01_05,topic_2_01_05_01,quiz_2_01_05_2,"Which GVP module focuses on Risk Management Systems, including Risk Management Plans (RMPs) and minimization measures?",A) Module II | B) Module V | C) Module VIII | D) Module IX,B
course_2,ch_2_01,les_2_01_05,topic_2_01_05_01,quiz_2_01_05_3,How long must safety records be retained after product withdrawal under GVP requirements?,A) 5 years | B) 7 years | C) 10 years or more | D) Indefinitely,C
course_2,ch_2_01,les_2_01_05,topic_2_01_05_01,quiz_2_01_05_4,Which regulation formally established GVP within the European Union?,A) Regulation (EU) No 1235/2010 and Directive 2010/84/EU | B) ICH E2C(R2) | C) FDA 21 CFR Part 314 | D) CIOMS VIII Guidelines,A
course_2,ch_2_01,les_2_01_05,topic_2_01_05_01,quiz_2_01_05_5,What is the key purpose of Module VII in the GVP framework?,A) Describing Pharmacovigilance Inspections | B) Managing Periodic Benefit–Risk Evaluation Reports (PBRERs) | C) Conducting Post-Authorisation Safety Studies (PASS) | D) Implementing Safety Communications,B
course_2,ch_2_01,les_2_01_06,topic_2_01_06_01,quiz_2_01_06_1,Which AI technology in pharmacovigilance is specifically used to extract insights from unstructured text like clinical notes or social media posts?,A) Deep Learning | B) Robotic Process Automation | C) Natural Language Processing | D) Bayesian Models,C
course_2,ch_2_01,les_2_01_06,topic_2_01_06_01,quiz_2_01_06_2,What is a key benefit of integrating AI into pharmacovigilance workflows?,A) Consistent and objective causality evaluations | B) Manual reporting speed | C) Reduced patient data | D) Limited data sources,A
course_2,ch_2_01,les_2_01_06,topic_2_01_06_01,quiz_2_01_06_3,Which challenge is associated with using AI in pharmacovigilance?,A) Regulation and Ethics | B) Increased subjectivity | C) Slower signal detection | D) Inability to handle structured data,A
course_2,ch_2_01,les_2_01_06,topic_2_01_06_01,quiz_2_01_06_4,Which AI application helps in forecasting patient populations at risk of adverse events?,A) Case Processing Automation | B) Predictive Analytics | C) Real-Time Monitoring | D) Signal Detection and Triage,B
course_2,ch_2_01,les_2_01_06,topic_2_01_06_01,quiz_2_01_06_5,Future directions of AI in pharmacovigilance include:,A) Multimodal data fusion | B) Eliminating human oversight completely | C) Restricting AI to only structured datasets | D) Reducing patient safety measures,A
course_2,ch_2_01,les_2_01_07,topic_2_01_07_01,quiz_2_01_07_1,"Which PV role is primarily responsible for logging, screening, and categorizing adverse event cases?",A) PV Scientist / Drug Safety Associate | B) PV Officer / PV Associate | C) Signal Detection Specialist | D) Medical Reviewer / PV Physician,B
course_2,ch_2_01,les_2_01_07,topic_2_01_07_01,quiz_2_01_07_2,Who in a pharmacovigilance team evaluates the medical plausibility of adverse events and provides expert input for causality assessment?,A) Regulatory Affairs Specialist | B) PV Manager / Lead | C) Medical Reviewer / PV Physician | D) PV Officer / Associate,C
course_2,ch_2_01,les_2_01_07,topic_2_01_07_01,quiz_2_01_07_3,Which responsibility is specific to a Signal Detection Specialist?,A) Trend analysis of AE data | B) Data entry and case processing | C) Preparing PSURs and DSURs | D) Conducting internal audits,A
course_2,ch_2_01,les_2_01_07,topic_2_01_07_01,quiz_2_01_07_4,Which guideline or standard ensures consistency in adverse event terminology in PV?,A) GVP Guidelines | B) MedDRA Coding Standards | C) ICH E2B(R3) | D) Local Regulatory Guidelines,B
course_2,ch_2_01,les_2_01_07,topic_2_01_07_01,quiz_2_01_07_5,A common mitigation strategy for delayed case reporting in PV is:,A) Cross-functional review | B) Automated alerts and dashboards | C) Regular audits | D) AI-assisted signal detection,B
course_2,ch_2_01,les_2_01_08,topic_2_01_08_01,quiz_2_01_08_1,What is the primary purpose of MedDRA?,A) Facilitate international regulatory compliance | B) Provide standardized medical terminology | C) Replace clinical trial protocols | D) Monitor patient adherence,B
course_2,ch_2_01,les_2_01_08,topic_2_01_08_01,quiz_2_01_08_2,"Which MedDRA level represents the most specific terms, including synonyms or colloquial expressions?",A) High-Level Term | B) Lowest Level Term | C) Preferred Term | D) System Organ Class,B
course_2,ch_2_01,les_2_01_08,topic_2_01_08_01,quiz_2_01_08_3,How does MedDRA support signal detection in pharmacovigilance?,A) By coding AEs uniformly across databases | B) By limiting AE reports to local systems | C) By replacing laboratory data | D) By controlling clinical trial recruitment,A
course_2,ch_2_01,les_2_01_08,topic_2_01_08_01,quiz_2_01_08_4,Which organization maintains MedDRA and provides biannual updates?,A) WHO | B) MSSO | C) FDA | D) ICH,B
course_2,ch_2_01,les_2_01_08,topic_2_01_08_01,quiz_2_01_08_5,What is a key challenge when implementing MedDRA in small organizations?,A) Multilingual translations | B) High complexity and training needs | C) Excessive signal detection | D) Regulatory approval delays,B
course_2,ch_2_01,les_2_01_09,topic_2_01_09_01,quiz_2_01_09_1,Which document serves as the central reference for a company’s pharmacovigilance operations and regulatory inspections?,A) Risk Management Plan (RMP) | B) Pharmacovigilance System Master File (PSMF) | C) Periodic Safety Update Report (PSUR) | D) Individual Case Safety Report (ICSR),B
course_2,ch_2_01,les_2_01_09,topic_2_01_09_01,quiz_2_01_09_2,The Risk Management Plan (RMP) is primarily designed to:,A) Collect individual adverse event data for signal detection | B) Manage identified and potential risks to maintain a favorable benefit-risk balance | C) Summarize aggregate safety and efficacy data for periodic review | D) Serve as the organizational blueprint for pharmacovigilance systems,B
course_2,ch_2_01,les_2_01_09,topic_2_01_09_01,quiz_2_01_09_3,"According to GVP Module VI, a serious adverse reaction must be reported to authorities within:",A) 7 days | B) 15 days | C) 30 days | D) 90 days,B
course_2,ch_2_01,les_2_01_09,topic_2_01_09_01,quiz_2_01_09_4,Which report evaluates a product’s benefit-risk profile by analyzing cumulative safety data collected over time?,A) Individual Case Safety Report (ICSR) | B) Post-Authorization Safety Study (PASS) Report | C) Periodic Safety Update Report (PSUR) / PBRER | D) Risk Management Plan (RMP),C
course_2,ch_2_01,les_2_01_09,topic_2_01_09_01,quiz_2_01_09_5,Safety Communication Documents such as DHPCs are issued primarily to:,A) Inform healthcare professionals and the public about new risks or safety measures | B) Update the internal audit trail of the MAH | C) Report aggregate data from clinical trials | D) Replace outdated versions of the PSMF,A
course_2,ch_2_01,les_2_01_10,topic_2_01_10_01,quiz_2_01_10_1,What is the main role of the International Council for Harmonisation (ICH) in Pharmacovigilance?,A) Managing global safety databases | B) Developing harmonized technical PV guidelines across jurisdictions | C) Investigating local drug safety incidents | D) Conducting inspections of manufacturing sites,B
course_2,ch_2_01,les_2_01_10,topic_2_01_10_01,quiz_2_01_10_2,Which AI application helps in forecasting patient populations at risk of adverse events?,A) Case Processing Automation | B) Predictive Analytics | C) Real-Time Monitoring | D) Signal Detection and Triage,B
course_2,ch_2_01,les_2_01_10,topic_2_01_10_01,quiz_2_01_10_3,How does MedDRA support signal detection in pharmacovigilance?,A) By coding AEs uniformly across databases | B) By limiting AE reports to local systems | C) By replacing laboratory data | D) By controlling clinical trial recruitment,A
course_2,ch_2_01,les_2_01_10,topic_2_01_10_01,quiz_2_01_10_4,What was the purpose of establishing the Uppsala Monitoring Centre (UMC) in 1978?,"A) To manage WHO’s global ADR database, VigiBase | B) To regulate European clinical trials | C) To monitor the safety of herbal medicines | D) To certify pharmaceutical manufacturers",A
course_2,ch_2_01,les_2_01_10,topic_2_01_10_01,quiz_2_01_10_5,What is a key benefit of integrating AI into pharmacovigilance workflows?,A) Consistent and objective causality evaluations | B) Manual reporting speed | C) Reduced patient data | D) Limited data sources,A
course_2,ch_2_02,les_2_02_01,topic_2_02_01_01,quiz_2_02_01_1,What is the primary purpose of an Individual Case Safety Report (ICSR) in pharmacovigilance?,A) To summarize aggregate clinical trial data | B) To document and report individual adverse events for signal detection and regulatory review | C) To describe company-wide risk management procedures | D) To manage periodic benefit-risk assessments,B
course_2,ch_2_02,les_2_02_01,topic_2_02_01_01,quiz_2_02_01_2,Which guideline defines the electronic transmission format for ICSRs used globally?,A) ICH E2B(R3) | B) GVP Module V | C) WHO-UMC Causality Scale | D) ICH E6(R2),A
course_2,ch_2_02,les_2_02_01,topic_2_02_01_01,quiz_2_02_01_3,"In an ICSR, which section includes details like drug name, dosage, indication, and administration dates?",A) Patient Information | B) Adverse Event Information | C) Medicinal Product Information | D) Administrative Information,C
course_2,ch_2_02,les_2_02_01,topic_2_02_01_01,quiz_2_02_01_4,What is the regulatory timeline for submitting a serious adverse event (SAE) according to GVP Module VI?,A) 30 calendar days | B) 7 calendar days | C) 90 calendar days | D) 15 calendar days,D
course_2,ch_2_02,les_2_02_01,topic_2_02_01_01,quiz_2_02_01_5,Which of the following is a key challenge in ICSR management?,A) Over-reporting of adverse events | B) Inconsistent coding using MedDRA terminology | C) Overuse of electronic submission systems | D) Delayed signal detection due to too many reports,B
course_2,ch_2_02,les_2_02_02,topic_2_02_02_01,quiz_2_02_02_1,Which of the following represents the minimum required information to create a valid AE case during intake?,"A) Patient details, suspected drug, event description, and reporter information | B) Reporter name and qualification only | C) Patient history and hospitalization outcome | D) Drug dosage and batch number only",A
course_2,ch_2_02,les_2_02_02,topic_2_02_02_01,quiz_2_02_02_2,What is the main purpose of triage in the AE Case Intake process?,A) To confirm the reporter’s identity for legal documentation | B) To classify cases by seriousness and priority for processing | C) To collect MedDRA terms for coding | D) To finalize causality assessment of the case,B
course_2,ch_2_02,les_2_02_02,topic_2_02_02_01,quiz_2_02_02_3,"During AE intake, which coding systems are primarily used for adverse events and drug names respectively?",A) ICD-10 and WHO-DD | B) MedDRA and WHO Drug Dictionary | C) ICH E2A and GVP Module VI | D) MeSH and MedDRA,B
course_2,ch_2_02,les_2_02_02,topic_2_02_02_01,quiz_2_02_02_4,Which of the following best describes the case logging step in AE intake?,A) Assigning a unique identification number and entering initial details into the safety database | B) Verifying seriousness classification and submitting to regulators | C) Conducting a causality assessment and labeling updates | D) Performing quality review and audit verification,A
course_2,ch_2_02,les_2_02_02,topic_2_02_02_01,quiz_2_02_02_5,Which strategy best helps mitigate the risk of duplicate AE reports in a safety database?,A) Conducting annual audits of case processors | B) Using automated duplicate detection and cross-checking identifiers | C) Delaying submission until follow-up data is received | D) Reviewing MedDRA hierarchy for every case manually,B
course_2,ch_2_02,les_2_02_03,topic_2_02_03_01,quiz_2_02_03_1,Which of the following scenarios best meets the ICH E2D minimum criteria for generating an ICSR during source document review?,"A) A patient reports mild dizziness after a generic supplement, but no suspect drug is identified. |
B) A nurse reports a patient rash following administration of Drug X, with treatment duration and outcome provided. |
C) A consumer email mentions fatigue but doesn’t specify any medication. |
D) A journal abstract discusses Drug Y’s pharmacokinetics in healthy volunteers.",B
course_2,ch_2_02,les_2_02_03,topic_2_02_03_01,quiz_2_02_03_2,"During SDR, a reviewer receives multiple hospital discharge summaries showing the same AE, patient initials, and treatment dates. What’s the most appropriate next step?","A) Discard duplicates and keep only the first received report. |
B) Combine all reports into a single ICSR without verification. |
C) Perform duplicate check using the safety database and link reports if validated. |
D) Enter each report separately since they came from different hospitals.",C
course_2,ch_2_02,les_2_02_03,topic_2_02_03_01,quiz_2_02_03_3,A document received from a medical journal includes a serious adverse reaction but lacks patient age and contact details. What should the reviewer do according to ICH E2D guidance?,"A) File the document as non-reportable due to missing data. |
B) Generate an ICSR immediately since the event is serious. |
C) Follow up with the publisher for missing information before confirming case validity. |
D) Disregard the document since literature cases aren’t considered valid.",C
course_2,ch_2_02,les_2_02_03,topic_2_02_03_01,quiz_2_02_03_4,Which combination correctly aligns with SDR workflow and regulatory compliance principles?,"A) Step 1: Extract data → Step 2: Triage → Step 3: Timestamp document. |
B) Step 1: Document receipt → Step 2: Preliminary triage → Step 3: Extraction → Step 4: Validity assessment → Step 5: Case generation. |
C) Step 1: Case generation → Step 2: AI validation → Step 3: Filing. |
D) Step 1: Regulatory submission → Step 2: Quality review → Step 3: Archiving.",B
course_2,ch_2_02,les_2_02_03,topic_2_02_03_01,quiz_2_02_03_5,"An SDR reviewer using an AI-based triage tool notices it flagged a patient email as “non-serious.” However, manual review reveals hospitalization details attached. What’s the correct response?","A) Accept AI output — the system prioritizes accuracy. |
B) Override AI decision, reclassify as “serious,” and document rationale in audit trail. |
C) Delete the record to avoid conflicting classifications. |
D) Re-run AI model to confirm its confidence score.",B
course_2,ch_2_02,les_2_02_04,topic_2_02_04_01,quiz_2_02_04_1,Which statement best captures the key difference between narrative writing and technical writing?,"A) Narrative writing uses precise facts and numerical data to inform readers. |
B) Narrative writing recreates experiences through emotion, imagery, and structure. |
C) Technical writing always includes a story arc and character dialogue. |
D) Technical writing avoids structure and focuses only on creativity.",B
course_2,ch_2_02,les_2_02_04,topic_2_02_04_01,quiz_2_02_04_2,"In a well-structured narrative, which part typically contains the highest tension or turning point of the story?","A) Exposition |
B) Climax |
C) Falling action |
D) Resolution",B
course_2,ch_2_02,les_2_02_04,topic_2_02_04_01,quiz_2_02_04_3,"A sentence reads: “She clenched the letter so tightly that her knuckles turned white.”
This sentence is an example of what key narrative writing technique?","A) Telling |
B) Showing |
C) Foreshadowing |
D) Flashback",B
course_2,ch_2_02,les_2_02_04,topic_2_02_04_01,quiz_2_02_04_4,A writer begins a story in first-person but halfway switches to third-person without reason. Which core narrative issue does this reflect?,"A) Inconsistent point of view |
B) Weak theme |
C) Overuse of dialogue |
D) Poor pacing",A
course_2,ch_2_02,les_2_02_04,topic_2_02_04_01,quiz_2_02_04_5,Why might a case report in healthcare benefit from narrative writing principles?,"A) It ensures compliance with ICH regulations. |
B) It transforms clinical data into an engaging, human-centered account of a patient’s journey. |
C) It replaces objective details with emotional interpretation. |
D) It eliminates the need for structured sections like “Findings” or “Discussion.”",B
course_2,ch_2_02,les_2_02_05,topic_2_02_05_01,quiz_2_02_05_1,What is the main goal of implementing AI in the ICSR triage process?,"A) To replace human reviewers entirely and automate regulatory submissions. |
B) To accelerate and standardize the prioritization of safety reports while reducing manual workload. |
C) To eliminate the need for database validation and audit trails. |
D) To classify only non-serious adverse events for quicker closure.",B
course_2,ch_2_02,les_2_02_05,topic_2_02_05_01,quiz_2_02_05_2,"In pharmacovigilance, which AI technology helps extract structured data from unstructured narrative text such as scanned PDFs or handwritten notes?","A) Predictive modeling |
B) Neural clustering |
C) Natural Language Processing (NLP) |
D) Deep text reconstruction",C
course_2,ch_2_02,les_2_02_05,topic_2_02_05_01,quiz_2_02_05_3,"A case flagged by AI as “non-serious” later turns out to involve hospitalization. According to best practices, what should the pharmacovigilance team do?","A) Trust the algorithm since it’s pre-validated. |
B) Reclassify the case manually, document the correction, and investigate why the AI misclassified it. |
C) Delete the AI output and re-run the system. |
D) Keep both classifications for record-keeping without changes.",B
course_2,ch_2_02,les_2_02_05,topic_2_02_05_01,quiz_2_02_05_4,Which statement best defines the “human-in-the-loop” approach in AI-based ICSR triage?,"A) Humans review only failed AI outputs and ignore all other cases. |
B) AI performs initial triage, but humans validate, correct, and finalize classifications. |
C) AI generates final decisions that are auto-submitted to regulators. |
D) Humans manually enter cases before AI takes over.",B
course_2,ch_2_02,les_2_02_05,topic_2_02_05_01,quiz_2_02_05_5,Why is regulatory validation critical when adopting AI tools in pharmacovigilance?,"A) Because agencies require proof of algorithm performance, version control, and compliance with GCP/ICH standards. |
B) Because validation increases the speed of triage by 60%. |
C) Because unvalidated models are faster but less expensive. |
D) Because it allows companies to skip human oversight in serious cases.",A
course_2,ch_2_02,les_2_02_06,topic_2_02_06_01,quiz_2_02_06_1,What is the primary goal of causality assessment in pharmacovigilance?,"A) To determine whether an adverse event is caused by the drug or coincidental. |
B) To calculate drug dosage adjustments based on patient age. |
C) To identify all possible side effects regardless of clinical evidence. |
D) To replace clinical judgment with algorithmic prediction.",A
course_2,ch_2_02,les_2_02_06,topic_2_02_06_01,quiz_2_02_06_2,"Which category best describes a case where an event disappears after drug withdrawal and reappears upon re-administration, with no other explanation?","A) Probable |
B) Certain |
C) Possible |
D) Unlikely",B
course_2,ch_2_02,les_2_02_06,topic_2_02_06_01,quiz_2_02_06_3,The Naranjo Algorithm determines causality primarily by:,"A) Using a point-based questionnaire evaluating timing, dechallenge, rechallenge, and alternative causes. |
B) Comparing patient events against population-level AI models. |
C) Reviewing narrative summaries and assigning causality through consensus voting. |
D) Predicting drug interactions through literature scanning only.",A
course_2,ch_2_02,les_2_02_06,topic_2_02_06_01,quiz_2_02_06_4,Which of the following factors is least likely to be used when performing a causality assessment?,"A) Dechallenge and rechallenge outcomes |
B) Patient demographics like age and sex |
C) Known pharmacology and prior literature reports |
D) Sales data of the suspect drug",D
course_2,ch_2_02,les_2_02_06,topic_2_02_06_01,quiz_2_02_06_5,Why is clear documentation of causality assessment essential in an ICSR?,"A) It ensures transparency, supports audits, and provides evidence for regulatory decisions. |
B) It helps shorten narrative writing by summarizing only results. |
C) It eliminates the need for medical peer review. |
D) It allows automation tools to finalize regulatory submissions.",A
course_2,ch_2_02,les_2_02_07,topic_2_02_07_01,quiz_2_02_07_1,What is the primary reason MedDRA coding is used in pharmacovigilance?,"A) To standardize medical terms for accurate global safety data analysis. |
B) To reduce the number of adverse events reported to regulators. |
C) To automatically infer causality between drug and event. |
D) To translate case reports into local languages.",A
course_2,ch_2_02,les_2_02_07,topic_2_02_07_01,quiz_2_02_07_2,Which MedDRA hierarchy level represents the most specific medical concept that directly reflects the reporter’s verbatim term?,"A) System Organ Class (S.O.C.) |
B) High Level Group Term (H.L.G.T.) |
C) Lowest Level Term (L.L.T.) |
D) Preferred Term (P.T.)",C
course_2,ch_2_02,les_2_02_07,topic_2_02_07_01,quiz_2_02_07_3,"During MedDRA coding, what should a coder avoid doing to maintain data accuracy?","A) Inferring causality or severity when selecting terms. |
B) Mapping multiple symptoms separately. |
C) Following company SOPs for borderline terms. |
D) Using the latest MedDRA version during updates.",A
course_2,ch_2_02,les_2_02_07,topic_2_02_07_01,quiz_2_02_07_4,"In the coding process, once the coder selects a Lowest Level Term (L.L.T.), what happens next?","A) It automatically maps to its corresponding Preferred Term (P.T.). |
B) It must be manually categorized under a System Organ Class. |
C) It is sent to regulatory authorities for confirmation. |
D) It gets linked to the adverse event narrative directly.",A
course_2,ch_2_02,les_2_02_07,topic_2_02_07_01,quiz_2_02_07_5,Which of the following best describes a common pitfall in MedDRA coding?,"A) Choosing a broad, nonspecific term instead of the most accurate one. |
B) Documenting rationale for each selected code. |
C) Separating and coding each symptom individually. |
D) Verifying term alignment with MedDRA hierarchy.",A
course_2,ch_2_02,les_2_02_08,topic_2_02_08_01,quiz_2_02_08_1,Why are quality checks considered critical in the I.C.S.R. process?,"A) To ensure reports are accurate, complete, and regulatory-compliant. |
B) To reduce the number of adverse events submitted to regulators. |
C) To automatically classify adverse events as serious or non-serious. |
D) To replace human review in pharmacovigilance.",A
course_2,ch_2_02,les_2_02_08,topic_2_02_08_01,quiz_2_02_08_2,"During the initial review step of I.C.S.R. quality checks, which of the following would be flagged for follow-up?","A) An adverse event occurring before drug administration. |
B) Correct MedDRA coding already applied. |
C) Fully completed mandatory fields. |
D) Accurate reporter contact information.",A
course_2,ch_2_02,les_2_02_08,topic_2_02_08_01,quiz_2_02_08_3,Which activity is a key part of source document verification?,"A) Comparing adverse event and drug details against original clinical records. |
B) Automatically assigning seriousness to the adverse event. |
C) Updating MedDRA coding without consulting source documents. |
D) Submitting the I.C.S.R. to regulators before validation.",A
course_2,ch_2_02,les_2_02_08,topic_2_02_08_01,quiz_2_02_08_4,Why is coding verification important in I.C.S.R. quality checks?,"A) It ensures meaningful aggregation of safety data and regulatory compliance. |
B) It allows inferring causality directly from adverse event descriptions. |
C) It eliminates the need for human review. |
D) It automatically prioritizes serious cases for submission.",A
course_2,ch_2_02,les_2_02_08,topic_2_02_08_01,quiz_2_02_08_5,Which of the following best describes a best practice for I.C.S.R. quality checks?,"A) Use checklists or templates and document all follow-up actions. |
B) Skip peer review for high-priority cases to save time. |
C) Rely solely on automated tools without human interpretation. |
D) Correct errors in the I.C.S.R. without contacting the reporter.",A
course_2,ch_2_02,les_2_02_09,topic_2_02_09_01,quiz_2_02_09_1,What is the usual regulatory submission timeline for serious and unexpected adverse events?,A) Within 30 calendar days | B) Within 15 calendar days | C) Within 45 calendar days | D) Within 7 business days,B
course_2,ch_2_02,les_2_02_09,topic_2_02_09_01,quiz_2_02_09_2,Which of the following is an example of a high-priority case for submission?,A) Non-serious and expected events | B) Serious but expected events | C) Fatal or life-threatening events | D) Periodic safety update reports,C
course_2,ch_2_02,les_2_02_09,topic_2_02_09_01,quiz_2_02_09_3,What information is mandatory to include in an Individual Case Safety Report (ICSR)?,"A) Patient demographics, drug details, event description | B) Company revenue data and market share | C) Investigator CV and credentials | D) Product advertising material",A
course_2,ch_2_02,les_2_02_09,topic_2_02_09_01,quiz_2_02_09_4,In which system are adverse event reports electronically submitted in the European Union?,A) EudraVigilance | B) MedWatch | C) VigiBase | D) DrugTrack,A
course_2,ch_2_02,les_2_02_09,topic_2_02_09_01,quiz_2_02_09_5,Which of the following best describes follow-up reporting?,A) Submitting marketing data for a product | B) Submitting additional or corrected case information promptly | C) Delaying report submission due to incomplete data | D) Resubmitting all reports every quarter,B
course_2,ch_2_02,les_2_02_10,topic_2_02_10_01,quiz_2_02_10_1,Which of the following conditions must be met before an ICSR can be closed?,A) Only seriousness assessment completed | B) All required case data collected and verified | C) Partial follow-up received | D) Regulatory reporting pending,B
course_2,ch_2_02,les_2_02_10,topic_2_02_10_01,quiz_2_02_10_2,What is the final action in the ICSR case closure workflow?,A) Database update and case lock | B) Follow-up verification | C) Quality control review | D) Causality assessment,A
course_2,ch_2_02,les_2_02_10,topic_2_02_10_01,quiz_2_02_10_3,Who is primarily responsible for confirming causality and clinical significance during case closure?,A) PV Associate | B) Regulatory Affairs Officer | C) PV Physician / Medical Reviewer | D) PV QA Specialist,C
course_2,ch_2_02,les_2_02_10,topic_2_02_10_01,quiz_2_02_10_4,Which tool is commonly used for coding adverse event terms during case closure?,A) WHO Drug Dictionary | B) MedDRA | C) Argus Safety Database | D) Veeva Vault,B
course_2,ch_2_02,les_2_02_10,topic_2_02_10_01,quiz_2_02_10_5,What is a key strategy to prevent premature closure of cases?,A) Skip the medical review step | B) Rely solely on automated systems | C) Implement checklist-based closure SOPs | D) Close all cases within 24 hours,C
course_2,ch_2_03,les_2_03_01,topic_2_03_01_01,quiz_2_03_01_1,Which global pharmacovigilance database is managed by the Uppsala Monitoring Centre (UMC) under the World Health Organization (WHO)?,A) EudraVigilance | B) VigiBase | C) FAERS | D) JADER,B
course_2,ch_2_03,les_2_03_01,topic_2_03_01_01,quiz_2_03_01_2,The EudraVigilance database primarily collects and manages safety data for which region?,A) Canada | B) United States | C) European Union | D) Japan,C
course_2,ch_2_03,les_2_03_01,topic_2_03_01_01,quiz_2_03_01_3,Which of the following statements best describes the purpose of MedDRA coding in PV databases?,A) It classifies medical devices for approval | B) It standardizes adverse event terminology | C) It tracks manufacturing sites | D) It verifies patient consent forms,B
course_2,ch_2_03,les_2_03_01,topic_2_03_01_01,quiz_2_03_01_4,The FDA FAERS database is designed to monitor adverse events related to:,A) Herbal products | B) Food supplements | C) Drugs and biologics | D) Medical devices only,C
course_2,ch_2_03,les_2_03_01,topic_2_03_01_01,quiz_2_03_01_5,"What is one of the major challenges faced by global PV databases, and how is it mitigated?",A) Excessive follow-ups – by ignoring duplicates | B) Data duplication – by using reconciliation algorithms | C) Limited global access – by reducing submissions | D) Incomplete reports – by closing cases early,B
course_2,ch_2_03,les_2_03_02,topic_2_03_02_01,quiz_2_03_02_1,What is the primary purpose of the E2B(R3) standard in pharmacovigilance?,A) To track global drug prices | B) To standardize electronic ICSR data exchange | C) To manage clinical site logistics | D) To record patient consent information,B
course_2,ch_2_03,les_2_03_02,topic_2_03_02_01,quiz_2_03_02_2,Which file format is used for transmitting E2B(R3) ICSR data?,A) CSV | B) JSON | C) XML | D) TXT,C
course_2,ch_2_03,les_2_03_02,topic_2_03_02_01,quiz_2_03_02_3,Which of the following is a major improvement introduced in E2B(R3) compared to E2B(R2)?,A) Manual data entry only | B) Limited MedDRA coding | C) Support for linked and follow-up cases | D) Removal of XML formatting,C
course_2,ch_2_03,les_2_03_02,topic_2_03_02_01,quiz_2_03_02_4,Which coding dictionaries are used to standardize terms in E2B(R3) case submissions?,A) ICD and SNOMED | B) MedDRA and WHO Drug Dictionary | C) DSM and ATC | D) UMLS and RxNorm,B
course_2,ch_2_03,les_2_03_02,topic_2_03_02_01,quiz_2_03_02_5,What is a key mitigation strategy for avoiding missing mandatory fields during E2B(R3) submissions?,A) Skip validation checks | B) Implement case intake checklists and validation rules | C) Submit cases before review | D) Use manual entry for faster reporting,B
course_2,ch_2_03,les_2_03_03,topic_2_03_03_01,quiz_2_03_03_1,What is the primary purpose of VigiBase in pharmacovigilance?,"A) Managing clinical trial data |
B) Detecting and monitoring drug safety signals |
C) Storing manufacturing quality records |
D) Tracking drug distribution globally",B
course_2,ch_2_03,les_2_03_03,topic_2_03_03_01,quiz_2_03_03_2,Which organization manages and maintains VigiBase?,"A) U.S. Food and Drug Administration (FDA) |
B) International Council for Harmonisation (ICH) |
C) WHO Uppsala Monitoring Centre (UMC) |
D) European Medicines Agency (EMA)",C
course_2,ch_2_03,les_2_03_03,topic_2_03_03_01,quiz_2_03_03_3,"In VigiBase, adverse events are standardized using which terminology system?","A) ATC Classification |
B) WHO-DD Dictionary |
C) MedDRA Coding |
D) SNOMED CT",C
course_2,ch_2_03,les_2_03_03,topic_2_03_03_01,quiz_2_03_03_4,"Which component of VigiBase allows users to narrow searches by seriousness, age group, or country?","A) Case Details Viewer |
B) Search & Query Module |
C) Filters & Facets |
D) Signal Detection Reports",C
course_2,ch_2_03,les_2_03_03,topic_2_03_03_01,quiz_2_03_03_5,What is a best practice before executing a query in VigiBase?,"A) Using all filters at once to cover every possible case |
B) Skipping MedDRA coding to save time |
C) Defining clear objectives to avoid unnecessary data overload |
D) Deleting previous query logs to start fresh",C
course_2,ch_2_03,les_2_03_04,topic_2_03_04_01,quiz_2_03_04_1,What is the main purpose of data reconciliation in FAERS?,"A) To enhance product marketing strategies |
B) To ensure accuracy and consistency between internal ICSRs and FAERS submissions |
C) To reduce the number of adverse events reported |
D) To merge data from global PV databases",B
course_2,ch_2_03,les_2_03_04,topic_2_03_04_01,quiz_2_03_04_2,Which type of FAERS data involves multiple submissions for the same case that must be linked or merged?,"A) Aggregate Reports |
B) Follow-up Reports |
C) Duplicate Reports |
D) Regulatory Submission Metadata",C
course_2,ch_2_03,les_2_03_04,topic_2_03_04_01,quiz_2_03_04_3,What is the correct first step in the FAERS reconciliation workflow?,"A) Resolve discrepancies in internal systems |
B) Identify FAERS submission cohort and extract internally submitted cases |
C) Document reconciliation actions |
D) Implement continuous monitoring",B
course_2,ch_2_03,les_2_03_04,topic_2_03_04_01,quiz_2_03_04_4,Which coding standards are typically used during FAERS data reconciliation?,"A) ICD-10 and CPT |
B) MedDRA and WHO Drug Dictionary |
C) SNOMED CT and RxNorm |
D) ATC and LOINC",B
course_2,ch_2_03,les_2_03_04,topic_2_03_04_01,quiz_2_03_04_5,What is a best practice to prevent duplicate reporting during FAERS reconciliation?,"A) Submitting all reports twice for confirmation |
B) Deleting earlier reports once new data is added |
C) Using unique identifiers and linking cases in internal systems |
D) Relying only on automated FAERS dashboards",C
course_2,ch_2_03,les_2_03_05,topic_2_03_05_01,quiz_2_03_05_1,What is the primary purpose of using AI in pharmacovigilance database queries?,"A) To fully replace manual case assessments |
B) To enhance accuracy, efficiency, and data insight |
C) To eliminate the need for MedDRA coding |
D) To avoid regulatory reporting steps",B
course_2,ch_2_03,les_2_03_05,topic_2_03_05_01,quiz_2_03_05_2,Which AI technique enables users to ask database queries in plain language?,"A) Predictive Analytics |
B) Machine Learning Models |
C) Natural Language Processing (NLP) |
D) Semantic Mapping",C
course_2,ch_2_03,les_2_03_05,topic_2_03_05_01,quiz_2_03_05_3,"In the AI-assisted querying workflow, which step ensures data is standardized and ready for analysis?","A) Query Definition |
B) Data Preprocessing |
C) Integration & Reporting |
D) Validation & Quality Check",B
course_2,ch_2_03,les_2_03_05,topic_2_03_05_01,quiz_2_03_05_4,How should PV professionals mitigate the risk of over-reliance on AI-generated results?,"A) Ignore validation checks to save time |
B) Validate results manually and cross-check coding |
C) Allow AI to self-correct errors automatically |
D) Depend entirely on NLP outputs",B
course_2,ch_2_03,les_2_03_05,topic_2_03_05_01,quiz_2_03_05_5,"According to best practices, how should AI outputs be used in pharmacovigilance workflows?","A) As replacements for expert decision-making |
B) To enhance expert judgment and streamline data retrieval |
C) As the sole basis for regulatory reporting |
D) Only for data visualization purposes",B
course_2,ch_2_03,les_2_03_06,topic_2_03_06_01,quiz_2_03_06_1,What is the primary purpose of the Argus Safety system in pharmacovigilance?,A) Conduct clinical trials | B) Centralized capture and management of ICSRs | C) Manufacturing of drugs | D) Marketing of pharmaceuticals,B
course_2,ch_2_03,les_2_03_06,topic_2_03_06_01,quiz_2_03_06_2,Which coding standards are used in Argus for adverse events and drugs?,A) ICD-10 and ATC | B) SNOMED CT and RxNorm | C) MedDRA and WHO Drug Dictionary | D) LOINC and UMLS,C
course_2,ch_2_03,les_2_03_06,topic_2_03_06_01,quiz_2_03_06_3,"During the Argus case workflow, which step involves requesting additional information from reporters?",A) Case Intake | B) Triage / Assignment | C) Follow-Up Management | D) Regulatory Submission,C
course_2,ch_2_03,les_2_03_06,topic_2_03_06_01,quiz_2_03_06_4,Which regulatory standard ensures electronic ICSR submissions from Argus are compliant?,A) HIPAA | B) ICH E2B(R3) | C) ISO 9001 | D) GxP,B
course_2,ch_2_03,les_2_03_06,topic_2_03_06_01,quiz_2_03_06_5,What is a key feature of Argus dashboards and reporting tools?,"A) Predicting market trends | B) Monitoring open cases, follow-ups, and compliance metrics | C) Creating marketing campaigns | D) Managing supply chain logistics",B
course_2,ch_2_03,les_2_03_07,topic_2_03_07_01,quiz_2_03_07_1,Which of the following best describes the primary purpose of ARISg in pharmacovigilance?,"A) Conduct preclinical drug testing | B) Centralized capture, management, and regulatory reporting of ICSRs | C) Marketing strategy analysis | D) Manufacturing quality control",B
course_2,ch_2_03,les_2_03_07,topic_2_03_07_01,quiz_2_03_07_2,"In ARISg, which coding standards are used for adverse events and medicinal products?",A) ICD-11 and RxNorm | B) MedDRA and WHO Drug Dictionary | C) SNOMED CT and ATC | D) LOINC and NDC,B
course_2,ch_2_03,les_2_03_07,topic_2_03_07_01,quiz_2_03_07_3,"During the ARISg workflow, what is the main purpose of the medical assessment step?","A) Assign cases to PV personnel | B) Validate XML for submission | C) Assess causality, seriousness, expectedness, and code AEs/drugs | D) Export dashboards for management review",C
course_2,ch_2_03,les_2_03_07,topic_2_03_07_01,quiz_2_03_07_4,Which ARISg feature ensures regulatory inspection readiness?,A) Audit trails that log user actions and case modifications | B) Signal detection dashboards | C) Natural language queries | D) Predictive AI analysis for trends,A
course_2,ch_2_03,les_2_03_07,topic_2_03_07_01,quiz_2_03_07_5,What is the role of follow-up management in ARISg?,"A) Collect AE reports from multiple sources | B) Track additional information, update case records, and maintain status logs | C) Generate marketing reports | D) Assign case priority based on workload",B
course_2,ch_2_03,les_2_03_08,topic_2_03_08_01,quiz_2_03_08_1,Which of the following is a key principle of GDPR relevant to pharmacovigilance?,A) Data ownership by healthcare provider | B) Purpose limitation and data minimization | C) Mandatory use of cloud storage | D) Full public access to patient data,B
course_2,ch_2_03,les_2_03_08,topic_2_03_08_01,quiz_2_03_08_2,"Under HIPAA, which rule defines safeguards for electronic protected health information (ePHI)?",A) Privacy Rule | B) Breach Notification Rule | C) Security Rule | D) Enforcement Rule,C
course_2,ch_2_03,les_2_03_08,topic_2_03_08_01,quiz_2_03_08_3,"In PV workflows, what is the primary purpose of pseudonymization?",A) Encrypt all data at rest | B) Replace direct identifiers with codes while keeping mapping separate | C) Remove all adverse event details | D) Allow public access to de-identified data,B
course_2,ch_2_03,les_2_03_08,topic_2_03_08_01,quiz_2_03_08_4,Which mechanism ensures GDPR-compliant data transfer outside the EU?,A) Sending unencrypted files via email | B) Using Standard Contractual Clauses or approved transfer agreements | C) Uploading to any cloud without consent | D) Publishing patient identifiers in public dashboards,B
course_2,ch_2_03,les_2_03_08,topic_2_03_08_01,quiz_2_03_08_5,What is a practical tip for maintaining data privacy in pharmacovigilance systems?,A) Capture all patient information to ensure completeness | B) Implement “privacy by design” and apply data minimization | C) Avoid encryption to reduce system load | D) Disable audit logging for faster processing,B
course_2,ch_2_03,les_2_03_09,topic_2_03_09_01,quiz_2_03_09_1,Which of the following is considered a validation error in a PV database?,A) Duplicate case entered twice | B) Missing adverse event date | C) Timeout during bulk upload | D) Unauthorized user editing a case,B
course_2,ch_2_03,les_2_03_09,topic_2_03_09_01,quiz_2_03_09_2,What is the primary purpose of automated monitoring in PV database error handling?,"A) To encrypt patient identifiers | B) To configure alerts for failed uploads, duplicates, or missing data | C) To submit ICSRs to regulatory authorities | D) To anonymize patient records",B
course_2,ch_2_03,les_2_03_09,topic_2_03_09_01,quiz_2_03_09_3,Which action is part of preventive measures for database errors in PV?,A) Rectifying invalid data | B) Updating SOPs and providing staff training | C) Manually merging duplicate ICSRs | D) Sending acknowledgment numbers to authorities,B
course_2,ch_2_03,les_2_03_09,topic_2_03_09_01,quiz_2_03_09_4,A data integration error in a PV system might occur due to:,A) System downtime | B) Mismatch during migration causing missing concomitant drug information | C) Invalid MedDRA coding at entry | D) Duplicate submission of ICSRs,B
course_2,ch_2_03,les_2_03_09,topic_2_03_09_01,quiz_2_03_09_5,Which tool helps track user edits and system changes for error investigation in PV databases?,A) Automated validation rules | B) Duplicate detection algorithms | C) Audit trails | D) ETL data reconciliation scripts,C
course_2,ch_2_03,les_2_03_10,topic_2_03_10_01,quiz_2_03_10_1,What is the primary goal of PV system integration?,"A) Reduce the number of PV personnel | B) Enable automated, accurate, and compliant data exchange across PV systems | C) Replace manual audits entirely | D) Eliminate the need for MedDRA coding",B
course_2,ch_2_03,les_2_03_10,topic_2_03_10_01,quiz_2_03_10_2,Which standard coding dictionaries are commonly aligned across integrated PV systems?,A) ICD-10 and SNOMED CT | B) MedDRA and WHO Drug Dictionary | C) LOINC and CPT | D) HL7 and FHIR,B
course_2,ch_2_03,les_2_03_10,topic_2_03_10_01,quiz_2_03_10_3,"During PV system integration, which method is used for real-time data exchange between systems?",A) CSV file downloads once per year | B) APIs / Web Services | C) Manual transcription | D) Paper-based reporting,B
course_2,ch_2_03,les_2_03_10,topic_2_03_10_01,quiz_2_03_10_4,What is a recommended mitigation strategy for handling data duplication or mismatch between integrated PV systems?,A) Ignoring discrepancies | B) Implement reconciliation scripts and automated deduplication | C) Manually rewriting all ICSRs | D) Submitting only one system’s data to regulators,B
course_2,ch_2_03,les_2_03_10,topic_2_03_10_01,quiz_2_03_10_5,Which practice ensures audit readiness during PV system integration?,A) Encrypting and tracking all data transfers with logs | B) Removing system logs periodically | C) Allowing unrestricted user access | D) Using unstructured templates for data mapping,A
course_2,ch_2_04,les_2_04_01,topic_2_04_01_01,quiz_2_04_01_1,What is the primary objective of signal detection in pharmacovigilance?,A) Replace regulatory reporting with automated alerts | B) Identify new or unknown risks or changes in known adverse effects | C) Only track drug sales trends | D) Reduce the need for medical review,B
course_2,ch_2_04,les_2_04_01,topic_2_04_01_01,quiz_2_04_01_2,Which of the following is a quantitative method used for signal generation?,A) PRR (Proportional Reporting Ratio) | B) WHO-UMC causality assessment | C) Literature case review | D) Patient consent verification,A
course_2,ch_2_04,les_2_04_01,topic_2_04_01_01,quiz_2_04_01_3,What is a key mitigation strategy for underreporting of adverse events?,A) Ignore missing reports | B) Encourage reporting and integrate multiple data sources | C) Only rely on clinical trial data | D) Delete duplicates automatically,B
course_2,ch_2_04,les_2_04_01,topic_2_04_01_01,quiz_2_04_01_4,Which regulatory guidance specifically addresses signal management in the EU?,A) FDA CFR Title 21 | B) EMA GVP Module IX | C) ICH E2B(R2) | D) HIPAA Privacy Rule,B
course_2,ch_2_04,les_2_04_01,topic_2_04_01_01,quiz_2_04_01_5,Why is multi-source data integration important in signal detection?,A) To reduce the workload of PV personnel | B) To improve signal sensitivity and detect emerging safety concerns | C) To avoid using MedDRA coding | D) To bypass statistical analysis,B
course_2,ch_2_04,les_2_04_02,topic_2_04_02_01,quiz_2_04_02_1,What is the main purpose of quantitative signal detection in pharmacovigilance?,A) Replace qualitative clinical review entirely | B) Early detection of potential safety issues using statistical methods | C) Track only patient demographics | D) Automate drug approval decisions,B
course_2,ch_2_04,les_2_04_02,topic_2_04_02_01,quiz_2_04_02_2,Which metric uses a Bayesian approach to compare observed versus expected AE reporting?,A) Proportional Reporting Ratio (PRR) | B) Reporting Odds Ratio (ROR) | C) Information Component (IC) | D) Case Narrative Score,C
course_2,ch_2_04,les_2_04_02,topic_2_04_02_01,quiz_2_04_02_3,Which of the following thresholds is commonly used to indicate a potential signal for PRR?,A) PRR ≥ 2 with χ² ≥ 4 | B) PRR ≤ 0.5 | C) PRR = 1 | D) PRR ≥ 10,A
course_2,ch_2_04,les_2_04_02,topic_2_04_02_01,quiz_2_04_02_4,How can false positives or noisy signals be mitigated in quantitative signal detection?,A) Ignore all low-frequency events | B) Combine quantitative metrics with qualitative clinical review | C) Only use PRR for detection | D) Avoid Bayesian methods,B
course_2,ch_2_04,les_2_04_02,topic_2_04_02_01,quiz_2_04_02_5,Why is integration with qualitative review important in quantitative signal detection?,A) To verify clinical plausibility and confirm true safety signals | B) To speed up data entry | C) To bypass regulatory documentation | D) To reduce the need for coding standards,A
course_2,ch_2_04,les_2_04_03,topic_2_04_03_01,quiz_2_04_03_1,What is the primary purpose of qualitative signal detection in PV?,"A) Identify new, rare, or serious ADRs through clinical review | B) Replace quantitative analysis entirely | C) Automate case entry in PV systems | D) Monitor system performance",A
course_2,ch_2_04,les_2_04_03,topic_2_04_03_01,quiz_2_04_03_2,Which tool is commonly used for causality assessment in qualitative signal detection?,A) Naranjo Algorithm | B) Proportional Reporting Ratio (PRR) | C) Information Component (IC) | D) EBGM,A
course_2,ch_2_04,les_2_04_03,topic_2_04_03_01,quiz_2_04_03_3,Why is integration with quantitative analysis important in qualitative signal detection?,A) To validate or prioritize signals identified through statistical methods | B) To eliminate the need for expert review | C) To speed up data entry in PV databases | D) To bypass regulatory documentation requirements,A
course_2,ch_2_04,les_2_04_03,topic_2_04_03_01,quiz_2_04_03_4,What is a common challenge in qualitative signal detection and its mitigation?,A) Subjectivity in assessment – use standardized causality scales and expert cross-review | B) System downtime – ignore reports | C) Data duplication – avoid follow-up | D) Low reporting frequency – reduce case intake,A
course_2,ch_2_04,les_2_04_03,topic_2_04_03_01,quiz_2_04_03_5,Which data source is typically used for qualitative signal review?,A) Clinical trial case narratives | B) Statistical disproportionality tables only | C) PV system error logs | D) Server performance dashboards,A
course_2,ch_2_04,les_2_04_04,topic_2_04_04_01,quiz_2_04_04_1,What is the main purpose of applying AI in signal noise reduction in PV?,"A) Reduce duplicates, filter low-quality reports, and prioritize meaningful signals | B) Replace qualitative medical review entirely | C) Automatically submit ICSRs to regulators | D) Increase the number of statistical outliers",A
course_2,ch_2_04,les_2_04_04,topic_2_04_04_01,quiz_2_04_04_2,Which AI/ML technique is primarily used to extract structured information from free-text case narratives?,A) Natural Language Processing (NLP) | B) Clustering & Pattern Recognition | C) Anomaly Detection Models | D) Supervised Machine Learning,A
course_2,ch_2_04,les_2_04_04,topic_2_04_04_01,quiz_2_04_04_3,Why is a hybrid approach recommended when using AI for noise reduction?,A) Combines AI outputs with expert review to avoid false negatives | B) Eliminates the need for data standardization | C) Reduces the number of ICSRs captured | D) Automatically generates regulatory submissions,A
course_2,ch_2_04,les_2_04_04,topic_2_04_04_01,quiz_2_04_04_4,Which challenge in AI-assisted PV can be mitigated by validating models with historical datasets?,A) AI bias and false negatives | B) Over-reliance on quantitative disproportionality | C) Duplicate MedDRA coding | D) Regulatory submission delays,A
course_2,ch_2_04,les_2_04_04,topic_2_04_04_01,quiz_2_04_04_5,What is a key best practice for AI-assisted signal noise reduction?,A) Maintain transparent workflows and document model parameters for audit readiness | B) Ignore low-quality ICSRs entirely | C) Avoid using NLP for free-text reports | D) Replace expert review with automated AI decisions,A
course_2,ch_2_04,les_2_04_05,topic_2_04_05_01,quiz_2_04_05_1,What is the primary purpose of a Risk Management Plan (RMP) in PV?,A) Replace routine PV activities entirely | B) Protect patient safety and support regulatory compliance | C) Generate spontaneous AE reports automatically | D) Increase marketing approvals,B
course_2,ch_2_04,les_2_04_05,topic_2_04_05_01,quiz_2_04_05_2,Which component of an RMP details both known and potential risks and missing safety information?,A) Pharmacovigilance Plan | B) Summary Table | C) Safety Specification | D) Risk Minimization Measures,C
course_2,ch_2_04,les_2_04_05,topic_2_04_05_01,quiz_2_04_05_3,What is considered an additional risk minimization measure in an RMP?,A) Standard product labeling | B) Collecting ICSRs | C) Educational programs and restricted prescribing | D) Routine AE reporting,C
course_2,ch_2_04,les_2_04_05,topic_2_04_05_01,quiz_2_04_05_4,Which workflow step evaluates whether risk minimization measures are working as intended?,A) Risk Identification | B) Regulatory Submission | C) Effectiveness Evaluation | D) Pharmacovigilance Planning,C
course_2,ch_2_04,les_2_04_05,topic_2_04_05_01,quiz_2_04_05_5,Which guideline provides the framework for RMP development in the EU?,A) MedDRA Coding Guide | B) ICH E2B(R3) | C) EMA GVP Module V | D) FDA REMS Guidance,C
course_2,ch_2_04,les_2_04_06,topic_2_04_06_01,quiz_2_04_06_1,What is the main objective of signal validation in PV?,A) Confirm credibility and relevance of detected signals | B) Generate spontaneous AE reports automatically | C) Replace qualitative review | D) Increase statistical noise,A
course_2,ch_2_04,les_2_04_06,topic_2_04_06_01,quiz_2_04_06_2,Which data source is commonly used for signal validation?,A) Social media forums only | B) Clinical trial reports | C) Marketing approval documents | D) Product labeling templates,B
course_2,ch_2_04,les_2_04_06,topic_2_04_06_01,quiz_2_04_06_3,Which tool is typically used to assess causality during signal validation?,A) WHO-UMC causality scale | B) PRR alone | C) Duplicate detection algorithm | D) Signal dashboard only,A
course_2,ch_2_04,les_2_04_06,topic_2_04_06_01,quiz_2_04_06_4,What is the purpose of data triangulation in signal validation?,A) Cross-check signals across multiple data sources for consistency | B) Reduce data entry errors | C) Generate ICSRs automatically | D) Replace expert review,A
course_2,ch_2_04,les_2_04_06,topic_2_04_06_01,quiz_2_04_06_5,"Which step ensures a signal is classified as credible, needs monitoring, or is noise?",A) Signal classification | B) Preliminary assessment | C) Data extraction | D) Regulatory submission,A
course_2,ch_2_04,les_2_04_07,topic_2_04_07_01,quiz_2_04_07_1,Why is integration with qualitative review important?,A) To validate statistical signals with case narratives and expert clinical assessment | B) To calculate PRR | C) To replace causality assessment | D) To update MedDRA coding automatically,A
course_2,ch_2_04,les_2_04_07,topic_2_04_07_01,quiz_2_04_07_2,What is the main purpose of disproportionality analysis in PV?,A) Detect unexpected safety signals | B) Replace qualitative review completely | C) Generate marketing reports | D) Standardize labeling,A
course_2,ch_2_04,les_2_04_07,topic_2_04_07_01,quiz_2_04_07_3,Which metric uses a Bayesian approach to compare observed vs. expected AE reporting?,A) Proportional Reporting Ratio (PRR) | B) Reporting Odds Ratio (ROR) | C) Information Component (IC) | D) Duplicate Detection Index,C
course_2,ch_2_04,les_2_04_07,topic_2_04_07_01,quiz_2_04_07_4,What does EBGM help address in disproportionality analysis?,A) Low-frequency events using Bayesian shrinkage | B) Duplicate reports | C) Literature case reviews | D) Regulatory submissions,A
course_2,ch_2_04,les_2_04_07,topic_2_04_07_01,quiz_2_04_07_5,Which workflow step ensures drug names and AEs are standardized?,A) Data Cleaning | B) Signal Prioritization | C) Metric Calculation | D) Regulatory Documentation,A
course_2,ch_2_04,les_2_04_08,topic_2_04_08_01,quiz_2_04_08_1,Which guideline defines the standardized electronic format for individual case safety report submission globally?,A) CIOMS IX Recommendations | B) ICH E2B(R3) | C) FDA Guidance | D) EMA GVP Module IX,B
course_2,ch_2_04,les_2_04_08,topic_2_04_08_01,quiz_2_04_08_2,What is the primary purpose of signal reporting standards in PV?,A) Ensure patient safety and regulatory compliance | B) Reduce clinical trial costs | C) Improve marketing strategies | D) Replace qualitative case review,A
course_2,ch_2_04,les_2_04_08,topic_2_04_08_01,quiz_2_04_08_3,What is a typical regulatory expectation for submitting a validated signal report after detection?,A) Within 7–30 days depending on seriousness and local regulations | B) Only annually in a periodic safety update report | C) After product launch only | D) Within 1–2 hours automatically,A
course_2,ch_2_04,les_2_04_08,topic_2_04_08_01,quiz_2_04_08_4,Which of the following is a best practice for maintaining audit readiness in signal reporting?,A) Maintain version-controlled signal reports with evidence logs | B) Send reports via email without internal record | C) Avoid documenting causality assessment | D) Only report quantitative data,A
course_2,ch_2_04,les_2_04_08,topic_2_04_08_01,quiz_2_04_08_5,"Which authority provides guidance for signal detection, validation, and reporting specifically for the EU?",A) EMA GVP Module IX | B) WHO Safety Monitoring | C) ICH E2B(R3) | D) FDA Guidance,A
course_2,ch_2_04,les_2_04_09,topic_2_04_09_01,quiz_2_04_09_1,Which of the following is an example of an additional risk minimization measure (aRMM)?,A) Labeling precautions | B) Package insert warnings | C) Standard contraindications | D) Educational materials for healthcare professionals,D
course_2,ch_2_04,les_2_04_09,topic_2_04_09_01,quiz_2_04_09_2,What is the main objective of risk minimization strategies in pharmacovigilance?,A) Protect patient safety and optimize the benefit-risk profile | B) Increase market share | C) Accelerate clinical trial recruitment | D) Reduce reporting workload for PV teams,A
course_2,ch_2_04,les_2_04_09,topic_2_04_09_01,quiz_2_04_09_3,"During which stage should preventive strategies, such as pre-screening patients, ideally be applied?",A) Pre-authorization / clinical development | B) Post-marketing only | C) After signal validation only | D) During regulatory inspection,A
course_2,ch_2_04,les_2_04_09,topic_2_04_09_01,quiz_2_04_09_4,Which tool is commonly used to monitor compliance with risk minimization measures and track adverse event trends?,A) Safety Dashboards | B) Literature search engines | C) Social media monitoring | D) Marketing analytics software,A
course_2,ch_2_04,les_2_04_09,topic_2_04_09_01,quiz_2_04_09_5,Which regulatory guidance specifically outlines risk evaluation and mitigation strategies in the US?,A) WHO Safety Monitoring | B) EMA GVP Module V | C) ICH E2B(R3) | D) FDA REMS Guidance,D
course_2,ch_2_04,les_2_04_10,topic_2_04_10_01,quiz_2_04_10_1,What is the primary purpose of a signal dashboard in pharmacovigilance?,A) Automate marketing strategies | B) Enhance signal detection efficiency and support regulatory reporting | C) Reduce clinical trial costs | D) Track employee performance,B
course_2,ch_2_04,les_2_04_10,topic_2_04_10_01,quiz_2_04_10_2,Which of the following is a key component that allows users to drill down into case-level data?,A) Alerts & notifications | B) Signal summary table | C) Filters and drill-down options | D) Disproportionality metrics,C
course_2,ch_2_04,les_2_04_10,topic_2_04_10_01,quiz_2_04_10_3,How do dashboards help mitigate information overload for PV teams?,"A) By excluding serious adverse events | B) By manually reviewing each ICSR | C) By using filters, thresholds, and prioritization rules | D) By limiting data sources to one database",C
course_2,ch_2_04,les_2_04_10,topic_2_04_10_01,quiz_2_04_10_4,Which visualization tool can be integrated with PV dashboards to track trends and metrics effectively?,A) SPSS | B) Tableau | C) Microsoft Word | D) Google Docs,B
course_2,ch_2_04,les_2_04_10,topic_2_04_10_01,quiz_2_04_10_5,What is essential for maintaining regulatory compliance when using signal dashboards?,A) Only updating dashboards quarterly | B) Ignoring duplicate ICSRs | C) Maintaining audit trails and documentation logs | D) Allowing unrestricted user edits,C
course_2,ch_2_05,les_2_05_01,topic_2_05_01_01,quiz_2_05_01_1,What is the primary purpose of a Periodic Safety Update Report (PSUR)?,A) To summarize marketing strategies | B) To provide regulators with updated safety information and support risk-benefit evaluation | C) To track sales performance | D) To audit clinical trial sites,B
course_2,ch_2_05,les_2_05_01,topic_2_05_01_01,quiz_2_05_01_2,Which section of a PSUR integrates efficacy and safety data to assess the overall benefit-risk profile?,A) Executive Summary | B) Product Information | C) Benefit-Risk Evaluation | D) Appendices,C
course_2,ch_2_05,les_2_05_01,topic_2_05_01_01,quiz_2_05_01_3,Which regulatory guideline provides a harmonized template for PSUR content and global consistency?,A) EMA GVP Module IX | B) FDA REMS Guidance | C) ICH E2C(R2) | D) CIOMS IX Recommendations,C
course_2,ch_2_05,les_2_05_01,topic_2_05_01_01,quiz_2_05_01_4,What is a common challenge in PSUR preparation and its mitigation?,A) Lack of funding; mitigate by hiring more staff | B) Large volume of data; mitigate with automated aggregation and analytics tools | C) Low patient adherence; mitigate with patient reminders | D) Limited clinical sites; mitigate by expanding trials,B
course_2,ch_2_05,les_2_05_01,topic_2_05_01_01,quiz_2_05_01_5,Which data sources are essential for compiling a PSUR?,"A) Sales and marketing reports | B) HR records and training logs | C) ICSRs, clinical trials, literature, real-world evidence | D) Stockholder meeting minutes",C
course_2,ch_2_05,les_2_05_02,topic_2_05_02_01,quiz_2_05_02_1,What is the main purpose of a Development Safety Update Report (DSUR)?,A) To track marketing approval timelines | B) To provide a cumulative annual review of safety data for an investigational medicinal product | C) To summarize manufacturing changes | D) To assess cost-effectiveness of trials,B
course_2,ch_2_05,les_2_05_02,topic_2_05_02_01,quiz_2_05_02_2,Which regulatory guideline provides the standard harmonized framework for DSUR preparation?,A) EMA GVP Module IX | B) FDA REMS Guidance | C) ICH E2F | D) CIOMS IX Recommendations,C
course_2,ch_2_05,les_2_05_02,topic_2_05_02_01,quiz_2_05_02_3,What is the typical submission timeline for a DSUR after the data lock point?,A) 30 days | B) 90 days | C) 60 days | D) 120 days,C
course_2,ch_2_05,les_2_05_02,topic_2_05_02_01,quiz_2_05_02_4,Which section of a DSUR summarizes emerging safety issues and trends detected during clinical trials?,A) Benefit-Risk Assessment | B) Title Page and Table of Contents | C) Summary of Important Risks | D) Appendices,C
course_2,ch_2_05,les_2_05_02,topic_2_05_02_01,quiz_2_05_02_5,Which tool is commonly used for aggregating clinical trial safety data for DSUR preparation?,A) HR Management System | B) Financial reporting software | C) CTMS (Clinical Trial Management System) | D) CRM software,C
course_2,ch_2_05,les_2_05_03,topic_2_05_03_01,quiz_2_05_03_1,What is the primary purpose of data aggregation in pharmacovigilance?,A) To manage clinical trial budgets | B) To combine safety data from multiple sources into a structured dataset for reporting and analysis | C) To design new clinical trials | D) To track marketing approvals,B
course_2,ch_2_05,les_2_05_03,topic_2_05_03_01,quiz_2_05_03_2,Which coding standards are typically applied during PV data standardization?,A) ICD-10 and CPT | B) LOINC and SNOMED CT | C) MedDRA for adverse events and WHO Drug Dictionary for drugs | D) HL7 V2 and FHIR,C
course_2,ch_2_05,les_2_05_03,topic_2_05_03_01,quiz_2_05_03_3,Which workflow step involves removing duplicates and checking for missing critical fields?,A) Data Collection | B) Data Integration | C) Data Cleaning | D) Preliminary Analysis,C
course_2,ch_2_05,les_2_05_03,topic_2_05_03_01,quiz_2_05_03_4,Which tool or technique is commonly used to visualize aggregated PV data trends?,A) Google Analytics | B) Salesforce | C) Tableau or Power BI dashboards | D) QuickBooks,C
course_2,ch_2_05,les_2_05_03,topic_2_05_03_01,quiz_2_05_03_5,"What is a key challenge in PV data aggregation, and its mitigation?",A) Small sample sizes → Ignore them | B) Slow internet → Use offline spreadsheets | C) Duplicates across multiple sources → Apply automated deduplication and cross-checking algorithms | D) Staff turnover → Hire more personnel,C
course_2,ch_2_05,les_2_05_04,topic_2_05_04_01,quiz_2_05_04_1,What is the primary role of AI in PSUR drafting?,"A) To replace human PV experts entirely | B) To file regulatory submissions automatically | C) To perform clinical trials | D) To assist in data aggregation, narrative generation, and visualization for faster and accurate PSUR preparation",D
course_2,ch_2_05,les_2_05_04,topic_2_05_04_01,quiz_2_05_04_2,Which AI task helps identify overlapping or duplicate cases across multiple safety data sources?,A) Signal Detection | B) Visualization | C) Narrative Summarization | D) Duplicate Detection,D
course_2,ch_2_05,les_2_05_04,topic_2_05_04_01,quiz_2_05_04_3,"In the AI-enhanced PSUR workflow, what is the purpose of narrative generation?",A) To detect statistical disproportionality | B) To validate AE coding | C) To create automated dashboards | D) To draft case summaries and section narratives using NLP for consistency and compliance,D
course_2,ch_2_05,les_2_05_04,topic_2_05_04_01,quiz_2_05_04_4,What is a critical best practice when using AI in PSUR drafting?,A) Validate all AI-generated content for clinical accuracy and regulatory compliance | B) Fully automate PSUR submission without human review | C) Use AI only for non-safety-related tasks | D) Ignore integration with PV systems,A
course_2,ch_2_05,les_2_05_04,topic_2_05_04_01,quiz_2_05_04_5,Which challenge of AI in PSUR drafting is mitigated by using de-identified datasets and secure AI pipelines?,A) AI output not clinically accurate | B) Over-reliance on AI | C) Integration with legacy PV systems | D) Data privacy concerns,D
course_2,ch_2_05,les_2_05_05,topic_2_05_05_01,quiz_2_05_05_1,What is the main purpose of line listings in pharmacovigilance?,"A) To summarize aggregated AE trends for reports | B) To provide predictive analytics for drug development | C) To replace narrative summaries in PSURs | D) To present individual case-level AE data with patient, drug, and event details",D
course_2,ch_2_05,les_2_05_05,topic_2_05_05_01,quiz_2_05_05_2,Which element is essential in a line listing for each case?,A) Graphical trend visualization | B) Regulatory authority approval date | C) Predicted AE occurrence | D) Case ID / ICSR number and patient demographics,D
course_2,ch_2_05,les_2_05_05,topic_2_05_05_01,quiz_2_05_05_3,Summary tabulations are primarily used to:,"A) Replace line listings in regulatory submissions | B) Provide raw narrative data | C) Aggregate AE data for quantitative analysis, trend detection, and signal evaluation | D) Conduct clinical trial randomization",C
course_2,ch_2_05,les_2_05_05,topic_2_05_05_01,quiz_2_05_05_4,"In constructing summary tabulations, which of the following practices ensures clarity and regulatory compliance?","A) Aggregating data without standard coding | B) Ignoring denominator consistency | C) Including only serious AE cases | D) Applying consistent denominators, highlighting trends, and including clarifications for unusual data",D
course_2,ch_2_05,les_2_05_05,topic_2_05_05_01,quiz_2_05_05_5,A common challenge when generating line listings and summary tabulations is duplicate or incomplete cases. Which mitigation is recommended?,A) Ignoring duplicates if minor | B) Using only manual cross-checks | C) Aggregating without validation | D) Applying deduplication algorithms and validation checks,D
course_2,ch_2_05,les_2_05_06,topic_2_05_06_01,quiz_2_05_06_1,What is the primary purpose of PSUR quality checks in pharmacovigilance?,"A) To accelerate report submission regardless of accuracy | B) To generate marketing insights | C) To maintain audit-ready documentation | D) To ensure accuracy, completeness, and regulatory compliance of the PSUR",D
course_2,ch_2_05,les_2_05_06,topic_2_05_06_01,quiz_2_05_06_2,Which area of PSUR review focuses on verifying MedDRA/WHO Drug Dictionary coding and consistency with aggregate tables?,A) Data Accuracy | B) Narratives & Summaries | C) Line Listings & Tabulations | D) Signal Analysis,C
course_2,ch_2_05,les_2_05_06,topic_2_05_06_01,quiz_2_05_06_3,"During the workflow for PSUR quality checks, what is a key activity in the narrative review step?",A) Aggregating ICSRs from multiple databases | B) Checking submission timelines | C) Ensuring medical and clinical accuracy of case summaries | D) Applying deduplication algorithms,C
course_2,ch_2_05,les_2_05_06,topic_2_05_06_01,quiz_2_05_06_4,Which tool or technique is specifically useful for detecting discrepancies in data trends during PSUR quality checks?,A) Automation for duplicate identification | B) MedDRA dictionary lookup | C) Standard checklists | D) Visualization tools such as heatmaps or discrepancy dashboards,D
course_2,ch_2_05,les_2_05_06,topic_2_05_06_01,quiz_2_05_06_5,A common challenge in PSUR quality checks is missing critical information in narratives. What is the recommended mitigation?,A) Ignoring minor omissions | B) Use only automated AI tools | C) Implement mandatory content templates and reviewer checklists | D) Aggregating data without validation,C
course_2,ch_2_05,les_2_05_07,topic_2_05_07_01,quiz_2_05_07_1,What is the main objective of case study analysis in DSUR preparation?,A) To generate marketing insights | B) To reduce clinical trial duration | C) To aggregate financial data | D) To identify emerging safety signals and support regulatory decision-making,D
course_2,ch_2_05,les_2_05_07,topic_2_05_07_01,quiz_2_05_07_2,Which key element in DSUR case study analysis captures the relationship between the adverse event and the investigational product?,A) Outcome | B) Patient Demographics | C) Causality Assessment | D) Regulatory Actions,C
course_2,ch_2_05,les_2_05_07,topic_2_05_07_01,quiz_2_05_07_3,"During workflow for case study analysis, what is the purpose of pattern and trend analysis?","A) To update clinical trial protocols only | B) To standardize MedDRA coding | C) To detect clusters, common AE types, or unexpected events | D) To prepare marketing materials",C
course_2,ch_2_05,les_2_05_07,topic_2_05_07_01,quiz_2_05_07_4,Which tool or technique is commonly used for visualizing trends and identifying signals across multiple DSUR cases?,"A) Automated regulatory submission portals | B) Financial dashboards | C) Excel macros only | D) Heatmaps, bar charts, and trend graphs",D
course_2,ch_2_05,les_2_05_07,topic_2_05_07_01,quiz_2_05_07_5,What is a recommended mitigation strategy for incomplete case data during DSUR case study analysis?,A) Ignore missing data | B) Use only historical reports | C) Perform follow-up with clinical trial sites or literature verification | D) Randomly impute missing values,C
course_2,ch_2_05,les_2_05_08,topic_2_05_08_01,quiz_2_05_08_1,What is the primary objective of regulatory submission of PV reports?,A) To market new drugs faster | B) To reduce clinical trial timelines | C) To generate internal analytics only | D) To ensure timely communication of safety information and regulatory compliance,D
course_2,ch_2_05,les_2_05_08,topic_2_05_08_01,quiz_2_05_08_2,Within what timeframe must a DSUR typically be submitted?,"A) 7–15 days after SAE occurrence | B) Every 3 months | C) Annually, within 60 days of the reporting period end | D) Only at the end of clinical development",C
course_2,ch_2_05,les_2_05_08,topic_2_05_08_01,quiz_2_05_08_3,Which electronic portal is commonly used for submitting PSURs in the EU?,A) FAERS | B) VigiBase | C) MedWatch | D) EudraVigilance,D
course_2,ch_2_05,les_2_05_08,topic_2_05_08_01,quiz_2_05_08_4,What is a key best practice for ensuring compliance during regulatory submission?,"A) Ignore minor formatting errors | B) Submit reports without multi-level review | C) Track only submissions without audit trail | D) Follow SOPs, use checklists, and maintain audit-ready documentation",D
course_2,ch_2_05,les_2_05_08,topic_2_05_08_01,quiz_2_05_08_5,Which challenge can occur during report submission and how is it mitigated?,A) Excessive report length – ignore it | B) Missing clinical data – publish anyway | C) Portal submission errors – pre-validate files and maintain helpdesk contacts | D) Duplicate submissions – delete original report,C
course_2,ch_2_05,les_2_05_09,topic_2_05_09_01,quiz_2_05_09_1,What is the main purpose of PSUR queries from regulatory authorities?,"A) To delay product approval | B) To increase report length | C) To test PV team knowledge | D) To ensure accuracy, completeness, and regulatory compliance of safety data",D
course_2,ch_2_05,les_2_05_09,topic_2_05_09_01,quiz_2_05_09_2,"Which type of query would involve missing demographic, drug, or AE details?",A) Signal analysis clarification | B) Narrative issues | C) Follow-up requests | D) Incomplete information,D
course_2,ch_2_05,les_2_05_09,topic_2_05_09_01,quiz_2_05_09_3,What is the recommended first step when a PSUR query is received?,A) Draft a response immediately | B) Ignore minor issues | C) Perform statistical analysis first | D) Capture query details in a centralized tracking system and assign responsibility,D
course_2,ch_2_05,les_2_05_09,topic_2_05_09_01,quiz_2_05_09_4,How can PV teams mitigate delayed responses to PSUR queries?,A) Respond only when requested again | B) Delay review until final report submission | C) Use ad-hoc emails | D) Maintain a query tracking system with assigned deadlines,D
course_2,ch_2_05,les_2_05_09,topic_2_05_09_01,quiz_2_05_09_5,What is a best practice when drafting responses to PSUR queries?,"A) Use informal language for faster processing | B) Avoid including tables or visuals | C) Submit without internal review | D) Use structured templates, verify data against source records, and include supporting documentation",D
course_2,ch_2_05,les_2_05_10,topic_2_05_10_01,quiz_2_05_10_1,What is the primary purpose of automating periodic pharmacovigilance reports?,"A) Reduce manual workload, human error, and improve timeliness | B) Increase report length for regulators | C) Replace PV experts entirely | D) Delay submission timelines",A
course_2,ch_2_05,les_2_05_10,topic_2_05_10_01,quiz_2_05_10_2,Which of the following report types can benefit from automated signal detection workflows?,A) Signal Detection Reports | B) Local SOP updates | C) Investigator brochures | D) Clinical trial informed consent forms,A
course_2,ch_2_05,les_2_05_10,topic_2_05_10_01,quiz_2_05_10_3,What is a key step in the automated workflow to ensure accuracy?,A) Manual guesswork | B) Data Cleaning & Validation to identify duplicates and inconsistencies | C) Skip standardization for faster processing | D) Ignoring validation rules,B
course_2,ch_2_05,les_2_05_10,topic_2_05_10_01,quiz_2_05_10_4,How should AI-assisted narrative generation be handled in PV report automation?,A) Fully automated without review | B) Used cautiously with expert review to ensure clarity and compliance | C) Ignore regulatory compliance | D) Avoid using AI entirely,B
course_2,ch_2_05,les_2_05_10,topic_2_05_10_01,quiz_2_05_10_5,Which of the following is a best practice for implementing report automation?,"A) Map all data sources, apply validation, maintain audit-ready logs | B) Randomly generate reports for speed | C) Avoid review to save time | D) Skip integration with PV databases",A
course_2,ch_2_06,les_2_06_01,topic_2_06_01_01,quiz_2_06_01_1,What is the broadest grouping level in the MedDRA hierarchy?,A) System Organ Class (SOC) | B) High-Level Term (HLT) | C) Preferred Term (PT) | D) Lowest Level Term (LLT),A
course_2,ch_2_06,les_2_06_01,topic_2_06_01_01,quiz_2_06_01_2,Which MedDRA level represents the exact verbatim term from a report?,A) Lowest Level Term (LLT) | B) Preferred Term (PT) | C) High-Level Group Term (HLGT) | D) System Organ Class (SOC),A
course_2,ch_2_06,les_2_06_01,topic_2_06_01_01,quiz_2_06_01_3,Why is mapping LLTs to PTs important in pharmacovigilance?,A) Ensures standardized reporting and regulatory compliance | B) Increases manual workload | C) Creates ambiguity in AE coding | D) Avoids data aggregation,A
course_2,ch_2_06,les_2_06_01,topic_2_06_01_01,quiz_2_06_01_4,Which MedDRA level groups related HLTs into broader categories?,A) High-Level Group Term (HLGT) | B) Lowest Level Term (LLT) | C) Preferred Term (PT) | D) System Organ Class (SOC),A
course_2,ch_2_06,les_2_06_01,topic_2_06_01_01,quiz_2_06_01_5,What is a best practice for maintaining coding quality in MedDRA?,A) Always use the latest MedDRA version and maintain audit trails | B) Skip version updates to save time | C) Use only LLTs for reporting | D) Avoid hierarchical aggregation,A
course_2,ch_2_06,les_2_06_02,topic_2_06_02_01,quiz_2_06_02_1,What is the role of a Lowest Level Term (LLT) in MedDRA coding?,A) Provides standardized representation for reporting | B) Broadly groups related PTs | C) Aggregates PTs for analysis | D) Captures the exact verbatim adverse event reported,D
course_2,ch_2_06,les_2_06_02,topic_2_06_02_01,quiz_2_06_02_2,Which MedDRA level is used for regulatory-compliant analysis and reporting?,A) Lowest Level Term (LLT) | B) Preferred Term (PT) | C) System Organ Class (SOC) | D) High-Level Term (HLT),B
course_2,ch_2_06,les_2_06_02,topic_2_06_02_01,quiz_2_06_02_3,Why are SOCs important in pharmacovigilance coding?,"A) Capture verbatim AE terms | B) Provide standard PT for reporting | C) Aggregate PTs for trend analysis, signal detection, and reporting | D) Map LLTs to PTs",C
course_2,ch_2_06,les_2_06_02,topic_2_06_02_01,quiz_2_06_02_4,What is a best practice when mapping LLTs to PTs?,A) Assign PT randomly to LLTs | B) Map LLTs to PTs without expert review | C) Apply consistent selection rules across cases and studies | D) Skip PT mapping for SOC analysis,C
course_2,ch_2_06,les_2_06_02,topic_2_06_02_01,quiz_2_06_02_5,Which tool can assist in validating LLT → PT → SOC mappings?,A) MedDRA Browser / Online Tools | B) Randomized spreadsheet entries | C) Non-standard dictionaries | D) Manual guesswork,A
course_2,ch_2_06,les_2_06_03,topic_2_06_03_01,quiz_2_06_03_1,What is the primary purpose of AI-based MedDRA auto-coding?,"A) Replace PV staff entirely | B) Generate random AE codes | C) Improve efficiency, consistency, and accuracy of coding | D) Eliminate audit requirements",C
course_2,ch_2_06,les_2_06_03,topic_2_06_03_01,quiz_2_06_03_2,"In AI auto-coding, what is the role of NLP models?","A) Detect hardware errors | B) Identify context, synonyms, and term variants in AE data | C) Map PTs to SOCs | D) Standardize reporting templates",B
course_2,ch_2_06,les_2_06_03,topic_2_06_03_01,quiz_2_06_03_3,How should low-confidence AI-coded terms be handled?,A) Automatically accept without review | B) Delete from the database | C) Flag for manual review by PV professionals | D) Assign randomly to an LLT,C
course_2,ch_2_06,les_2_06_03,topic_2_06_03_01,quiz_2_06_03_4,Why is it important to update AI models with new MedDRA versions?,A) To reduce server load | B) To improve regulatory inspection reports | C) To ensure accurate mapping to current LLTs and PTs | D) To avoid using dashboards,C
course_2,ch_2_06,les_2_06_03,topic_2_06_03_01,quiz_2_06_03_5,What is a best practice when integrating AI auto-coding into PV workflows?,"A) Skip human validation for speed | B) Ignore low-confidence predictions | C) Maintain audit trail, human-in-the-loop validation, and periodic model updates | D) Use AI outputs only for training data",C
course_2,ch_2_06,les_2_06_04,topic_2_06_04_01,quiz_2_06_04_1,What is the main objective of coding accuracy checks in pharmacovigilance?,A) Generate random AE codes | B) Ensure data integrity and regulatory compliance | C) Replace PV staff entirely | D) Skip manual verification,B
course_2,ch_2_06,les_2_06_04,topic_2_06_04_01,quiz_2_06_04_2,Which of the following is an example of an incorrect LLT/PT assignment?,A) “Severe headache” coded as “Migraine” instead of “Headache” | B) Duplicate AE entries | C) Missing LLT/PT | D) Brand name mapped to active substance,A
course_2,ch_2_06,les_2_06_04,topic_2_06_04_01,quiz_2_06_04_3,How can SOC misclassification occur?,A) Assigning PT to a wrong System Organ Class | B) Using AI for auto-coding | C) Updating MedDRA versions | D) Running automated scripts,A
course_2,ch_2_06,les_2_06_04,topic_2_06_04_01,quiz_2_06_04_4,What is the recommended workflow for coding accuracy checks?,"A) Manual review only, ignoring automated tools | B) Automated verification, manual review, cross-reference checks, documentation, feedback | C) Randomly assigning LLTs/PTs | D) Only checking SOCs",B
course_2,ch_2_06,les_2_06_04,topic_2_06_04_01,quiz_2_06_04_5,Which tool can help detect duplicate AE coding?,A) Dashboards | B) Python/R scripts | C) Training programs | D) SOP checklists,B
course_2,ch_2_06,les_2_06_05,topic_2_06_05_01,quiz_2_06_05_1,Which scenario qualifies as a complex case in pharmacovigilance?,A) Single AE with no drug exposure | B) Multiple AEs per patient with multi-drug exposure | C) Minor AE in a healthy volunteer | D) Case with complete verbatim description and one drug,B
course_2,ch_2_06,les_2_06_05,topic_2_06_05_01,quiz_2_06_05_2,What is a primary challenge in coding multi-drug exposure cases?,A) Assigning PTs to LLTs | B) Determining which drug is related to which AE | C) Formatting line listings | D) Integrating dashboards,B
course_2,ch_2_06,les_2_06_05,topic_2_06_05_01,quiz_2_06_05_3,How should overlapping adverse events be handled?,A) Treat each term as a separate AE regardless of similarity | B) Distinguish distinct events versus multiple terms for the same AE | C) Map all to SOC only | D) Ignore duplicates,B
course_2,ch_2_06,les_2_06_05,topic_2_06_05_01,quiz_2_06_05_4,Which tool is recommended for evaluating causality in complex cases?,A) Excel macros | B) WHO-UMC or Naranjo algorithms | C) E2B(R3) XML | D) PDF viewers,B
course_2,ch_2_06,les_2_06_05,topic_2_06_05_01,quiz_2_06_05_5,What is the correct workflow for serious AE coding in complex cases?,A) Map PTs only and skip SOC aggregation | B) Apply SOC-specific rules and annotate outcomes like hospitalization or death | C) Assign LLT randomly | D) Use dashboards only,B
course_2,ch_2_06,les_2_06_06,topic_2_06_06_01,quiz_2_06_06_1,What is the primary purpose of high-quality narratives in pharmacovigilance?,"A) To generate AI-only reports | B) To provide a complete, accurate account of the AE and associated drug(s) | C) To summarize lab results only | D) To track submission IDs",B
course_2,ch_2_06,les_2_06_06,topic_2_06_06_01,quiz_2_06_06_2,Which element should be included in every high-quality ICSR narrative?,"A) Reporter information, patient details, AE description, causality assessment | B) Only patient age and sex | C) Just the drug name | D) Only the adverse event outcome",A
course_2,ch_2_06,les_2_06_06,topic_2_06_06_01,quiz_2_06_06_3,What is a recommended practice for narrative clarity and consistency?,"A) Use abbreviations liberally | B) Align narrative with MedDRA coding, seriousness, and causality assessments | C) Focus on irrelevant details | D) Avoid audit trails",B
course_2,ch_2_06,les_2_06_06,topic_2_06_06_01,quiz_2_06_06_4,How should AI-assisted tools be used in narrative drafting?,A) To fully replace expert review | B) To assist drafting while maintaining human validation | C) To ignore coding integration | D) To bypass regulatory requirements,B
course_2,ch_2_06,les_2_06_06,topic_2_06_06_01,quiz_2_06_06_5,Which workflow step ensures that narratives meet regulatory standards before submission?,A) Automated extraction only | B) Final approval and audit trail with multi-tiered quality checks | C) Drafting without review | D) Skipping medical review,B
course_2,ch_2_06,les_2_06_07,topic_2_06_07_01,quiz_2_06_07_1,What is a follow-up case in pharmacovigilance?,A) Any initial ICSR submitted to the regulatory authority | B) Any additional or updated information received after the initial ICSR submission | C) A duplicate case report | D) Only serious AE reports,B
course_2,ch_2_06,les_2_06_07,topic_2_06_07_01,quiz_2_06_07_2,Which of the following is a trigger for initiating follow-up case processing?,A) Receipt of clarifying patient demographics or medical history | B) Submission of the initial ICSR only | C) Regulatory audit requests unrelated to case data | D) Updating PV system dashboards,A
course_2,ch_2_06,les_2_06_07,topic_2_06_07_01,quiz_2_06_07_3,What is an essential step when integrating follow-up data into PV systems?,A) Replace original case without linking follow-up | B) Update the ICSR in PV databases and maintain the link and audit trail | C) Ignore MedDRA coding updates | D) Only track follow-up in spreadsheets outside PV systems,B
course_2,ch_2_06,les_2_06_07,topic_2_06_07_01,quiz_2_06_07_4,Which challenge is commonly encountered in follow-up case processing?,A) Automated report generation without human review | B) Conflicting data in the follow-up and original case | C) Lack of templates for initial ICSRs | D) MedDRA hierarchy confusion only,B
course_2,ch_2_06,les_2_06_07,topic_2_06_07_01,quiz_2_06_07_5,What is a recommended best practice for follow-up case processing?,A) Maintain unique identifiers and apply structured templates for capturing updates | B) Process follow-ups only if the case is serious | C) Skip quality checks to save time | D) Avoid using PV dashboards or AI tools,A
course_2,ch_2_06,les_2_06_08,topic_2_06_08_01,quiz_2_06_08_1,Which of the following is an example of a MedDRA coding error?,A) Mapping “Severe headache” as “Migraine” instead of “Headache” | B) Updating follow-up lab results | C) Submitting PSUR on time | D) Using structured narrative templates,A
course_2,ch_2_06,les_2_06_08,topic_2_06_08_01,quiz_2_06_08_2,What is the first step in coding error resolution workflow?,"A) Correction & re-coding | B) Error identification through automated scripts, dashboards, or manual review | C) Documentation for audit trail | D) Preventive staff training",B
course_2,ch_2_06,les_2_06_08,topic_2_06_08_01,quiz_2_06_08_3,How should high-impact coding errors be prioritized?,"A) Based on alphabetical order of AE terms | B) By seriousness, causality, or regulatory reporting impact | C) Randomly assigned | D) Only after follow-up cases are closed",B
course_2,ch_2_06,les_2_06_08,topic_2_06_08_01,quiz_2_06_08_4,Which tool can help highlight low-confidence coding for review?,A) PV Systems with AI-assisted modules | B) Standard word processors | C) Regulatory submission PDFs | D) Printed case files,A
course_2,ch_2_06,les_2_06_08,topic_2_06_08_01,quiz_2_06_08_5,What is a recommended best practice for preventing recurring coding errors?,A) Track error trends and update coding guidelines or AI models | B) Ignore minor duplicates to save time | C) Apply corrections without review | D) Limit PV staff access to coding data,A
course_2,ch_2_06,les_2_06_09,topic_2_06_09_01,quiz_2_06_09_1,How frequently are MedDRA version updates released?,A) Quarterly | B) Twice yearly (March and September) | C) Annually | D) Every month,B
course_2,ch_2_06,les_2_06_09,topic_2_06_09_01,quiz_2_06_09_2,Which of the following is considered a type of update in a new MedDRA release?,A) Addition of new LLTs and PTs | B) Changes in office layout | C) Hiring new PV staff | D) Updating PV system software unrelated to MedDRA,A
course_2,ch_2_06,les_2_06_09,topic_2_06_09_01,quiz_2_06_09_3,What is the recommended first step when a new MedDRA version is released?,A) Immediately update PV dashboards | B) Backup current PV system data and review official release notes | C) Start writing narratives | D) Ignore historical cases,B
course_2,ch_2_06,les_2_06_09,topic_2_06_09_01,quiz_2_06_09_4,How should historical cases affected by deleted or modified terms be handled?,A) Leave them as-is to save time | B) Recode impacted cases and validate coding against the new version | C) Delete the cases | D) Only recode serious cases without validation,B
course_2,ch_2_06,les_2_06_09,topic_2_06_09_01,quiz_2_06_09_5,Which practice ensures compliance and minimizes errors during MedDRA version updates?,A) Maintain audit-ready documentation and train staff on new terms | B) Skip staff training to save time | C) Update only the AI auto-coding modules | D) Ignore SOPs for version control,A
course_2,ch_2_06,les_2_06_10,topic_2_06_10_01,quiz_2_06_10_1,What is the primary purpose of case quality dashboards in pharmacovigilance?,A) Track company profits | B) Monitor and improve the quality of ICSRs | C) Schedule staff shifts | D) Manage clinical trial recruitment,B
course_2,ch_2_06,les_2_06_10,topic_2_06_10_01,quiz_2_06_10_2,Which metric indicates the percentage of ICSRs with all mandatory fields completed?,A) Follow-Up Status | B) Completeness Score | C) Coding Accuracy | D) Regulatory Timeliness,B
course_2,ch_2_06,les_2_06_10,topic_2_06_10_01,quiz_2_06_10_3,What is an ideal target for coding accuracy of adverse events and drug terms?,A) ≥ 98% | B) ≥ 80% | C) 100% | D) ≥ 90%,A
course_2,ch_2_06,les_2_06_10,topic_2_06_10_01,quiz_2_06_10_4,Which of the following is a best practice when using case quality dashboards?,A) Configure dashboards with actionable metrics and real-time alerts | B) Ignore KPIs and focus only on total cases | C) Use dashboards only for annual reporting | D) Avoid integrating AI tools to simplify dashboards,A
course_2,ch_2_06,les_2_06_10,topic_2_06_10_01,quiz_2_06_10_5,How can dashboards support regulatory and audit processes?,A) Generate audit-ready logs and reports for regulatory submission | B) Replace PV staff review entirely | C) Predict new adverse events automatically | D) Eliminate the need for SOPs,A
course_2,ch_2_07,les_2_07_01,topic_2_07_01_01,quiz_2_07_01_1,,,
course_2,ch_2_07,les_2_07_01,topic_2_07_01_01,quiz_2_07_01_2,,,
course_2,ch_2_07,les_2_07_01,topic_2_07_01_01,quiz_2_07_01_3,,,
course_2,ch_2_07,les_2_07_01,topic_2_07_01_01,quiz_2_07_01_4,,,
course_2,ch_2_07,les_2_07_01,topic_2_07_01_01,quiz_2_07_01_5,,,
course_2,ch_2_07,les_2_07_02,topic_2_07_02_01,quiz_2_07_02_1,,,
course_2,ch_2_07,les_2_07_02,topic_2_07_02_01,quiz_2_07_02_2,,,
course_2,ch_2_07,les_2_07_02,topic_2_07_02_01,quiz_2_07_02_3,,,
course_2,ch_2_07,les_2_07_02,topic_2_07_02_01,quiz_2_07_02_4,,,
course_2,ch_2_07,les_2_07_02,topic_2_07_02_01,quiz_2_07_02_5,,,
course_2,ch_2_07,les_2_07_03,topic_2_07_03_01,quiz_2_07_03_1,,,
course_2,ch_2_07,les_2_07_03,topic_2_07_03_01,quiz_2_07_03_2,,,
course_2,ch_2_07,les_2_07_03,topic_2_07_03_01,quiz_2_07_03_3,,,
course_2,ch_2_07,les_2_07_03,topic_2_07_03_01,quiz_2_07_03_4,,,
course_2,ch_2_07,les_2_07_03,topic_2_07_03_01,quiz_2_07_03_5,,,
course_2,ch_2_07,les_2_07_04,topic_2_07_04_01,quiz_2_07_04_1,,,
course_2,ch_2_07,les_2_07_04,topic_2_07_04_01,quiz_2_07_04_2,,,
course_2,ch_2_07,les_2_07_04,topic_2_07_04_01,quiz_2_07_04_3,,,
course_2,ch_2_07,les_2_07_04,topic_2_07_04_01,quiz_2_07_04_4,,,
course_2,ch_2_07,les_2_07_04,topic_2_07_04_01,quiz_2_07_04_5,,,
course_2,ch_2_07,les_2_07_05,topic_2_07_05_01,quiz_2_07_05_1,,,
course_2,ch_2_07,les_2_07_05,topic_2_07_05_01,quiz_2_07_05_2,,,
course_2,ch_2_07,les_2_07_05,topic_2_07_05_01,quiz_2_07_05_3,,,
course_2,ch_2_07,les_2_07_05,topic_2_07_05_01,quiz_2_07_05_4,,,
course_2,ch_2_07,les_2_07_05,topic_2_07_05_01,quiz_2_07_05_5,,,
course_2,ch_2_07,les_2_07_06,topic_2_07_06_01,quiz_2_07_06_1,,,
course_2,ch_2_07,les_2_07_06,topic_2_07_06_01,quiz_2_07_06_2,,,
course_2,ch_2_07,les_2_07_06,topic_2_07_06_01,quiz_2_07_06_3,,,
course_2,ch_2_07,les_2_07_06,topic_2_07_06_01,quiz_2_07_06_4,,,
course_2,ch_2_07,les_2_07_06,topic_2_07_06_01,quiz_2_07_06_5,,,
course_2,ch_2_07,les_2_07_07,topic_2_07_07_01,quiz_2_07_07_1,,,
course_2,ch_2_07,les_2_07_07,topic_2_07_07_01,quiz_2_07_07_2,,,
course_2,ch_2_07,les_2_07_07,topic_2_07_07_01,quiz_2_07_07_3,,,
course_2,ch_2_07,les_2_07_07,topic_2_07_07_01,quiz_2_07_07_4,,,
course_2,ch_2_07,les_2_07_07,topic_2_07_07_01,quiz_2_07_07_5,,,
course_2,ch_2_07,les_2_07_08,topic_2_07_08_01,quiz_2_07_08_1,,,
course_2,ch_2_07,les_2_07_08,topic_2_07_08_01,quiz_2_07_08_2,,,
course_2,ch_2_07,les_2_07_08,topic_2_07_08_01,quiz_2_07_08_3,,,
course_2,ch_2_07,les_2_07_08,topic_2_07_08_01,quiz_2_07_08_4,,,
course_2,ch_2_07,les_2_07_08,topic_2_07_08_01,quiz_2_07_08_5,,,
course_2,ch_2_07,les_2_07_09,topic_2_07_09_01,quiz_2_07_09_1,,,
course_2,ch_2_07,les_2_07_09,topic_2_07_09_01,quiz_2_07_09_2,,,
course_2,ch_2_07,les_2_07_09,topic_2_07_09_01,quiz_2_07_09_3,,,
course_2,ch_2_07,les_2_07_09,topic_2_07_09_01,quiz_2_07_09_4,,,
course_2,ch_2_07,les_2_07_09,topic_2_07_09_01,quiz_2_07_09_5,,,
course_2,ch_2_07,les_2_07_10,topic_2_07_10_01,quiz_2_07_10_1,,,
course_2,ch_2_07,les_2_07_10,topic_2_07_10_01,quiz_2_07_10_2,,,
course_2,ch_2_07,les_2_07_10,topic_2_07_10_01,quiz_2_07_10_3,,,
course_2,ch_2_07,les_2_07_10,topic_2_07_10_01,quiz_2_07_10_4,,,
course_2,ch_2_07,les_2_07_10,topic_2_07_10_01,quiz_2_07_10_5,,,
course_2,ch_2_08,les_2_08_01,topic_2_08_01_01,quiz_2_08_01_1,,,
course_2,ch_2_08,les_2_08_01,topic_2_08_01_01,quiz_2_08_01_2,,,
course_2,ch_2_08,les_2_08_01,topic_2_08_01_01,quiz_2_08_01_3,,,
course_2,ch_2_08,les_2_08_01,topic_2_08_01_01,quiz_2_08_01_4,,,
course_2,ch_2_08,les_2_08_01,topic_2_08_01_01,quiz_2_08_01_5,,,
course_2,ch_2_08,les_2_08_02,topic_2_08_02_01,quiz_2_08_02_1,,,
course_2,ch_2_08,les_2_08_02,topic_2_08_02_01,quiz_2_08_02_2,,,
course_2,ch_2_08,les_2_08_02,topic_2_08_02_01,quiz_2_08_02_3,,,
course_2,ch_2_08,les_2_08_02,topic_2_08_02_01,quiz_2_08_02_4,,,
course_2,ch_2_08,les_2_08_02,topic_2_08_02_01,quiz_2_08_02_5,,,
course_2,ch_2_08,les_2_08_03,topic_2_08_03_01,quiz_2_08_03_1,,,
course_2,ch_2_08,les_2_08_03,topic_2_08_03_01,quiz_2_08_03_2,,,
course_2,ch_2_08,les_2_08_03,topic_2_08_03_01,quiz_2_08_03_3,,,
course_2,ch_2_08,les_2_08_03,topic_2_08_03_01,quiz_2_08_03_4,,,
course_2,ch_2_08,les_2_08_03,topic_2_08_03_01,quiz_2_08_03_5,,,
course_2,ch_2_08,les_2_08_04,topic_2_08_04_01,quiz_2_08_04_1,,,
course_2,ch_2_08,les_2_08_04,topic_2_08_04_01,quiz_2_08_04_2,,,
course_2,ch_2_08,les_2_08_04,topic_2_08_04_01,quiz_2_08_04_3,,,
course_2,ch_2_08,les_2_08_04,topic_2_08_04_01,quiz_2_08_04_4,,,
course_2,ch_2_08,les_2_08_04,topic_2_08_04_01,quiz_2_08_04_5,,,
course_2,ch_2_08,les_2_08_05,topic_2_08_05_01,quiz_2_08_05_1,,,
course_2,ch_2_08,les_2_08_05,topic_2_08_05_01,quiz_2_08_05_2,,,
course_2,ch_2_08,les_2_08_05,topic_2_08_05_01,quiz_2_08_05_3,,,
course_2,ch_2_08,les_2_08_05,topic_2_08_05_01,quiz_2_08_05_4,,,
course_2,ch_2_08,les_2_08_05,topic_2_08_05_01,quiz_2_08_05_5,,,
course_2,ch_2_08,les_2_08_06,topic_2_08_06_01,quiz_2_08_06_1,,,
course_2,ch_2_08,les_2_08_06,topic_2_08_06_01,quiz_2_08_06_2,,,
course_2,ch_2_08,les_2_08_06,topic_2_08_06_01,quiz_2_08_06_3,,,
course_2,ch_2_08,les_2_08_06,topic_2_08_06_01,quiz_2_08_06_4,,,
course_2,ch_2_08,les_2_08_06,topic_2_08_06_01,quiz_2_08_06_5,,,
course_2,ch_2_08,les_2_08_07,topic_2_08_07_01,quiz_2_08_07_1,,,
course_2,ch_2_08,les_2_08_07,topic_2_08_07_01,quiz_2_08_07_2,,,
course_2,ch_2_08,les_2_08_07,topic_2_08_07_01,quiz_2_08_07_3,,,
course_2,ch_2_08,les_2_08_07,topic_2_08_07_01,quiz_2_08_07_4,,,
course_2,ch_2_08,les_2_08_07,topic_2_08_07_01,quiz_2_08_07_5,,,
course_2,ch_2_08,les_2_08_08,topic_2_08_08_01,quiz_2_08_08_1,,,
course_2,ch_2_08,les_2_08_08,topic_2_08_08_01,quiz_2_08_08_2,,,
course_2,ch_2_08,les_2_08_08,topic_2_08_08_01,quiz_2_08_08_3,,,
course_2,ch_2_08,les_2_08_08,topic_2_08_08_01,quiz_2_08_08_4,,,
course_2,ch_2_08,les_2_08_08,topic_2_08_08_01,quiz_2_08_08_5,,,
course_2,ch_2_08,les_2_08_09,topic_2_08_09_01,quiz_2_08_09_1,,,
course_2,ch_2_08,les_2_08_09,topic_2_08_09_01,quiz_2_08_09_2,,,
course_2,ch_2_08,les_2_08_09,topic_2_08_09_01,quiz_2_08_09_3,,,
course_2,ch_2_08,les_2_08_09,topic_2_08_09_01,quiz_2_08_09_4,,,
course_2,ch_2_08,les_2_08_09,topic_2_08_09_01,quiz_2_08_09_5,,,
course_2,ch_2_08,les_2_08_10,topic_2_08_10_01,quiz_2_08_10_1,,,
course_2,ch_2_08,les_2_08_10,topic_2_08_10_01,quiz_2_08_10_2,,,
course_2,ch_2_08,les_2_08_10,topic_2_08_10_01,quiz_2_08_10_3,,,
course_2,ch_2_08,les_2_08_10,topic_2_08_10_01,quiz_2_08_10_4,,,
course_2,ch_2_08,les_2_08_10,topic_2_08_10_01,quiz_2_08_10_5,,,
course_2,ch_2_09,les_2_09_01,topic_2_09_01_01,quiz_2_09_01_1,,,
course_2,ch_2_09,les_2_09_01,topic_2_09_01_01,quiz_2_09_01_2,,,
course_2,ch_2_09,les_2_09_01,topic_2_09_01_01,quiz_2_09_01_3,,,
course_2,ch_2_09,les_2_09_01,topic_2_09_01_01,quiz_2_09_01_4,,,
course_2,ch_2_09,les_2_09_01,topic_2_09_01_01,quiz_2_09_01_5,,,
course_2,ch_2_09,les_2_09_02,topic_2_09_02_01,quiz_2_09_02_1,,,
course_2,ch_2_09,les_2_09_02,topic_2_09_02_01,quiz_2_09_02_2,,,
course_2,ch_2_09,les_2_09_02,topic_2_09_02_01,quiz_2_09_02_3,,,
course_2,ch_2_09,les_2_09_02,topic_2_09_02_01,quiz_2_09_02_4,,,
course_2,ch_2_09,les_2_09_02,topic_2_09_02_01,quiz_2_09_02_5,,,
course_2,ch_2_09,les_2_09_03,topic_2_09_03_01,quiz_2_09_03_1,,,
course_2,ch_2_09,les_2_09_03,topic_2_09_03_01,quiz_2_09_03_2,,,
course_2,ch_2_09,les_2_09_03,topic_2_09_03_01,quiz_2_09_03_3,,,
course_2,ch_2_09,les_2_09_03,topic_2_09_03_01,quiz_2_09_03_4,,,
course_2,ch_2_09,les_2_09_03,topic_2_09_03_01,quiz_2_09_03_5,,,
course_2,ch_2_09,les_2_09_04,topic_2_09_04_01,quiz_2_09_04_1,,,
course_2,ch_2_09,les_2_09_04,topic_2_09_04_01,quiz_2_09_04_2,,,
course_2,ch_2_09,les_2_09_04,topic_2_09_04_01,quiz_2_09_04_3,,,
course_2,ch_2_09,les_2_09_04,topic_2_09_04_01,quiz_2_09_04_4,,,
course_2,ch_2_09,les_2_09_04,topic_2_09_04_01,quiz_2_09_04_5,,,
course_2,ch_2_09,les_2_09_05,topic_2_09_05_01,quiz_2_09_05_1,,,
course_2,ch_2_09,les_2_09_05,topic_2_09_05_01,quiz_2_09_05_2,,,
course_2,ch_2_09,les_2_09_05,topic_2_09_05_01,quiz_2_09_05_3,,,
course_2,ch_2_09,les_2_09_05,topic_2_09_05_01,quiz_2_09_05_4,,,
course_2,ch_2_09,les_2_09_05,topic_2_09_05_01,quiz_2_09_05_5,,,
course_2,ch_2_09,les_2_09_06,topic_2_09_06_01,quiz_2_09_06_1,,,
course_2,ch_2_09,les_2_09_06,topic_2_09_06_01,quiz_2_09_06_2,,,
course_2,ch_2_09,les_2_09_06,topic_2_09_06_01,quiz_2_09_06_3,,,
course_2,ch_2_09,les_2_09_06,topic_2_09_06_01,quiz_2_09_06_4,,,
course_2,ch_2_09,les_2_09_06,topic_2_09_06_01,quiz_2_09_06_5,,,
course_2,ch_2_09,les_2_09_07,topic_2_09_07_01,quiz_2_09_07_1,,,
course_2,ch_2_09,les_2_09_07,topic_2_09_07_01,quiz_2_09_07_2,,,
course_2,ch_2_09,les_2_09_07,topic_2_09_07_01,quiz_2_09_07_3,,,
course_2,ch_2_09,les_2_09_07,topic_2_09_07_01,quiz_2_09_07_4,,,
course_2,ch_2_09,les_2_09_07,topic_2_09_07_01,quiz_2_09_07_5,,,
course_2,ch_2_09,les_2_09_08,topic_2_09_08_01,quiz_2_09_08_1,,,
course_2,ch_2_09,les_2_09_08,topic_2_09_08_01,quiz_2_09_08_2,,,
course_2,ch_2_09,les_2_09_08,topic_2_09_08_01,quiz_2_09_08_3,,,
course_2,ch_2_09,les_2_09_08,topic_2_09_08_01,quiz_2_09_08_4,,,
course_2,ch_2_09,les_2_09_08,topic_2_09_08_01,quiz_2_09_08_5,,,
course_2,ch_2_09,les_2_09_09,topic_2_09_09_01,quiz_2_09_09_1,,,
course_2,ch_2_09,les_2_09_09,topic_2_09_09_01,quiz_2_09_09_2,,,
course_2,ch_2_09,les_2_09_09,topic_2_09_09_01,quiz_2_09_09_3,,,
course_2,ch_2_09,les_2_09_09,topic_2_09_09_01,quiz_2_09_09_4,,,
course_2,ch_2_09,les_2_09_09,topic_2_09_09_01,quiz_2_09_09_5,,,
course_2,ch_2_09,les_2_09_10,topic_2_09_10_01,quiz_2_09_10_1,,,
course_2,ch_2_09,les_2_09_10,topic_2_09_10_01,quiz_2_09_10_2,,,
course_2,ch_2_09,les_2_09_10,topic_2_09_10_01,quiz_2_09_10_3,,,
course_2,ch_2_09,les_2_09_10,topic_2_09_10_01,quiz_2_09_10_4,,,
course_2,ch_2_09,les_2_09_10,topic_2_09_10_01,quiz_2_09_10_5,,,
course_2,ch_2_10,les_2_10_01,topic_2_10_01_01,quiz_2_10_01_1,,,
course_2,ch_2_10,les_2_10_01,topic_2_10_01_01,quiz_2_10_01_2,,,
course_2,ch_2_10,les_2_10_01,topic_2_10_01_01,quiz_2_10_01_3,,,
course_2,ch_2_10,les_2_10_01,topic_2_10_01_01,quiz_2_10_01_4,,,
course_2,ch_2_10,les_2_10_01,topic_2_10_01_01,quiz_2_10_01_5,,,
course_2,ch_2_10,les_2_10_02,topic_2_10_02_01,quiz_2_10_02_1,,,
course_2,ch_2_10,les_2_10_02,topic_2_10_02_01,quiz_2_10_02_2,,,
course_2,ch_2_10,les_2_10_02,topic_2_10_02_01,quiz_2_10_02_3,,,
course_2,ch_2_10,les_2_10_02,topic_2_10_02_01,quiz_2_10_02_4,,,
course_2,ch_2_10,les_2_10_02,topic_2_10_02_01,quiz_2_10_02_5,,,
course_2,ch_2_10,les_2_10_03,topic_2_10_03_01,quiz_2_10_03_1,,,
course_2,ch_2_10,les_2_10_03,topic_2_10_03_01,quiz_2_10_03_2,,,
course_2,ch_2_10,les_2_10_03,topic_2_10_03_01,quiz_2_10_03_3,,,
course_2,ch_2_10,les_2_10_03,topic_2_10_03_01,quiz_2_10_03_4,,,
course_2,ch_2_10,les_2_10_03,topic_2_10_03_01,quiz_2_10_03_5,,,
course_2,ch_2_10,les_2_10_04,topic_2_10_04_01,quiz_2_10_04_1,,,
course_2,ch_2_10,les_2_10_04,topic_2_10_04_01,quiz_2_10_04_2,,,
course_2,ch_2_10,les_2_10_04,topic_2_10_04_01,quiz_2_10_04_3,,,
course_2,ch_2_10,les_2_10_04,topic_2_10_04_01,quiz_2_10_04_4,,,
course_2,ch_2_10,les_2_10_04,topic_2_10_04_01,quiz_2_10_04_5,,,
course_2,ch_2_10,les_2_10_05,topic_2_10_05_01,quiz_2_10_05_1,,,
course_2,ch_2_10,les_2_10_05,topic_2_10_05_01,quiz_2_10_05_2,,,
course_2,ch_2_10,les_2_10_05,topic_2_10_05_01,quiz_2_10_05_3,,,
course_2,ch_2_10,les_2_10_05,topic_2_10_05_01,quiz_2_10_05_4,,,
course_2,ch_2_10,les_2_10_05,topic_2_10_05_01,quiz_2_10_05_5,,,
course_2,ch_2_10,les_2_10_06,topic_2_10_06_01,quiz_2_10_06_1,,,
course_2,ch_2_10,les_2_10_06,topic_2_10_06_01,quiz_2_10_06_2,,,
course_2,ch_2_10,les_2_10_06,topic_2_10_06_01,quiz_2_10_06_3,,,
course_2,ch_2_10,les_2_10_06,topic_2_10_06_01,quiz_2_10_06_4,,,
course_2,ch_2_10,les_2_10_06,topic_2_10_06_01,quiz_2_10_06_5,,,
course_2,ch_2_10,les_2_10_07,topic_2_10_07_01,quiz_2_10_07_1,,,
course_2,ch_2_10,les_2_10_07,topic_2_10_07_01,quiz_2_10_07_2,,,
course_2,ch_2_10,les_2_10_07,topic_2_10_07_01,quiz_2_10_07_3,,,
course_2,ch_2_10,les_2_10_07,topic_2_10_07_01,quiz_2_10_07_4,,,
course_2,ch_2_10,les_2_10_07,topic_2_10_07_01,quiz_2_10_07_5,,,
course_2,ch_2_10,les_2_10_08,topic_2_10_08_01,quiz_2_10_08_1,,,
course_2,ch_2_10,les_2_10_08,topic_2_10_08_01,quiz_2_10_08_2,,,
course_2,ch_2_10,les_2_10_08,topic_2_10_08_01,quiz_2_10_08_3,,,
course_2,ch_2_10,les_2_10_08,topic_2_10_08_01,quiz_2_10_08_4,,,
course_2,ch_2_10,les_2_10_08,topic_2_10_08_01,quiz_2_10_08_5,,,
course_2,ch_2_10,les_2_10_09,topic_2_10_09_01,quiz_2_10_09_1,,,
course_2,ch_2_10,les_2_10_09,topic_2_10_09_01,quiz_2_10_09_2,,,
course_2,ch_2_10,les_2_10_09,topic_2_10_09_01,quiz_2_10_09_3,,,
course_2,ch_2_10,les_2_10_09,topic_2_10_09_01,quiz_2_10_09_4,,,
course_2,ch_2_10,les_2_10_09,topic_2_10_09_01,quiz_2_10_09_5,,,
course_2,ch_2_10,les_2_10_10,topic_2_10_10_01,quiz_2_10_10_1,,,
course_2,ch_2_10,les_2_10_10,topic_2_10_10_01,quiz_2_10_10_2,,,
course_2,ch_2_10,les_2_10_10,topic_2_10_10_01,quiz_2_10_10_3,,,
course_2,ch_2_10,les_2_10_10,topic_2_10_10_01,quiz_2_10_10_4,,,
course_2,ch_2_10,les_2_10_10,topic_2_10_10_01,quiz_2_10_10_5,,,
course_2,ch_2_11,les_2_11_01,topic_2_11_01_01,quiz_2_11_01_1,,,
course_2,ch_2_11,les_2_11_01,topic_2_11_01_01,quiz_2_11_01_2,,,
course_2,ch_2_11,les_2_11_01,topic_2_11_01_01,quiz_2_11_01_3,,,
course_2,ch_2_11,les_2_11_01,topic_2_11_01_01,quiz_2_11_01_4,,,
course_2,ch_2_11,les_2_11_01,topic_2_11_01_01,quiz_2_11_01_5,,,
course_2,ch_2_11,les_2_11_02,topic_2_11_02_01,quiz_2_11_02_1,,,
course_2,ch_2_11,les_2_11_02,topic_2_11_02_01,quiz_2_11_02_2,,,
course_2,ch_2_11,les_2_11_02,topic_2_11_02_01,quiz_2_11_02_3,,,
course_2,ch_2_11,les_2_11_02,topic_2_11_02_01,quiz_2_11_02_4,,,
course_2,ch_2_11,les_2_11_02,topic_2_11_02_01,quiz_2_11_02_5,,,
course_2,ch_2_11,les_2_11_03,topic_2_11_03_01,quiz_2_11_03_1,,,
course_2,ch_2_11,les_2_11_03,topic_2_11_03_01,quiz_2_11_03_2,,,
course_2,ch_2_11,les_2_11_03,topic_2_11_03_01,quiz_2_11_03_3,,,
course_2,ch_2_11,les_2_11_03,topic_2_11_03_01,quiz_2_11_03_4,,,
course_2,ch_2_11,les_2_11_03,topic_2_11_03_01,quiz_2_11_03_5,,,
course_2,ch_2_11,les_2_11_04,topic_2_11_04_01,quiz_2_11_04_1,,,
course_2,ch_2_11,les_2_11_04,topic_2_11_04_01,quiz_2_11_04_2,,,
course_2,ch_2_11,les_2_11_04,topic_2_11_04_01,quiz_2_11_04_3,,,
course_2,ch_2_11,les_2_11_04,topic_2_11_04_01,quiz_2_11_04_4,,,
course_2,ch_2_11,les_2_11_04,topic_2_11_04_01,quiz_2_11_04_5,,,
course_2,ch_2_11,les_2_11_05,topic_2_11_05_01,quiz_2_11_05_1,,,
course_2,ch_2_11,les_2_11_05,topic_2_11_05_01,quiz_2_11_05_2,,,
course_2,ch_2_11,les_2_11_05,topic_2_11_05_01,quiz_2_11_05_3,,,
course_2,ch_2_11,les_2_11_05,topic_2_11_05_01,quiz_2_11_05_4,,,
course_2,ch_2_11,les_2_11_05,topic_2_11_05_01,quiz_2_11_05_5,,,
course_2,ch_2_11,les_2_11_06,topic_2_11_06_01,quiz_2_11_06_1,,,
course_2,ch_2_11,les_2_11_06,topic_2_11_06_01,quiz_2_11_06_2,,,
course_2,ch_2_11,les_2_11_06,topic_2_11_06_01,quiz_2_11_06_3,,,
course_2,ch_2_11,les_2_11_06,topic_2_11_06_01,quiz_2_11_06_4,,,
course_2,ch_2_11,les_2_11_06,topic_2_11_06_01,quiz_2_11_06_5,,,
course_2,ch_2_11,les_2_11_07,topic_2_11_07_01,quiz_2_11_07_1,,,
course_2,ch_2_11,les_2_11_07,topic_2_11_07_01,quiz_2_11_07_2,,,
course_2,ch_2_11,les_2_11_07,topic_2_11_07_01,quiz_2_11_07_3,,,
course_2,ch_2_11,les_2_11_07,topic_2_11_07_01,quiz_2_11_07_4,,,
course_2,ch_2_11,les_2_11_07,topic_2_11_07_01,quiz_2_11_07_5,,,
course_2,ch_2_11,les_2_11_08,topic_2_11_08_01,quiz_2_11_08_1,,,
course_2,ch_2_11,les_2_11_08,topic_2_11_08_01,quiz_2_11_08_2,,,
course_2,ch_2_11,les_2_11_08,topic_2_11_08_01,quiz_2_11_08_3,,,
course_2,ch_2_11,les_2_11_08,topic_2_11_08_01,quiz_2_11_08_4,,,
course_2,ch_2_11,les_2_11_08,topic_2_11_08_01,quiz_2_11_08_5,,,
course_2,ch_2_11,les_2_11_09,topic_2_11_09_01,quiz_2_11_09_1,,,
course_2,ch_2_11,les_2_11_09,topic_2_11_09_01,quiz_2_11_09_2,,,
course_2,ch_2_11,les_2_11_09,topic_2_11_09_01,quiz_2_11_09_3,,,
course_2,ch_2_11,les_2_11_09,topic_2_11_09_01,quiz_2_11_09_4,,,
course_2,ch_2_11,les_2_11_09,topic_2_11_09_01,quiz_2_11_09_5,,,
course_2,ch_2_11,les_2_11_10,topic_2_11_10_01,quiz_2_11_10_1,,,
course_2,ch_2_11,les_2_11_10,topic_2_11_10_01,quiz_2_11_10_2,,,
course_2,ch_2_11,les_2_11_10,topic_2_11_10_01,quiz_2_11_10_3,,,
course_2,ch_2_11,les_2_11_10,topic_2_11_10_01,quiz_2_11_10_4,,,
course_2,ch_2_11,les_2_11_10,topic_2_11_10_01,quiz_2_11_10_5,,,
course_2,ch_2_12,les_2_12_01,topic_2_12_01_01,quiz_2_12_01_1,,,
course_2,ch_2_12,les_2_12_01,topic_2_12_01_01,quiz_2_12_01_2,,,
course_2,ch_2_12,les_2_12_01,topic_2_12_01_01,quiz_2_12_01_3,,,
course_2,ch_2_12,les_2_12_01,topic_2_12_01_01,quiz_2_12_01_4,,,
course_2,ch_2_12,les_2_12_01,topic_2_12_01_01,quiz_2_12_01_5,,,
course_2,ch_2_12,les_2_12_02,topic_2_12_02_01,quiz_2_12_02_1,,,
course_2,ch_2_12,les_2_12_02,topic_2_12_02_01,quiz_2_12_02_2,,,
course_2,ch_2_12,les_2_12_02,topic_2_12_02_01,quiz_2_12_02_3,,,
course_2,ch_2_12,les_2_12_02,topic_2_12_02_01,quiz_2_12_02_4,,,
course_2,ch_2_12,les_2_12_02,topic_2_12_02_01,quiz_2_12_02_5,,,
course_2,ch_2_12,les_2_12_03,topic_2_12_03_01,quiz_2_12_03_1,,,
course_2,ch_2_12,les_2_12_03,topic_2_12_03_01,quiz_2_12_03_2,,,
course_2,ch_2_12,les_2_12_03,topic_2_12_03_01,quiz_2_12_03_3,,,
course_2,ch_2_12,les_2_12_03,topic_2_12_03_01,quiz_2_12_03_4,,,
course_2,ch_2_12,les_2_12_03,topic_2_12_03_01,quiz_2_12_03_5,,,
course_2,ch_2_12,les_2_12_04,topic_2_12_04_01,quiz_2_12_04_1,,,
course_2,ch_2_12,les_2_12_04,topic_2_12_04_01,quiz_2_12_04_2,,,
course_2,ch_2_12,les_2_12_04,topic_2_12_04_01,quiz_2_12_04_3,,,
course_2,ch_2_12,les_2_12_04,topic_2_12_04_01,quiz_2_12_04_4,,,
course_2,ch_2_12,les_2_12_04,topic_2_12_04_01,quiz_2_12_04_5,,,
course_2,ch_2_12,les_2_12_05,topic_2_12_05_01,quiz_2_12_05_1,,,
course_2,ch_2_12,les_2_12_05,topic_2_12_05_01,quiz_2_12_05_2,,,
course_2,ch_2_12,les_2_12_05,topic_2_12_05_01,quiz_2_12_05_3,,,
course_2,ch_2_12,les_2_12_05,topic_2_12_05_01,quiz_2_12_05_4,,,
course_2,ch_2_12,les_2_12_05,topic_2_12_05_01,quiz_2_12_05_5,,,
course_2,ch_2_12,les_2_12_06,topic_2_12_06_01,quiz_2_12_06_1,,,
course_2,ch_2_12,les_2_12_06,topic_2_12_06_01,quiz_2_12_06_2,,,
course_2,ch_2_12,les_2_12_06,topic_2_12_06_01,quiz_2_12_06_3,,,
course_2,ch_2_12,les_2_12_06,topic_2_12_06_01,quiz_2_12_06_4,,,
course_2,ch_2_12,les_2_12_06,topic_2_12_06_01,quiz_2_12_06_5,,,
course_2,ch_2_12,les_2_12_07,topic_2_12_07_01,quiz_2_12_07_1,,,
course_2,ch_2_12,les_2_12_07,topic_2_12_07_01,quiz_2_12_07_2,,,
course_2,ch_2_12,les_2_12_07,topic_2_12_07_01,quiz_2_12_07_3,,,
course_2,ch_2_12,les_2_12_07,topic_2_12_07_01,quiz_2_12_07_4,,,
course_2,ch_2_12,les_2_12_07,topic_2_12_07_01,quiz_2_12_07_5,,,
course_2,ch_2_12,les_2_12_08,topic_2_12_08_01,quiz_2_12_08_1,,,
course_2,ch_2_12,les_2_12_08,topic_2_12_08_01,quiz_2_12_08_2,,,
course_2,ch_2_12,les_2_12_08,topic_2_12_08_01,quiz_2_12_08_3,,,
course_2,ch_2_12,les_2_12_08,topic_2_12_08_01,quiz_2_12_08_4,,,
course_2,ch_2_12,les_2_12_08,topic_2_12_08_01,quiz_2_12_08_5,,,
course_2,ch_2_12,les_2_12_09,topic_2_12_09_01,quiz_2_12_09_1,,,
course_2,ch_2_12,les_2_12_09,topic_2_12_09_01,quiz_2_12_09_2,,,
course_2,ch_2_12,les_2_12_09,topic_2_12_09_01,quiz_2_12_09_3,,,
course_2,ch_2_12,les_2_12_09,topic_2_12_09_01,quiz_2_12_09_4,,,
course_2,ch_2_12,les_2_12_09,topic_2_12_09_01,quiz_2_12_09_5,,,
course_2,ch_2_12,les_2_12_10,topic_2_12_10_01,quiz_2_12_10_1,,,
course_2,ch_2_12,les_2_12_10,topic_2_12_10_01,quiz_2_12_10_2,,,
course_2,ch_2_12,les_2_12_10,topic_2_12_10_01,quiz_2_12_10_3,,,
course_2,ch_2_12,les_2_12_10,topic_2_12_10_01,quiz_2_12_10_4,,,
course_2,ch_2_12,les_2_12_10,topic_2_12_10_01,quiz_2_12_10_5,,,
course_3,ch_3_01,les_3_01_01,topic_3_01_01_01,quiz_3_01_01_1,What is the primary goal of Phase 1 clinical trials?,A) To confirm the drug's effectiveness in a large group | B) To test the drug's safety in healthy volunteers | C) To monitor long-term effects after market approval | D) To compare the drug to existing treatments,B
course_3,ch_3_01,les_3_01_01,topic_3_01_01_01,quiz_3_01_01_2,"In Phase 2 trials, which group of participants is typically involved?",A) Thousands of patients globally | B) Healthy volunteers only | C) Patients with the targeted condition | D) Millions of users post-approval,C
course_3,ch_3_01,les_3_01_01,topic_3_01_01_01,quiz_3_01_01_3,Approximately what percentage of drugs successfully pass Phase 3 trials?,A) 70 percent | B) One-third | C) 25 to 30 percent | D) Nearly all that enter,C
course_3,ch_3_01,les_3_01_01,topic_3_01_01_01,quiz_3_01_01_4,What occurs during Phase 4 of clinical research?,A) Initial safety testing in small groups | B) Post-marketing surveillance for long-term effects | C) Preclinical lab experiments on cells or animals | D) Regulatory review by agencies like the FDA,B
course_3,ch_3_01,les_3_01_01,topic_3_01_01_01,quiz_3_01_01_5,"How long does the entire drug development process typically take, including all phases?",A) A few months to a year | B) 10 to 15 years | C) Under five years | D) Several decades for most drugs,B
course_3,ch_3_01,les_3_01_02,topic_3_01_02_01,quiz_3_01_02_1,Which event directly led to the creation of the 1974 National Research Act in the U.S.?,A) The sulfanilamide disaster of 1937 | B) Exposure of the Tuskegee syphilis study | C) James Lind’s scurvy trial in 1747 | D) Introduction of electronic data systems in the 2000s,B
course_3,ch_3_01,les_3_01_02,topic_3_01_02_01,quiz_3_01_02_2,What was the primary innovation in James Lind’s 1747 experiment that distinguished it from earlier medical tests?,A) Use of artificial intelligence for data analysis | B) Dividing patients into groups with different treatments | C) Requiring informed consent from participants | D) Monitoring patients remotely using wearable devices,B
course_3,ch_3_01,les_3_01_02,topic_3_01_02_01,quiz_3_01_02_3,The 1962 Kefauver-Harris Amendments in the U.S. introduced a new requirement for drugs beyond just proving safety. What was it?,A) Large-scale global testing | B) Proof of efficacy | C) Use of placebos in all trials | D) Long-term Phase 4 monitoring,B
course_3,ch_3_01,les_3_01_02,topic_3_01_02_01,quiz_3_01_02_4,"Which development in the 1990s was driven by patient advocacy groups, particularly those affected by HIV-AIDS?",A) The Declaration of Helsinki | B) Randomized controlled trials (RCTs) | C) Accelerated approval processes | D) Electronic data capture systems,C
course_3,ch_3_01,les_3_01_02,topic_3_01_02_01,quiz_3_01_02_5,"In modern AI-powered clinical trials, what is a key challenge mentioned regarding the use of artificial intelligence?",A) Inability to analyze genetic data | B) Ensuring data privacy and avoiding algorithmic bias | C) Lack of internet connectivity in rural areas | D) High cost of wearable monitoring devices,B
course_3,ch_3_01,les_3_01_03,topic_3_01_03_01,quiz_3_01_03_1,Who is primarily responsible for designing the trial protocol and funding the study drug?,A) Clinical Research Coordinator | B) Principal Investigator | C) Sponsor | D) Regulatory Affairs Specialist,C
course_3,ch_3_01,les_3_01_03,topic_3_01_03_01,quiz_3_01_03_2,Which role acts as the “quality control expert” by visiting trial sites to verify compliance with protocol and regulations?,A) Biostatistician | B) Data Manager | C) Clinical Research Associate (CRA) | D) Pharmacist,C
course_3,ch_3_01,les_3_01_03,topic_3_01_03_01,quiz_3_01_03_3,"In a clinical trial, who ensures that all blood test results and side effect reports are accurately tracked and cleaned using software?",A) Principal Investigator | B) Medical Monitor | C) Data Manager | D) Clinical Research Coordinator,C
course_3,ch_3_01,les_3_01_03,topic_3_01_03_01,quiz_3_01_03_4,Which team member uses statistical methods to determine whether a new diabetes drug significantly lowers blood sugar compared to a placebo?,A) Biostatistician | B) Sponsor’s Project Manager | C) Regulatory Affairs Specialist | D) Lab Technician,A
course_3,ch_3_01,les_3_01_03,topic_3_01_03_01,quiz_3_01_03_5,"Who at the trial site manages patient recruitment, scheduling, and ensures informed consent is properly obtained?",A) Principal Investigator | B) Clinical Research Coordinator (CRC) | C) Clinical Research Associate | D) Pharmacist,B
course_3,ch_3_01,les_3_01_04,topic_3_01_04_01,quiz_3_01_04_1,Which entity sets the global standard for Good Clinical Practice (GCP)?,A) FDA | B) European Medicines Agency | C) World Health Organization | D) International Council for Harmonisation (ICH),D
course_3,ch_3_01,les_3_01_04,topic_3_01_04_01,quiz_3_01_04_2,"Before a clinical trial begins, GCP requires that risks are justified by reviewing what type of prior evidence?",A) Preclinical data from lab or animal studies | B) Phase 3 trial results from similar drugs | C) Patient testimonials from earlier treatments | D) Economic cost-benefit analysis,A
course_3,ch_3_01,les_3_01_04,topic_3_01_04_01,quiz_3_01_04_3,"In GCP, who must approve the detailed trial plan known as the protocol?",A) Principal Investigator | B) Institutional Review Board (IRB) or ethics committee | C) Clinical Research Associate | D) Sponsor’s project manager,B
course_3,ch_3_01,les_3_01_04,topic_3_01_04_01,quiz_3_01_04_4,What does GCP mandate when a participant reports a headache during a trial?,A) Summarize it in weekly team meetings | B) Record it exactly as reported in source documents | C) Report it only if it persists for 48 hours | D) Anonymize it immediately before recording,B
course_3,ch_3_01,les_3_01_04,topic_3_01_04_01,quiz_3_01_04_5,Which GCP principle ensures that trial results—positive or negative—are reported accurately and shared with regulators and the public?,A) Transparency | B) Quality control | C) Confidentiality | D) Qualified personnel,A
course_3,ch_3_01,les_3_01_05,topic_3_01_05_01,quiz_3_01_05_1,"Which historical document, published in 1979, established the three core ethical principles for clinical trials?",A) Declaration of Helsinki | B) Belmont Report | C) Good Clinical Practice (GCP) guidelines | D) Tuskegee Study Final Report,B
course_3,ch_3_01,les_3_01_05,topic_3_01_05_01,quiz_3_01_05_2,"In a pediatric vaccine trial, when parents give consent but the child is old enough to understand, what additional ethical step is recommended under respect for persons?",A) Require a second physician’s approval | B) Obtain the child’s assent | C) Use only placebo for children | D) Seek the child’s assent,D
course_3,ch_3_01,les_3_01_05,topic_3_01_05_01,quiz_3_01_05_3,A new cancer drug shows life-extending potential but causes severe fatigue in early tests. Which ethical principle requires researchers to weigh this benefit against the harm before continuing?,A) Beneficence | B) Justice | C) Confidentiality | D) Transparency,A
course_3,ch_3_01,les_3_01_05,topic_3_01_05_01,quiz_3_01_05_4,"To uphold justice in an expensive HIV drug trial in a low-income community, GCP guidelines suggest researchers should:",A) Exclude participants over 50 | B) Limit recruitment to 100 people | C) Provide post-trial access or other benefits | D) Use only anonymized data from the start,C
course_3,ch_3_01,les_3_01_05,topic_3_01_05_01,quiz_3_01_05_5,"According to the Belmont Report, when is it ethically acceptable to use a placebo in a trial for a new headache drug?",A) If participants are paid extra | B) If no standard effective treatment exists and participants are informed | C) Only in Phase 1 trials | D) When the drug is already FDA-approved,B
course_3,ch_3_01,les_3_01_06,topic_3_01_06_01,quiz_3_01_06_1,Which regulatory body is responsible for approving drugs across the 27 member countries of the European Union?,A) European Medicines Agency (EMA) | B) Medicines and Healthcare products Regulatory Agency (MHRA) | C) Pharmaceuticals and Medical Devices Agency (PMDA) | D) National Medical Products Administration (NMPA),A
course_3,ch_3_01,les_3_01_06,topic_3_01_06_01,quiz_3_01_06_2,"In Japan, why might a blood pressure drug already approved in the U.S. require additional trials before PMDA approval?",A) To reduce manufacturing costs | B) To align with ICH Phase 4 requirements | C) To confirm efficacy in Japanese patients with different genetics or lifestyles | D) To include pediatric participants only,C
course_3,ch_3_01,les_3_01_06,topic_3_01_06_01,quiz_3_01_06_3,Which agency reviews trial protocols for a new diabetes drug in the United States and monitors post-approval side effects through Phase 4 studies?,A) World Health Organization (WHO) | B) FDA | C) Central Drugs Standard Control Organisation (CDSCO) | D) International Council for Harmonisation (ICH),B
course_3,ch_3_01,les_3_01_06,topic_3_01_06_01,quiz_3_01_06_4,"In India, the CDSCO ensures that a malaria drug trial across rural and urban areas protects participants’ rights by following guidelines set by:",A) FDA and EMA jointly | B) PMDA and NMPA | C) ICH exclusively | D) WHO,D
course_3,ch_3_01,les_3_01_06,topic_3_01_06_01,quiz_3_01_06_5,"Although the WHO does not approve drugs, what critical global function does it perform for regulatory bodies worldwide?",A) Funds all Phase 3 trials | B) Conducts final drug manufacturing inspections | C) Sets ethical and scientific standards like the Declaration of Helsinki | D) Replaces national agencies in low-income countries,C
course_3,ch_3_01,les_3_01_07,topic_3_01_07_01,quiz_3_01_07_1,What is the primary purpose of randomization in a randomized controlled trial (RCT)?,A) To increase trial cost efficiency | B) To allow participants to choose their group | C) To reduce bias by making treatment and control groups similar | D) To eliminate the need for blinding,C
course_3,ch_3_01,les_3_01_07,topic_3_01_07_01,quiz_3_01_07_2,"In a double-blind RCT for a painkiller, who remains unaware of which participants receive the drug versus placebo until the study ends?",A) Both participants and researchers | B) Only the data analysts | C) Only the sponsor | D) Participants and the ethics board,A
course_3,ch_3_01,les_3_01_07,topic_3_01_07_01,quiz_3_01_07_3,Which trial design has each participant act as their own control by receiving both the treatment and placebo at different times?,A) Observational cohort study | B) Open-label trial | C) Case-control study | D) Crossover trial,D
course_3,ch_3_01,les_3_01_07,topic_3_01_07_01,quiz_3_01_07_4,Why are observational studies less able to prove cause and effect compared to RCTs?,"A) They require more funding | B) They lack randomization, so group differences may skew results | C) They are always single-blind | D) They prohibit placebo use entirely",B
course_3,ch_3_01,les_3_01_07,topic_3_01_07_01,quiz_3_01_07_5,When might researchers choose an open-label trial instead of a double-blind RCT?,"A) When a placebo would be unethical, such as denying care in a life-saving cancer drug study | B) When the drug is already market-approved | C) When only 10 participants are available | D) When real-world cost data is the primary outcome",A
course_3,ch_3_01,les_3_01_08,topic_3_01_08_01,quiz_3_01_08_1,"Which document serves as the detailed blueprint outlining trial goals, participant criteria, dosing, and data collection methods?",A) Investigator’s brochure | B) Trial protocol | C) Case report form | D) Safety report,B
course_3,ch_3_01,les_3_01_08,topic_3_01_08_01,quiz_3_01_08_2,"In the eTMF, what happens when a revised dosing schedule is submitted to the PMDA?",A) It is stored only in paper format | B) It is flagged for deletion | C) It is entered as a new C.R.F. | D) The updated protocol is uploaded with regulatory submission records,D
course_3,ch_3_01,les_3_01_08,topic_3_01_08_01,quiz_3_01_08_3,What role does the eTMF workflow play when an IRB reviews the trial protocol?,"A) It tracks review comments, approvals, and timestamps digitally | B) It automatically generates consent forms | C) It assigns participants to treatment groups | D) It calculates statistical significance",A
course_3,ch_3_01,les_3_01_08,topic_3_01_08_01,quiz_3_01_08_4,Which document in the eTMF captures a participant’s reported headache and pain score during a painkiller trial?,A) Informed consent form | B) Investigator’s brochure | C) Case report form (C.R.F.) | D) Regulatory submission,C
course_3,ch_3_01,les_3_01_08,topic_3_01_08_01,quiz_3_01_08_5,Why is the eTMF considered superior to traditional paper files during an FDA audit?,"A) It is searchable, secure, and provides a complete, organized digital record in one place | B) It eliminates the need for informed consent | C) It automatically approves trial changes | D) It stores only safety data",A
course_3,ch_3_01,les_3_01_09,topic_3_01_09_01,quiz_3_01_09_1,"In a heart drug trial, what early AI function would flag a blood pressure reading of 500 mmHg as an error?",A) Predictive analytics for patient response | B) Adaptive dose adjustment | C) Real-time wearable monitoring | D) Data entry error detection,D
course_3,ch_3_01,les_3_01_09,topic_3_01_09_01,quiz_3_01_09_2,How does AI improve patient recruitment for a new insulin trial?,A) By scheduling clinic visits automatically | B) By scanning medical records to identify eligible participants | C) By designing the trial protocol | D) By replacing informed consent forms,B
course_3,ch_3_01,les_3_01_09,topic_3_01_09_01,quiz_3_01_09_3,"In an Alzheimer’s drug trial, AI uses genetic data to predict which patients will respond best. This is an example of:",A) Predictive analytics | B) Natural language processing | C) Case report form entry | D) Regulatory submission automation,A
course_3,ch_3_01,les_3_01_09,topic_3_01_09_01,quiz_3_01_09_4,"During a painkiller trial, AI analyzes early results and suggests testing a higher dose sooner. This supports which trial type?",A) Observational cohort study | B) Open-label trial | C) Adaptive trial | D) Crossover design,C
course_3,ch_3_01,les_3_01_09,topic_3_01_09_01,quiz_3_01_09_5,Why must AI systems anonymize patient data using codes like “Patient 123” in a trial?,A) To comply with EMA and GCP privacy regulations | B) To reduce trial costs | C) To speed up data entry | D) To allow public access to raw data,A
course_3,ch_3_01,les_3_01_10,topic_3_01_10_01,quiz_3_01_10_1,"In a diabetes drug trial, when a researcher corrects a blood sugar value in the eTMF, what must the audit trail capture to remain GCP-compliant?","A) Only the final corrected value | B) The sponsor’s approval signature | C) Original entry, correction, user, timestamp, and reason for change | D) Only the date of correction",C
course_3,ch_3_01,les_3_01_10,topic_3_01_10_01,quiz_3_01_10_2,What is the primary purpose of an audit trail in clinical trial systems like the eTMF?,"A) To ensure transparency, accountability, and tamper-proof documentation of all actions | B) To automatically generate case report forms | C) To replace informed consent documentation | D) To reduce the number of regulatory submissions",A
course_3,ch_3_01,les_3_01_10,topic_3_01_10_01,quiz_3_01_10_3,"During an FDA inspection of a flu vaccine trial, how does the audit trail help verify that a side effect like dizziness was reported on time?",A) By showing participant recruitment logs | B) By displaying the protocol version history | C) By linking the safety report to ethics board submission with exact timestamps | D) By tracking only user login times,D
course_3,ch_3_01,les_3_01_10,topic_3_01_10_01,quiz_3_01_10_4,Which area of audit trail coverage ensures that only authorized personnel view sensitive patient data in a heart drug trial?,A) Document management | B) User access tracking | C) Data export logs | D) Protocol amendment frequency,B
course_3,ch_3_01,les_3_01_10,topic_3_01_10_01,quiz_3_01_10_5,Why is an audit trail described as “tamper-proof” under GCP?,A) Any attempt to alter it leaves a traceable record of the change | B) It is stored on paper only | C) It auto-deletes after 30 days | D) It requires physical signatures,A
course_3,ch_3_02,les_3_02_01,topic_3_02_01_01,quiz_3_02_01_1,"In the sample migraine drug trial protocol, which section specifies that participants must be adults aged 18–65 with at least four migraines per month?",A) Study design | B) Inclusion and exclusion criteria | C) Safety monitoring plan | D) Statistical analysis plan,B
course_3,ch_3_02,les_3_02_01,topic_3_02_01_01,quiz_3_02_01_2,What is the primary endpoint used to measure the main goal of reducing migraine frequency in the sample trial?,A) Weekly blood test results | B) Pain intensity scores on a 0–10 scale | C) Patient-reported side effects | D) Number of migraine-free days over a month,D
course_3,ch_3_02,les_3_02_01,topic_3_02_01_01,quiz_3_02_01_3,Which protocol section describes the use of electronic case report forms (C.R.F.s) stored in an e.T.M.F. with participant codes like “Participant 123”?,A) Data collection and management | B) Treatment plan | C) Background and rationale | D) Ethical considerations,A
course_3,ch_3_02,les_3_02_01,topic_3_02_01_01,quiz_3_02_01_4,"In the sample protocol, the double-blind RCT design with 200 participants split evenly between Drug X and placebo is detailed in which section?",A) Objectives and endpoints | B) Title and general information | C) Study design | D) Regulatory compliance,C
course_3,ch_3_02,les_3_02_01,topic_3_02_01_01,quiz_3_02_01_5,Which protocol section outlines rules to stop the drug if weekly blood tests show liver function problems?,A) Safety monitoring plan | B) Statistical analysis plan | C) Inclusion criteria | D) Investigator contacts,A
course_3,ch_3_02,les_3_02_02,topic_3_02_02_01,quiz_3_02_02_1,"In the hypotension trial, which objective type investigates whether the drug improves sleep quality?",A) Primary | B) Secondary | C) Clinical | D) Exploratory,D
course_3,ch_3_02,les_3_02_02,topic_3_02_02_01,quiz_3_02_02_2,What is the primary endpoint used to measure the main goal of reducing blood pressure in the hypotension trial?,A) Average change in systolic blood pressure (mmHg) over 12 weeks | B) Percentage of patients reporting fewer headaches | C) Change in heart rate (beats per minute) | D) Quality-of-life survey score,A
course_3,ch_3_02,les_3_02_02,topic_3_02_02_01,quiz_3_02_02_3,Which type of endpoint uses cholesterol levels as a stand-in for predicting heart attack risk?,A) Clinical | B) Surrogate | C) Patient-reported | D) Exploratory,B
course_3,ch_3_02,les_3_02_02,topic_3_02_02_01,quiz_3_02_02_4,"In the sample trial, the secondary endpoint measuring the number of headache-free days is collected via:",A) Weekly blood pressure cuff readings | B) Standardized sleep duration logs | C) Patient diaries | D) Electrocardiogram (ECG) results,C
course_3,ch_3_02,les_3_02_02,topic_3_02_02_01,quiz_3_02_02_5,Why do regulators like the FDA primarily focus on the primary endpoint when deciding drug approval?,A) It is the make-or-break result determining if the treatment works | B) It is always a patient-reported outcome | C) It is the only endpoint stored in the eTMF | D) It requires the least statistical analysis,A
course_3,ch_3_02,les_3_02_03,topic_3_02_03_01,quiz_3_02_03_1,"In the Asthmacure trial, which group is part of the target study population?",A) Children under 12 with mild asthma | B) Adults aged 18–65 with moderate to severe asthma | C) Elderly patients over 75 with heart disease | D) Pregnant women experiencing asthma attacks,B
course_3,ch_3_02,les_3_02_03,topic_3_02_03_01,quiz_3_02_03_2,A 25-year-old man with severe asthma for 5 years and no conflicting conditions is enrolled. Which criterion allowed his inclusion?,A) Experiencing at least two asthma attacks per month | B) Taking a beta-blocker for heart issues | C) Being pregnant | D) Having mild asthma diagnosed last month,D
course_3,ch_3_02,les_3_02_03,topic_3_02_03_01,quiz_3_02_03_3,Why are pregnant women excluded from the Asthmacure trial?,A) To prevent unknown risks to the fetus | B) To reduce recruitment costs | C) To ensure faster lung function improvements | D) To limit the trial to male participants,A
course_3,ch_3_02,les_3_02_03,topic_3_02_03_01,quiz_3_02_03_4,Which ethical guideline requires that inclusion–exclusion criteria do not unfairly exclude certain ethnic groups without scientific justification?,A) FDA Phase 3 requirements | B) ICH-GCP only | C) Declaration of Helsinki (WHO) | D) eTMF storage rules,C
course_3,ch_3_02,les_3_02_03,topic_3_02_03_01,quiz_3_02_03_5,"During an EMA audit, how are inclusion–exclusion decisions verified for the Asthmacure trial?",A) By reviewing participant records and criteria in the eTMF | B) By re-measuring lung function of all 300 participants | C) By checking only the primary endpoint data | D) By interviewing the sponsor’s marketing team,A
course_3,ch_3_02,les_3_02_04,topic_3_02_04_01,quiz_3_02_04_1,"In the JointEase trial, what is the specified dose and frequency of the intervention for participants in the treatment arm?",A) 10 mg twice daily | B) 20 mg once weekly | C) 20 mg once daily for 12 weeks | D) 40 mg every other day,C
course_3,ch_3_02,les_3_02_04,topic_3_02_04_01,quiz_3_02_04_2,Why are JointEase and placebo tablets made identical in appearance during the trial?,A) To maintain double-blinding and reduce bias | B) To lower production costs | C) To allow dose adjustments without notice | D) To simplify pharmacy storage,A
course_3,ch_3_02,les_3_02_04,topic_3_02_04_01,quiz_3_02_04_3,"According to the protocol, who prepares and dispenses the JointEase or placebo tablets at the trial site?",A) Principal Investigator | B) Data Safety Monitoring Board | C) Clinical Research Coordinator | D) Site pharmacist,D
course_3,ch_3_02,les_3_02_04,topic_3_02_04_01,quiz_3_02_04_4,"If a participant reports severe nausea, what action might the protocol allow under the safety monitoring plan?",A) Increase dose to 30 mg | B) Reduce dose to 10 mg or stop the drug with PI approval | C) Switch to open-label immediately | D) Ignore unless it lasts over 48 hours,B
course_3,ch_3_02,les_3_02_04,topic_3_02_04_01,quiz_3_02_04_5,How is participant adherence to the daily JointEase or placebo regimen tracked in the trial?,A) Via a patient diary logging intake and side effects | B) Through weekly blood tests only | C) By automatic wearable device alerts | D) Via sponsor phone surveys monthly,A
course_3,ch_3_02,les_3_02_05,topic_3_02_05_01,quiz_3_02_05_1,What is the primary function of a schedule of assessments in a clinical trial?,"A) To assign participants to treatment groups | B) To map out all tasks, tests, and evaluations with precise timing | C) To calculate statistical endpoints | D) To store informed consent forms",B
course_3,ch_3_02,les_3_02_05,topic_3_02_05_01,quiz_3_02_05_2,"In the asthma inhaler trial example, what happens when a patient misses a lung function test?",A) The trial is automatically terminated | B) The site is fined by the FDA | C) The schedule prompts rescheduling within three days | D) The schedule prompts rescheduling within three days,D
course_3,ch_3_02,les_3_02_05,topic_3_02_05_01,quiz_3_02_05_3,Which group uses the schedule of assessments to verify that a vaccine is stored at 2–8°C during site visits?,A) Monitors | B) Data safety monitoring board | C) Pharmacists | D) Patients,A
course_3,ch_3_02,les_3_02_05,topic_3_02_05_01,quiz_3_02_05_4,What is a recommended feature for making a schedule of assessments user-friendly and effective?,A) Using only text without tables | B) Listing tasks without specific timelines | C) Color-coded tables for quick reference | D) Requiring manual paper updates only,C
course_3,ch_3_02,les_3_02_05,topic_3_02_05_01,quiz_3_02_05_5,"According to best practices, when should the schedule of assessments be built and who should be involved?","A) Early in study planning, involving all stakeholders | B) After the first patient visit, by the PI only | C) During FDA submission, by the sponsor alone | D) At the end of Phase 3, by site staff",A
course_3,ch_3_02,les_3_02_06,topic_3_02_06_01,quiz_3_02_06_1,"In the OncoRelief trial, how is the risk of low white blood cell count classified using the risk matrix?","A) High likelihood, low impact | B) Low likelihood, low impact | C) Low likelihood, high impact | D) High likelihood, high impact",C
course_3,ch_3_02,les_3_02_06,topic_3_02_06_01,quiz_3_02_06_2,What mitigation strategy does the protocol implement for the identified risk of nausea in the OncoRelief trial?,A) Allow anti-nausea medication and require daily symptom reporting | B) Increase drug dose to reduce nausea | C) Exclude all participants with prior nausea history | D) Perform monthly blood tests only,A
course_3,ch_3_02,les_3_02_06,topic_3_02_06_01,quiz_3_02_06_3,"When a participant reports severe fatigue and blood tests show low white cell count, what immediate action does the protocol require?",A) Continue dosing and monitor weekly | B) Switch to placebo immediately | C) Notify sponsor only | D) Pause the drug per mitigation plan,D
course_3,ch_3_02,les_3_02_06,topic_3_02_06_01,quiz_3_02_06_4,Which group is named in the protocol to review serious risks during the OncoRelief trial and recommend actions like stopping the study?,A) Clinical Research Coordinators | B) Data Safety Monitoring Board (DSMB) | C) Site Pharmacists | D) FDA auditors,B
course_3,ch_3_02,les_3_02_06,topic_3_02_06_01,quiz_3_02_06_5,"How are data errors, such as a misrecorded lab result, mitigated in the OncoRelief trial?",A) Using electronic C.R.F.s in the eTMF with audit trails to track changes | B) Relying on paper forms with manual corrections | C) Allowing open edits without logging | D) Storing data only at the sponsor’s office,A
course_3,ch_3_02,les_3_02_07,topic_3_02_07_01,quiz_3_02_07_1,What is the primary role of AI in drafting a clinical trial protocol?,A) Automatically approving the final version for FDA submission | B) Suggesting content like dosing schedules and flagging missing safety steps | C) Replacing the principal investigator’s oversight | D) Generating patient consent forms without review,B
course_3,ch_3_02,les_3_02_07,topic_3_02_07_01,quiz_3_02_07_2,"In the heart medication trial example, how long did it take to finalize the AI-assisted protocol after team review?",A) Several weeks | B) One month | C) Several months | D) Days,D
course_3,ch_3_02,les_3_02_07,topic_3_02_07_01,quiz_3_02_07_3,Which regulatory standard must AI tools comply with to ensure data security during protocol writing?,A) HIPAA | B) ICH-GCP only | C) FDA Phase 1 rules | D) eTMF storage guidelines,A
course_3,ch_3_02,les_3_02_07,topic_3_02_07_01,quiz_3_02_07_4,What type of AI capability ensures protocol language is clear and avoids excessive jargon?,A) Predictive analytics | B) Statistical modeling | C) Natural language processing | D) Image recognition,C
course_3,ch_3_02,les_3_02_07,topic_3_02_07_01,quiz_3_02_07_5,Why is human oversight still essential when using AI to draft a protocol?,A) AI might miss context-specific nuances or suggest impractical elements | B) AI automatically submits to the IRB | C) AI replaces the need for team collaboration | D) AI generates the entire protocol without input,A
course_3,ch_3_02,les_3_02_08,topic_3_02_08_01,quiz_3_02_08_1,What might prompt a protocol amendment in a Phase 2 trial showing mild side effects from a 5 mg/kg drug dose?,A) Expand the age range to 18–70 | B) Retrain staff on unchanged procedures | C) Reduce the dose to 3 mg/kg | D) Ignore the side effects for efficacy,C
course_3,ch_3_02,les_3_02_08,topic_3_02_08_01,quiz_3_02_08_2,"In the change control workflow, what is the first step when identifying a need for an amendment, such as slow recruitment?",A) Propose the change and trigger the workflow | B) Update the protocol document immediately | C) Log it in REDCap version 2 | D) Inform participants before review,A
course_3,ch_3_02,les_3_02_08,topic_3_02_08_01,quiz_3_02_08_3,"During the documentation step of a protocol amendment, what must be included along with the rationale for a dosing change?",A) Only the new dosing schedule | B) A list of unaffected sites | C) The amendment's effective date | D) Impact on participant safety or data analysis,D
course_3,ch_3_02,les_3_02_08,topic_3_02_08_01,quiz_3_02_08_4,Who is involved in reviewing a protocol amendment to ensure it aligns with ethical standards?,"A) Only the sponsor and FDA | B) Key stakeholders like the principal investigator, ethics committees, and regulatory bodies | C) Site nurses and participants | D) The WHO exclusively",B
course_3,ch_3_02,les_3_02_08,topic_3_02_08_01,quiz_3_02_08_5,What does the tracking step in change control workflows use to create an audit trail for amendments?,"A) Systems like REDCap to log changes, reasons, and approvals | B) Verbal communications with staff | C) Unstructured email threads | D) Participant feedback forms",A
course_3,ch_3_02,les_3_02_09,topic_3_02_09_01,quiz_3_02_09_1,"In a Phase 3 diabetes drug trial, what statistical method determines the required 500 participants?",A) Randomization assignment | B) T-test selection | C) Power calculations for meaningful blood sugar drop | D) P-value threshold setting,C
course_3,ch_3_02,les_3_02_09,topic_3_02_09_01,quiz_3_02_09_2,"What is the primary endpoint in the diabetes drug trial example, and how is it measured?",A) Reducing hemoglobin A1c by 1% via blood tests at weeks 0 and 12 | B) Patient-reported side effects weekly | C) Heart rate changes via ECG | D) Cost-effectiveness ratio,A
course_3,ch_3_02,les_3_02_09,topic_3_02_09_01,quiz_3_02_09_3,Which statistical test is named in the protocol to compare average blood sugar levels between drug and placebo groups?,A) Chi-square test | B) ANOVA | C) Regression analysis | D) T-test,D
course_3,ch_3_02,les_3_02_09,topic_3_02_09_01,quiz_3_02_09_4,"If some patients drop out in the diabetes trial, what analysis method does the protocol specify to include their data?",A) Per-protocol analysis only | B) Intention-to-treat analysis | C) Case-control comparison | D) Exploratory subgroup review,B
course_3,ch_3_02,les_3_02_09,topic_3_02_09_01,quiz_3_02_09_5,Why does the protocol set a significance level of 0.05 for p-values?,A) To confirm the drug’s effect is not due to random chance | B) To reduce sample size requirements | C) To speed up data entry | D) To eliminate the need for randomization,A
course_3,ch_3_02,les_3_02_10,topic_3_02_10_01,quiz_3_02_10_1,"In the protocol review process, what is the primary focus of the Institutional Review Board (IRB)?","A) Verifying the study's timeline feasibility | B) Ensuring participant safety, rights, and clear consent processes | C) Checking compliance with ICH laws | D) Confirming statistical tests like t-tests",B
course_3,ch_3_02,les_3_02_10,topic_3_02_10_01,quiz_3_02_10_2,"For a Phase 2 cancer drug trial, why might the principal investigator suggest extending recruitment during review?",A) To align with FDA endpoints | B) To ensure measurable tumor size reduction | C) To comply with EMA guidelines | D) To make the trial feasible by recruiting enough patients aged 18–65,D
course_3,ch_3_02,les_3_02_10,topic_3_02_10_01,quiz_3_02_10_3,Which regulatory body is mentioned as reviewing protocols for compliance with international standards like those from ICH?,A) FDA or EMA | B) Principal Investigator | C) REDCap system administrators | D) Phase 2 trial sponsors,A
course_3,ch_3_02,les_3_02_10,topic_3_02_10_01,quiz_3_02_10_4,"What happens after stakeholders provide feedback on a protocol draft, such as adding a safety check for heart conditions?",A) The study begins immediately | B) Approval is documented in REDCap | C) The team revises and resubmits for further review | D) The endpoint is changed to tumor reduction,C
course_3,ch_3_02,les_3_02_10,topic_3_02_10_01,quiz_3_02_10_5,"In the review checklist, which element ensures the study is robust by specifying a significance level of 0.05?","A) Statistical plans, including tests like t-tests | B) Participant recruitment criteria | C) Drug dosing at 5 mg/kg | D) Consent form language",A
course_3,ch_3_03,les_3_03_01,topic_3_03_01_01,quiz_3_03_01_1,"In the GlucoSafe trial, which criterion ensures the site has a qualified endocrinologist as the principal investigator and experienced CRCs?",A) Patient access | B) Infrastructure | C) Ethical compliance | D) Expertise and experience,D
course_3,ch_3_03,les_3_03_01,topic_3_03_01_01,quiz_3_03_01_2,Why might a rural clinic be excluded from the GlucoSafe trial site selection?,A) It lacks an IRB | B) It has insufficient eligible type 2 diabetes patients for recruitment | C) It uses outdated eTMF systems | D) It is too close to the sponsor,B
course_3,ch_3_03,les_3_03_01,topic_3_03_01_01,quiz_3_03_01_3,"For weekly glucose testing in the GlucoSafe trial, what site selection criterion requires reliable lab equipment and trained technicians?",A) Infrastructure | B) Operational capacity | C) Geographic diversity | D) Logistical proximity,A
course_3,ch_3_03,les_3_03_01,topic_3_03_01_01,quiz_3_03_01_4,"Which regulatory body values site selection in the U.S., Europe, and Asia to ensure GlucoSafe results apply broadly across populations?",A) FDA only | B) PMDA exclusively | C) European Medicines Agency | D) WHO,C
course_3,ch_3_03,les_3_03_01,topic_3_03_01_01,quiz_3_03_01_5,"In the scenario, why is the Tokyo research clinic selected alongside the Chicago hospital for GlucoSafe?",A) It offers strong operational capacity and contributes to geographic diversity | B) It has lower costs than U.S. sites | C) It replaces the need for an IRB | D) It is located near the PMDA,A
course_3,ch_3_03,les_3_03_02,topic_3_03_02_01,quiz_3_03_02_1,"In the CardioVital trial, which feasibility factor is confirmed by a board-certified cardiologist with five prior trials serving as the principal investigator?",A) Investigator and staff expertise | B) Patient recruitment potential | C) Infrastructure and equipment | D) Logistical feasibility,A
course_3,ch_3_03,les_3_03_02,topic_3_03_02_01,quiz_3_03_02_2,How does the Boston hospital demonstrate patient recruitment potential for enrolling 50 participants in three months?,A) It has an active IRB | B) It uses an eTMF system | C) Based on patient records showing 200 heart failure cases annually | D) It is located near the sponsor,C
course_3,ch_3_03,les_3_03_02,topic_3_03_02_01,quiz_3_03_02_3,"For biweekly check-ups over six months in CardioVital, which factor ensures the site’s staff availability and scheduling can manage the workload?",A) Ethical and regulatory compliance | B) Operational capacity | C) Geographic diversity | D) Equipment certification,B
course_3,ch_3_03,les_3_03_02,topic_3_03_02_01,quiz_3_03_02_4,What action might the sponsor take if a feasibility assessment reveals a site lacks an echocardiogram machine for CardioVital?,A) Automatically approve the site | B) Change the trial to Phase 2 | C) Reject the site or provide funding for new equipment | D) Reject the site or provide funding for new equipment,D
course_3,ch_3_03,les_3_03_02,topic_3_03_02_01,quiz_3_03_02_5,Where are the Boston hospital’s feasibility assessment findings and audit trails logged for FDA review?,A) eTMF | B) Local pharmacy records | C) Participant consent forms | D) Sponsor’s marketing plan,A
course_3,ch_3_03,les_3_03_03,topic_3_03_03_01,quiz_3_03_03_1,"In the ClearLung trial, which qualification confirms Dr. Jane Smith’s understanding of asthma biology and treatment?",A) GCP training certificate | B) Medical degree and board certification in pulmonology | C) Leadership in two prior trials | D) 20 hours weekly availability,B
course_3,ch_3_03,les_3_03_03,topic_3_03_03_01,quiz_3_03_03_2,What prior experience does Dr. Smith have that meets GCP requirements for clinical trial leadership in the ClearLung trial?,A) General practice with no asthma focus | B) Completed ethics course only | C) Managed patient consent in non-trial settings | D) Led two previous asthma trials,D
course_3,ch_3_03,les_3_03_03,topic_3_03_03_01,quiz_3_03_03_3,Which qualification ensures Dr. Smith can explain risks like wheezing and obtain informed consent per WHO guidelines?,A) Ethical training in GCP and IRB processes | B) Time commitment of 20 hours weekly | C) Communication with sponsor | D) Staff training on dosing,A
course_3,ch_3_03,les_3_03_03,topic_3_03_03_01,quiz_3_03_03_4,"During feasibility assessment for ClearLung, how is Dr. Smith’s availability verified?",A) By reviewing her CV only | B) Through sponsor interview | C) Via a survey confirming 20 hours weekly dedication | D) By checking eTMF access logs,C
course_3,ch_3_03,les_3_03_03,topic_3_03_03_01,quiz_3_03_03_5,"Where are Dr. Jane Smith’s CV, training records, and qualification audit trails stored for FDA and IRB review?",A) eTMF | B) Local hospital HR files | C) Participant diaries | D) Sponsor’s marketing database,A
course_3,ch_3_03,les_3_03_04,topic_3_03_04_01,quiz_3_03_04_1,"In the Pressura trial, what does the site contract require the London hospital to submit within 48 hours of collection?",A) Participant stipends | B) Blood pressure cuff invoices | C) Trial data to the eTMF | D) IRB meeting minutes,C
course_3,ch_3_03,les_3_03_04,topic_3_03_04_01,quiz_3_03_04_2,"Which budget component in the Pressura trial covers facility fees, typically 20–30% of direct costs?",A) Overhead | B) Staff time for PI and CRCs | C) Lab tests for blood draws | D) Participant travel stipends,A
course_3,ch_3_03,les_3_03_04,topic_3_03_04_01,quiz_3_03_04_3,"During negotiation for the Chicago site in Pressura, why does the hospital counter with a higher lab test cost?",A) To include PI salary | B) To cover participant recruitment ads | C) To reduce overhead percentage | D) Due to local cost variations,D
course_3,ch_3_03,les_3_03_04,topic_3_03_04_01,quiz_3_03_04_4,What allows the Chicago site to increase its lab test budget mid-trial if costs exceed the plan?,"A) Automatic FDA approval | B) Contract amendment with sponsor approval, logged in eTMF | C) IRB unilateral decision | D) Participant vote",B
course_3,ch_3_03,les_3_03_04,topic_3_03_04_01,quiz_3_03_04_5,"How are the final Pressura contract and budget documents, including audit trails of negotiations, stored for EMA review?",A) eTMF | B) Local site pharmacy | C) Sponsor’s public website | D) Participant consent binders,A
course_3,ch_3_03,les_3_03_05,topic_3_03_05_01,quiz_3_03_05_1,"In the TumorGuard trial, what key document submitted to the FDA in the IND outlines the 12-week study comparing TumorGuard to placebo?",A) Investigator’s brochure | B) Informed consent form | C) Site facility certification | D) Trial protocol,D
course_3,ch_3_03,les_3_03_05,topic_3_03_05_01,quiz_3_03_05_2,"For the Berlin clinic in TumorGuard, which submission requires local ethics approval in addition to the protocol and preclinical data?",A) IND | B) CTA | C) IRB form | D) Feasibility questionnaire,B
course_3,ch_3_03,les_3_03_05,topic_3_03_05_01,quiz_3_03_05_3,What does the IRB review in TumorGuard submissions to ensure participants understand risks like nausea in plain language?,A) Informed consent forms | B) Preclinical animal data | C) Principal investigator CV | D) Weekly tumor scan schedule,A
course_3,ch_3_03,les_3_03_05,topic_3_03_05_01,quiz_3_03_05_4,Which site-specific document in TumorGuard submissions confirms the principal investigator is a qualified oncologist?,A) Lab test pricing | B) Recruitment advertisement | C) Principal investigator’s CV | D) Participant stipend plan,C
course_3,ch_3_03,les_3_03_05,topic_3_03_05_01,quiz_3_03_05_5,"Where are all TumorGuard regulatory submissions, including audit trails of FDA/EMA clarifications on dosing, stored for review?",A) eTMF | B) Local pharmacy log | C) Sponsor’s public portal | D) Participant medical charts,A
course_3,ch_3_03,les_3_03_06,topic_3_03_06_01,quiz_3_03_06_1,"In the PainFree trial Start-Up Meeting, what is reviewed to ensure sites understand the 15 mg daily dosing and migraine-free day endpoint?",A) Site budget negotiations | B) Protocol overview | C) Participant travel reimbursements | D) Post-trial marketing plans,B
course_3,ch_3_03,les_3_03_06,topic_3_03_06_01,quiz_3_03_06_2,"During the PainFree virtual SIV, who confirms their team’s GCP training and asks about handling missed doses?",A) Sponsor pharmacist | B) CRO data manager | C) Tokyo site staff | D) London principal investigator,D
course_3,ch_3_03,les_3_03_06,topic_3_03_06_01,quiz_3_03_06_3,Which role is assigned in the PainFree SIV to handle patient recruitment and logging pain scores in case report forms?,A) Clinical Research Coordinators (CRCs) | B) Principal Investigator | C) Sponsor medical monitor | D) IRB chairperson,A
course_3,ch_3_03,les_3_03_06,topic_3_03_06_01,quiz_3_03_06_4,What logistical item is confirmed in the PainFree SIV to ensure sites can enroll 40 patients within three months?,A) Drug storage temperature | B) Blood pressure monitor availability | C) Recruitment feasibility | D) eTMF password reset,C
course_3,ch_3_03,les_3_03_06,topic_3_03_06_01,quiz_3_03_06_5,Where are the PainFree Start-Up Meeting minutes and audit trails stored for EMA and IRB review?,A) eTMF | B) Local site pharmacy log | C) Sponsor’s public website | D) Participant consent binders,A
course_3,ch_3_03,les_3_03_07,topic_3_03_07_01,quiz_3_03_07_1,"In the NeuroClear trial, which AI-analyzed factor scores a London hospital high due to 150 Alzheimer’s patients and a 10-year experienced principal investigator?",A) Patient recruitment potential and site expertise | B) Drug storage temperature compliance | C) Participant stipend levels | D) Post-trial marketing data,A
course_3,ch_3_03,les_3_03_07,topic_3_03_07_01,quiz_3_03_07_2,How does the ML model predict a rural clinic will take nine months to recruit patients for NeuroClear?,A) Based on IRB approval speed | B) By analyzing past trial delays only | C) Using historical enrollment rates and low patient volume (20 eligible) | D) Via sponsor budget preferences,C
course_3,ch_3_03,les_3_03_07,topic_3_03_07_01,quiz_3_03_07_3,Which infrastructure element does AI evaluate to confirm a site can handle NeuroClear’s monthly brain scans?,A) Blood pressure cuff availability | B) MRI machine presence | C) eTMF login frequency | D) Staff vacation schedules,B
course_3,ch_3_03,les_3_03_07,topic_3_03_07_01,quiz_3_03_07_4,What ensures GCP compliance when using AI site feasibility predictions for NeuroClear?,A) Automatic FDA approval | B) Sponsor override of all scores | C) CRA verification during site visits | D) Human oversight and eTMF documentation,D
course_3,ch_3_03,les_3_03_07,topic_3_03_07_01,quiz_3_03_07_5,"Where are the NeuroClear AI site scores (e.g., London 90/100) and audit trails of selection decisions stored for EMA review?",A) eTMF | B) Local clinic patient charts | C) Sponsor’s public dashboard | D) Participant consent binders,A
course_3,ch_3_03,les_3_03_08,topic_3_03_08_01,quiz_3_03_08_1,"In the MoodLift trial, which training component teaches staff to report severe fatigue to the IRB within 24 hours?",A) Protocol dosing procedures | B) Participant consent discussions | C) Safety and adverse event reporting | D) eTMF password management,C
course_3,ch_3_03,les_3_03_08,topic_3_03_08_01,quiz_3_03_08_2,"During MoodLift’s virtual SIV, what is practiced to ensure participants understand the 12-week duration and visit schedule?",A) Role-playing for informed consent | B) Blood test calibration | C) Sponsor budget review | D) Post-trial data archiving,A
course_3,ch_3_03,les_3_03_08,topic_3_03_08_01,quiz_3_03_08_3,How are MoodLift depression scores logged accurately and confidentially using participant codes like “Patient 123”?,A) Paper case report forms | B) Sponsor email summaries | C) Local hospital EHR only | D) Electronic case report forms in the eTMF,D
course_3,ch_3_03,les_3_03_08,topic_3_03_08_01,quiz_3_03_08_4,Who verifies MoodLift staff training completion during site visits before FDA audit?,A) IRB chairperson | B) Clinical Research Associates (CRAs) | C) Pharmacist | D) Data Safety Monitoring Board,B
course_3,ch_3_03,les_3_03_08,topic_3_03_08_01,quiz_3_03_08_5,"Where are MoodLift staff GCP certificates, SIV attendance, and training audit trails stored for EMA review?",A) eTMF | B) Local staff HR files | C) Participant diaries | D) Sponsor’s marketing portal,A
course_3,ch_3_03,les_3_03_09,topic_3_03_09_01,quiz_3_03_09_1,"In the GlucoEase trial, which checklist milestone requires the Miami clinic to have IRB-approved consent forms explaining hypoglycemia risks?",A) Staff training completion | B) Investigational product storage | C) Recruitment database access | D) Regulatory and ethics approvals,D
course_3,ch_3_03,les_3_03_09,topic_3_03_09_01,quiz_3_03_09_2,"What does the GlucoEase site contract milestone finalize for the Miami clinic, including $20,000 for staff and $5,000 for lab tests?",A) GCP refresher schedule | B) Site contracts and budgets | C) Glucose meter calibration | D) Post-activation marketing,B
course_3,ch_3_03,les_3_03_09,topic_3_03_09_01,quiz_3_03_09_3,"For GlucoEase, which checklist item confirms the principal investigator completed protocol-specific training on 10 mg dosing and glucose monitors?",A) Staff training | B) Pharmacy placebo matching | C) Patient support group outreach | D) eTMF password setup,A
course_3,ch_3_03,les_3_03_09,topic_3_03_09_01,quiz_3_03_09_4,"During GlucoEase activation, what readiness milestone verifies the Miami pharmacy has 10 mg tablets and placebos stored at correct temperature?",A) Budget approval | B) CRA site visit | C) Investigational product readiness | D) FDA IND submission,C
course_3,ch_3_03,les_3_03_09,topic_3_03_09_01,quiz_3_03_09_5,"Where are all GlucoEase Miami clinic checklist milestones, audit trails, and CRA verification records stored for FDA audit?",A) eTMF | B) Local clinic HR files | C) Participant consent binders | D) Sponsor’s public portal,A
course_3,ch_3_03,les_3_03_10,topic_3_03_10_01,quiz_3_03_10_1,"In the FlexiJoint trial, which pitfall caused a three-month delay at the Chicago hospital due to missing preclinical safety data?",A) Delayed drug shipment | B) Incomplete regulatory submissions | C) Overestimated patient recruitment | D) Unsigned site budget,B
course_3,ch_3_03,les_3_03_10,topic_3_03_10_01,quiz_3_03_10_2,What prevention strategy for FlexiJoint uses AI-driven tools to accurately predict a rural clinic’s low enrollment of only 10 arthritis patients?,A) Mandatory CRA visits | B) IRB consent review | C) eTMF password reset | D) Thorough site feasibility assessments,D
course_3,ch_3_03,les_3_03_10,topic_3_03_10_01,quiz_3_03_10_3,"For FlexiJoint, incorrect 20 mg dosing instead of 10 mg resulted from which pitfall at a site?",A) Insufficient staff training | B) Contract negotiation disputes | C) Missing X-ray equipment | D) Placebo storage error,A
course_3,ch_3_03,les_3_03_10,topic_3_03_10_01,quiz_3_03_10_4,Which FlexiJoint pitfall stalled the London clinic for two months over lab cost disputes?,A) GCP training skip | B) Incomplete CTA submission | C) Delayed contracts and budgets | D) Logistical drug delay,C
course_3,ch_3_03,les_3_03_10,topic_3_03_10_01,quiz_3_03_10_5,"Where are FlexiJoint pitfall resolutions, like checklist fixes and AI feasibility findings, logged for EMA and IRB review?",A) eTMF | B) Local site pharmacy | C) Participant diaries | D) Sponsor’s marketing files,A
course_3,ch_3_04,les_3_04_01,topic_3_04_01_01,quiz_3_04_01_1,"In a recruitment strategy for a life sciences role like a lab technician, what must-have qualification might be included in the job description?",A) Familiarity with data analysis tools | B) Experience in team collaboration | C) Degree in unrelated field | D) Certification or degree in biology,D
course_3,ch_3_04,les_3_04_01,topic_3_04_01_01,quiz_3_04_01_2,Which recruitment approach involves using platforms like BioSpace to connect with specialized talent in life sciences?,A) Internal sourcing from current employees | B) External sourcing via industry-specific job boards | C) Networking at general job fairs | D) Employer branding on social media,B
course_3,ch_3_04,les_3_04_01,topic_3_04_01_01,quiz_3_04_01_3,How can an organization build a strong employer brand to attract candidates who share its values in healthcare?,"A) Share stories on social media about team impact, like a new drug improving lives | B) Focus only on job postings with high salary offers | C) Attend diversity job fairs without outreach | D) Use AI chatbots for all candidate interactions",A
course_3,ch_3_04,les_3_04_01,topic_3_04_01_01,quiz_3_04_01_4,"To promote diversity in recruitment for a research lab, what step should be taken when writing job descriptions?",A) Include biased terms like “rockstar” to attract ambitious candidates | B) Focus exclusively on must-have technical skills | C) Review for biased language and use terms like “team player” | D) Partner only with general organizations like NSBE,C
course_3,ch_3_04,les_3_04_01,topic_3_04_01_01,quiz_3_04_01_5,"What is a key benefit of building a talent pipeline, such as through internships for nursing students at a hospital?",A) Having a pool of familiar candidates ready when positions open | B) Reducing the need for external job boards | C) Eliminating behavioral interviews | D) Automating all applicant tracking,A
course_3,ch_3_04,les_3_04_02,topic_3_04_02_01,quiz_3_04_02_1,"In a cholesterol drug trial, what full screening step might confirm a patient’s cholesterol level is above 200 mg/dL?",A) Phone pre-screening for age | B) Online questionnaire for allergies | C) Blood test during medical evaluation | D) Social media advertisement review,C
course_3,ch_3_04,les_3_04_02,topic_3_04_02_01,quiz_3_04_02_2,Which step in patient eligibility screening uses EHRs or software to automatically flag patients with a hemoglobin A1C above 7% for a diabetes study?,A) Leveraging technology in full screening | B) Defining inclusion criteria | C) Handling non-qualifying patients | D) Documenting decisions,A
course_3,ch_3_04,les_3_04_02,topic_3_04_02_01,quiz_3_04_02_3,"For a pediatric vaccine trial limiting participants to children aged 2–12, what challenge does this criteria address?",A) Ensuring diversity in underrepresented groups | B) Excluding adults for ethical reasons | C) Broadening the study for more participants | D) Balancing inclusivity with precision for focused immune response,D
course_3,ch_3_04,les_3_04_02,topic_3_04_02_01,quiz_3_04_02_4,"When a patient does not qualify for an asthma trial due to a conflicting condition, what is the recommended approach?",A) Ignore the exclusion and enroll them | B) Explain sensitively and offer alternatives like other trials or treatments | C) Require them to sign a waiver | D) Automatically refer them to the IRB,B
course_3,ch_3_04,les_3_04_02,topic_3_04_02_01,quiz_3_04_02_5,What is the final step in patient eligibility screening that ensures transparency and compliance with WHO guidelines?,A) Documenting every inclusion/exclusion decision for audits | B) Advertising through patient advocacy groups | C) Setting age-based exclusion criteria | D) Conducting pre-screening calls,A
course_3,ch_3_04,les_3_04_03,topic_3_04_03_01,quiz_3_04_03_1,"In a diabetes medication trial, what informed consent step explains the goal of lowering hemoglobin A1C below 7% and daily pill intake?",A) Discussing alternatives like standard care | B) Providing clear information on purpose and procedures | C) Confirming voluntary withdrawal rights | D) Using e-consent video modules,B
course_3,ch_3_04,les_3_04_03,topic_3_04_03_01,quiz_3_04_03_2,"For a new heart stent trial, which step ensures patients know they can continue with medication instead of participating?",A) Addressing cultural concerns | B) Recording signed form details | C) Ensuring understanding via teach-back | D) Explaining alternatives,D
course_3,ch_3_04,les_3_04_03,topic_3_04_03_01,quiz_3_04_03_3,"How is patient understanding confirmed in the informed consent process, such as explaining “CT scan” as a detailed X-ray?",A) Asking patients to repeat back key points in plain language | B) Requiring guardian assent for adults | C) Skipping jargon only in e-consent | D) Documenting risks at 5% allergic reaction,A
course_3,ch_3_04,les_3_04_03,topic_3_04_03_01,quiz_3_04_03_4,"In emergency trauma research where prior consent is impossible, what is required before proceeding?",A) Community leader partnership | B) Child assent addition | C) Ethics board approval with later family notification | D) Eighth-grade reading level form only,C
course_3,ch_3_04,les_3_04_03,topic_3_04_03_01,quiz_3_04_03_5,"What is the final step in the informed consent process that records discussions, questions, and signed forms for regulatory compliance?",A) Documentation | B) Voluntary participation emphasis | C) Risk-benefit discussion | D) Cultural sensitivity tailoring,A
course_3,ch_3_04,les_3_04_04,topic_3_04_04_01,quiz_3_04_04_1,"In recruitment for a biotech lab, which step sets a specific goal like 30% of new hires from underrepresented racial groups within two years?",A) Expanding outreach to HBCUs | B) Setting clear diversity goals aligned with mission | C) Blind resume screening | D) Sharing employee stories on website,B
course_3,ch_3_04,les_3_04_04,topic_3_04_04_01,quiz_3_04_04_2,What recruitment step uses text analysis software to flag biased words like “aggressive” in job descriptions?,A) Training team on unconscious bias | B) Leveraging ATS for applicant management | C) Fostering inclusive workplace culture | D) Reviewing process for bias,D
course_3,ch_3_04,les_3_04_04,topic_3_04_04_01,quiz_3_04_04_3,"To attract diverse STEM candidates, which outreach example partners with the National Society of Black Engineers (NSBE)?",A) Posting only on LinkedIn | B) Attending Society of Women Engineers job fairs | C) Using general job boards | D) Internal promotions only,A
course_3,ch_3_04,les_3_04_04,topic_3_04_04_01,quiz_3_04_04_4,"Which bias-reduction technique in recruitment uses structured interviews where every candidate answers the same question, like “Describe a time you solved a complex problem”?",A) Applicant Tracking System keyword filters | B) Employer branding via social media | C) Training hiring managers | D) Blind resume screening,C
course_3,ch_3_04,les_3_04_04,topic_3_04_04_01,quiz_3_04_04_5,"How is progress measured in diversity recruitment, such as tracking that only 10% of research role applicants are women?","A) Tracking and reporting application, hire, and promotion data | B) Offering mentorship programs | C) Highlighting nurse leadership stories | D) Partnering with NAACP chapters",A
course_3,ch_3_04,les_3_04_05,topic_3_04_05_01,quiz_3_04_05_1,"In a life sciences lab, which retention step offers training in CRISPR gene editing to help a technician grow professionally?",A) Competitive compensation with tuition reimbursement | B) Wellness programs like yoga classes | C) Providing growth opportunities | D) Exit interviews for departing staff,C
course_3,ch_3_04,les_3_04_05,topic_3_04_05_01,quiz_3_04_05_2,What retention technique allows a nurse to choose shifts that fit their family life or a data analyst to work from home two days a week?,A) Supporting work-life balance with flexible policies | B) Recognizing contributions via Employee of the Month | C) Using HR software to track satisfaction surveys | D) Forming employee resource groups for women in STEM,A
course_3,ch_3_04,les_3_04_05,topic_3_04_05_01,quiz_3_04_05_3,How does a hospital foster a positive work environment by celebrating the completion of a major clinical trial?,A) Offering mental health therapy coverage | B) Conducting structured exit interviews | C) Encouraging open communication through team meetings | D) Fostering a positive work environment,D
course_3,ch_3_04,les_3_04_05,topic_3_04_05_01,quiz_3_04_05_4,Which step helps a biotech company retain underrepresented talent by creating groups for women in STEM to share experiences?,A) Monitoring workloads to prevent burnout | B) Diversity and inclusion through employee resource groups | C) Bonuses for completing diagnostic tests | D) Suggestion boxes for lab efficiency ideas,B
course_3,ch_3_04,les_3_04_05,topic_3_04_05_01,quiz_3_04_05_5,"What is the final retention step that learns why a pharmacist left due to feeling undervalued, to improve for remaining staff?",A) Conducting exit interviews | B) Offering extra vacation days as rewards | C) Clear career paths from coordinator to manager | D) One-on-one check-ins on employee values,A
course_3,ch_3_04,les_3_04_06,topic_3_04_06_01,quiz_3_04_06_1,"In AI-powered patient matching for a rare genetic disorder trial, what technology scans electronic health records to identify patients with the exact mutation?",A) Generative models for outcome simulation | B) Machine learning algorithms analyzing anonymized data | C) Federated databases only | D) FHIR integration standards,B
course_3,ch_3_04,les_3_04_06,topic_3_04_06_01,quiz_3_04_06_2,"According to the material, what is a primary benefit of AI in patient matching that addresses the issue of 85% of trials failing to meet enrollment goals?",A) Eliminating all data privacy concerns | B) Automating informed consent forms | C) Predicting patient responses pre-trial | D) Enrolling patients faster and improving success rates,D
course_3,ch_3_04,les_3_04_06,topic_3_04_06_01,quiz_3_04_06_3,"In the matching process for an oncology trial, which AI technique reads unstructured doctor notes about ""mild hypertension"" to match breast cancer patients by tumor genetics like HER2-positive?",A) Natural language processing | B) Cloud-based processing of millions of records | C) Explainability features for validation | D) Predictive analytics for condition development,A
course_3,ch_3_04,les_3_04_06,topic_3_04_06_01,quiz_3_04_06_4,What challenge in AI-powered patient matching might overlook rural patients if training data underrepresents them?,A) Legacy system integration with FHIR | B) Ethical consent for data use | C) Bias in datasets leading to skewed matches | D) Human oversight in validation,C
course_3,ch_3_04,les_3_04_06,topic_3_04_06_01,quiz_3_04_06_5,"In the real-world COVID vaccine booster trial example, how does AI enable faster matching of thousands of patients by age, comorbidities, and vaccination status?","A) By analyzing vast EHRs, lab results, and wearables in days instead of months | B) Through generative models simulating responses | C) Via eTMF storage of matching scores | D) Using Antidote platforms exclusively",A
course_3,ch_3_04,les_3_04_07,topic_3_04_07_01,quiz_3_04_07_1,"In a cancer trial consent form, what must be summarized at an eighth-grade reading level, including tumor-shrinking goals and risks like nausea?","A) Clinician’s personal notes | B) Purpose, risks, benefits, alternatives, and rights | C) Patient’s prior medical bills | D) Trial sponsor’s marketing plan",B
course_3,ch_3_04,les_3_04_07,topic_3_04_07_01,quiz_3_04_07_2,"During consent for a diabetes study, how is a patient’s question about blood test frequency recorded?",A) In a secure patient portal only | B) In a discussion log as part of the informed consent process | C) Via e-consent quiz scores | D) On the assent form for guardians,B
course_3,ch_3_04,les_3_04_07,topic_3_04_07_01,quiz_3_04_07_3,"For a 10-year-old in a vaccine trial, what additional simplified document captures their agreement alongside parental consent?",A) Assent form | B) HIPAA waiver | C) Updated CT scan addendum | D) Audit trail report,A
course_3,ch_3_04,les_3_04_07,topic_3_04_07_01,quiz_3_04_07_4,"In emergency trauma research where a patient is unconscious, how is the consent exception documented for IRB review?",A) With a new signature after recovery | B) By noting waiver approval and later family notification | C) Through interactive e-consent video | D) Via community liaison explanation,B
course_3,ch_3_04,les_3_04_07,topic_3_04_07_01,quiz_3_04_07_5,"Where are long-term arthritis trial consent forms, discussion logs, and audit trails stored securely for 15+ years under HIPAA?",A) EHR systems with encryption | B) Paper cabinets in public areas | C) Patient’s personal email | D) Sponsor’s public website,A
course_3,ch_3_04,les_3_04_08,topic_3_04_08_01,quiz_3_04_08_1,"For hiring a lab technician in a talent-short field like bioinformatics, what solution widens the net by offering internships to biomedical engineering majors?",A) Structured interviews with deadline questions | B) Partnering with universities for early recruitment | C) AI chatbots for 24/7 salary queries | D) Blind resume screening for PCR experience,B
course_3,ch_3_04,les_3_04_08,topic_3_04_08_01,quiz_3_04_08_2,"To reduce unconscious bias when hiring a trial manager, which technique removes names and photos to focus only on PCR machine experience?",A) Applicant Tracking System keyword filtering | B) Exit interviews for departing employees | C) Inclusive language like “team player” | D) Blind resume screening,D
course_3,ch_3_04,les_3_04_08,topic_3_04_08_01,quiz_3_04_08_3,How can a hospital streamline hiring for in-demand nurses to avoid losing them to competitors within a week?,A) Aim for application-to-offer in 2–3 weeks using ATS for “clinical experience” keywords | B) Offer sabbaticals after five years | C) Share LinkedIn stories about CRISPER projects | D) Conduct diversity job fairs only,A
course_3,ch_3_04,les_3_04_08,topic_3_04_08_01,quiz_3_04_08_4,What improves candidate experience for a clinical coordinator by communicating “follow up within five days” and polite rejection emails?,A) Over-relying on AI for all decisions | B) Highlighting mission impact on Alzheimer’s patients | C) Improving candidate experience with clear timelines | D) Partnering with NSBE for engineers,C
course_3,ch_3_04,les_3_04_08,topic_3_04_08_01,quiz_3_04_08_5,Where does a biotech company learn from a bad hire by analyzing if the job description overemphasized a Ph.D. over practical experience?,A) Learning from mistakes via exit interviews and feedback | B) Global virtual career fairs | C) Wellness program perks | D) Human oversight of AI suggestions,A
course_3,ch_3_04,les_3_04_09,topic_3_04_09_01,quiz_3_04_09_1,"In a hospital hiring nurses, which metric tracks the average days from job posting to offer acceptance, aiming for under 45 days?",A) Cost-per-hire including ad fees | B) Applicant Net Promoter Score | C) Time-to-hire | D) Sourcing from university partnerships,C
course_3,ch_3_04,les_3_04_09,topic_3_04_09_01,quiz_3_04_09_2,"For quality of hire in a biotech lab, what metric measures if 80% of new lab techs remain after one year?","A) First-year retention rate | B) Diversity percentage in interviews | C) Drop-off rate in applications | D) Cost-per-hire average of $4,000",A
course_3,ch_3_04,les_3_04_09,topic_3_04_09_01,quiz_3_04_09_3,"To monitor diversity in life sciences research roles targeting 40% women hires, which metric compares applications, interviews, and offers by demographics?",A) Employee referral success rate | B) Cultural fit survey responses | C) Time-to-hire reduction to 40 days | D) Diversity and inclusion metrics,D
course_3,ch_3_04,les_3_04_09,topic_3_04_09_01,quiz_3_04_09_4,"In monthly recruitment reports, what visualizes trends like diversity hires up 10% or applications boosted 25% by new ads?",A) Exit interview summaries | B) Dashboards in Tableau or Google Data Studio | C) Predictive analytics for shortages | D) HIPAA-compliant data privacy logs,B
course_3,ch_3_04,les_3_04_09,topic_3_04_09_01,quiz_3_04_09_5,Where does a healthcare organization benchmark its 42-day average time-to-hire against SHRM industry standards?,A) Benchmarking and goal-setting | B) Applicant experience NPS above 50 | C) Sourcing effectiveness from job fairs | D) Continuous improvement loop,A
course_3,ch_3_04,les_3_04_10,topic_3_04_10_01,quiz_3_04_10_1,"For screening clinical research candidates with PCR experience, which ethical AI step defines the tool’s goal to improve efficiency without sacrificing fairness?",A) Continuous monitoring for bias | B) Understanding the AI’s purpose | C) Engaging diversity committee | D) Secure HIPAA-compliant systems,B
course_3,ch_3_04,les_3_04_10,topic_3_04_10_01,quiz_3_04_10_2,"To prevent AI from favoring mostly male historical hires in biotech, what step trains the system on resumes from varied universities and regions?","A) Human oversight of flagged candidates | B) Transparency statements on career site | C) Blind screening hiding personal details | D) Using high-quality, diverse data",D
course_3,ch_3_04,les_3_04_10,topic_3_04_10_01,quiz_3_04_10_3,"How does ethical AI ensure candidates know it prioritizes Python proficiency for a data analyst role, with human review?",A) Ensuring transparency | B) Bias-detection for resume gaps | C) Explainability features in Workable | D) Stakeholder training sessions,A
course_3,ch_3_04,les_3_04_10,topic_3_04_10_01,quiz_3_04_10_4,"When AI might disadvantage caregivers with resume gaps, which step adjusts algorithms to focus on skills like EHR experience instead of proxies?",A) Choosing platforms like Greenhouse | B) Auditing for rural candidate undervaluation | C) Minimizing bias with detection tools | D) Consent forms for data use,C
course_3,ch_3_04,les_3_04_10,topic_3_04_10_01,quiz_3_04_10_5,Where does a hospital’s diversity committee review AI screening for nurses to avoid undervaluing rural candidates?,A) Engaging stakeholders | B) Continuous improvement updates | C) EEOC regulatory alignment | D) Publication record prioritization,A
course_3,ch_3_05,les_3_05_01,topic_3_05_01_01,quiz_3_05_01_1,"In a diabetes drug trial CRF, which principle ensures focus on hemoglobin A1C levels rather than unrelated data like eye color?",A) Ensuring data quality with range checks | B) Accommodating diverse global users | C) Aligning with the study protocol | D) Using electronic auto-calculations,C
course_3,ch_3_05,les_3_05_01,topic_3_05_01_01,quiz_3_05_01_2,"For a cancer trial CRF, what design principle groups tumor measurements and adverse events under clear headings like “Lab Results”?",A) Structuring for ease of use | B) Regulatory compliance for FDA | C) Clarity with plain language | D) Testing via pilot with coordinators,A
course_3,ch_3_05,les_3_05_01,topic_3_05_01_01,quiz_3_05_01_3,"To prevent errors in an arthritis trial CRF, which principle sets a pain score scale of 0–10 and requires month-day-year date format?",A) Accommodating patient symptom diaries | B) Technology with REDCap dropdowns | C) Clarity avoiding “hypertension” jargon | D) Ensuring data quality with validation rules,D
course_3,ch_3_05,les_3_05_01,topic_3_05_01_01,quiz_3_05_01_4,"In a global vaccine trial CRF, what principle provides translations and uses “electrocardiogram” instead of “EKG” for consistency?",A) Regulatory ICH adverse event fields | B) Accommodating diverse users | C) Pilot testing for joint pain clarity | D) Auto-BMI calculation in eCRFs,B
course_3,ch_3_05,les_3_05_01,topic_3_05_01_01,quiz_3_05_01_5,Where does a heart stent trial CRF include fields for informed consent dates and bleeding complications to meet FDA standards?,A) Regulatory compliance | B) Simplicity with concise questions | C) Real-time eCRF monitoring | D) Checkbox smoking status,A
course_3,ch_3_05,les_3_05_02,topic_3_05_02_01,quiz_3_05_02_1,"In a large multi-site cancer therapy trial tracking tumor sizes in real time, which method is ideal due to high data volume across locations?",A) Paper CRFs with weekly manual checks | B) EDC systems like Medidata | C) Hybrid scanning of handwritten forms | D) Single-site wound care paper forms,B
course_3,ch_3_05,les_3_05_02,topic_3_05_02_01,quiz_3_05_02_2,"For a small single-site wound care study, what step justifies using paper CRFs due to low data volume and nearby staff?",A) Real-time analytics for fatigue trends | B) Validation rules for heart rate 40–120 | C) Hybrid weekly uploads to EDC | D) Understanding study needs for size and resources,D
course_3,ch_3_05,les_3_05_02,topic_3_05_02_01,quiz_3_05_02_3,"In a diabetes trial, which EDC design feature includes dropdowns for side effects and ensures heart rate entries between 40–120 bpm?",A) Designing the data collection tool with validation rules | B) Manual transcription from paper to database | C) Locked cabinet storage for HIPAA | D) Pilot testing with one rural site,A
course_3,ch_3_05,les_3_05_02,topic_3_05_02_01,quiz_3_05_02_4,"During an asthma inhaler trial, what EDC step flags a missing lab result instantly or alerts for temperature entered as 200°F instead of 98.6?",A) Training on month-day-year dates | B) Secure encryption for authorized access | C) Data entry and monitoring with real-time checks | D) ICH-compliant adverse event fields,C
course_3,ch_3_05,les_3_05_02,topic_3_05_02_01,quiz_3_05_02_5,"Where does a vaccine study hybrid approach use paper CRFs on-site in rural clinics with spotty internet, then scan weekly to EDC?",A) Choosing the right mix | B) Veeva EDC EHR integration | C) Manual 10% weekly paper review | D) Costly Medidata setup,A
course_3,ch_3_05,les_3_05_03,topic_3_05_03_01,quiz_3_05_03_1,"In a diabetes trial, which SDV step prioritizes verifying HbA1C levels over non-critical data using ICH-guided risk-based monitoring?",A) Resolving discrepancies in dose entries | B) Documenting 95% adverse event matches | C) Performing verification by comparing CRF to thermometer log | D) Selecting data for verification focusing on primary endpoints,D
course_3,ch_3_05,les_3_05_03,topic_3_05_03_01,quiz_3_05_03_2,"For a heart drug trial, what SDV step identifies original EHR nurse notes or lab printouts showing glucose 150 mg/dL as the source for CRF weight entries?",A) Identifying source documents | B) Remote EDC secure access | C) Training on consistent date formats | D) Flagging 200 bpm heart rate,A
course_3,ch_3_05,les_3_05_03,topic_3_05_03_01,quiz_3_05_03_3,"During a vaccine trial, how does a monitor resolve a CRF reporting 10 mg dose when the source says 5 mg?","A) Pilot testing with one site | B) Secure HIPAA storage of reports | C) Investigating and correcting with site, documenting audit trail | D) Using Veeva EDC auto-integration",C
course_3,ch_3_05,les_3_05_03,topic_3_05_03_01,quiz_3_05_03_4,"In a global asthma inhaler trial, what SDV step ensures monitors in different countries verify tumor response rates the same way?",A) Risk-based 100% verification | B) Training and oversight on protocol procedures | C) Manual scanning of handwritten notes | D) Real-time analytics for fatigue trends,B
course_3,ch_3_05,les_3_05_03,topic_3_05_03_01,quiz_3_05_03_5,"Where does an EDC system like REDCap flag a suspicious heart rate of 200 bpm, prompting a check against the patient’s chart?",A) Technology in SDV with built-in alerts | B) Paper CRF weekly 10% review | C) Hybrid rural clinic scanning | D) FDA inspection preparation,A
course_3,ch_3_05,les_3_05_04,topic_3_05_04_01,quiz_3_05_04_1,"In a cancer trial, which query management step raises a clear query about an impossible CT scan date of February 30?",A) Monitoring 95% resolution within five days | B) Identifying queries during SDV data review | C) Escalating ignored adverse event queries | D) Reviewing patterns of 30% missing labs,B
course_3,ch_3_05,les_3_05_04,topic_3_05_04_01,quiz_3_05_04_2,"For a diabetes drug trial with CRF dose listed as 50 mg but source showing 5 mg, what step creates the specific query “Please confirm the correct dose”?",A) Resolving with lab slip evidence | B) Sending via EDC secure messaging | C) Monitoring resolution within a week | D) Creating the query with clear wording,D
course_3,ch_3_05,les_3_05_04,topic_3_05_04_01,quiz_3_05_04_3,"In a vaccine study, how does EDC like REDCap automate flagging a cholesterol level of 900 mg/dL as outside normal ranges?",A) Technology in query management with instant alerts | B) Manual spreadsheet for paper trials | C) HIPAA-secure audit trail storage | D) Site training on EHR lookup,A
course_3,ch_3_05,les_3_05_04,topic_3_05_04_01,quiz_3_05_04_4,"During an asthma inhaler trial, what step tracks that 95% of inhaler dose queries were resolved within five days, escalating delays if needed?",A) Learning from 30% missing lab patterns | B) Documenting who raised the query | C) Monitoring query resolution | D) Using ICH-compliant templates,C
course_3,ch_3_05,les_3_05_04,topic_3_05_04_01,quiz_3_05_04_5,Where does a heart stent trial query about a missing consent date show the added date was verified and recorded for FDA audit?,A) Ensuring compliance and documentation | B) Prompt sending within days | C) Vague query confusion avoidance | D) Hybrid paper-EDC hybrid,A
course_3,ch_3_05,les_3_05_05,topic_3_05_05_01,quiz_3_05_05_1,"In a clinical trial, when handling Missing at Random data where older patients tend to skip surveys, which approach is recommended over simple deletion if the missing proportion exceeds 5%?",A) Delete records | B) Impute using mean age from similar patients | C) Ignore blanks | D) Flag as outlier,B
course_3,ch_3_05,les_3_05_05,topic_3_05_05_01,quiz_3_05_05_2,A cancer trial using AI for data cleaning achieved a 30% reduction in cleaning time primarily by:,A) Predicting common typos across sites | B) Manually reviewing every CRF | C) Standardizing gender entries | D) Running range checks on ages,A
course_3,ch_3_05,les_3_05_05,topic_3_05_05_01,quiz_3_05_05_3,"According to ICH E6 guidelines, what must be logged for every data correction such as fixing a lab value typo?","A) Site coordinator name only | B) Who made change, when, and rationale | C) Patient ID and timestamp | D) Software version used",B
course_3,ch_3_05,les_3_05_05,topic_3_05_05_01,quiz_3_05_05_4,"During validation, a 2024 trial identified 10% more errors than manual review alone by:",A) Cross-validating eCRF with hospital records | B) Using scatter plots for duplicates | C) Converting all weights to kilograms | D) Training site staff on entry,A
course_3,ch_3_05,les_3_05_05,topic_3_05_05_01,quiz_3_05_05_5,Which error type would an automated edit check in Medidata Rave flag in real time if a temperature is entered as 200°F?,A) Duplicate patient ID | B) Inconsistent date format | C) Out-of-range value | D) Missing visit date,C
course_3,ch_3_05,les_3_05_06,topic_3_05_06_01,quiz_3_05_06_1,Which AI capability enables real-time detection of inconsistent lab values during data entry in eCRFs?,A) Protocol scanning | B) Real-time validation | C) Synthetic data generation | D) Source data verification,B
course_3,ch_3_05,les_3_05_06,topic_3_05_06_01,quiz_3_05_06_2,"In imaging-heavy trials for Alzheimer’s drugs, what does AI do directly within the eCRF workflow?",A) Generates drop-down fatigue scales | B) Highlights changes in brain scans in real time | C) Anonymizes patient data per GDPR | D) Predicts site dropout rates,B
course_3,ch_3_05,les_3_05_06,topic_3_05_06_01,quiz_3_05_06_3,"According to the material, what is a key regulatory requirement that AI systems must comply with during CRF automation?",A) Using only urban patient data | B) Ironclad security and anonymization per GDPR | C) Eliminating all human oversight | D) Generating synthetic data for live trials,B
course_3,ch_3_05,les_3_05_06,topic_3_05_06_01,quiz_3_05_06_4,Which company’s platform is cited for automating source data verification and reducing errors by up to 30%?,A) Saama | B) IQVIA | C) Castor | D) Clinion,C
course_3,ch_3_05,les_3_05_06,topic_3_05_06_01,quiz_3_05_06_5,"What specific trial outcome was improved by 45% using AI-driven automation, as reported by Veeva?",A) Patient enrollment speed | B) Site activation time | C) Imaging review accuracy | D) Data cleanup duration,D
course_3,ch_3_05,les_3_05_07,topic_3_05_07_01,quiz_3_05_07_1,Which missing data mechanism requires domain knowledge to detect because the missingness depends directly on the unobserved values themselves?,A) Missing at Random | B) Missing Completely at Random | C) Missing Not at Random | D) Pattern-Mixture Models,C
course_3,ch_3_05,les_3_05_07,topic_3_05_07_01,quiz_3_05_07_2,"In a cardiovascular study, which method revealed a treatment effect that single imputation failed to detect?",A) Last Observation Carried Forward | B) Multiple Imputation | C) Mean Imputation | D) Listwise Deletion,B
course_3,ch_3_05,les_3_05_07,topic_3_05_07_01,quiz_3_05_07_3,What statistical rule is used to pool results across multiple imputed datasets to obtain valid estimates and confidence intervals?,A) Little's Test | B) Rubin's Rules | C) Hot-Deck Matching | D) K-Nearest Neighbors,B
course_3,ch_3_05,les_3_05_07,topic_3_05_07_01,quiz_3_05_07_4,Which AI-driven imputation technique uses decision trees to predict missing values while automatically handling variable interactions?,A) Variational Autoencoders | B) Random Forests | C) Autoencoders | D) Generative Adversarial Networks,B
course_3,ch_3_05,les_3_05_07,topic_3_05_07_01,quiz_3_05_07_5,"According to ICH E9 Addendum, what must be clearly defined when analyzing trials with missing data?",A) Estimands | B) Sensitivity thresholds | C) Imputation iterations | D) Heatmap clustering,A
course_3,ch_3_05,les_3_05_08,topic_3_05_08_01,quiz_3_05_08_1,"Which core principle requires collecting only the essential variables for a trial, such as blood pressure without unrelated dietary details?",A) Access control | B) Data minimization | C) Encryption at rest | D) Multi-factor authentication,B
course_3,ch_3_05,les_3_05_08,topic_3_05_08_01,quiz_3_05_08_2,"In a 2024 pilot, which emerging technology reduced audit times by 25% through tamper-proof logging of trial data changes?",A) AI anomaly detection | B) Blockchain | C) Token-based APIs | D) Penetration testing,B
course_3,ch_3_05,les_3_05_08,topic_3_05_08_01,quiz_3_05_08_3,"Under GDPR, within how many hours must a data breach be notified to regulators after discovery?",A) 24 | B) 48 | C) 72 | D) 96,C
course_3,ch_3_05,les_3_05_08,topic_3_05_08_01,quiz_3_05_08_4,"Which platform example is cited for enforcing access logs that track user ID, timestamp, and specific eCRF field changes like dose adjustments?",A) OpenClinica | B) AWS Cloud | C) Veeva Vault | D) Medidata,C
course_3,ch_3_05,les_3_05_08,topic_3_05_08_01,quiz_3_05_08_5,What standard encryption algorithm is explicitly named in the material as the benchmark for high-security data scrambling?,A) AES-256 | B) RSA-2048 | C) SHA-512 | D) DES-128,A
course_3,ch_3_05,les_3_05_09,topic_3_05_09_01,quiz_3_05_09_1,"In a Phase 3 vaccine trial example, what immediate system action prevented accidental use of the old CRF after adding an antibody level field?",A) Email notification to sites | B) Locking version 1 | C) Webinar training | D) Real-time AI suggestion,B
course_3,ch_3_05,les_3_05_09,topic_3_05_09_01,quiz_3_05_09_2,"According to ICH guideline E6, what must accompany every CRF amendment in the documentation?",A) Statistical imputation plan | B) Rationale and date | C) Site-specific budget | D) AI prediction report,B
course_3,ch_3_05,les_3_05_09,topic_3_05_09_01,quiz_3_05_09_3,Which eCRF platform is cited for auto-generating version histories and flagging data entered on outdated CRFs?,A) Medi-data Rave | B) Oracle Clinical | C) Veeva Vault | D) OpenClinica,C
course_3,ch_3_05,les_3_05_09,topic_3_05_09_01,quiz_3_05_09_4,A 2023 study found that poorly planned CRF amendments caused delays in what percentage of trials?,A) 10% | B) 15% | C) 20% | D) 25%,C
course_3,ch_3_05,les_3_05_09,topic_3_05_09_01,quiz_3_05_09_5,"When a new field is added in version 2, how should data from prior visits (now missing the new field) be addressed in the analysis plan?",A) Retroactively collect from sites | B) Use multiple imputation or note in plan | C) Ignore in final dataset | D) Revert all sites to version 1,B
course_3,ch_3_05,les_3_05_10,topic_3_05_10_01,quiz_3_05_10_1,"In a 2024 diabetes trial, integration of EDC with which device reduced data entry time by 40% through auto-population of eCRF fields?",A) Glucose monitors | B) Wearable step counters | C) Blood pressure cuffs | D) Mobile symptom apps,A
course_3,ch_3_05,les_3_05_10,topic_3_05_10_01,quiz_3_05_10_2,Which EDC platform is highlighted for open-source flexibility and suitability for academic trials with limited budgets?,A) Medidata Rave | B) OpenClinica | C) Veeva Vault | D) Castor,B
course_3,ch_3_05,les_3_05_10,topic_3_05_10_01,quiz_3_05_10_3,"According to a 2022 study, paper-based trials showed how many more data errors compared to EDC systems?",A) 10% | B) 15% | C) 20% | D) 25%,C
course_3,ch_3_05,les_3_05_10,topic_3_05_10_01,quiz_3_05_10_4,"In a 2023 AI-enhanced EDC pilot, what percentage of data entry errors were detected before reaching final analysis?",A) 70% | B) 80% | C) 90% | D) 95%,C
course_3,ch_3_05,les_3_05_10,topic_3_05_10_01,quiz_3_05_10_5,"Which ICH guideline is explicitly cited as requiring EDC systems to maintain data integrity through encryption, access controls, and audit trails?",A) E6 | B) E8 | C) E9 | D) E10,A
course_3,ch_3_06,les_3_06_01,topic_3_06_01_01,quiz_3_06_01_1,"In Step 4 of monitoring plan development, what frequency is recommended for high-risk areas such as patient safety?",A) Monthly | B) Every two weeks | C) Weekly | D) Quarterly,B
course_3,ch_3_06,les_3_06_01,topic_3_06_01_01,quiz_3_06_01_2,Which role is explicitly assigned to review electronic case report forms weekly in the diabetes drug trial example?,A) Clinical research associate | B) Safety officer | C) Data team | D) Study coordinator,C
course_3,ch_3_06,les_3_06_01,topic_3_06_01_01,quiz_3_06_01_3,"According to the material, within how many hours must a serious patient safety concern be escalated to the IRB?",A) 12 | B) 24 | C) 48 | D) 72,B
course_3,ch_3_06,les_3_06_01,topic_3_06_01_01,quiz_3_06_01_4,"In Step 1, what specific example is given for a monitoring objective related to drug dosing in a heart disease trial?",A) No patient exceeds 5 mg/kg daily | B) All consent forms signed within 7 days | C) Data accuracy above 95% | D) Enrollment target met by week 8,A
course_3,ch_3_06,les_3_06_01,topic_3_06_01_01,quiz_3_06_01_5,Which step in monitoring plan development involves creating templates for documenting findings and deciding escalation pathways?,A) Step 2: Identify what needs monitoring | B) Step 3: Assign roles | C) Step 4: Set methods and schedule | D) Step 5: Plan for reporting and follow-up,D
course_3,ch_3_06,les_3_06_02,topic_3_06_02_01,quiz_3_06_02_1,What is a key characteristic of on-site monitoring?,A) It is done entirely through digital tools | B) It involves physically visiting the study site | C) It eliminates the need for interviewing staff | D) It can only be performed once a year,B
course_3,ch_3_06,les_3_06_02,topic_3_06_02_01,quiz_3_06_02_2,Remote monitoring offers which main advantage compared to on-site monitoring?,A) Better observation of physical procedures | B) More frequent checks with no travel required | C) Stronger relationship building with site staff | D) Guaranteed perfect data accuracy,B
course_3,ch_3_06,les_3_06_02,topic_3_06_02_01,quiz_3_06_02_3,Which type of study would most likely require more on-site monitoring?,A) Low-risk observational study | B) Phase 3 trial involving experimental drugs | C) Study with limited funding and resources | D) A site with excellent digital data systems,B
course_3,ch_3_06,les_3_06_02,topic_3_06_02_01,quiz_3_06_02_4,What is one limitation of remote monitoring mentioned in the material?,A) It always costs more than on-site visits | B) It cannot review data entries | C) It depends heavily on accurate data entry by the site | D) It always replaces on-site visits,C
course_3,ch_3_06,les_3_06_02,topic_3_06_02_01,quiz_3_06_02_5,"When choosing between on-site and remote monitoring, which factor should be considered?","A) Only the location of the site | B) Project complexity, budget, and technology | C) How many staff members like visitors | D) Whether the study is interesting",B
course_3,ch_3_06,les_3_06_03,topic_3_06_03_01,quiz_3_06_03_1,Which statement best describes the difference between a site visit and an inspection?,A) Site visits are informal checks by monitors | B) Inspections are usually done by regulatory authorities like the FDA | C) Site visits always focus on legal compliance only | D) Inspections are less formal than site visits,B
course_3,ch_3_06,les_3_06_03,topic_3_06_03_01,quiz_3_06_03_2,What is one key reason site visits are important in clinical trials?,A) They help spot problems early | B) They approve new treatments directly | C) They replace regulatory inspections | D) They eliminate the need for trained staff,A
course_3,ch_3_06,les_3_06_03,topic_3_06_03_01,quiz_3_06_03_3,"In the preparation phase of a site visit, what is recommended?",A) Avoid making checklists | B) Schedule with the site in advance | C) Keep important records unorganized | D) Rely on memory instead of written plans,B
course_3,ch_3_06,les_3_06_03,topic_3_06_03_01,quiz_3_06_03_4,"During the execution phase of an inspection, what might regulators ask for?",A) Institutional Review Board approvals | B) Party planning details | C) Only equipment storage temperatures | D) Nothing related to documentation,A
course_3,ch_3_06,les_3_06_03,topic_3_06_03_01,quiz_3_06_03_5,"After a site visit, what should be done when issues are found?",A) Ignore them if they seem small | B) Write a report and suggest corrective actions | C) Wait indefinitely to respond | D) Avoid sharing findings with the site,B
course_3,ch_3_06,les_3_06_04,topic_3_06_04_01,quiz_3_06_04_1,What best describes a deviation in a clinical study?,A) A complete failure to follow regulatory standards | B) A minor unintentional departure from the study protocol | C) A deliberate violation reported to the FDA | D) The total shutdown of a study,B
course_3,ch_3_06,les_3_06_04,topic_3_06_04_01,quiz_3_06_04_2,Which situation represents non-compliance?,A) A patient misses one scheduled visit by one day | B) Equipment calibration is recorded properly | C) A serious adverse event is not reported to the IRB within the required timeframe | D) Staff attend scheduled retraining sessions,C
course_3,ch_3_06,les_3_06_04,topic_3_06_04_01,quiz_3_06_04_3,"After identifying a deviation, what is the next appropriate step?",A) Ignore it if the patient seems fine | B) Immediately notify the media | C) Assess the impact on safety and data quality | D) Shut down the study site,C
course_3,ch_3_06,les_3_06_04,topic_3_06_04_01,quiz_3_06_04_4,Which action is part of Step 3: Corrective Action Planning?,A) Conducting interviews with patients | B) Writing clear actions with deadlines and responsibilities | C) Removing all staff involved in the issue | D) Ending the clinical trial early,B
course_3,ch_3_06,les_3_06_04,topic_3_06_04_01,quiz_3_06_04_5,Why must non-compliance be handled quickly and formally?,A) To avoid having to use digital reporting tools | B) Because it typically has no effect on patient safety | C) It can lead to regulatory penalties or study disruptions if ignored | D) It is optional for most clinical studies,C
course_3,ch_3_06,les_3_06_05,topic_3_06_05_01,quiz_3_06_05_1,Which of the following best describes investigator oversight?,A) Handling only paperwork while staff manage the study entirely | B) The principal investigator supervising all study activities at the site | C) Allowing the sponsor to make all protocol decisions | D) Conducting only post-study data reviews,B
course_3,ch_3_06,les_3_06_05,topic_3_06_05_01,quiz_3_06_05_2,Why is strong investigator oversight important in clinical trials?,A) It ensures participants receive correct treatment and accurate data is collected | B) It eliminates the need for IRB approvals | C) It guarantees zero deviations ever occur | D) It replaces Good Clinical Practice guidelines entirely,A
course_3,ch_3_06,les_3_06_05,topic_3_06_05_01,quiz_3_06_05_3,What is the first essential step an investigator must take before a study begins?,A) Conduct weekly meetings with the sponsor immediately | B) Understand the protocol and applicable regulations | C) Approve all patient healthcare costs personally | D) Skip training for experienced staff,B
course_3,ch_3_06,les_3_06_05,topic_3_06_05_01,quiz_3_06_05_4,Which action represents proper oversight for data and safety reporting?,A) Reporting adverse events only at the end of a study | B) Reviewing electronic case report forms regularly for errors | C) Allowing untrained staff to enter clinical data | D) Ignoring missed patient visits if outcomes look normal,B
course_3,ch_3_06,les_3_06_05,topic_3_06_05_01,quiz_3_06_05_5,Which responsibility falls under investigator communication duties?,A) Reporting deviations to the sponsor and proposing corrective actions | B) Avoiding contact with the IRB unless asked | C) Only discussing issues after the study ends | D) Telling staff not to report minor mistakes,A
course_3,ch_3_06,les_3_06_06,topic_3_06_06_01,quiz_3_06_06_1,What is the primary function of AI-driven monitoring alerts in clinical trials?,"A) To manually review every patient report |
B) To automatically detect patterns or anomalies in real-time data |
C) To replace clinical investigators entirely |
D) To store paper records securely",B
course_3,ch_3_06,les_3_06_06,topic_3_06_06_01,quiz_3_06_06_2,Which of the following best describes a high-priority alert threshold?,"A) A single overdue entry in a non-essential field |
B) A slight delay in patient follow-up scheduling |
C) An adverse event not reported within 24 hours to the IRB |
D) A duplicate phone number in patient profile",C
course_3,ch_3_06,les_3_06_06,topic_3_06_06_01,quiz_3_06_06_3,Why is human oversight still needed even when using AI-driven alerts?,"A) AI cannot be connected to digital tools |
B) Humans must validate alerts and take corrective action |
C) AI cannot scan multiple sites |
D) Humans are faster at reading lab results",B
course_3,ch_3_06,les_3_06_06,topic_3_06_06_01,quiz_3_06_06_4,Which step involves testing alerts with mock scenarios and ensuring alerts reach the correct person?,"A) Reviewing and refining accuracy every month |
B) Setting up AI tools and training them with historical data |
C) Integrating the system into the study workflow |
D) Defining thresholds like 80 percent of enrollment rate",C
course_3,ch_3_06,les_3_06_06,topic_3_06_06_01,quiz_3_06_06_5,What is one major benefit of AI alerts compared to traditional manual monitoring?,"A) They completely eliminate the FDA’s involvement |
B) They can detect subtle data issues early to prevent risks |
C) They reduce the need to store patient data securely |
D) They run only during business hours",B
course_3,ch_3_06,les_3_06_07,topic_3_06_07_01,quiz_3_06_07_1,Where does central monitoring typically take place?,"A) At hospitals or clinics where patients are treated |
B) At a sponsor’s or CRO’s remote office using electronic systems |
C) Inside patient homes during treatment delivery |
D) At regulatory authority field stations",B
course_3,ch_3_06,les_3_06_07,topic_3_06_07_01,quiz_3_06_07_2,What is a major advantage of local monitoring?,"A) It eliminates the need for site staff |
B) It allows direct observation of procedures and real-time practices |
C) It fully replaces all data review activities |
D) It requires no scheduling or travel",B
course_3,ch_3_06,les_3_06_07,topic_3_06_07_01,quiz_3_06_07_3,Which situation would most strongly support using central monitoring?,"A) High-risk trials needing intensive safety checks |
B) Observational studies with large patient numbers across many sites |
C) Trials where drug storage needs daily inspection |
D) Studies with frequent protocol training gaps",B
course_3,ch_3_06,les_3_06_07,topic_3_06_07_01,quiz_3_06_07_4,What is a common limitation of central monitoring?,"A) It depends heavily on accurate remote data entry |
B) It requires constant travel to global sites |
C) It prevents data from being aggregated across locations |
D) It interrupts patient care during visits",A
course_3,ch_3_06,les_3_06_07,topic_3_06_07_01,quiz_3_06_07_5,How does a hybrid monitoring approach improve trial performance?,"A) By avoiding any direct interaction with study sites |
B) By combining broad data oversight with targeted on-site checks |
C) By focusing only on equipment calibration |
D) By stopping monitoring once enrollment reaches 90 percent",B
course_3,ch_3_06,les_3_06_08,topic_3_06_08_01,quiz_3_06_08_1,What is the main purpose of escalation procedures in clinical trials?,"A) To delay reporting issues until a site visit occurs |
B) To ensure serious problems are quickly reported to higher authority |
C) To eliminate documentation requirements |
D) To avoid communication with sponsors",B
course_3,ch_3_06,les_3_06_08,topic_3_06_08_01,quiz_3_06_08_2,Which of the following would most likely trigger an escalation?,"A) A minor typo in a patient questionnaire |
B) A single rescheduled appointment with no impact |
C) A serious side effect from a dose of five milligrams per kilogram |
D) A monitor asking for basic clarification",C
course_3,ch_3_06,les_3_06_08,topic_3_06_08_01,quiz_3_06_08_3,Who is typically notified first when a site issue cannot be resolved at the initial level?,"A) The sponsor’s financial team |
B) The hospital’s receptionist |
C) The principal investigator or study manager |
D) The local media",C
course_3,ch_3_06,les_3_06_08,topic_3_06_08_01,quiz_3_06_08_4,Why is documentation important during escalation?,"A) It allows issues to be ignored later |
B) It increases travel requirements |
C) It provides accountability and supports compliance |
D) It replaces communication between teams",C
course_3,ch_3_06,les_3_06_08,topic_3_06_08_01,quiz_3_06_08_5,Which action improves the effectiveness of escalation procedures?,"A) Avoiding staff training to save time |
B) Hiding mistakes to reduce reported issues |
C) Using updated contact lists and mock scenario testing |
D) Reporting only after the study concludes",C
course_3,ch_3_06,les_3_06_09,topic_3_06_09_01,quiz_3_06_09_1,What is the primary purpose of a monitoring report in a clinical trial?,"A) To replace communication between sponsors and sites |
B) To summarize monitoring findings and guide corrective actions |
C) To advertise the study to new sites |
D) To remove the need for protocol compliance",B
course_3,ch_3_06,les_3_06_09,topic_3_06_09_01,quiz_3_06_09_2,Which of the following would typically be included in a monitoring report?,"A) Personal opinions of the monitor only |
B) Site name, visit date, findings, and corrective actions |
C) Marketing strategy for future studies |
D) Irrelevant patient personal history not related to the trial",B
course_3,ch_3_06,les_3_06_09,topic_3_06_09_01,quiz_3_06_09_3,Why are monitoring reports important for regulatory oversight?,"A) They prevent sites from using electronic systems |
B) They allow regulatory bodies like the FDA to verify compliance |
C) They eliminate the need for site staff training |
D) They only highlight positive findings",B
course_3,ch_3_06,les_3_06_09,topic_3_06_09_01,quiz_3_06_09_4,Which of these is considered a critical finding that a monitoring report should highlight urgently?,"A) A minor spelling error in a filename |
B) Brief storage temperature above eight degrees Celsius for a vaccine |
C) Extra copies of blank consent forms in storage |
D) Overuse of medical abbreviations",B
course_3,ch_3_06,les_3_06_09,topic_3_06_09_01,quiz_3_06_09_5,What helps improve the effectiveness of monitoring reports?,"A) Delaying submission to collect more errors |
B) Prioritizing issues and using clear, objective language |
C) Keeping reports extremely vague to save time |
D) Ignoring follow-ups after recommendations",B
course_3,ch_3_06,les_3_06_10,topic_3_06_10_01,quiz_3_06_10_1,What is the primary purpose of close-out monitoring in a clinical trial?,"A) To begin enrolling new participants at the site |
B) To verify that all study activities are completed accurately and compliantly |
C) To replace earlier monitoring visits |
D) To recruit the monitor for future studies",B
course_3,ch_3_06,les_3_06_10,topic_3_06_10_01,quiz_3_06_10_2,Which of the following is a key activity during close-out monitoring?,"A) Adding new patient data after the trial ends |
B) Checking that all required documents and data entries are complete |
C) Removing protocol requirements from the study binder |
D) Storing unused drugs indefinitely at the site",B
course_3,ch_3_06,les_3_06_10,topic_3_06_10_01,quiz_3_06_10_3,Who typically leads the close-out monitoring process at a study site?,"A) The hospital receptionist |
B) A clinical research associate or monitor |
C) The marketing team |
D) Local news reporters",B
course_3,ch_3_06,les_3_06_10,topic_3_06_10_01,quiz_3_06_10_4,Which situation would require resolution before a site can be closed out?,"A) Study binder arranged alphabetically |
B) Missing final visit lab results for a participant |
C) Extra chairs in the monitoring room |
D) A personal photo on the coordinator’s desk",B
course_3,ch_3_06,les_3_06_10,topic_3_06_10_01,quiz_3_06_10_5,What helps ensure an efficient and effective close-out visit?,"A) Organizing records throughout the study and using checklists |
B) Waiting until the last day to gather all documents |
C) Avoiding communication between monitor and site staff |
D) Submitting the close-out report months later",A
course_3,ch_3_07,les_3_07_01,topic_3_07_01_01,quiz_3_07_01_1,,,
course_3,ch_3_07,les_3_07_01,topic_3_07_01_01,quiz_3_07_01_2,,,
course_3,ch_3_07,les_3_07_01,topic_3_07_01_01,quiz_3_07_01_3,,,
course_3,ch_3_07,les_3_07_01,topic_3_07_01_01,quiz_3_07_01_4,,,
course_3,ch_3_07,les_3_07_01,topic_3_07_01_01,quiz_3_07_01_5,,,
course_3,ch_3_07,les_3_07_02,topic_3_07_02_01,quiz_3_07_02_1,,,
course_3,ch_3_07,les_3_07_02,topic_3_07_02_01,quiz_3_07_02_2,,,
course_3,ch_3_07,les_3_07_02,topic_3_07_02_01,quiz_3_07_02_3,,,
course_3,ch_3_07,les_3_07_02,topic_3_07_02_01,quiz_3_07_02_4,,,
course_3,ch_3_07,les_3_07_02,topic_3_07_02_01,quiz_3_07_02_5,,,
course_3,ch_3_07,les_3_07_03,topic_3_07_03_01,quiz_3_07_03_1,,,
course_3,ch_3_07,les_3_07_03,topic_3_07_03_01,quiz_3_07_03_2,,,
course_3,ch_3_07,les_3_07_03,topic_3_07_03_01,quiz_3_07_03_3,,,
course_3,ch_3_07,les_3_07_03,topic_3_07_03_01,quiz_3_07_03_4,,,
course_3,ch_3_07,les_3_07_03,topic_3_07_03_01,quiz_3_07_03_5,,,
course_3,ch_3_07,les_3_07_04,topic_3_07_04_01,quiz_3_07_04_1,,,
course_3,ch_3_07,les_3_07_04,topic_3_07_04_01,quiz_3_07_04_2,,,
course_3,ch_3_07,les_3_07_04,topic_3_07_04_01,quiz_3_07_04_3,,,
course_3,ch_3_07,les_3_07_04,topic_3_07_04_01,quiz_3_07_04_4,,,
course_3,ch_3_07,les_3_07_04,topic_3_07_04_01,quiz_3_07_04_5,,,
course_3,ch_3_07,les_3_07_05,topic_3_07_05_01,quiz_3_07_05_1,,,
course_3,ch_3_07,les_3_07_05,topic_3_07_05_01,quiz_3_07_05_2,,,
course_3,ch_3_07,les_3_07_05,topic_3_07_05_01,quiz_3_07_05_3,,,
course_3,ch_3_07,les_3_07_05,topic_3_07_05_01,quiz_3_07_05_4,,,
course_3,ch_3_07,les_3_07_05,topic_3_07_05_01,quiz_3_07_05_5,,,
course_3,ch_3_07,les_3_07_06,topic_3_07_06_01,quiz_3_07_06_1,,,
course_3,ch_3_07,les_3_07_06,topic_3_07_06_01,quiz_3_07_06_2,,,
course_3,ch_3_07,les_3_07_06,topic_3_07_06_01,quiz_3_07_06_3,,,
course_3,ch_3_07,les_3_07_06,topic_3_07_06_01,quiz_3_07_06_4,,,
course_3,ch_3_07,les_3_07_06,topic_3_07_06_01,quiz_3_07_06_5,,,
course_3,ch_3_07,les_3_07_07,topic_3_07_07_01,quiz_3_07_07_1,,,
course_3,ch_3_07,les_3_07_07,topic_3_07_07_01,quiz_3_07_07_2,,,
course_3,ch_3_07,les_3_07_07,topic_3_07_07_01,quiz_3_07_07_3,,,
course_3,ch_3_07,les_3_07_07,topic_3_07_07_01,quiz_3_07_07_4,,,
course_3,ch_3_07,les_3_07_07,topic_3_07_07_01,quiz_3_07_07_5,,,
course_3,ch_3_07,les_3_07_08,topic_3_07_08_01,quiz_3_07_08_1,,,
course_3,ch_3_07,les_3_07_08,topic_3_07_08_01,quiz_3_07_08_2,,,
course_3,ch_3_07,les_3_07_08,topic_3_07_08_01,quiz_3_07_08_3,,,
course_3,ch_3_07,les_3_07_08,topic_3_07_08_01,quiz_3_07_08_4,,,
course_3,ch_3_07,les_3_07_08,topic_3_07_08_01,quiz_3_07_08_5,,,
course_3,ch_3_07,les_3_07_09,topic_3_07_09_01,quiz_3_07_09_1,,,
course_3,ch_3_07,les_3_07_09,topic_3_07_09_01,quiz_3_07_09_2,,,
course_3,ch_3_07,les_3_07_09,topic_3_07_09_01,quiz_3_07_09_3,,,
course_3,ch_3_07,les_3_07_09,topic_3_07_09_01,quiz_3_07_09_4,,,
course_3,ch_3_07,les_3_07_09,topic_3_07_09_01,quiz_3_07_09_5,,,
course_3,ch_3_07,les_3_07_10,topic_3_07_10_01,quiz_3_07_10_1,,,
course_3,ch_3_07,les_3_07_10,topic_3_07_10_01,quiz_3_07_10_2,,,
course_3,ch_3_07,les_3_07_10,topic_3_07_10_01,quiz_3_07_10_3,,,
course_3,ch_3_07,les_3_07_10,topic_3_07_10_01,quiz_3_07_10_4,,,
course_3,ch_3_07,les_3_07_10,topic_3_07_10_01,quiz_3_07_10_5,,,
course_3,ch_3_08,les_3_08_01,topic_3_08_01_01,quiz_3_08_01_1,,,
course_3,ch_3_08,les_3_08_01,topic_3_08_01_01,quiz_3_08_01_2,,,
course_3,ch_3_08,les_3_08_01,topic_3_08_01_01,quiz_3_08_01_3,,,
course_3,ch_3_08,les_3_08_01,topic_3_08_01_01,quiz_3_08_01_4,,,
course_3,ch_3_08,les_3_08_01,topic_3_08_01_01,quiz_3_08_01_5,,,
course_3,ch_3_08,les_3_08_02,topic_3_08_02_01,quiz_3_08_02_1,,,
course_3,ch_3_08,les_3_08_02,topic_3_08_02_01,quiz_3_08_02_2,,,
course_3,ch_3_08,les_3_08_02,topic_3_08_02_01,quiz_3_08_02_3,,,
course_3,ch_3_08,les_3_08_02,topic_3_08_02_01,quiz_3_08_02_4,,,
course_3,ch_3_08,les_3_08_02,topic_3_08_02_01,quiz_3_08_02_5,,,
course_3,ch_3_08,les_3_08_03,topic_3_08_03_01,quiz_3_08_03_1,,,
course_3,ch_3_08,les_3_08_03,topic_3_08_03_01,quiz_3_08_03_2,,,
course_3,ch_3_08,les_3_08_03,topic_3_08_03_01,quiz_3_08_03_3,,,
course_3,ch_3_08,les_3_08_03,topic_3_08_03_01,quiz_3_08_03_4,,,
course_3,ch_3_08,les_3_08_03,topic_3_08_03_01,quiz_3_08_03_5,,,
course_3,ch_3_08,les_3_08_04,topic_3_08_04_01,quiz_3_08_04_1,,,
course_3,ch_3_08,les_3_08_04,topic_3_08_04_01,quiz_3_08_04_2,,,
course_3,ch_3_08,les_3_08_04,topic_3_08_04_01,quiz_3_08_04_3,,,
course_3,ch_3_08,les_3_08_04,topic_3_08_04_01,quiz_3_08_04_4,,,
course_3,ch_3_08,les_3_08_04,topic_3_08_04_01,quiz_3_08_04_5,,,
course_3,ch_3_08,les_3_08_05,topic_3_08_05_01,quiz_3_08_05_1,,,
course_3,ch_3_08,les_3_08_05,topic_3_08_05_01,quiz_3_08_05_2,,,
course_3,ch_3_08,les_3_08_05,topic_3_08_05_01,quiz_3_08_05_3,,,
course_3,ch_3_08,les_3_08_05,topic_3_08_05_01,quiz_3_08_05_4,,,
course_3,ch_3_08,les_3_08_05,topic_3_08_05_01,quiz_3_08_05_5,,,
course_3,ch_3_08,les_3_08_06,topic_3_08_06_01,quiz_3_08_06_1,,,
course_3,ch_3_08,les_3_08_06,topic_3_08_06_01,quiz_3_08_06_2,,,
course_3,ch_3_08,les_3_08_06,topic_3_08_06_01,quiz_3_08_06_3,,,
course_3,ch_3_08,les_3_08_06,topic_3_08_06_01,quiz_3_08_06_4,,,
course_3,ch_3_08,les_3_08_06,topic_3_08_06_01,quiz_3_08_06_5,,,
course_3,ch_3_08,les_3_08_07,topic_3_08_07_01,quiz_3_08_07_1,,,
course_3,ch_3_08,les_3_08_07,topic_3_08_07_01,quiz_3_08_07_2,,,
course_3,ch_3_08,les_3_08_07,topic_3_08_07_01,quiz_3_08_07_3,,,
course_3,ch_3_08,les_3_08_07,topic_3_08_07_01,quiz_3_08_07_4,,,
course_3,ch_3_08,les_3_08_07,topic_3_08_07_01,quiz_3_08_07_5,,,
course_3,ch_3_08,les_3_08_08,topic_3_08_08_01,quiz_3_08_08_1,,,
course_3,ch_3_08,les_3_08_08,topic_3_08_08_01,quiz_3_08_08_2,,,
course_3,ch_3_08,les_3_08_08,topic_3_08_08_01,quiz_3_08_08_3,,,
course_3,ch_3_08,les_3_08_08,topic_3_08_08_01,quiz_3_08_08_4,,,
course_3,ch_3_08,les_3_08_08,topic_3_08_08_01,quiz_3_08_08_5,,,
course_3,ch_3_08,les_3_08_09,topic_3_08_09_01,quiz_3_08_09_1,,,
course_3,ch_3_08,les_3_08_09,topic_3_08_09_01,quiz_3_08_09_2,,,
course_3,ch_3_08,les_3_08_09,topic_3_08_09_01,quiz_3_08_09_3,,,
course_3,ch_3_08,les_3_08_09,topic_3_08_09_01,quiz_3_08_09_4,,,
course_3,ch_3_08,les_3_08_09,topic_3_08_09_01,quiz_3_08_09_5,,,
course_3,ch_3_08,les_3_08_10,topic_3_08_10_01,quiz_3_08_10_1,,,
course_3,ch_3_08,les_3_08_10,topic_3_08_10_01,quiz_3_08_10_2,,,
course_3,ch_3_08,les_3_08_10,topic_3_08_10_01,quiz_3_08_10_3,,,
course_3,ch_3_08,les_3_08_10,topic_3_08_10_01,quiz_3_08_10_4,,,
course_3,ch_3_08,les_3_08_10,topic_3_08_10_01,quiz_3_08_10_5,,,
course_3,ch_3_09,les_3_09_01,topic_3_09_01_01,quiz_3_09_01_1,,,
course_3,ch_3_09,les_3_09_01,topic_3_09_01_01,quiz_3_09_01_2,,,
course_3,ch_3_09,les_3_09_01,topic_3_09_01_01,quiz_3_09_01_3,,,
course_3,ch_3_09,les_3_09_01,topic_3_09_01_01,quiz_3_09_01_4,,,
course_3,ch_3_09,les_3_09_01,topic_3_09_01_01,quiz_3_09_01_5,,,
course_3,ch_3_09,les_3_09_02,topic_3_09_02_01,quiz_3_09_02_1,,,
course_3,ch_3_09,les_3_09_02,topic_3_09_02_01,quiz_3_09_02_2,,,
course_3,ch_3_09,les_3_09_02,topic_3_09_02_01,quiz_3_09_02_3,,,
course_3,ch_3_09,les_3_09_02,topic_3_09_02_01,quiz_3_09_02_4,,,
course_3,ch_3_09,les_3_09_02,topic_3_09_02_01,quiz_3_09_02_5,,,
course_3,ch_3_09,les_3_09_03,topic_3_09_03_01,quiz_3_09_03_1,,,
course_3,ch_3_09,les_3_09_03,topic_3_09_03_01,quiz_3_09_03_2,,,
course_3,ch_3_09,les_3_09_03,topic_3_09_03_01,quiz_3_09_03_3,,,
course_3,ch_3_09,les_3_09_03,topic_3_09_03_01,quiz_3_09_03_4,,,
course_3,ch_3_09,les_3_09_03,topic_3_09_03_01,quiz_3_09_03_5,,,
course_3,ch_3_09,les_3_09_04,topic_3_09_04_01,quiz_3_09_04_1,,,
course_3,ch_3_09,les_3_09_04,topic_3_09_04_01,quiz_3_09_04_2,,,
course_3,ch_3_09,les_3_09_04,topic_3_09_04_01,quiz_3_09_04_3,,,
course_3,ch_3_09,les_3_09_04,topic_3_09_04_01,quiz_3_09_04_4,,,
course_3,ch_3_09,les_3_09_04,topic_3_09_04_01,quiz_3_09_04_5,,,
course_3,ch_3_09,les_3_09_05,topic_3_09_05_01,quiz_3_09_05_1,,,
course_3,ch_3_09,les_3_09_05,topic_3_09_05_01,quiz_3_09_05_2,,,
course_3,ch_3_09,les_3_09_05,topic_3_09_05_01,quiz_3_09_05_3,,,
course_3,ch_3_09,les_3_09_05,topic_3_09_05_01,quiz_3_09_05_4,,,
course_3,ch_3_09,les_3_09_05,topic_3_09_05_01,quiz_3_09_05_5,,,
course_3,ch_3_09,les_3_09_06,topic_3_09_06_01,quiz_3_09_06_1,,,
course_3,ch_3_09,les_3_09_06,topic_3_09_06_01,quiz_3_09_06_2,,,
course_3,ch_3_09,les_3_09_06,topic_3_09_06_01,quiz_3_09_06_3,,,
course_3,ch_3_09,les_3_09_06,topic_3_09_06_01,quiz_3_09_06_4,,,
course_3,ch_3_09,les_3_09_06,topic_3_09_06_01,quiz_3_09_06_5,,,
course_3,ch_3_09,les_3_09_07,topic_3_09_07_01,quiz_3_09_07_1,,,
course_3,ch_3_09,les_3_09_07,topic_3_09_07_01,quiz_3_09_07_2,,,
course_3,ch_3_09,les_3_09_07,topic_3_09_07_01,quiz_3_09_07_3,,,
course_3,ch_3_09,les_3_09_07,topic_3_09_07_01,quiz_3_09_07_4,,,
course_3,ch_3_09,les_3_09_07,topic_3_09_07_01,quiz_3_09_07_5,,,
course_3,ch_3_09,les_3_09_08,topic_3_09_08_01,quiz_3_09_08_1,,,
course_3,ch_3_09,les_3_09_08,topic_3_09_08_01,quiz_3_09_08_2,,,
course_3,ch_3_09,les_3_09_08,topic_3_09_08_01,quiz_3_09_08_3,,,
course_3,ch_3_09,les_3_09_08,topic_3_09_08_01,quiz_3_09_08_4,,,
course_3,ch_3_09,les_3_09_08,topic_3_09_08_01,quiz_3_09_08_5,,,
course_3,ch_3_09,les_3_09_09,topic_3_09_09_01,quiz_3_09_09_1,,,
course_3,ch_3_09,les_3_09_09,topic_3_09_09_01,quiz_3_09_09_2,,,
course_3,ch_3_09,les_3_09_09,topic_3_09_09_01,quiz_3_09_09_3,,,
course_3,ch_3_09,les_3_09_09,topic_3_09_09_01,quiz_3_09_09_4,,,
course_3,ch_3_09,les_3_09_09,topic_3_09_09_01,quiz_3_09_09_5,,,
course_3,ch_3_09,les_3_09_10,topic_3_09_10_01,quiz_3_09_10_1,,,
course_3,ch_3_09,les_3_09_10,topic_3_09_10_01,quiz_3_09_10_2,,,
course_3,ch_3_09,les_3_09_10,topic_3_09_10_01,quiz_3_09_10_3,,,
course_3,ch_3_09,les_3_09_10,topic_3_09_10_01,quiz_3_09_10_4,,,
course_3,ch_3_09,les_3_09_10,topic_3_09_10_01,quiz_3_09_10_5,,,
course_3,ch_3_10,les_3_10_01,topic_3_10_01_01,quiz_3_10_01_1,,,
course_3,ch_3_10,les_3_10_01,topic_3_10_01_01,quiz_3_10_01_2,,,
course_3,ch_3_10,les_3_10_01,topic_3_10_01_01,quiz_3_10_01_3,,,
course_3,ch_3_10,les_3_10_01,topic_3_10_01_01,quiz_3_10_01_4,,,
course_3,ch_3_10,les_3_10_01,topic_3_10_01_01,quiz_3_10_01_5,,,
course_3,ch_3_10,les_3_10_02,topic_3_10_02_01,quiz_3_10_02_1,,,
course_3,ch_3_10,les_3_10_02,topic_3_10_02_01,quiz_3_10_02_2,,,
course_3,ch_3_10,les_3_10_02,topic_3_10_02_01,quiz_3_10_02_3,,,
course_3,ch_3_10,les_3_10_02,topic_3_10_02_01,quiz_3_10_02_4,,,
course_3,ch_3_10,les_3_10_02,topic_3_10_02_01,quiz_3_10_02_5,,,
course_3,ch_3_10,les_3_10_03,topic_3_10_03_01,quiz_3_10_03_1,,,
course_3,ch_3_10,les_3_10_03,topic_3_10_03_01,quiz_3_10_03_2,,,
course_3,ch_3_10,les_3_10_03,topic_3_10_03_01,quiz_3_10_03_3,,,
course_3,ch_3_10,les_3_10_03,topic_3_10_03_01,quiz_3_10_03_4,,,
course_3,ch_3_10,les_3_10_03,topic_3_10_03_01,quiz_3_10_03_5,,,
course_3,ch_3_10,les_3_10_04,topic_3_10_04_01,quiz_3_10_04_1,,,
course_3,ch_3_10,les_3_10_04,topic_3_10_04_01,quiz_3_10_04_2,,,
course_3,ch_3_10,les_3_10_04,topic_3_10_04_01,quiz_3_10_04_3,,,
course_3,ch_3_10,les_3_10_04,topic_3_10_04_01,quiz_3_10_04_4,,,
course_3,ch_3_10,les_3_10_04,topic_3_10_04_01,quiz_3_10_04_5,,,
course_3,ch_3_10,les_3_10_05,topic_3_10_05_01,quiz_3_10_05_1,,,
course_3,ch_3_10,les_3_10_05,topic_3_10_05_01,quiz_3_10_05_2,,,
course_3,ch_3_10,les_3_10_05,topic_3_10_05_01,quiz_3_10_05_3,,,
course_3,ch_3_10,les_3_10_05,topic_3_10_05_01,quiz_3_10_05_4,,,
course_3,ch_3_10,les_3_10_05,topic_3_10_05_01,quiz_3_10_05_5,,,
course_3,ch_3_10,les_3_10_06,topic_3_10_06_01,quiz_3_10_06_1,,,
course_3,ch_3_10,les_3_10_06,topic_3_10_06_01,quiz_3_10_06_2,,,
course_3,ch_3_10,les_3_10_06,topic_3_10_06_01,quiz_3_10_06_3,,,
course_3,ch_3_10,les_3_10_06,topic_3_10_06_01,quiz_3_10_06_4,,,
course_3,ch_3_10,les_3_10_06,topic_3_10_06_01,quiz_3_10_06_5,,,
course_3,ch_3_10,les_3_10_07,topic_3_10_07_01,quiz_3_10_07_1,,,
course_3,ch_3_10,les_3_10_07,topic_3_10_07_01,quiz_3_10_07_2,,,
course_3,ch_3_10,les_3_10_07,topic_3_10_07_01,quiz_3_10_07_3,,,
course_3,ch_3_10,les_3_10_07,topic_3_10_07_01,quiz_3_10_07_4,,,
course_3,ch_3_10,les_3_10_07,topic_3_10_07_01,quiz_3_10_07_5,,,
course_3,ch_3_10,les_3_10_08,topic_3_10_08_01,quiz_3_10_08_1,,,
course_3,ch_3_10,les_3_10_08,topic_3_10_08_01,quiz_3_10_08_2,,,
course_3,ch_3_10,les_3_10_08,topic_3_10_08_01,quiz_3_10_08_3,,,
course_3,ch_3_10,les_3_10_08,topic_3_10_08_01,quiz_3_10_08_4,,,
course_3,ch_3_10,les_3_10_08,topic_3_10_08_01,quiz_3_10_08_5,,,
course_3,ch_3_10,les_3_10_09,topic_3_10_09_01,quiz_3_10_09_1,,,
course_3,ch_3_10,les_3_10_09,topic_3_10_09_01,quiz_3_10_09_2,,,
course_3,ch_3_10,les_3_10_09,topic_3_10_09_01,quiz_3_10_09_3,,,
course_3,ch_3_10,les_3_10_09,topic_3_10_09_01,quiz_3_10_09_4,,,
course_3,ch_3_10,les_3_10_09,topic_3_10_09_01,quiz_3_10_09_5,,,
course_3,ch_3_10,les_3_10_10,topic_3_10_10_01,quiz_3_10_10_1,,,
course_3,ch_3_10,les_3_10_10,topic_3_10_10_01,quiz_3_10_10_2,,,
course_3,ch_3_10,les_3_10_10,topic_3_10_10_01,quiz_3_10_10_3,,,
course_3,ch_3_10,les_3_10_10,topic_3_10_10_01,quiz_3_10_10_4,,,
course_3,ch_3_10,les_3_10_10,topic_3_10_10_01,quiz_3_10_10_5,,,
course_3,ch_3_11,les_3_11_01,topic_3_11_01_01,quiz_3_11_01_1,,,
course_3,ch_3_11,les_3_11_01,topic_3_11_01_01,quiz_3_11_01_2,,,
course_3,ch_3_11,les_3_11_01,topic_3_11_01_01,quiz_3_11_01_3,,,
course_3,ch_3_11,les_3_11_01,topic_3_11_01_01,quiz_3_11_01_4,,,
course_3,ch_3_11,les_3_11_01,topic_3_11_01_01,quiz_3_11_01_5,,,
course_3,ch_3_11,les_3_11_02,topic_3_11_02_01,quiz_3_11_02_1,,,
course_3,ch_3_11,les_3_11_02,topic_3_11_02_01,quiz_3_11_02_2,,,
course_3,ch_3_11,les_3_11_02,topic_3_11_02_01,quiz_3_11_02_3,,,
course_3,ch_3_11,les_3_11_02,topic_3_11_02_01,quiz_3_11_02_4,,,
course_3,ch_3_11,les_3_11_02,topic_3_11_02_01,quiz_3_11_02_5,,,
course_3,ch_3_11,les_3_11_03,topic_3_11_03_01,quiz_3_11_03_1,,,
course_3,ch_3_11,les_3_11_03,topic_3_11_03_01,quiz_3_11_03_2,,,
course_3,ch_3_11,les_3_11_03,topic_3_11_03_01,quiz_3_11_03_3,,,
course_3,ch_3_11,les_3_11_03,topic_3_11_03_01,quiz_3_11_03_4,,,
course_3,ch_3_11,les_3_11_03,topic_3_11_03_01,quiz_3_11_03_5,,,
course_3,ch_3_11,les_3_11_04,topic_3_11_04_01,quiz_3_11_04_1,,,
course_3,ch_3_11,les_3_11_04,topic_3_11_04_01,quiz_3_11_04_2,,,
course_3,ch_3_11,les_3_11_04,topic_3_11_04_01,quiz_3_11_04_3,,,
course_3,ch_3_11,les_3_11_04,topic_3_11_04_01,quiz_3_11_04_4,,,
course_3,ch_3_11,les_3_11_04,topic_3_11_04_01,quiz_3_11_04_5,,,
course_3,ch_3_11,les_3_11_05,topic_3_11_05_01,quiz_3_11_05_1,,,
course_3,ch_3_11,les_3_11_05,topic_3_11_05_01,quiz_3_11_05_2,,,
course_3,ch_3_11,les_3_11_05,topic_3_11_05_01,quiz_3_11_05_3,,,
course_3,ch_3_11,les_3_11_05,topic_3_11_05_01,quiz_3_11_05_4,,,
course_3,ch_3_11,les_3_11_05,topic_3_11_05_01,quiz_3_11_05_5,,,
course_3,ch_3_11,les_3_11_06,topic_3_11_06_01,quiz_3_11_06_1,,,
course_3,ch_3_11,les_3_11_06,topic_3_11_06_01,quiz_3_11_06_2,,,
course_3,ch_3_11,les_3_11_06,topic_3_11_06_01,quiz_3_11_06_3,,,
course_3,ch_3_11,les_3_11_06,topic_3_11_06_01,quiz_3_11_06_4,,,
course_3,ch_3_11,les_3_11_06,topic_3_11_06_01,quiz_3_11_06_5,,,
course_3,ch_3_11,les_3_11_07,topic_3_11_07_01,quiz_3_11_07_1,,,
course_3,ch_3_11,les_3_11_07,topic_3_11_07_01,quiz_3_11_07_2,,,
course_3,ch_3_11,les_3_11_07,topic_3_11_07_01,quiz_3_11_07_3,,,
course_3,ch_3_11,les_3_11_07,topic_3_11_07_01,quiz_3_11_07_4,,,
course_3,ch_3_11,les_3_11_07,topic_3_11_07_01,quiz_3_11_07_5,,,
course_3,ch_3_11,les_3_11_08,topic_3_11_08_01,quiz_3_11_08_1,,,
course_3,ch_3_11,les_3_11_08,topic_3_11_08_01,quiz_3_11_08_2,,,
course_3,ch_3_11,les_3_11_08,topic_3_11_08_01,quiz_3_11_08_3,,,
course_3,ch_3_11,les_3_11_08,topic_3_11_08_01,quiz_3_11_08_4,,,
course_3,ch_3_11,les_3_11_08,topic_3_11_08_01,quiz_3_11_08_5,,,
course_3,ch_3_11,les_3_11_09,topic_3_11_09_01,quiz_3_11_09_1,,,
course_3,ch_3_11,les_3_11_09,topic_3_11_09_01,quiz_3_11_09_2,,,
course_3,ch_3_11,les_3_11_09,topic_3_11_09_01,quiz_3_11_09_3,,,
course_3,ch_3_11,les_3_11_09,topic_3_11_09_01,quiz_3_11_09_4,,,
course_3,ch_3_11,les_3_11_09,topic_3_11_09_01,quiz_3_11_09_5,,,
course_3,ch_3_11,les_3_11_10,topic_3_11_10_01,quiz_3_11_10_1,,,
course_3,ch_3_11,les_3_11_10,topic_3_11_10_01,quiz_3_11_10_2,,,
course_3,ch_3_11,les_3_11_10,topic_3_11_10_01,quiz_3_11_10_3,,,
course_3,ch_3_11,les_3_11_10,topic_3_11_10_01,quiz_3_11_10_4,,,
course_3,ch_3_11,les_3_11_10,topic_3_11_10_01,quiz_3_11_10_5,,,
course_3,ch_3_12,les_3_12_01,topic_3_12_01_01,quiz_3_12_01_1,,,
course_3,ch_3_12,les_3_12_01,topic_3_12_01_01,quiz_3_12_01_2,,,
course_3,ch_3_12,les_3_12_01,topic_3_12_01_01,quiz_3_12_01_3,,,
course_3,ch_3_12,les_3_12_01,topic_3_12_01_01,quiz_3_12_01_4,,,
course_3,ch_3_12,les_3_12_01,topic_3_12_01_01,quiz_3_12_01_5,,,
course_3,ch_3_12,les_3_12_02,topic_3_12_02_01,quiz_3_12_02_1,,,
course_3,ch_3_12,les_3_12_02,topic_3_12_02_01,quiz_3_12_02_2,,,
course_3,ch_3_12,les_3_12_02,topic_3_12_02_01,quiz_3_12_02_3,,,
course_3,ch_3_12,les_3_12_02,topic_3_12_02_01,quiz_3_12_02_4,,,
course_3,ch_3_12,les_3_12_02,topic_3_12_02_01,quiz_3_12_02_5,,,
course_3,ch_3_12,les_3_12_03,topic_3_12_03_01,quiz_3_12_03_1,,,
course_3,ch_3_12,les_3_12_03,topic_3_12_03_01,quiz_3_12_03_2,,,
course_3,ch_3_12,les_3_12_03,topic_3_12_03_01,quiz_3_12_03_3,,,
course_3,ch_3_12,les_3_12_03,topic_3_12_03_01,quiz_3_12_03_4,,,
course_3,ch_3_12,les_3_12_03,topic_3_12_03_01,quiz_3_12_03_5,,,
course_3,ch_3_12,les_3_12_04,topic_3_12_04_01,quiz_3_12_04_1,,,
course_3,ch_3_12,les_3_12_04,topic_3_12_04_01,quiz_3_12_04_2,,,
course_3,ch_3_12,les_3_12_04,topic_3_12_04_01,quiz_3_12_04_3,,,
course_3,ch_3_12,les_3_12_04,topic_3_12_04_01,quiz_3_12_04_4,,,
course_3,ch_3_12,les_3_12_04,topic_3_12_04_01,quiz_3_12_04_5,,,
course_3,ch_3_12,les_3_12_05,topic_3_12_05_01,quiz_3_12_05_1,,,
course_3,ch_3_12,les_3_12_05,topic_3_12_05_01,quiz_3_12_05_2,,,
course_3,ch_3_12,les_3_12_05,topic_3_12_05_01,quiz_3_12_05_3,,,
course_3,ch_3_12,les_3_12_05,topic_3_12_05_01,quiz_3_12_05_4,,,
course_3,ch_3_12,les_3_12_05,topic_3_12_05_01,quiz_3_12_05_5,,,
course_3,ch_3_12,les_3_12_06,topic_3_12_06_01,quiz_3_12_06_1,,,
course_3,ch_3_12,les_3_12_06,topic_3_12_06_01,quiz_3_12_06_2,,,
course_3,ch_3_12,les_3_12_06,topic_3_12_06_01,quiz_3_12_06_3,,,
course_3,ch_3_12,les_3_12_06,topic_3_12_06_01,quiz_3_12_06_4,,,
course_3,ch_3_12,les_3_12_06,topic_3_12_06_01,quiz_3_12_06_5,,,
course_3,ch_3_12,les_3_12_07,topic_3_12_07_01,quiz_3_12_07_1,,,
course_3,ch_3_12,les_3_12_07,topic_3_12_07_01,quiz_3_12_07_2,,,
course_3,ch_3_12,les_3_12_07,topic_3_12_07_01,quiz_3_12_07_3,,,
course_3,ch_3_12,les_3_12_07,topic_3_12_07_01,quiz_3_12_07_4,,,
course_3,ch_3_12,les_3_12_07,topic_3_12_07_01,quiz_3_12_07_5,,,
course_3,ch_3_12,les_3_12_08,topic_3_12_08_01,quiz_3_12_08_1,,,
course_3,ch_3_12,les_3_12_08,topic_3_12_08_01,quiz_3_12_08_2,,,
course_3,ch_3_12,les_3_12_08,topic_3_12_08_01,quiz_3_12_08_3,,,
course_3,ch_3_12,les_3_12_08,topic_3_12_08_01,quiz_3_12_08_4,,,
course_3,ch_3_12,les_3_12_08,topic_3_12_08_01,quiz_3_12_08_5,,,
course_3,ch_3_12,les_3_12_09,topic_3_12_09_01,quiz_3_12_09_1,,,
course_3,ch_3_12,les_3_12_09,topic_3_12_09_01,quiz_3_12_09_2,,,
course_3,ch_3_12,les_3_12_09,topic_3_12_09_01,quiz_3_12_09_3,,,
course_3,ch_3_12,les_3_12_09,topic_3_12_09_01,quiz_3_12_09_4,,,
course_3,ch_3_12,les_3_12_09,topic_3_12_09_01,quiz_3_12_09_5,,,
course_3,ch_3_12,les_3_12_10,topic_3_12_10_01,quiz_3_12_10_1,,,
course_3,ch_3_12,les_3_12_10,topic_3_12_10_01,quiz_3_12_10_2,,,
course_3,ch_3_12,les_3_12_10,topic_3_12_10_01,quiz_3_12_10_3,,,
course_3,ch_3_12,les_3_12_10,topic_3_12_10_01,quiz_3_12_10_4,,,
course_3,ch_3_12,les_3_12_10,topic_3_12_10_01,quiz_3_12_10_5,,,
course_4,ch_4_01,les_4_01_01,topic_4_01_01_01,quiz_4_01_01_1,,,
course_4,ch_4_01,les_4_01_01,topic_4_01_01_01,quiz_4_01_01_2,,,
course_4,ch_4_01,les_4_01_01,topic_4_01_01_01,quiz_4_01_01_3,,,
course_4,ch_4_01,les_4_01_01,topic_4_01_01_01,quiz_4_01_01_4,,,
course_4,ch_4_01,les_4_01_01,topic_4_01_01_01,quiz_4_01_01_5,,,
course_4,ch_4_01,les_4_01_02,topic_4_01_02_01,quiz_4_01_02_1,,,
course_4,ch_4_01,les_4_01_02,topic_4_01_02_01,quiz_4_01_02_2,,,
course_4,ch_4_01,les_4_01_02,topic_4_01_02_01,quiz_4_01_02_3,,,
course_4,ch_4_01,les_4_01_02,topic_4_01_02_01,quiz_4_01_02_4,,,
course_4,ch_4_01,les_4_01_02,topic_4_01_02_01,quiz_4_01_02_5,,,
course_4,ch_4_01,les_4_01_03,topic_4_01_03_01,quiz_4_01_03_1,,,
course_4,ch_4_01,les_4_01_03,topic_4_01_03_01,quiz_4_01_03_2,,,
course_4,ch_4_01,les_4_01_03,topic_4_01_03_01,quiz_4_01_03_3,,,
course_4,ch_4_01,les_4_01_03,topic_4_01_03_01,quiz_4_01_03_4,,,
course_4,ch_4_01,les_4_01_03,topic_4_01_03_01,quiz_4_01_03_5,,,
course_4,ch_4_01,les_4_01_04,topic_4_01_04_01,quiz_4_01_04_1,,,
course_4,ch_4_01,les_4_01_04,topic_4_01_04_01,quiz_4_01_04_2,,,
course_4,ch_4_01,les_4_01_04,topic_4_01_04_01,quiz_4_01_04_3,,,
course_4,ch_4_01,les_4_01_04,topic_4_01_04_01,quiz_4_01_04_4,,,
course_4,ch_4_01,les_4_01_04,topic_4_01_04_01,quiz_4_01_04_5,,,
course_4,ch_4_01,les_4_01_05,topic_4_01_05_01,quiz_4_01_05_1,,,
course_4,ch_4_01,les_4_01_05,topic_4_01_05_01,quiz_4_01_05_2,,,
course_4,ch_4_01,les_4_01_05,topic_4_01_05_01,quiz_4_01_05_3,,,
course_4,ch_4_01,les_4_01_05,topic_4_01_05_01,quiz_4_01_05_4,,,
course_4,ch_4_01,les_4_01_05,topic_4_01_05_01,quiz_4_01_05_5,,,
course_4,ch_4_01,les_4_01_06,topic_4_01_06_01,quiz_4_01_06_1,,,
course_4,ch_4_01,les_4_01_06,topic_4_01_06_01,quiz_4_01_06_2,,,
course_4,ch_4_01,les_4_01_06,topic_4_01_06_01,quiz_4_01_06_3,,,
course_4,ch_4_01,les_4_01_06,topic_4_01_06_01,quiz_4_01_06_4,,,
course_4,ch_4_01,les_4_01_06,topic_4_01_06_01,quiz_4_01_06_5,,,
course_4,ch_4_01,les_4_01_07,topic_4_01_07_01,quiz_4_01_07_1,,,
course_4,ch_4_01,les_4_01_07,topic_4_01_07_01,quiz_4_01_07_2,,,
course_4,ch_4_01,les_4_01_07,topic_4_01_07_01,quiz_4_01_07_3,,,
course_4,ch_4_01,les_4_01_07,topic_4_01_07_01,quiz_4_01_07_4,,,
course_4,ch_4_01,les_4_01_07,topic_4_01_07_01,quiz_4_01_07_5,,,
course_4,ch_4_01,les_4_01_08,topic_4_01_08_01,quiz_4_01_08_1,,,
course_4,ch_4_01,les_4_01_08,topic_4_01_08_01,quiz_4_01_08_2,,,
course_4,ch_4_01,les_4_01_08,topic_4_01_08_01,quiz_4_01_08_3,,,
course_4,ch_4_01,les_4_01_08,topic_4_01_08_01,quiz_4_01_08_4,,,
course_4,ch_4_01,les_4_01_08,topic_4_01_08_01,quiz_4_01_08_5,,,
course_4,ch_4_01,les_4_01_09,topic_4_01_09_01,quiz_4_01_09_1,,,
course_4,ch_4_01,les_4_01_09,topic_4_01_09_01,quiz_4_01_09_2,,,
course_4,ch_4_01,les_4_01_09,topic_4_01_09_01,quiz_4_01_09_3,,,
course_4,ch_4_01,les_4_01_09,topic_4_01_09_01,quiz_4_01_09_4,,,
course_4,ch_4_01,les_4_01_09,topic_4_01_09_01,quiz_4_01_09_5,,,
course_4,ch_4_01,les_4_01_10,topic_4_01_10_01,quiz_4_01_10_1,,,
course_4,ch_4_01,les_4_01_10,topic_4_01_10_01,quiz_4_01_10_2,,,
course_4,ch_4_01,les_4_01_10,topic_4_01_10_01,quiz_4_01_10_3,,,
course_4,ch_4_01,les_4_01_10,topic_4_01_10_01,quiz_4_01_10_4,,,
course_4,ch_4_01,les_4_01_10,topic_4_01_10_01,quiz_4_01_10_5,,,
course_4,ch_4_02,les_4_02_01,topic_4_02_01_01,quiz_4_02_01_1,,,
course_4,ch_4_02,les_4_02_01,topic_4_02_01_01,quiz_4_02_01_2,,,
course_4,ch_4_02,les_4_02_01,topic_4_02_01_01,quiz_4_02_01_3,,,
course_4,ch_4_02,les_4_02_01,topic_4_02_01_01,quiz_4_02_01_4,,,
course_4,ch_4_02,les_4_02_01,topic_4_02_01_01,quiz_4_02_01_5,,,
course_4,ch_4_02,les_4_02_02,topic_4_02_02_01,quiz_4_02_02_1,,,
course_4,ch_4_02,les_4_02_02,topic_4_02_02_01,quiz_4_02_02_2,,,
course_4,ch_4_02,les_4_02_02,topic_4_02_02_01,quiz_4_02_02_3,,,
course_4,ch_4_02,les_4_02_02,topic_4_02_02_01,quiz_4_02_02_4,,,
course_4,ch_4_02,les_4_02_02,topic_4_02_02_01,quiz_4_02_02_5,,,
course_4,ch_4_02,les_4_02_03,topic_4_02_03_01,quiz_4_02_03_1,,,
course_4,ch_4_02,les_4_02_03,topic_4_02_03_01,quiz_4_02_03_2,,,
course_4,ch_4_02,les_4_02_03,topic_4_02_03_01,quiz_4_02_03_3,,,
course_4,ch_4_02,les_4_02_03,topic_4_02_03_01,quiz_4_02_03_4,,,
course_4,ch_4_02,les_4_02_03,topic_4_02_03_01,quiz_4_02_03_5,,,
course_4,ch_4_02,les_4_02_04,topic_4_02_04_01,quiz_4_02_04_1,,,
course_4,ch_4_02,les_4_02_04,topic_4_02_04_01,quiz_4_02_04_2,,,
course_4,ch_4_02,les_4_02_04,topic_4_02_04_01,quiz_4_02_04_3,,,
course_4,ch_4_02,les_4_02_04,topic_4_02_04_01,quiz_4_02_04_4,,,
course_4,ch_4_02,les_4_02_04,topic_4_02_04_01,quiz_4_02_04_5,,,
course_4,ch_4_02,les_4_02_05,topic_4_02_05_01,quiz_4_02_05_1,,,
course_4,ch_4_02,les_4_02_05,topic_4_02_05_01,quiz_4_02_05_2,,,
course_4,ch_4_02,les_4_02_05,topic_4_02_05_01,quiz_4_02_05_3,,,
course_4,ch_4_02,les_4_02_05,topic_4_02_05_01,quiz_4_02_05_4,,,
course_4,ch_4_02,les_4_02_05,topic_4_02_05_01,quiz_4_02_05_5,,,
course_4,ch_4_02,les_4_02_06,topic_4_02_06_01,quiz_4_02_06_1,,,
course_4,ch_4_02,les_4_02_06,topic_4_02_06_01,quiz_4_02_06_2,,,
course_4,ch_4_02,les_4_02_06,topic_4_02_06_01,quiz_4_02_06_3,,,
course_4,ch_4_02,les_4_02_06,topic_4_02_06_01,quiz_4_02_06_4,,,
course_4,ch_4_02,les_4_02_06,topic_4_02_06_01,quiz_4_02_06_5,,,
course_4,ch_4_02,les_4_02_07,topic_4_02_07_01,quiz_4_02_07_1,,,
course_4,ch_4_02,les_4_02_07,topic_4_02_07_01,quiz_4_02_07_2,,,
course_4,ch_4_02,les_4_02_07,topic_4_02_07_01,quiz_4_02_07_3,,,
course_4,ch_4_02,les_4_02_07,topic_4_02_07_01,quiz_4_02_07_4,,,
course_4,ch_4_02,les_4_02_07,topic_4_02_07_01,quiz_4_02_07_5,,,
course_4,ch_4_02,les_4_02_08,topic_4_02_08_01,quiz_4_02_08_1,,,
course_4,ch_4_02,les_4_02_08,topic_4_02_08_01,quiz_4_02_08_2,,,
course_4,ch_4_02,les_4_02_08,topic_4_02_08_01,quiz_4_02_08_3,,,
course_4,ch_4_02,les_4_02_08,topic_4_02_08_01,quiz_4_02_08_4,,,
course_4,ch_4_02,les_4_02_08,topic_4_02_08_01,quiz_4_02_08_5,,,
course_4,ch_4_02,les_4_02_09,topic_4_02_09_01,quiz_4_02_09_1,,,
course_4,ch_4_02,les_4_02_09,topic_4_02_09_01,quiz_4_02_09_2,,,
course_4,ch_4_02,les_4_02_09,topic_4_02_09_01,quiz_4_02_09_3,,,
course_4,ch_4_02,les_4_02_09,topic_4_02_09_01,quiz_4_02_09_4,,,
course_4,ch_4_02,les_4_02_09,topic_4_02_09_01,quiz_4_02_09_5,,,
course_4,ch_4_02,les_4_02_10,topic_4_02_10_01,quiz_4_02_10_1,,,
course_4,ch_4_02,les_4_02_10,topic_4_02_10_01,quiz_4_02_10_2,,,
course_4,ch_4_02,les_4_02_10,topic_4_02_10_01,quiz_4_02_10_3,,,
course_4,ch_4_02,les_4_02_10,topic_4_02_10_01,quiz_4_02_10_4,,,
course_4,ch_4_02,les_4_02_10,topic_4_02_10_01,quiz_4_02_10_5,,,
course_4,ch_4_03,les_4_03_01,topic_4_03_01_01,quiz_4_03_01_1,,,
course_4,ch_4_03,les_4_03_01,topic_4_03_01_01,quiz_4_03_01_2,,,
course_4,ch_4_03,les_4_03_01,topic_4_03_01_01,quiz_4_03_01_3,,,
course_4,ch_4_03,les_4_03_01,topic_4_03_01_01,quiz_4_03_01_4,,,
course_4,ch_4_03,les_4_03_01,topic_4_03_01_01,quiz_4_03_01_5,,,
course_4,ch_4_03,les_4_03_02,topic_4_03_02_01,quiz_4_03_02_1,,,
course_4,ch_4_03,les_4_03_02,topic_4_03_02_01,quiz_4_03_02_2,,,
course_4,ch_4_03,les_4_03_02,topic_4_03_02_01,quiz_4_03_02_3,,,
course_4,ch_4_03,les_4_03_02,topic_4_03_02_01,quiz_4_03_02_4,,,
course_4,ch_4_03,les_4_03_02,topic_4_03_02_01,quiz_4_03_02_5,,,
course_4,ch_4_03,les_4_03_03,topic_4_03_03_01,quiz_4_03_03_1,,,
course_4,ch_4_03,les_4_03_03,topic_4_03_03_01,quiz_4_03_03_2,,,
course_4,ch_4_03,les_4_03_03,topic_4_03_03_01,quiz_4_03_03_3,,,
course_4,ch_4_03,les_4_03_03,topic_4_03_03_01,quiz_4_03_03_4,,,
course_4,ch_4_03,les_4_03_03,topic_4_03_03_01,quiz_4_03_03_5,,,
course_4,ch_4_03,les_4_03_04,topic_4_03_04_01,quiz_4_03_04_1,,,
course_4,ch_4_03,les_4_03_04,topic_4_03_04_01,quiz_4_03_04_2,,,
course_4,ch_4_03,les_4_03_04,topic_4_03_04_01,quiz_4_03_04_3,,,
course_4,ch_4_03,les_4_03_04,topic_4_03_04_01,quiz_4_03_04_4,,,
course_4,ch_4_03,les_4_03_04,topic_4_03_04_01,quiz_4_03_04_5,,,
course_4,ch_4_03,les_4_03_05,topic_4_03_05_01,quiz_4_03_05_1,,,
course_4,ch_4_03,les_4_03_05,topic_4_03_05_01,quiz_4_03_05_2,,,
course_4,ch_4_03,les_4_03_05,topic_4_03_05_01,quiz_4_03_05_3,,,
course_4,ch_4_03,les_4_03_05,topic_4_03_05_01,quiz_4_03_05_4,,,
course_4,ch_4_03,les_4_03_05,topic_4_03_05_01,quiz_4_03_05_5,,,
course_4,ch_4_03,les_4_03_06,topic_4_03_06_01,quiz_4_03_06_1,,,
course_4,ch_4_03,les_4_03_06,topic_4_03_06_01,quiz_4_03_06_2,,,
course_4,ch_4_03,les_4_03_06,topic_4_03_06_01,quiz_4_03_06_3,,,
course_4,ch_4_03,les_4_03_06,topic_4_03_06_01,quiz_4_03_06_4,,,
course_4,ch_4_03,les_4_03_06,topic_4_03_06_01,quiz_4_03_06_5,,,
course_4,ch_4_03,les_4_03_07,topic_4_03_07_01,quiz_4_03_07_1,,,
course_4,ch_4_03,les_4_03_07,topic_4_03_07_01,quiz_4_03_07_2,,,
course_4,ch_4_03,les_4_03_07,topic_4_03_07_01,quiz_4_03_07_3,,,
course_4,ch_4_03,les_4_03_07,topic_4_03_07_01,quiz_4_03_07_4,,,
course_4,ch_4_03,les_4_03_07,topic_4_03_07_01,quiz_4_03_07_5,,,
course_4,ch_4_03,les_4_03_08,topic_4_03_08_01,quiz_4_03_08_1,,,
course_4,ch_4_03,les_4_03_08,topic_4_03_08_01,quiz_4_03_08_2,,,
course_4,ch_4_03,les_4_03_08,topic_4_03_08_01,quiz_4_03_08_3,,,
course_4,ch_4_03,les_4_03_08,topic_4_03_08_01,quiz_4_03_08_4,,,
course_4,ch_4_03,les_4_03_08,topic_4_03_08_01,quiz_4_03_08_5,,,
course_4,ch_4_03,les_4_03_09,topic_4_03_09_01,quiz_4_03_09_1,,,
course_4,ch_4_03,les_4_03_09,topic_4_03_09_01,quiz_4_03_09_2,,,
course_4,ch_4_03,les_4_03_09,topic_4_03_09_01,quiz_4_03_09_3,,,
course_4,ch_4_03,les_4_03_09,topic_4_03_09_01,quiz_4_03_09_4,,,
course_4,ch_4_03,les_4_03_09,topic_4_03_09_01,quiz_4_03_09_5,,,
course_4,ch_4_03,les_4_03_10,topic_4_03_10_01,quiz_4_03_10_1,,,
course_4,ch_4_03,les_4_03_10,topic_4_03_10_01,quiz_4_03_10_2,,,
course_4,ch_4_03,les_4_03_10,topic_4_03_10_01,quiz_4_03_10_3,,,
course_4,ch_4_03,les_4_03_10,topic_4_03_10_01,quiz_4_03_10_4,,,
course_4,ch_4_03,les_4_03_10,topic_4_03_10_01,quiz_4_03_10_5,,,
course_4,ch_4_04,les_4_04_01,topic_4_04_01_01,quiz_4_04_01_1,,,
course_4,ch_4_04,les_4_04_01,topic_4_04_01_01,quiz_4_04_01_2,,,
course_4,ch_4_04,les_4_04_01,topic_4_04_01_01,quiz_4_04_01_3,,,
course_4,ch_4_04,les_4_04_01,topic_4_04_01_01,quiz_4_04_01_4,,,
course_4,ch_4_04,les_4_04_01,topic_4_04_01_01,quiz_4_04_01_5,,,
course_4,ch_4_04,les_4_04_02,topic_4_04_02_01,quiz_4_04_02_1,,,
course_4,ch_4_04,les_4_04_02,topic_4_04_02_01,quiz_4_04_02_2,,,
course_4,ch_4_04,les_4_04_02,topic_4_04_02_01,quiz_4_04_02_3,,,
course_4,ch_4_04,les_4_04_02,topic_4_04_02_01,quiz_4_04_02_4,,,
course_4,ch_4_04,les_4_04_02,topic_4_04_02_01,quiz_4_04_02_5,,,
course_4,ch_4_04,les_4_04_03,topic_4_04_03_01,quiz_4_04_03_1,,,
course_4,ch_4_04,les_4_04_03,topic_4_04_03_01,quiz_4_04_03_2,,,
course_4,ch_4_04,les_4_04_03,topic_4_04_03_01,quiz_4_04_03_3,,,
course_4,ch_4_04,les_4_04_03,topic_4_04_03_01,quiz_4_04_03_4,,,
course_4,ch_4_04,les_4_04_03,topic_4_04_03_01,quiz_4_04_03_5,,,
course_4,ch_4_04,les_4_04_04,topic_4_04_04_01,quiz_4_04_04_1,,,
course_4,ch_4_04,les_4_04_04,topic_4_04_04_01,quiz_4_04_04_2,,,
course_4,ch_4_04,les_4_04_04,topic_4_04_04_01,quiz_4_04_04_3,,,
course_4,ch_4_04,les_4_04_04,topic_4_04_04_01,quiz_4_04_04_4,,,
course_4,ch_4_04,les_4_04_04,topic_4_04_04_01,quiz_4_04_04_5,,,
course_4,ch_4_04,les_4_04_05,topic_4_04_05_01,quiz_4_04_05_1,,,
course_4,ch_4_04,les_4_04_05,topic_4_04_05_01,quiz_4_04_05_2,,,
course_4,ch_4_04,les_4_04_05,topic_4_04_05_01,quiz_4_04_05_3,,,
course_4,ch_4_04,les_4_04_05,topic_4_04_05_01,quiz_4_04_05_4,,,
course_4,ch_4_04,les_4_04_05,topic_4_04_05_01,quiz_4_04_05_5,,,
course_4,ch_4_04,les_4_04_06,topic_4_04_06_01,quiz_4_04_06_1,,,
course_4,ch_4_04,les_4_04_06,topic_4_04_06_01,quiz_4_04_06_2,,,
course_4,ch_4_04,les_4_04_06,topic_4_04_06_01,quiz_4_04_06_3,,,
course_4,ch_4_04,les_4_04_06,topic_4_04_06_01,quiz_4_04_06_4,,,
course_4,ch_4_04,les_4_04_06,topic_4_04_06_01,quiz_4_04_06_5,,,
course_4,ch_4_04,les_4_04_07,topic_4_04_07_01,quiz_4_04_07_1,,,
course_4,ch_4_04,les_4_04_07,topic_4_04_07_01,quiz_4_04_07_2,,,
course_4,ch_4_04,les_4_04_07,topic_4_04_07_01,quiz_4_04_07_3,,,
course_4,ch_4_04,les_4_04_07,topic_4_04_07_01,quiz_4_04_07_4,,,
course_4,ch_4_04,les_4_04_07,topic_4_04_07_01,quiz_4_04_07_5,,,
course_4,ch_4_04,les_4_04_08,topic_4_04_08_01,quiz_4_04_08_1,,,
course_4,ch_4_04,les_4_04_08,topic_4_04_08_01,quiz_4_04_08_2,,,
course_4,ch_4_04,les_4_04_08,topic_4_04_08_01,quiz_4_04_08_3,,,
course_4,ch_4_04,les_4_04_08,topic_4_04_08_01,quiz_4_04_08_4,,,
course_4,ch_4_04,les_4_04_08,topic_4_04_08_01,quiz_4_04_08_5,,,
course_4,ch_4_04,les_4_04_09,topic_4_04_09_01,quiz_4_04_09_1,,,
course_4,ch_4_04,les_4_04_09,topic_4_04_09_01,quiz_4_04_09_2,,,
course_4,ch_4_04,les_4_04_09,topic_4_04_09_01,quiz_4_04_09_3,,,
course_4,ch_4_04,les_4_04_09,topic_4_04_09_01,quiz_4_04_09_4,,,
course_4,ch_4_04,les_4_04_09,topic_4_04_09_01,quiz_4_04_09_5,,,
course_4,ch_4_04,les_4_04_10,topic_4_04_10_01,quiz_4_04_10_1,,,
course_4,ch_4_04,les_4_04_10,topic_4_04_10_01,quiz_4_04_10_2,,,
course_4,ch_4_04,les_4_04_10,topic_4_04_10_01,quiz_4_04_10_3,,,
course_4,ch_4_04,les_4_04_10,topic_4_04_10_01,quiz_4_04_10_4,,,
course_4,ch_4_04,les_4_04_10,topic_4_04_10_01,quiz_4_04_10_5,,,
course_4,ch_4_05,les_4_05_01,topic_4_05_01_01,quiz_4_05_01_1,,,
course_4,ch_4_05,les_4_05_01,topic_4_05_01_01,quiz_4_05_01_2,,,
course_4,ch_4_05,les_4_05_01,topic_4_05_01_01,quiz_4_05_01_3,,,
course_4,ch_4_05,les_4_05_01,topic_4_05_01_01,quiz_4_05_01_4,,,
course_4,ch_4_05,les_4_05_01,topic_4_05_01_01,quiz_4_05_01_5,,,
course_4,ch_4_05,les_4_05_02,topic_4_05_02_01,quiz_4_05_02_1,,,
course_4,ch_4_05,les_4_05_02,topic_4_05_02_01,quiz_4_05_02_2,,,
course_4,ch_4_05,les_4_05_02,topic_4_05_02_01,quiz_4_05_02_3,,,
course_4,ch_4_05,les_4_05_02,topic_4_05_02_01,quiz_4_05_02_4,,,
course_4,ch_4_05,les_4_05_02,topic_4_05_02_01,quiz_4_05_02_5,,,
course_4,ch_4_05,les_4_05_03,topic_4_05_03_01,quiz_4_05_03_1,,,
course_4,ch_4_05,les_4_05_03,topic_4_05_03_01,quiz_4_05_03_2,,,
course_4,ch_4_05,les_4_05_03,topic_4_05_03_01,quiz_4_05_03_3,,,
course_4,ch_4_05,les_4_05_03,topic_4_05_03_01,quiz_4_05_03_4,,,
course_4,ch_4_05,les_4_05_03,topic_4_05_03_01,quiz_4_05_03_5,,,
course_4,ch_4_05,les_4_05_04,topic_4_05_04_01,quiz_4_05_04_1,,,
course_4,ch_4_05,les_4_05_04,topic_4_05_04_01,quiz_4_05_04_2,,,
course_4,ch_4_05,les_4_05_04,topic_4_05_04_01,quiz_4_05_04_3,,,
course_4,ch_4_05,les_4_05_04,topic_4_05_04_01,quiz_4_05_04_4,,,
course_4,ch_4_05,les_4_05_04,topic_4_05_04_01,quiz_4_05_04_5,,,
course_4,ch_4_05,les_4_05_05,topic_4_05_05_01,quiz_4_05_05_1,,,
course_4,ch_4_05,les_4_05_05,topic_4_05_05_01,quiz_4_05_05_2,,,
course_4,ch_4_05,les_4_05_05,topic_4_05_05_01,quiz_4_05_05_3,,,
course_4,ch_4_05,les_4_05_05,topic_4_05_05_01,quiz_4_05_05_4,,,
course_4,ch_4_05,les_4_05_05,topic_4_05_05_01,quiz_4_05_05_5,,,
course_4,ch_4_05,les_4_05_06,topic_4_05_06_01,quiz_4_05_06_1,,,
course_4,ch_4_05,les_4_05_06,topic_4_05_06_01,quiz_4_05_06_2,,,
course_4,ch_4_05,les_4_05_06,topic_4_05_06_01,quiz_4_05_06_3,,,
course_4,ch_4_05,les_4_05_06,topic_4_05_06_01,quiz_4_05_06_4,,,
course_4,ch_4_05,les_4_05_06,topic_4_05_06_01,quiz_4_05_06_5,,,
course_4,ch_4_05,les_4_05_07,topic_4_05_07_01,quiz_4_05_07_1,,,
course_4,ch_4_05,les_4_05_07,topic_4_05_07_01,quiz_4_05_07_2,,,
course_4,ch_4_05,les_4_05_07,topic_4_05_07_01,quiz_4_05_07_3,,,
course_4,ch_4_05,les_4_05_07,topic_4_05_07_01,quiz_4_05_07_4,,,
course_4,ch_4_05,les_4_05_07,topic_4_05_07_01,quiz_4_05_07_5,,,
course_4,ch_4_05,les_4_05_08,topic_4_05_08_01,quiz_4_05_08_1,,,
course_4,ch_4_05,les_4_05_08,topic_4_05_08_01,quiz_4_05_08_2,,,
course_4,ch_4_05,les_4_05_08,topic_4_05_08_01,quiz_4_05_08_3,,,
course_4,ch_4_05,les_4_05_08,topic_4_05_08_01,quiz_4_05_08_4,,,
course_4,ch_4_05,les_4_05_08,topic_4_05_08_01,quiz_4_05_08_5,,,
course_4,ch_4_05,les_4_05_09,topic_4_05_09_01,quiz_4_05_09_1,,,
course_4,ch_4_05,les_4_05_09,topic_4_05_09_01,quiz_4_05_09_2,,,
course_4,ch_4_05,les_4_05_09,topic_4_05_09_01,quiz_4_05_09_3,,,
course_4,ch_4_05,les_4_05_09,topic_4_05_09_01,quiz_4_05_09_4,,,
course_4,ch_4_05,les_4_05_09,topic_4_05_09_01,quiz_4_05_09_5,,,
course_4,ch_4_05,les_4_05_10,topic_4_05_10_01,quiz_4_05_10_1,,,
course_4,ch_4_05,les_4_05_10,topic_4_05_10_01,quiz_4_05_10_2,,,
course_4,ch_4_05,les_4_05_10,topic_4_05_10_01,quiz_4_05_10_3,,,
course_4,ch_4_05,les_4_05_10,topic_4_05_10_01,quiz_4_05_10_4,,,
course_4,ch_4_05,les_4_05_10,topic_4_05_10_01,quiz_4_05_10_5,,,
course_4,ch_4_06,les_4_06_01,topic_4_06_01_01,quiz_4_06_01_1,,,
course_4,ch_4_06,les_4_06_01,topic_4_06_01_01,quiz_4_06_01_2,,,
course_4,ch_4_06,les_4_06_01,topic_4_06_01_01,quiz_4_06_01_3,,,
course_4,ch_4_06,les_4_06_01,topic_4_06_01_01,quiz_4_06_01_4,,,
course_4,ch_4_06,les_4_06_01,topic_4_06_01_01,quiz_4_06_01_5,,,
course_4,ch_4_06,les_4_06_02,topic_4_06_02_01,quiz_4_06_02_1,,,
course_4,ch_4_06,les_4_06_02,topic_4_06_02_01,quiz_4_06_02_2,,,
course_4,ch_4_06,les_4_06_02,topic_4_06_02_01,quiz_4_06_02_3,,,
course_4,ch_4_06,les_4_06_02,topic_4_06_02_01,quiz_4_06_02_4,,,
course_4,ch_4_06,les_4_06_02,topic_4_06_02_01,quiz_4_06_02_5,,,
course_4,ch_4_06,les_4_06_03,topic_4_06_03_01,quiz_4_06_03_1,,,
course_4,ch_4_06,les_4_06_03,topic_4_06_03_01,quiz_4_06_03_2,,,
course_4,ch_4_06,les_4_06_03,topic_4_06_03_01,quiz_4_06_03_3,,,
course_4,ch_4_06,les_4_06_03,topic_4_06_03_01,quiz_4_06_03_4,,,
course_4,ch_4_06,les_4_06_03,topic_4_06_03_01,quiz_4_06_03_5,,,
course_4,ch_4_06,les_4_06_04,topic_4_06_04_01,quiz_4_06_04_1,,,
course_4,ch_4_06,les_4_06_04,topic_4_06_04_01,quiz_4_06_04_2,,,
course_4,ch_4_06,les_4_06_04,topic_4_06_04_01,quiz_4_06_04_3,,,
course_4,ch_4_06,les_4_06_04,topic_4_06_04_01,quiz_4_06_04_4,,,
course_4,ch_4_06,les_4_06_04,topic_4_06_04_01,quiz_4_06_04_5,,,
course_4,ch_4_06,les_4_06_05,topic_4_06_05_01,quiz_4_06_05_1,,,
course_4,ch_4_06,les_4_06_05,topic_4_06_05_01,quiz_4_06_05_2,,,
course_4,ch_4_06,les_4_06_05,topic_4_06_05_01,quiz_4_06_05_3,,,
course_4,ch_4_06,les_4_06_05,topic_4_06_05_01,quiz_4_06_05_4,,,
course_4,ch_4_06,les_4_06_05,topic_4_06_05_01,quiz_4_06_05_5,,,
course_4,ch_4_06,les_4_06_06,topic_4_06_06_01,quiz_4_06_06_1,,,
course_4,ch_4_06,les_4_06_06,topic_4_06_06_01,quiz_4_06_06_2,,,
course_4,ch_4_06,les_4_06_06,topic_4_06_06_01,quiz_4_06_06_3,,,
course_4,ch_4_06,les_4_06_06,topic_4_06_06_01,quiz_4_06_06_4,,,
course_4,ch_4_06,les_4_06_06,topic_4_06_06_01,quiz_4_06_06_5,,,
course_4,ch_4_06,les_4_06_07,topic_4_06_07_01,quiz_4_06_07_1,,,
course_4,ch_4_06,les_4_06_07,topic_4_06_07_01,quiz_4_06_07_2,,,
course_4,ch_4_06,les_4_06_07,topic_4_06_07_01,quiz_4_06_07_3,,,
course_4,ch_4_06,les_4_06_07,topic_4_06_07_01,quiz_4_06_07_4,,,
course_4,ch_4_06,les_4_06_07,topic_4_06_07_01,quiz_4_06_07_5,,,
course_4,ch_4_06,les_4_06_08,topic_4_06_08_01,quiz_4_06_08_1,,,
course_4,ch_4_06,les_4_06_08,topic_4_06_08_01,quiz_4_06_08_2,,,
course_4,ch_4_06,les_4_06_08,topic_4_06_08_01,quiz_4_06_08_3,,,
course_4,ch_4_06,les_4_06_08,topic_4_06_08_01,quiz_4_06_08_4,,,
course_4,ch_4_06,les_4_06_08,topic_4_06_08_01,quiz_4_06_08_5,,,
course_4,ch_4_06,les_4_06_09,topic_4_06_09_01,quiz_4_06_09_1,,,
course_4,ch_4_06,les_4_06_09,topic_4_06_09_01,quiz_4_06_09_2,,,
course_4,ch_4_06,les_4_06_09,topic_4_06_09_01,quiz_4_06_09_3,,,
course_4,ch_4_06,les_4_06_09,topic_4_06_09_01,quiz_4_06_09_4,,,
course_4,ch_4_06,les_4_06_09,topic_4_06_09_01,quiz_4_06_09_5,,,
course_4,ch_4_06,les_4_06_10,topic_4_06_10_01,quiz_4_06_10_1,,,
course_4,ch_4_06,les_4_06_10,topic_4_06_10_01,quiz_4_06_10_2,,,
course_4,ch_4_06,les_4_06_10,topic_4_06_10_01,quiz_4_06_10_3,,,
course_4,ch_4_06,les_4_06_10,topic_4_06_10_01,quiz_4_06_10_4,,,
course_4,ch_4_06,les_4_06_10,topic_4_06_10_01,quiz_4_06_10_5,,,
course_4,ch_4_07,les_4_07_01,topic_4_07_01_01,quiz_4_07_01_1,,,
course_4,ch_4_07,les_4_07_01,topic_4_07_01_01,quiz_4_07_01_2,,,
course_4,ch_4_07,les_4_07_01,topic_4_07_01_01,quiz_4_07_01_3,,,
course_4,ch_4_07,les_4_07_01,topic_4_07_01_01,quiz_4_07_01_4,,,
course_4,ch_4_07,les_4_07_01,topic_4_07_01_01,quiz_4_07_01_5,,,
course_4,ch_4_07,les_4_07_02,topic_4_07_02_01,quiz_4_07_02_1,,,
course_4,ch_4_07,les_4_07_02,topic_4_07_02_01,quiz_4_07_02_2,,,
course_4,ch_4_07,les_4_07_02,topic_4_07_02_01,quiz_4_07_02_3,,,
course_4,ch_4_07,les_4_07_02,topic_4_07_02_01,quiz_4_07_02_4,,,
course_4,ch_4_07,les_4_07_02,topic_4_07_02_01,quiz_4_07_02_5,,,
course_4,ch_4_07,les_4_07_03,topic_4_07_03_01,quiz_4_07_03_1,,,
course_4,ch_4_07,les_4_07_03,topic_4_07_03_01,quiz_4_07_03_2,,,
course_4,ch_4_07,les_4_07_03,topic_4_07_03_01,quiz_4_07_03_3,,,
course_4,ch_4_07,les_4_07_03,topic_4_07_03_01,quiz_4_07_03_4,,,
course_4,ch_4_07,les_4_07_03,topic_4_07_03_01,quiz_4_07_03_5,,,
course_4,ch_4_07,les_4_07_04,topic_4_07_04_01,quiz_4_07_04_1,,,
course_4,ch_4_07,les_4_07_04,topic_4_07_04_01,quiz_4_07_04_2,,,
course_4,ch_4_07,les_4_07_04,topic_4_07_04_01,quiz_4_07_04_3,,,
course_4,ch_4_07,les_4_07_04,topic_4_07_04_01,quiz_4_07_04_4,,,
course_4,ch_4_07,les_4_07_04,topic_4_07_04_01,quiz_4_07_04_5,,,
course_4,ch_4_07,les_4_07_05,topic_4_07_05_01,quiz_4_07_05_1,,,
course_4,ch_4_07,les_4_07_05,topic_4_07_05_01,quiz_4_07_05_2,,,
course_4,ch_4_07,les_4_07_05,topic_4_07_05_01,quiz_4_07_05_3,,,
course_4,ch_4_07,les_4_07_05,topic_4_07_05_01,quiz_4_07_05_4,,,
course_4,ch_4_07,les_4_07_05,topic_4_07_05_01,quiz_4_07_05_5,,,
course_4,ch_4_07,les_4_07_06,topic_4_07_06_01,quiz_4_07_06_1,,,
course_4,ch_4_07,les_4_07_06,topic_4_07_06_01,quiz_4_07_06_2,,,
course_4,ch_4_07,les_4_07_06,topic_4_07_06_01,quiz_4_07_06_3,,,
course_4,ch_4_07,les_4_07_06,topic_4_07_06_01,quiz_4_07_06_4,,,
course_4,ch_4_07,les_4_07_06,topic_4_07_06_01,quiz_4_07_06_5,,,
course_4,ch_4_07,les_4_07_07,topic_4_07_07_01,quiz_4_07_07_1,,,
course_4,ch_4_07,les_4_07_07,topic_4_07_07_01,quiz_4_07_07_2,,,
course_4,ch_4_07,les_4_07_07,topic_4_07_07_01,quiz_4_07_07_3,,,
course_4,ch_4_07,les_4_07_07,topic_4_07_07_01,quiz_4_07_07_4,,,
course_4,ch_4_07,les_4_07_07,topic_4_07_07_01,quiz_4_07_07_5,,,
course_4,ch_4_07,les_4_07_08,topic_4_07_08_01,quiz_4_07_08_1,,,
course_4,ch_4_07,les_4_07_08,topic_4_07_08_01,quiz_4_07_08_2,,,
course_4,ch_4_07,les_4_07_08,topic_4_07_08_01,quiz_4_07_08_3,,,
course_4,ch_4_07,les_4_07_08,topic_4_07_08_01,quiz_4_07_08_4,,,
course_4,ch_4_07,les_4_07_08,topic_4_07_08_01,quiz_4_07_08_5,,,
course_4,ch_4_07,les_4_07_09,topic_4_07_09_01,quiz_4_07_09_1,,,
course_4,ch_4_07,les_4_07_09,topic_4_07_09_01,quiz_4_07_09_2,,,
course_4,ch_4_07,les_4_07_09,topic_4_07_09_01,quiz_4_07_09_3,,,
course_4,ch_4_07,les_4_07_09,topic_4_07_09_01,quiz_4_07_09_4,,,
course_4,ch_4_07,les_4_07_09,topic_4_07_09_01,quiz_4_07_09_5,,,
course_4,ch_4_07,les_4_07_10,topic_4_07_10_01,quiz_4_07_10_1,,,
course_4,ch_4_07,les_4_07_10,topic_4_07_10_01,quiz_4_07_10_2,,,
course_4,ch_4_07,les_4_07_10,topic_4_07_10_01,quiz_4_07_10_3,,,
course_4,ch_4_07,les_4_07_10,topic_4_07_10_01,quiz_4_07_10_4,,,
course_4,ch_4_07,les_4_07_10,topic_4_07_10_01,quiz_4_07_10_5,,,
course_4,ch_4_08,les_4_08_01,topic_4_08_01_01,quiz_4_08_01_1,,,
course_4,ch_4_08,les_4_08_01,topic_4_08_01_01,quiz_4_08_01_2,,,
course_4,ch_4_08,les_4_08_01,topic_4_08_01_01,quiz_4_08_01_3,,,
course_4,ch_4_08,les_4_08_01,topic_4_08_01_01,quiz_4_08_01_4,,,
course_4,ch_4_08,les_4_08_01,topic_4_08_01_01,quiz_4_08_01_5,,,
course_4,ch_4_08,les_4_08_02,topic_4_08_02_01,quiz_4_08_02_1,,,
course_4,ch_4_08,les_4_08_02,topic_4_08_02_01,quiz_4_08_02_2,,,
course_4,ch_4_08,les_4_08_02,topic_4_08_02_01,quiz_4_08_02_3,,,
course_4,ch_4_08,les_4_08_02,topic_4_08_02_01,quiz_4_08_02_4,,,
course_4,ch_4_08,les_4_08_02,topic_4_08_02_01,quiz_4_08_02_5,,,
course_4,ch_4_08,les_4_08_03,topic_4_08_03_01,quiz_4_08_03_1,,,
course_4,ch_4_08,les_4_08_03,topic_4_08_03_01,quiz_4_08_03_2,,,
course_4,ch_4_08,les_4_08_03,topic_4_08_03_01,quiz_4_08_03_3,,,
course_4,ch_4_08,les_4_08_03,topic_4_08_03_01,quiz_4_08_03_4,,,
course_4,ch_4_08,les_4_08_03,topic_4_08_03_01,quiz_4_08_03_5,,,
course_4,ch_4_08,les_4_08_04,topic_4_08_04_01,quiz_4_08_04_1,,,
course_4,ch_4_08,les_4_08_04,topic_4_08_04_01,quiz_4_08_04_2,,,
course_4,ch_4_08,les_4_08_04,topic_4_08_04_01,quiz_4_08_04_3,,,
course_4,ch_4_08,les_4_08_04,topic_4_08_04_01,quiz_4_08_04_4,,,
course_4,ch_4_08,les_4_08_04,topic_4_08_04_01,quiz_4_08_04_5,,,
course_4,ch_4_08,les_4_08_05,topic_4_08_05_01,quiz_4_08_05_1,,,
course_4,ch_4_08,les_4_08_05,topic_4_08_05_01,quiz_4_08_05_2,,,
course_4,ch_4_08,les_4_08_05,topic_4_08_05_01,quiz_4_08_05_3,,,
course_4,ch_4_08,les_4_08_05,topic_4_08_05_01,quiz_4_08_05_4,,,
course_4,ch_4_08,les_4_08_05,topic_4_08_05_01,quiz_4_08_05_5,,,
course_4,ch_4_08,les_4_08_06,topic_4_08_06_01,quiz_4_08_06_1,,,
course_4,ch_4_08,les_4_08_06,topic_4_08_06_01,quiz_4_08_06_2,,,
course_4,ch_4_08,les_4_08_06,topic_4_08_06_01,quiz_4_08_06_3,,,
course_4,ch_4_08,les_4_08_06,topic_4_08_06_01,quiz_4_08_06_4,,,
course_4,ch_4_08,les_4_08_06,topic_4_08_06_01,quiz_4_08_06_5,,,
course_4,ch_4_08,les_4_08_07,topic_4_08_07_01,quiz_4_08_07_1,,,
course_4,ch_4_08,les_4_08_07,topic_4_08_07_01,quiz_4_08_07_2,,,
course_4,ch_4_08,les_4_08_07,topic_4_08_07_01,quiz_4_08_07_3,,,
course_4,ch_4_08,les_4_08_07,topic_4_08_07_01,quiz_4_08_07_4,,,
course_4,ch_4_08,les_4_08_07,topic_4_08_07_01,quiz_4_08_07_5,,,
course_4,ch_4_08,les_4_08_08,topic_4_08_08_01,quiz_4_08_08_1,,,
course_4,ch_4_08,les_4_08_08,topic_4_08_08_01,quiz_4_08_08_2,,,
course_4,ch_4_08,les_4_08_08,topic_4_08_08_01,quiz_4_08_08_3,,,
course_4,ch_4_08,les_4_08_08,topic_4_08_08_01,quiz_4_08_08_4,,,
course_4,ch_4_08,les_4_08_08,topic_4_08_08_01,quiz_4_08_08_5,,,
course_4,ch_4_08,les_4_08_09,topic_4_08_09_01,quiz_4_08_09_1,,,
course_4,ch_4_08,les_4_08_09,topic_4_08_09_01,quiz_4_08_09_2,,,
course_4,ch_4_08,les_4_08_09,topic_4_08_09_01,quiz_4_08_09_3,,,
course_4,ch_4_08,les_4_08_09,topic_4_08_09_01,quiz_4_08_09_4,,,
course_4,ch_4_08,les_4_08_09,topic_4_08_09_01,quiz_4_08_09_5,,,
course_4,ch_4_08,les_4_08_10,topic_4_08_10_01,quiz_4_08_10_1,,,
course_4,ch_4_08,les_4_08_10,topic_4_08_10_01,quiz_4_08_10_2,,,
course_4,ch_4_08,les_4_08_10,topic_4_08_10_01,quiz_4_08_10_3,,,
course_4,ch_4_08,les_4_08_10,topic_4_08_10_01,quiz_4_08_10_4,,,
course_4,ch_4_08,les_4_08_10,topic_4_08_10_01,quiz_4_08_10_5,,,
course_4,ch_4_09,les_4_09_01,topic_4_09_01_01,quiz_4_09_01_1,,,
course_4,ch_4_09,les_4_09_01,topic_4_09_01_01,quiz_4_09_01_2,,,
course_4,ch_4_09,les_4_09_01,topic_4_09_01_01,quiz_4_09_01_3,,,
course_4,ch_4_09,les_4_09_01,topic_4_09_01_01,quiz_4_09_01_4,,,
course_4,ch_4_09,les_4_09_01,topic_4_09_01_01,quiz_4_09_01_5,,,
course_4,ch_4_09,les_4_09_02,topic_4_09_02_01,quiz_4_09_02_1,,,
course_4,ch_4_09,les_4_09_02,topic_4_09_02_01,quiz_4_09_02_2,,,
course_4,ch_4_09,les_4_09_02,topic_4_09_02_01,quiz_4_09_02_3,,,
course_4,ch_4_09,les_4_09_02,topic_4_09_02_01,quiz_4_09_02_4,,,
course_4,ch_4_09,les_4_09_02,topic_4_09_02_01,quiz_4_09_02_5,,,
course_4,ch_4_09,les_4_09_03,topic_4_09_03_01,quiz_4_09_03_1,,,
course_4,ch_4_09,les_4_09_03,topic_4_09_03_01,quiz_4_09_03_2,,,
course_4,ch_4_09,les_4_09_03,topic_4_09_03_01,quiz_4_09_03_3,,,
course_4,ch_4_09,les_4_09_03,topic_4_09_03_01,quiz_4_09_03_4,,,
course_4,ch_4_09,les_4_09_03,topic_4_09_03_01,quiz_4_09_03_5,,,
course_4,ch_4_09,les_4_09_04,topic_4_09_04_01,quiz_4_09_04_1,,,
course_4,ch_4_09,les_4_09_04,topic_4_09_04_01,quiz_4_09_04_2,,,
course_4,ch_4_09,les_4_09_04,topic_4_09_04_01,quiz_4_09_04_3,,,
course_4,ch_4_09,les_4_09_04,topic_4_09_04_01,quiz_4_09_04_4,,,
course_4,ch_4_09,les_4_09_04,topic_4_09_04_01,quiz_4_09_04_5,,,
course_4,ch_4_09,les_4_09_05,topic_4_09_05_01,quiz_4_09_05_1,,,
course_4,ch_4_09,les_4_09_05,topic_4_09_05_01,quiz_4_09_05_2,,,
course_4,ch_4_09,les_4_09_05,topic_4_09_05_01,quiz_4_09_05_3,,,
course_4,ch_4_09,les_4_09_05,topic_4_09_05_01,quiz_4_09_05_4,,,
course_4,ch_4_09,les_4_09_05,topic_4_09_05_01,quiz_4_09_05_5,,,
course_4,ch_4_09,les_4_09_06,topic_4_09_06_01,quiz_4_09_06_1,,,
course_4,ch_4_09,les_4_09_06,topic_4_09_06_01,quiz_4_09_06_2,,,
course_4,ch_4_09,les_4_09_06,topic_4_09_06_01,quiz_4_09_06_3,,,
course_4,ch_4_09,les_4_09_06,topic_4_09_06_01,quiz_4_09_06_4,,,
course_4,ch_4_09,les_4_09_06,topic_4_09_06_01,quiz_4_09_06_5,,,
course_4,ch_4_09,les_4_09_07,topic_4_09_07_01,quiz_4_09_07_1,,,
course_4,ch_4_09,les_4_09_07,topic_4_09_07_01,quiz_4_09_07_2,,,
course_4,ch_4_09,les_4_09_07,topic_4_09_07_01,quiz_4_09_07_3,,,
course_4,ch_4_09,les_4_09_07,topic_4_09_07_01,quiz_4_09_07_4,,,
course_4,ch_4_09,les_4_09_07,topic_4_09_07_01,quiz_4_09_07_5,,,
course_4,ch_4_09,les_4_09_08,topic_4_09_08_01,quiz_4_09_08_1,,,
course_4,ch_4_09,les_4_09_08,topic_4_09_08_01,quiz_4_09_08_2,,,
course_4,ch_4_09,les_4_09_08,topic_4_09_08_01,quiz_4_09_08_3,,,
course_4,ch_4_09,les_4_09_08,topic_4_09_08_01,quiz_4_09_08_4,,,
course_4,ch_4_09,les_4_09_08,topic_4_09_08_01,quiz_4_09_08_5,,,
course_4,ch_4_09,les_4_09_09,topic_4_09_09_01,quiz_4_09_09_1,,,
course_4,ch_4_09,les_4_09_09,topic_4_09_09_01,quiz_4_09_09_2,,,
course_4,ch_4_09,les_4_09_09,topic_4_09_09_01,quiz_4_09_09_3,,,
course_4,ch_4_09,les_4_09_09,topic_4_09_09_01,quiz_4_09_09_4,,,
course_4,ch_4_09,les_4_09_09,topic_4_09_09_01,quiz_4_09_09_5,,,
course_4,ch_4_09,les_4_09_10,topic_4_09_10_01,quiz_4_09_10_1,,,
course_4,ch_4_09,les_4_09_10,topic_4_09_10_01,quiz_4_09_10_2,,,
course_4,ch_4_09,les_4_09_10,topic_4_09_10_01,quiz_4_09_10_3,,,
course_4,ch_4_09,les_4_09_10,topic_4_09_10_01,quiz_4_09_10_4,,,
course_4,ch_4_09,les_4_09_10,topic_4_09_10_01,quiz_4_09_10_5,,,
course_4,ch_4_10,les_4_10_01,topic_4_10_01_01,quiz_4_10_01_1,,,
course_4,ch_4_10,les_4_10_01,topic_4_10_01_01,quiz_4_10_01_2,,,
course_4,ch_4_10,les_4_10_01,topic_4_10_01_01,quiz_4_10_01_3,,,
course_4,ch_4_10,les_4_10_01,topic_4_10_01_01,quiz_4_10_01_4,,,
course_4,ch_4_10,les_4_10_01,topic_4_10_01_01,quiz_4_10_01_5,,,
course_4,ch_4_10,les_4_10_02,topic_4_10_02_01,quiz_4_10_02_1,,,
course_4,ch_4_10,les_4_10_02,topic_4_10_02_01,quiz_4_10_02_2,,,
course_4,ch_4_10,les_4_10_02,topic_4_10_02_01,quiz_4_10_02_3,,,
course_4,ch_4_10,les_4_10_02,topic_4_10_02_01,quiz_4_10_02_4,,,
course_4,ch_4_10,les_4_10_02,topic_4_10_02_01,quiz_4_10_02_5,,,
course_4,ch_4_10,les_4_10_03,topic_4_10_03_01,quiz_4_10_03_1,,,
course_4,ch_4_10,les_4_10_03,topic_4_10_03_01,quiz_4_10_03_2,,,
course_4,ch_4_10,les_4_10_03,topic_4_10_03_01,quiz_4_10_03_3,,,
course_4,ch_4_10,les_4_10_03,topic_4_10_03_01,quiz_4_10_03_4,,,
course_4,ch_4_10,les_4_10_03,topic_4_10_03_01,quiz_4_10_03_5,,,
course_4,ch_4_10,les_4_10_04,topic_4_10_04_01,quiz_4_10_04_1,,,
course_4,ch_4_10,les_4_10_04,topic_4_10_04_01,quiz_4_10_04_2,,,
course_4,ch_4_10,les_4_10_04,topic_4_10_04_01,quiz_4_10_04_3,,,
course_4,ch_4_10,les_4_10_04,topic_4_10_04_01,quiz_4_10_04_4,,,
course_4,ch_4_10,les_4_10_04,topic_4_10_04_01,quiz_4_10_04_5,,,
course_4,ch_4_10,les_4_10_05,topic_4_10_05_01,quiz_4_10_05_1,,,
course_4,ch_4_10,les_4_10_05,topic_4_10_05_01,quiz_4_10_05_2,,,
course_4,ch_4_10,les_4_10_05,topic_4_10_05_01,quiz_4_10_05_3,,,
course_4,ch_4_10,les_4_10_05,topic_4_10_05_01,quiz_4_10_05_4,,,
course_4,ch_4_10,les_4_10_05,topic_4_10_05_01,quiz_4_10_05_5,,,
course_4,ch_4_10,les_4_10_06,topic_4_10_06_01,quiz_4_10_06_1,,,
course_4,ch_4_10,les_4_10_06,topic_4_10_06_01,quiz_4_10_06_2,,,
course_4,ch_4_10,les_4_10_06,topic_4_10_06_01,quiz_4_10_06_3,,,
course_4,ch_4_10,les_4_10_06,topic_4_10_06_01,quiz_4_10_06_4,,,
course_4,ch_4_10,les_4_10_06,topic_4_10_06_01,quiz_4_10_06_5,,,
course_4,ch_4_10,les_4_10_07,topic_4_10_07_01,quiz_4_10_07_1,,,
course_4,ch_4_10,les_4_10_07,topic_4_10_07_01,quiz_4_10_07_2,,,
course_4,ch_4_10,les_4_10_07,topic_4_10_07_01,quiz_4_10_07_3,,,
course_4,ch_4_10,les_4_10_07,topic_4_10_07_01,quiz_4_10_07_4,,,
course_4,ch_4_10,les_4_10_07,topic_4_10_07_01,quiz_4_10_07_5,,,
course_4,ch_4_10,les_4_10_08,topic_4_10_08_01,quiz_4_10_08_1,,,
course_4,ch_4_10,les_4_10_08,topic_4_10_08_01,quiz_4_10_08_2,,,
course_4,ch_4_10,les_4_10_08,topic_4_10_08_01,quiz_4_10_08_3,,,
course_4,ch_4_10,les_4_10_08,topic_4_10_08_01,quiz_4_10_08_4,,,
course_4,ch_4_10,les_4_10_08,topic_4_10_08_01,quiz_4_10_08_5,,,
course_4,ch_4_10,les_4_10_09,topic_4_10_09_01,quiz_4_10_09_1,,,
course_4,ch_4_10,les_4_10_09,topic_4_10_09_01,quiz_4_10_09_2,,,
course_4,ch_4_10,les_4_10_09,topic_4_10_09_01,quiz_4_10_09_3,,,
course_4,ch_4_10,les_4_10_09,topic_4_10_09_01,quiz_4_10_09_4,,,
course_4,ch_4_10,les_4_10_09,topic_4_10_09_01,quiz_4_10_09_5,,,
course_4,ch_4_10,les_4_10_10,topic_4_10_10_01,quiz_4_10_10_1,,,
course_4,ch_4_10,les_4_10_10,topic_4_10_10_01,quiz_4_10_10_2,,,
course_4,ch_4_10,les_4_10_10,topic_4_10_10_01,quiz_4_10_10_3,,,
course_4,ch_4_10,les_4_10_10,topic_4_10_10_01,quiz_4_10_10_4,,,
course_4,ch_4_10,les_4_10_10,topic_4_10_10_01,quiz_4_10_10_5,,,
course_4,ch_4_11,les_4_11_01,topic_4_11_01_01,quiz_4_11_01_1,,,
course_4,ch_4_11,les_4_11_01,topic_4_11_01_01,quiz_4_11_01_2,,,
course_4,ch_4_11,les_4_11_01,topic_4_11_01_01,quiz_4_11_01_3,,,
course_4,ch_4_11,les_4_11_01,topic_4_11_01_01,quiz_4_11_01_4,,,
course_4,ch_4_11,les_4_11_01,topic_4_11_01_01,quiz_4_11_01_5,,,
course_4,ch_4_11,les_4_11_02,topic_4_11_02_01,quiz_4_11_02_1,,,
course_4,ch_4_11,les_4_11_02,topic_4_11_02_01,quiz_4_11_02_2,,,
course_4,ch_4_11,les_4_11_02,topic_4_11_02_01,quiz_4_11_02_3,,,
course_4,ch_4_11,les_4_11_02,topic_4_11_02_01,quiz_4_11_02_4,,,
course_4,ch_4_11,les_4_11_02,topic_4_11_02_01,quiz_4_11_02_5,,,
course_4,ch_4_11,les_4_11_03,topic_4_11_03_01,quiz_4_11_03_1,,,
course_4,ch_4_11,les_4_11_03,topic_4_11_03_01,quiz_4_11_03_2,,,
course_4,ch_4_11,les_4_11_03,topic_4_11_03_01,quiz_4_11_03_3,,,
course_4,ch_4_11,les_4_11_03,topic_4_11_03_01,quiz_4_11_03_4,,,
course_4,ch_4_11,les_4_11_03,topic_4_11_03_01,quiz_4_11_03_5,,,
course_4,ch_4_11,les_4_11_04,topic_4_11_04_01,quiz_4_11_04_1,,,
course_4,ch_4_11,les_4_11_04,topic_4_11_04_01,quiz_4_11_04_2,,,
course_4,ch_4_11,les_4_11_04,topic_4_11_04_01,quiz_4_11_04_3,,,
course_4,ch_4_11,les_4_11_04,topic_4_11_04_01,quiz_4_11_04_4,,,
course_4,ch_4_11,les_4_11_04,topic_4_11_04_01,quiz_4_11_04_5,,,
course_4,ch_4_11,les_4_11_05,topic_4_11_05_01,quiz_4_11_05_1,,,
course_4,ch_4_11,les_4_11_05,topic_4_11_05_01,quiz_4_11_05_2,,,
course_4,ch_4_11,les_4_11_05,topic_4_11_05_01,quiz_4_11_05_3,,,
course_4,ch_4_11,les_4_11_05,topic_4_11_05_01,quiz_4_11_05_4,,,
course_4,ch_4_11,les_4_11_05,topic_4_11_05_01,quiz_4_11_05_5,,,
course_4,ch_4_11,les_4_11_06,topic_4_11_06_01,quiz_4_11_06_1,,,
course_4,ch_4_11,les_4_11_06,topic_4_11_06_01,quiz_4_11_06_2,,,
course_4,ch_4_11,les_4_11_06,topic_4_11_06_01,quiz_4_11_06_3,,,
course_4,ch_4_11,les_4_11_06,topic_4_11_06_01,quiz_4_11_06_4,,,
course_4,ch_4_11,les_4_11_06,topic_4_11_06_01,quiz_4_11_06_5,,,
course_4,ch_4_11,les_4_11_07,topic_4_11_07_01,quiz_4_11_07_1,,,
course_4,ch_4_11,les_4_11_07,topic_4_11_07_01,quiz_4_11_07_2,,,
course_4,ch_4_11,les_4_11_07,topic_4_11_07_01,quiz_4_11_07_3,,,
course_4,ch_4_11,les_4_11_07,topic_4_11_07_01,quiz_4_11_07_4,,,
course_4,ch_4_11,les_4_11_07,topic_4_11_07_01,quiz_4_11_07_5,,,
course_4,ch_4_11,les_4_11_08,topic_4_11_08_01,quiz_4_11_08_1,,,
course_4,ch_4_11,les_4_11_08,topic_4_11_08_01,quiz_4_11_08_2,,,
course_4,ch_4_11,les_4_11_08,topic_4_11_08_01,quiz_4_11_08_3,,,
course_4,ch_4_11,les_4_11_08,topic_4_11_08_01,quiz_4_11_08_4,,,
course_4,ch_4_11,les_4_11_08,topic_4_11_08_01,quiz_4_11_08_5,,,
course_4,ch_4_11,les_4_11_09,topic_4_11_09_01,quiz_4_11_09_1,,,
course_4,ch_4_11,les_4_11_09,topic_4_11_09_01,quiz_4_11_09_2,,,
course_4,ch_4_11,les_4_11_09,topic_4_11_09_01,quiz_4_11_09_3,,,
course_4,ch_4_11,les_4_11_09,topic_4_11_09_01,quiz_4_11_09_4,,,
course_4,ch_4_11,les_4_11_09,topic_4_11_09_01,quiz_4_11_09_5,,,
course_4,ch_4_11,les_4_11_10,topic_4_11_10_01,quiz_4_11_10_1,,,
course_4,ch_4_11,les_4_11_10,topic_4_11_10_01,quiz_4_11_10_2,,,
course_4,ch_4_11,les_4_11_10,topic_4_11_10_01,quiz_4_11_10_3,,,
course_4,ch_4_11,les_4_11_10,topic_4_11_10_01,quiz_4_11_10_4,,,
course_4,ch_4_11,les_4_11_10,topic_4_11_10_01,quiz_4_11_10_5,,,
course_4,ch_4_12,les_4_12_01,topic_4_12_01_01,quiz_4_12_01_1,,,
course_4,ch_4_12,les_4_12_01,topic_4_12_01_01,quiz_4_12_01_2,,,
course_4,ch_4_12,les_4_12_01,topic_4_12_01_01,quiz_4_12_01_3,,,
course_4,ch_4_12,les_4_12_01,topic_4_12_01_01,quiz_4_12_01_4,,,
course_4,ch_4_12,les_4_12_01,topic_4_12_01_01,quiz_4_12_01_5,,,
course_4,ch_4_12,les_4_12_02,topic_4_12_02_01,quiz_4_12_02_1,,,
course_4,ch_4_12,les_4_12_02,topic_4_12_02_01,quiz_4_12_02_2,,,
course_4,ch_4_12,les_4_12_02,topic_4_12_02_01,quiz_4_12_02_3,,,
course_4,ch_4_12,les_4_12_02,topic_4_12_02_01,quiz_4_12_02_4,,,
course_4,ch_4_12,les_4_12_02,topic_4_12_02_01,quiz_4_12_02_5,,,
course_4,ch_4_12,les_4_12_03,topic_4_12_03_01,quiz_4_12_03_1,,,
course_4,ch_4_12,les_4_12_03,topic_4_12_03_01,quiz_4_12_03_2,,,
course_4,ch_4_12,les_4_12_03,topic_4_12_03_01,quiz_4_12_03_3,,,
course_4,ch_4_12,les_4_12_03,topic_4_12_03_01,quiz_4_12_03_4,,,
course_4,ch_4_12,les_4_12_03,topic_4_12_03_01,quiz_4_12_03_5,,,
course_4,ch_4_12,les_4_12_04,topic_4_12_04_01,quiz_4_12_04_1,,,
course_4,ch_4_12,les_4_12_04,topic_4_12_04_01,quiz_4_12_04_2,,,
course_4,ch_4_12,les_4_12_04,topic_4_12_04_01,quiz_4_12_04_3,,,
course_4,ch_4_12,les_4_12_04,topic_4_12_04_01,quiz_4_12_04_4,,,
course_4,ch_4_12,les_4_12_04,topic_4_12_04_01,quiz_4_12_04_5,,,
course_4,ch_4_12,les_4_12_05,topic_4_12_05_01,quiz_4_12_05_1,,,
course_4,ch_4_12,les_4_12_05,topic_4_12_05_01,quiz_4_12_05_2,,,
course_4,ch_4_12,les_4_12_05,topic_4_12_05_01,quiz_4_12_05_3,,,
course_4,ch_4_12,les_4_12_05,topic_4_12_05_01,quiz_4_12_05_4,,,
course_4,ch_4_12,les_4_12_05,topic_4_12_05_01,quiz_4_12_05_5,,,
course_4,ch_4_12,les_4_12_06,topic_4_12_06_01,quiz_4_12_06_1,,,
course_4,ch_4_12,les_4_12_06,topic_4_12_06_01,quiz_4_12_06_2,,,
course_4,ch_4_12,les_4_12_06,topic_4_12_06_01,quiz_4_12_06_3,,,
course_4,ch_4_12,les_4_12_06,topic_4_12_06_01,quiz_4_12_06_4,,,
course_4,ch_4_12,les_4_12_06,topic_4_12_06_01,quiz_4_12_06_5,,,
course_4,ch_4_12,les_4_12_07,topic_4_12_07_01,quiz_4_12_07_1,,,
course_4,ch_4_12,les_4_12_07,topic_4_12_07_01,quiz_4_12_07_2,,,
course_4,ch_4_12,les_4_12_07,topic_4_12_07_01,quiz_4_12_07_3,,,
course_4,ch_4_12,les_4_12_07,topic_4_12_07_01,quiz_4_12_07_4,,,
course_4,ch_4_12,les_4_12_07,topic_4_12_07_01,quiz_4_12_07_5,,,
course_4,ch_4_12,les_4_12_08,topic_4_12_08_01,quiz_4_12_08_1,,,
course_4,ch_4_12,les_4_12_08,topic_4_12_08_01,quiz_4_12_08_2,,,
course_4,ch_4_12,les_4_12_08,topic_4_12_08_01,quiz_4_12_08_3,,,
course_4,ch_4_12,les_4_12_08,topic_4_12_08_01,quiz_4_12_08_4,,,
course_4,ch_4_12,les_4_12_08,topic_4_12_08_01,quiz_4_12_08_5,,,
course_4,ch_4_12,les_4_12_09,topic_4_12_09_01,quiz_4_12_09_1,,,
course_4,ch_4_12,les_4_12_09,topic_4_12_09_01,quiz_4_12_09_2,,,
course_4,ch_4_12,les_4_12_09,topic_4_12_09_01,quiz_4_12_09_3,,,
course_4,ch_4_12,les_4_12_09,topic_4_12_09_01,quiz_4_12_09_4,,,
course_4,ch_4_12,les_4_12_09,topic_4_12_09_01,quiz_4_12_09_5,,,
course_4,ch_4_12,les_4_12_10,topic_4_12_10_01,quiz_4_12_10_1,,,
course_4,ch_4_12,les_4_12_10,topic_4_12_10_01,quiz_4_12_10_2,,,
course_4,ch_4_12,les_4_12_10,topic_4_12_10_01,quiz_4_12_10_3,,,
course_4,ch_4_12,les_4_12_10,topic_4_12_10_01,quiz_4_12_10_4,,,
course_4,ch_4_12,les_4_12_10,topic_4_12_10_01,quiz_4_12_10_5,,,
,,,,,,,
,,,,,,,
,,,,,,,
course_5,ch_5_01,les_5_01_01,topic_5_01_01_01,quiz_5_01_01_1,,,
course_5,ch_5_01,les_5_01_01,topic_5_01_01_01,quiz_5_01_01_2,,,
course_5,ch_5_01,les_5_01_01,topic_5_01_01_01,quiz_5_01_01_3,,,
course_5,ch_5_01,les_5_01_01,topic_5_01_01_01,quiz_5_01_01_4,,,
course_5,ch_5_01,les_5_01_01,topic_5_01_01_01,quiz_5_01_01_5,,,
course_5,ch_5_01,les_5_01_02,topic_5_01_02_01,quiz_5_01_02_1,,,
course_5,ch_5_01,les_5_01_02,topic_5_01_02_01,quiz_5_01_02_2,,,
course_5,ch_5_01,les_5_01_02,topic_5_01_02_01,quiz_5_01_02_3,,,
course_5,ch_5_01,les_5_01_02,topic_5_01_02_01,quiz_5_01_02_4,,,
course_5,ch_5_01,les_5_01_02,topic_5_01_02_01,quiz_5_01_02_5,,,
course_5,ch_5_01,les_5_01_03,topic_5_01_03_01,quiz_5_01_03_1,,,
course_5,ch_5_01,les_5_01_03,topic_5_01_03_01,quiz_5_01_03_2,,,
course_5,ch_5_01,les_5_01_03,topic_5_01_03_01,quiz_5_01_03_3,,,
course_5,ch_5_01,les_5_01_03,topic_5_01_03_01,quiz_5_01_03_4,,,
course_5,ch_5_01,les_5_01_03,topic_5_01_03_01,quiz_5_01_03_5,,,
course_5,ch_5_01,les_5_01_04,topic_5_01_04_01,quiz_5_01_04_1,,,
course_5,ch_5_01,les_5_01_04,topic_5_01_04_01,quiz_5_01_04_2,,,
course_5,ch_5_01,les_5_01_04,topic_5_01_04_01,quiz_5_01_04_3,,,
course_5,ch_5_01,les_5_01_04,topic_5_01_04_01,quiz_5_01_04_4,,,
course_5,ch_5_01,les_5_01_04,topic_5_01_04_01,quiz_5_01_04_5,,,
course_5,ch_5_01,les_5_01_05,topic_5_01_05_01,quiz_5_01_05_1,,,
course_5,ch_5_01,les_5_01_05,topic_5_01_05_01,quiz_5_01_05_2,,,
course_5,ch_5_01,les_5_01_05,topic_5_01_05_01,quiz_5_01_05_3,,,
course_5,ch_5_01,les_5_01_05,topic_5_01_05_01,quiz_5_01_05_4,,,
course_5,ch_5_01,les_5_01_05,topic_5_01_05_01,quiz_5_01_05_5,,,
course_5,ch_5_01,les_5_01_06,topic_5_01_06_01,quiz_5_01_06_1,,,
course_5,ch_5_01,les_5_01_06,topic_5_01_06_01,quiz_5_01_06_2,,,
course_5,ch_5_01,les_5_01_06,topic_5_01_06_01,quiz_5_01_06_3,,,
course_5,ch_5_01,les_5_01_06,topic_5_01_06_01,quiz_5_01_06_4,,,
course_5,ch_5_01,les_5_01_06,topic_5_01_06_01,quiz_5_01_06_5,,,
course_5,ch_5_01,les_5_01_07,topic_5_01_07_01,quiz_5_01_07_1,,,
course_5,ch_5_01,les_5_01_07,topic_5_01_07_01,quiz_5_01_07_2,,,
course_5,ch_5_01,les_5_01_07,topic_5_01_07_01,quiz_5_01_07_3,,,
course_5,ch_5_01,les_5_01_07,topic_5_01_07_01,quiz_5_01_07_4,,,
course_5,ch_5_01,les_5_01_07,topic_5_01_07_01,quiz_5_01_07_5,,,
course_5,ch_5_01,les_5_01_08,topic_5_01_08_01,quiz_5_01_08_1,,,
course_5,ch_5_01,les_5_01_08,topic_5_01_08_01,quiz_5_01_08_2,,,
course_5,ch_5_01,les_5_01_08,topic_5_01_08_01,quiz_5_01_08_3,,,
course_5,ch_5_01,les_5_01_08,topic_5_01_08_01,quiz_5_01_08_4,,,
course_5,ch_5_01,les_5_01_08,topic_5_01_08_01,quiz_5_01_08_5,,,
course_5,ch_5_01,les_5_01_09,topic_5_01_09_01,quiz_5_01_09_1,,,
course_5,ch_5_01,les_5_01_09,topic_5_01_09_01,quiz_5_01_09_2,,,
course_5,ch_5_01,les_5_01_09,topic_5_01_09_01,quiz_5_01_09_3,,,
course_5,ch_5_01,les_5_01_09,topic_5_01_09_01,quiz_5_01_09_4,,,
course_5,ch_5_01,les_5_01_09,topic_5_01_09_01,quiz_5_01_09_5,,,
course_5,ch_5_01,les_5_01_10,topic_5_01_10_01,quiz_5_01_10_1,,,
course_5,ch_5_01,les_5_01_10,topic_5_01_10_01,quiz_5_01_10_2,,,
course_5,ch_5_01,les_5_01_10,topic_5_01_10_01,quiz_5_01_10_3,,,
course_5,ch_5_01,les_5_01_10,topic_5_01_10_01,quiz_5_01_10_4,,,
course_5,ch_5_01,les_5_01_10,topic_5_01_10_01,quiz_5_01_10_5,,,
course_5,ch_5_02,les_5_02_01,topic_5_02_01_01,quiz_5_02_01_1,,,
course_5,ch_5_02,les_5_02_01,topic_5_02_01_01,quiz_5_02_01_2,,,
course_5,ch_5_02,les_5_02_01,topic_5_02_01_01,quiz_5_02_01_3,,,
course_5,ch_5_02,les_5_02_01,topic_5_02_01_01,quiz_5_02_01_4,,,
course_5,ch_5_02,les_5_02_01,topic_5_02_01_01,quiz_5_02_01_5,,,
course_5,ch_5_02,les_5_02_02,topic_5_02_02_01,quiz_5_02_02_1,,,
course_5,ch_5_02,les_5_02_02,topic_5_02_02_01,quiz_5_02_02_2,,,
course_5,ch_5_02,les_5_02_02,topic_5_02_02_01,quiz_5_02_02_3,,,
course_5,ch_5_02,les_5_02_02,topic_5_02_02_01,quiz_5_02_02_4,,,
course_5,ch_5_02,les_5_02_02,topic_5_02_02_01,quiz_5_02_02_5,,,
course_5,ch_5_02,les_5_02_03,topic_5_02_03_01,quiz_5_02_03_1,,,
course_5,ch_5_02,les_5_02_03,topic_5_02_03_01,quiz_5_02_03_2,,,
course_5,ch_5_02,les_5_02_03,topic_5_02_03_01,quiz_5_02_03_3,,,
course_5,ch_5_02,les_5_02_03,topic_5_02_03_01,quiz_5_02_03_4,,,
course_5,ch_5_02,les_5_02_03,topic_5_02_03_01,quiz_5_02_03_5,,,
course_5,ch_5_02,les_5_02_04,topic_5_02_04_01,quiz_5_02_04_1,,,
course_5,ch_5_02,les_5_02_04,topic_5_02_04_01,quiz_5_02_04_2,,,
course_5,ch_5_02,les_5_02_04,topic_5_02_04_01,quiz_5_02_04_3,,,
course_5,ch_5_02,les_5_02_04,topic_5_02_04_01,quiz_5_02_04_4,,,
course_5,ch_5_02,les_5_02_04,topic_5_02_04_01,quiz_5_02_04_5,,,
course_5,ch_5_02,les_5_02_05,topic_5_02_05_01,quiz_5_02_05_1,,,
course_5,ch_5_02,les_5_02_05,topic_5_02_05_01,quiz_5_02_05_2,,,
course_5,ch_5_02,les_5_02_05,topic_5_02_05_01,quiz_5_02_05_3,,,
course_5,ch_5_02,les_5_02_05,topic_5_02_05_01,quiz_5_02_05_4,,,
course_5,ch_5_02,les_5_02_05,topic_5_02_05_01,quiz_5_02_05_5,,,
course_5,ch_5_02,les_5_02_06,topic_5_02_06_01,quiz_5_02_06_1,,,
course_5,ch_5_02,les_5_02_06,topic_5_02_06_01,quiz_5_02_06_2,,,
course_5,ch_5_02,les_5_02_06,topic_5_02_06_01,quiz_5_02_06_3,,,
course_5,ch_5_02,les_5_02_06,topic_5_02_06_01,quiz_5_02_06_4,,,
course_5,ch_5_02,les_5_02_06,topic_5_02_06_01,quiz_5_02_06_5,,,
course_5,ch_5_02,les_5_02_07,topic_5_02_07_01,quiz_5_02_07_1,,,
course_5,ch_5_02,les_5_02_07,topic_5_02_07_01,quiz_5_02_07_2,,,
course_5,ch_5_02,les_5_02_07,topic_5_02_07_01,quiz_5_02_07_3,,,
course_5,ch_5_02,les_5_02_07,topic_5_02_07_01,quiz_5_02_07_4,,,
course_5,ch_5_02,les_5_02_07,topic_5_02_07_01,quiz_5_02_07_5,,,
course_5,ch_5_02,les_5_02_08,topic_5_02_08_01,quiz_5_02_08_1,,,
course_5,ch_5_02,les_5_02_08,topic_5_02_08_01,quiz_5_02_08_2,,,
course_5,ch_5_02,les_5_02_08,topic_5_02_08_01,quiz_5_02_08_3,,,
course_5,ch_5_02,les_5_02_08,topic_5_02_08_01,quiz_5_02_08_4,,,
course_5,ch_5_02,les_5_02_08,topic_5_02_08_01,quiz_5_02_08_5,,,
course_5,ch_5_02,les_5_02_09,topic_5_02_09_01,quiz_5_02_09_1,,,
course_5,ch_5_02,les_5_02_09,topic_5_02_09_01,quiz_5_02_09_2,,,
course_5,ch_5_02,les_5_02_09,topic_5_02_09_01,quiz_5_02_09_3,,,
course_5,ch_5_02,les_5_02_09,topic_5_02_09_01,quiz_5_02_09_4,,,
course_5,ch_5_02,les_5_02_09,topic_5_02_09_01,quiz_5_02_09_5,,,
course_5,ch_5_02,les_5_02_10,topic_5_02_10_01,quiz_5_02_10_1,,,
course_5,ch_5_02,les_5_02_10,topic_5_02_10_01,quiz_5_02_10_2,,,
course_5,ch_5_02,les_5_02_10,topic_5_02_10_01,quiz_5_02_10_3,,,
course_5,ch_5_02,les_5_02_10,topic_5_02_10_01,quiz_5_02_10_4,,,
course_5,ch_5_02,les_5_02_10,topic_5_02_10_01,quiz_5_02_10_5,,,
course_5,ch_5_03,les_5_03_01,topic_5_03_01_01,quiz_5_03_01_1,,,
course_5,ch_5_03,les_5_03_01,topic_5_03_01_01,quiz_5_03_01_2,,,
course_5,ch_5_03,les_5_03_01,topic_5_03_01_01,quiz_5_03_01_3,,,
course_5,ch_5_03,les_5_03_01,topic_5_03_01_01,quiz_5_03_01_4,,,
course_5,ch_5_03,les_5_03_01,topic_5_03_01_01,quiz_5_03_01_5,,,
course_5,ch_5_03,les_5_03_02,topic_5_03_02_01,quiz_5_03_02_1,,,
course_5,ch_5_03,les_5_03_02,topic_5_03_02_01,quiz_5_03_02_2,,,
course_5,ch_5_03,les_5_03_02,topic_5_03_02_01,quiz_5_03_02_3,,,
course_5,ch_5_03,les_5_03_02,topic_5_03_02_01,quiz_5_03_02_4,,,
course_5,ch_5_03,les_5_03_02,topic_5_03_02_01,quiz_5_03_02_5,,,
course_5,ch_5_03,les_5_03_03,topic_5_03_03_01,quiz_5_03_03_1,,,
course_5,ch_5_03,les_5_03_03,topic_5_03_03_01,quiz_5_03_03_2,,,
course_5,ch_5_03,les_5_03_03,topic_5_03_03_01,quiz_5_03_03_3,,,
course_5,ch_5_03,les_5_03_03,topic_5_03_03_01,quiz_5_03_03_4,,,
course_5,ch_5_03,les_5_03_03,topic_5_03_03_01,quiz_5_03_03_5,,,
course_5,ch_5_03,les_5_03_04,topic_5_03_04_01,quiz_5_03_04_1,,,
course_5,ch_5_03,les_5_03_04,topic_5_03_04_01,quiz_5_03_04_2,,,
course_5,ch_5_03,les_5_03_04,topic_5_03_04_01,quiz_5_03_04_3,,,
course_5,ch_5_03,les_5_03_04,topic_5_03_04_01,quiz_5_03_04_4,,,
course_5,ch_5_03,les_5_03_04,topic_5_03_04_01,quiz_5_03_04_5,,,
course_5,ch_5_03,les_5_03_05,topic_5_03_05_01,quiz_5_03_05_1,,,
course_5,ch_5_03,les_5_03_05,topic_5_03_05_01,quiz_5_03_05_2,,,
course_5,ch_5_03,les_5_03_05,topic_5_03_05_01,quiz_5_03_05_3,,,
course_5,ch_5_03,les_5_03_05,topic_5_03_05_01,quiz_5_03_05_4,,,
course_5,ch_5_03,les_5_03_05,topic_5_03_05_01,quiz_5_03_05_5,,,
course_5,ch_5_03,les_5_03_06,topic_5_03_06_01,quiz_5_03_06_1,,,
course_5,ch_5_03,les_5_03_06,topic_5_03_06_01,quiz_5_03_06_2,,,
course_5,ch_5_03,les_5_03_06,topic_5_03_06_01,quiz_5_03_06_3,,,
course_5,ch_5_03,les_5_03_06,topic_5_03_06_01,quiz_5_03_06_4,,,
course_5,ch_5_03,les_5_03_06,topic_5_03_06_01,quiz_5_03_06_5,,,
course_5,ch_5_03,les_5_03_07,topic_5_03_07_01,quiz_5_03_07_1,,,
course_5,ch_5_03,les_5_03_07,topic_5_03_07_01,quiz_5_03_07_2,,,
course_5,ch_5_03,les_5_03_07,topic_5_03_07_01,quiz_5_03_07_3,,,
course_5,ch_5_03,les_5_03_07,topic_5_03_07_01,quiz_5_03_07_4,,,
course_5,ch_5_03,les_5_03_07,topic_5_03_07_01,quiz_5_03_07_5,,,
course_5,ch_5_03,les_5_03_08,topic_5_03_08_01,quiz_5_03_08_1,,,
course_5,ch_5_03,les_5_03_08,topic_5_03_08_01,quiz_5_03_08_2,,,
course_5,ch_5_03,les_5_03_08,topic_5_03_08_01,quiz_5_03_08_3,,,
course_5,ch_5_03,les_5_03_08,topic_5_03_08_01,quiz_5_03_08_4,,,
course_5,ch_5_03,les_5_03_08,topic_5_03_08_01,quiz_5_03_08_5,,,
course_5,ch_5_03,les_5_03_09,topic_5_03_09_01,quiz_5_03_09_1,,,
course_5,ch_5_03,les_5_03_09,topic_5_03_09_01,quiz_5_03_09_2,,,
course_5,ch_5_03,les_5_03_09,topic_5_03_09_01,quiz_5_03_09_3,,,
course_5,ch_5_03,les_5_03_09,topic_5_03_09_01,quiz_5_03_09_4,,,
course_5,ch_5_03,les_5_03_09,topic_5_03_09_01,quiz_5_03_09_5,,,
course_5,ch_5_03,les_5_03_10,topic_5_03_10_01,quiz_5_03_10_1,,,
course_5,ch_5_03,les_5_03_10,topic_5_03_10_01,quiz_5_03_10_2,,,
course_5,ch_5_03,les_5_03_10,topic_5_03_10_01,quiz_5_03_10_3,,,
course_5,ch_5_03,les_5_03_10,topic_5_03_10_01,quiz_5_03_10_4,,,
course_5,ch_5_03,les_5_03_10,topic_5_03_10_01,quiz_5_03_10_5,,,
course_5,ch_5_04,les_5_04_01,topic_5_04_01_01,quiz_5_04_01_1,,,
course_5,ch_5_04,les_5_04_01,topic_5_04_01_01,quiz_5_04_01_2,,,
course_5,ch_5_04,les_5_04_01,topic_5_04_01_01,quiz_5_04_01_3,,,
course_5,ch_5_04,les_5_04_01,topic_5_04_01_01,quiz_5_04_01_4,,,
course_5,ch_5_04,les_5_04_01,topic_5_04_01_01,quiz_5_04_01_5,,,
course_5,ch_5_04,les_5_04_02,topic_5_04_02_01,quiz_5_04_02_1,,,
course_5,ch_5_04,les_5_04_02,topic_5_04_02_01,quiz_5_04_02_2,,,
course_5,ch_5_04,les_5_04_02,topic_5_04_02_01,quiz_5_04_02_3,,,
course_5,ch_5_04,les_5_04_02,topic_5_04_02_01,quiz_5_04_02_4,,,
course_5,ch_5_04,les_5_04_02,topic_5_04_02_01,quiz_5_04_02_5,,,
course_5,ch_5_04,les_5_04_03,topic_5_04_03_01,quiz_5_04_03_1,,,
course_5,ch_5_04,les_5_04_03,topic_5_04_03_01,quiz_5_04_03_2,,,
course_5,ch_5_04,les_5_04_03,topic_5_04_03_01,quiz_5_04_03_3,,,
course_5,ch_5_04,les_5_04_03,topic_5_04_03_01,quiz_5_04_03_4,,,
course_5,ch_5_04,les_5_04_03,topic_5_04_03_01,quiz_5_04_03_5,,,
course_5,ch_5_04,les_5_04_04,topic_5_04_04_01,quiz_5_04_04_1,,,
course_5,ch_5_04,les_5_04_04,topic_5_04_04_01,quiz_5_04_04_2,,,
course_5,ch_5_04,les_5_04_04,topic_5_04_04_01,quiz_5_04_04_3,,,
course_5,ch_5_04,les_5_04_04,topic_5_04_04_01,quiz_5_04_04_4,,,
course_5,ch_5_04,les_5_04_04,topic_5_04_04_01,quiz_5_04_04_5,,,
course_5,ch_5_04,les_5_04_05,topic_5_04_05_01,quiz_5_04_05_1,,,
course_5,ch_5_04,les_5_04_05,topic_5_04_05_01,quiz_5_04_05_2,,,
course_5,ch_5_04,les_5_04_05,topic_5_04_05_01,quiz_5_04_05_3,,,
course_5,ch_5_04,les_5_04_05,topic_5_04_05_01,quiz_5_04_05_4,,,
course_5,ch_5_04,les_5_04_05,topic_5_04_05_01,quiz_5_04_05_5,,,
course_5,ch_5_04,les_5_04_06,topic_5_04_06_01,quiz_5_04_06_1,,,
course_5,ch_5_04,les_5_04_06,topic_5_04_06_01,quiz_5_04_06_2,,,
course_5,ch_5_04,les_5_04_06,topic_5_04_06_01,quiz_5_04_06_3,,,
course_5,ch_5_04,les_5_04_06,topic_5_04_06_01,quiz_5_04_06_4,,,
course_5,ch_5_04,les_5_04_06,topic_5_04_06_01,quiz_5_04_06_5,,,
course_5,ch_5_04,les_5_04_07,topic_5_04_07_01,quiz_5_04_07_1,,,
course_5,ch_5_04,les_5_04_07,topic_5_04_07_01,quiz_5_04_07_2,,,
course_5,ch_5_04,les_5_04_07,topic_5_04_07_01,quiz_5_04_07_3,,,
course_5,ch_5_04,les_5_04_07,topic_5_04_07_01,quiz_5_04_07_4,,,
course_5,ch_5_04,les_5_04_07,topic_5_04_07_01,quiz_5_04_07_5,,,
course_5,ch_5_04,les_5_04_08,topic_5_04_08_01,quiz_5_04_08_1,,,
course_5,ch_5_04,les_5_04_08,topic_5_04_08_01,quiz_5_04_08_2,,,
course_5,ch_5_04,les_5_04_08,topic_5_04_08_01,quiz_5_04_08_3,,,
course_5,ch_5_04,les_5_04_08,topic_5_04_08_01,quiz_5_04_08_4,,,
course_5,ch_5_04,les_5_04_08,topic_5_04_08_01,quiz_5_04_08_5,,,
course_5,ch_5_04,les_5_04_09,topic_5_04_09_01,quiz_5_04_09_1,,,
course_5,ch_5_04,les_5_04_09,topic_5_04_09_01,quiz_5_04_09_2,,,
course_5,ch_5_04,les_5_04_09,topic_5_04_09_01,quiz_5_04_09_3,,,
course_5,ch_5_04,les_5_04_09,topic_5_04_09_01,quiz_5_04_09_4,,,
course_5,ch_5_04,les_5_04_09,topic_5_04_09_01,quiz_5_04_09_5,,,
course_5,ch_5_04,les_5_04_10,topic_5_04_10_01,quiz_5_04_10_1,,,
course_5,ch_5_04,les_5_04_10,topic_5_04_10_01,quiz_5_04_10_2,,,
course_5,ch_5_04,les_5_04_10,topic_5_04_10_01,quiz_5_04_10_3,,,
course_5,ch_5_04,les_5_04_10,topic_5_04_10_01,quiz_5_04_10_4,,,
course_5,ch_5_04,les_5_04_10,topic_5_04_10_01,quiz_5_04_10_5,,,
course_5,ch_5_05,les_5_05_01,topic_5_05_01_01,quiz_5_05_01_1,,,
course_5,ch_5_05,les_5_05_01,topic_5_05_01_01,quiz_5_05_01_2,,,
course_5,ch_5_05,les_5_05_01,topic_5_05_01_01,quiz_5_05_01_3,,,
course_5,ch_5_05,les_5_05_01,topic_5_05_01_01,quiz_5_05_01_4,,,
course_5,ch_5_05,les_5_05_01,topic_5_05_01_01,quiz_5_05_01_5,,,
course_5,ch_5_05,les_5_05_02,topic_5_05_02_01,quiz_5_05_02_1,,,
course_5,ch_5_05,les_5_05_02,topic_5_05_02_01,quiz_5_05_02_2,,,
course_5,ch_5_05,les_5_05_02,topic_5_05_02_01,quiz_5_05_02_3,,,
course_5,ch_5_05,les_5_05_02,topic_5_05_02_01,quiz_5_05_02_4,,,
course_5,ch_5_05,les_5_05_02,topic_5_05_02_01,quiz_5_05_02_5,,,
course_5,ch_5_05,les_5_05_03,topic_5_05_03_01,quiz_5_05_03_1,,,
course_5,ch_5_05,les_5_05_03,topic_5_05_03_01,quiz_5_05_03_2,,,
course_5,ch_5_05,les_5_05_03,topic_5_05_03_01,quiz_5_05_03_3,,,
course_5,ch_5_05,les_5_05_03,topic_5_05_03_01,quiz_5_05_03_4,,,
course_5,ch_5_05,les_5_05_03,topic_5_05_03_01,quiz_5_05_03_5,,,
course_5,ch_5_05,les_5_05_04,topic_5_05_04_01,quiz_5_05_04_1,,,
course_5,ch_5_05,les_5_05_04,topic_5_05_04_01,quiz_5_05_04_2,,,
course_5,ch_5_05,les_5_05_04,topic_5_05_04_01,quiz_5_05_04_3,,,
course_5,ch_5_05,les_5_05_04,topic_5_05_04_01,quiz_5_05_04_4,,,
course_5,ch_5_05,les_5_05_04,topic_5_05_04_01,quiz_5_05_04_5,,,
course_5,ch_5_05,les_5_05_05,topic_5_05_05_01,quiz_5_05_05_1,,,
course_5,ch_5_05,les_5_05_05,topic_5_05_05_01,quiz_5_05_05_2,,,
course_5,ch_5_05,les_5_05_05,topic_5_05_05_01,quiz_5_05_05_3,,,
course_5,ch_5_05,les_5_05_05,topic_5_05_05_01,quiz_5_05_05_4,,,
course_5,ch_5_05,les_5_05_05,topic_5_05_05_01,quiz_5_05_05_5,,,
course_5,ch_5_05,les_5_05_06,topic_5_05_06_01,quiz_5_05_06_1,,,
course_5,ch_5_05,les_5_05_06,topic_5_05_06_01,quiz_5_05_06_2,,,
course_5,ch_5_05,les_5_05_06,topic_5_05_06_01,quiz_5_05_06_3,,,
course_5,ch_5_05,les_5_05_06,topic_5_05_06_01,quiz_5_05_06_4,,,
course_5,ch_5_05,les_5_05_06,topic_5_05_06_01,quiz_5_05_06_5,,,
course_5,ch_5_05,les_5_05_07,topic_5_05_07_01,quiz_5_05_07_1,,,
course_5,ch_5_05,les_5_05_07,topic_5_05_07_01,quiz_5_05_07_2,,,
course_5,ch_5_05,les_5_05_07,topic_5_05_07_01,quiz_5_05_07_3,,,
course_5,ch_5_05,les_5_05_07,topic_5_05_07_01,quiz_5_05_07_4,,,
course_5,ch_5_05,les_5_05_07,topic_5_05_07_01,quiz_5_05_07_5,,,
course_5,ch_5_05,les_5_05_08,topic_5_05_08_01,quiz_5_05_08_1,,,
course_5,ch_5_05,les_5_05_08,topic_5_05_08_01,quiz_5_05_08_2,,,
course_5,ch_5_05,les_5_05_08,topic_5_05_08_01,quiz_5_05_08_3,,,
course_5,ch_5_05,les_5_05_08,topic_5_05_08_01,quiz_5_05_08_4,,,
course_5,ch_5_05,les_5_05_08,topic_5_05_08_01,quiz_5_05_08_5,,,
course_5,ch_5_05,les_5_05_09,topic_5_05_09_01,quiz_5_05_09_1,,,
course_5,ch_5_05,les_5_05_09,topic_5_05_09_01,quiz_5_05_09_2,,,
course_5,ch_5_05,les_5_05_09,topic_5_05_09_01,quiz_5_05_09_3,,,
course_5,ch_5_05,les_5_05_09,topic_5_05_09_01,quiz_5_05_09_4,,,
course_5,ch_5_05,les_5_05_09,topic_5_05_09_01,quiz_5_05_09_5,,,
course_5,ch_5_05,les_5_05_10,topic_5_05_10_01,quiz_5_05_10_1,,,
course_5,ch_5_05,les_5_05_10,topic_5_05_10_01,quiz_5_05_10_2,,,
course_5,ch_5_05,les_5_05_10,topic_5_05_10_01,quiz_5_05_10_3,,,
course_5,ch_5_05,les_5_05_10,topic_5_05_10_01,quiz_5_05_10_4,,,
course_5,ch_5_05,les_5_05_10,topic_5_05_10_01,quiz_5_05_10_5,,,
course_5,ch_5_06,les_5_06_01,topic_5_06_01_01,quiz_5_06_01_1,,,
course_5,ch_5_06,les_5_06_01,topic_5_06_01_01,quiz_5_06_01_2,,,
course_5,ch_5_06,les_5_06_01,topic_5_06_01_01,quiz_5_06_01_3,,,
course_5,ch_5_06,les_5_06_01,topic_5_06_01_01,quiz_5_06_01_4,,,
course_5,ch_5_06,les_5_06_01,topic_5_06_01_01,quiz_5_06_01_5,,,
course_5,ch_5_06,les_5_06_02,topic_5_06_02_01,quiz_5_06_02_1,,,
course_5,ch_5_06,les_5_06_02,topic_5_06_02_01,quiz_5_06_02_2,,,
course_5,ch_5_06,les_5_06_02,topic_5_06_02_01,quiz_5_06_02_3,,,
course_5,ch_5_06,les_5_06_02,topic_5_06_02_01,quiz_5_06_02_4,,,
course_5,ch_5_06,les_5_06_02,topic_5_06_02_01,quiz_5_06_02_5,,,
course_5,ch_5_06,les_5_06_03,topic_5_06_03_01,quiz_5_06_03_1,,,
course_5,ch_5_06,les_5_06_03,topic_5_06_03_01,quiz_5_06_03_2,,,
course_5,ch_5_06,les_5_06_03,topic_5_06_03_01,quiz_5_06_03_3,,,
course_5,ch_5_06,les_5_06_03,topic_5_06_03_01,quiz_5_06_03_4,,,
course_5,ch_5_06,les_5_06_03,topic_5_06_03_01,quiz_5_06_03_5,,,
course_5,ch_5_06,les_5_06_04,topic_5_06_04_01,quiz_5_06_04_1,,,
course_5,ch_5_06,les_5_06_04,topic_5_06_04_01,quiz_5_06_04_2,,,
course_5,ch_5_06,les_5_06_04,topic_5_06_04_01,quiz_5_06_04_3,,,
course_5,ch_5_06,les_5_06_04,topic_5_06_04_01,quiz_5_06_04_4,,,
course_5,ch_5_06,les_5_06_04,topic_5_06_04_01,quiz_5_06_04_5,,,
course_5,ch_5_06,les_5_06_05,topic_5_06_05_01,quiz_5_06_05_1,,,
course_5,ch_5_06,les_5_06_05,topic_5_06_05_01,quiz_5_06_05_2,,,
course_5,ch_5_06,les_5_06_05,topic_5_06_05_01,quiz_5_06_05_3,,,
course_5,ch_5_06,les_5_06_05,topic_5_06_05_01,quiz_5_06_05_4,,,
course_5,ch_5_06,les_5_06_05,topic_5_06_05_01,quiz_5_06_05_5,,,
course_5,ch_5_06,les_5_06_06,topic_5_06_06_01,quiz_5_06_06_1,,,
course_5,ch_5_06,les_5_06_06,topic_5_06_06_01,quiz_5_06_06_2,,,
course_5,ch_5_06,les_5_06_06,topic_5_06_06_01,quiz_5_06_06_3,,,
course_5,ch_5_06,les_5_06_06,topic_5_06_06_01,quiz_5_06_06_4,,,
course_5,ch_5_06,les_5_06_06,topic_5_06_06_01,quiz_5_06_06_5,,,
course_5,ch_5_06,les_5_06_07,topic_5_06_07_01,quiz_5_06_07_1,,,
course_5,ch_5_06,les_5_06_07,topic_5_06_07_01,quiz_5_06_07_2,,,
course_5,ch_5_06,les_5_06_07,topic_5_06_07_01,quiz_5_06_07_3,,,
course_5,ch_5_06,les_5_06_07,topic_5_06_07_01,quiz_5_06_07_4,,,
course_5,ch_5_06,les_5_06_07,topic_5_06_07_01,quiz_5_06_07_5,,,
course_5,ch_5_06,les_5_06_08,topic_5_06_08_01,quiz_5_06_08_1,,,
course_5,ch_5_06,les_5_06_08,topic_5_06_08_01,quiz_5_06_08_2,,,
course_5,ch_5_06,les_5_06_08,topic_5_06_08_01,quiz_5_06_08_3,,,
course_5,ch_5_06,les_5_06_08,topic_5_06_08_01,quiz_5_06_08_4,,,
course_5,ch_5_06,les_5_06_08,topic_5_06_08_01,quiz_5_06_08_5,,,
course_5,ch_5_06,les_5_06_09,topic_5_06_09_01,quiz_5_06_09_1,,,
course_5,ch_5_06,les_5_06_09,topic_5_06_09_01,quiz_5_06_09_2,,,
course_5,ch_5_06,les_5_06_09,topic_5_06_09_01,quiz_5_06_09_3,,,
course_5,ch_5_06,les_5_06_09,topic_5_06_09_01,quiz_5_06_09_4,,,
course_5,ch_5_06,les_5_06_09,topic_5_06_09_01,quiz_5_06_09_5,,,
course_5,ch_5_06,les_5_06_10,topic_5_06_10_01,quiz_5_06_10_1,,,
course_5,ch_5_06,les_5_06_10,topic_5_06_10_01,quiz_5_06_10_2,,,
course_5,ch_5_06,les_5_06_10,topic_5_06_10_01,quiz_5_06_10_3,,,
course_5,ch_5_06,les_5_06_10,topic_5_06_10_01,quiz_5_06_10_4,,,
course_5,ch_5_06,les_5_06_10,topic_5_06_10_01,quiz_5_06_10_5,,,
course_5,ch_5_07,les_5_07_01,topic_5_07_01_01,quiz_5_07_01_1,,,
course_5,ch_5_07,les_5_07_01,topic_5_07_01_01,quiz_5_07_01_2,,,
course_5,ch_5_07,les_5_07_01,topic_5_07_01_01,quiz_5_07_01_3,,,
course_5,ch_5_07,les_5_07_01,topic_5_07_01_01,quiz_5_07_01_4,,,
course_5,ch_5_07,les_5_07_01,topic_5_07_01_01,quiz_5_07_01_5,,,
course_5,ch_5_07,les_5_07_02,topic_5_07_02_01,quiz_5_07_02_1,,,
course_5,ch_5_07,les_5_07_02,topic_5_07_02_01,quiz_5_07_02_2,,,
course_5,ch_5_07,les_5_07_02,topic_5_07_02_01,quiz_5_07_02_3,,,
course_5,ch_5_07,les_5_07_02,topic_5_07_02_01,quiz_5_07_02_4,,,
course_5,ch_5_07,les_5_07_02,topic_5_07_02_01,quiz_5_07_02_5,,,
course_5,ch_5_07,les_5_07_03,topic_5_07_03_01,quiz_5_07_03_1,,,
course_5,ch_5_07,les_5_07_03,topic_5_07_03_01,quiz_5_07_03_2,,,
course_5,ch_5_07,les_5_07_03,topic_5_07_03_01,quiz_5_07_03_3,,,
course_5,ch_5_07,les_5_07_03,topic_5_07_03_01,quiz_5_07_03_4,,,
course_5,ch_5_07,les_5_07_03,topic_5_07_03_01,quiz_5_07_03_5,,,
course_5,ch_5_07,les_5_07_04,topic_5_07_04_01,quiz_5_07_04_1,,,
course_5,ch_5_07,les_5_07_04,topic_5_07_04_01,quiz_5_07_04_2,,,
course_5,ch_5_07,les_5_07_04,topic_5_07_04_01,quiz_5_07_04_3,,,
course_5,ch_5_07,les_5_07_04,topic_5_07_04_01,quiz_5_07_04_4,,,
course_5,ch_5_07,les_5_07_04,topic_5_07_04_01,quiz_5_07_04_5,,,
course_5,ch_5_07,les_5_07_05,topic_5_07_05_01,quiz_5_07_05_1,,,
course_5,ch_5_07,les_5_07_05,topic_5_07_05_01,quiz_5_07_05_2,,,
course_5,ch_5_07,les_5_07_05,topic_5_07_05_01,quiz_5_07_05_3,,,
course_5,ch_5_07,les_5_07_05,topic_5_07_05_01,quiz_5_07_05_4,,,
course_5,ch_5_07,les_5_07_05,topic_5_07_05_01,quiz_5_07_05_5,,,
course_5,ch_5_07,les_5_07_06,topic_5_07_06_01,quiz_5_07_06_1,,,
course_5,ch_5_07,les_5_07_06,topic_5_07_06_01,quiz_5_07_06_2,,,
course_5,ch_5_07,les_5_07_06,topic_5_07_06_01,quiz_5_07_06_3,,,
course_5,ch_5_07,les_5_07_06,topic_5_07_06_01,quiz_5_07_06_4,,,
course_5,ch_5_07,les_5_07_06,topic_5_07_06_01,quiz_5_07_06_5,,,
course_5,ch_5_07,les_5_07_07,topic_5_07_07_01,quiz_5_07_07_1,,,
course_5,ch_5_07,les_5_07_07,topic_5_07_07_01,quiz_5_07_07_2,,,
course_5,ch_5_07,les_5_07_07,topic_5_07_07_01,quiz_5_07_07_3,,,
course_5,ch_5_07,les_5_07_07,topic_5_07_07_01,quiz_5_07_07_4,,,
course_5,ch_5_07,les_5_07_07,topic_5_07_07_01,quiz_5_07_07_5,,,
course_5,ch_5_07,les_5_07_08,topic_5_07_08_01,quiz_5_07_08_1,,,
course_5,ch_5_07,les_5_07_08,topic_5_07_08_01,quiz_5_07_08_2,,,
course_5,ch_5_07,les_5_07_08,topic_5_07_08_01,quiz_5_07_08_3,,,
course_5,ch_5_07,les_5_07_08,topic_5_07_08_01,quiz_5_07_08_4,,,
course_5,ch_5_07,les_5_07_08,topic_5_07_08_01,quiz_5_07_08_5,,,
course_5,ch_5_07,les_5_07_09,topic_5_07_09_01,quiz_5_07_09_1,,,
course_5,ch_5_07,les_5_07_09,topic_5_07_09_01,quiz_5_07_09_2,,,
course_5,ch_5_07,les_5_07_09,topic_5_07_09_01,quiz_5_07_09_3,,,
course_5,ch_5_07,les_5_07_09,topic_5_07_09_01,quiz_5_07_09_4,,,
course_5,ch_5_07,les_5_07_09,topic_5_07_09_01,quiz_5_07_09_5,,,
course_5,ch_5_07,les_5_07_10,topic_5_07_10_01,quiz_5_07_10_1,,,
course_5,ch_5_07,les_5_07_10,topic_5_07_10_01,quiz_5_07_10_2,,,
course_5,ch_5_07,les_5_07_10,topic_5_07_10_01,quiz_5_07_10_3,,,
course_5,ch_5_07,les_5_07_10,topic_5_07_10_01,quiz_5_07_10_4,,,
course_5,ch_5_07,les_5_07_10,topic_5_07_10_01,quiz_5_07_10_5,,,
course_5,ch_5_08,les_5_08_01,topic_5_08_01_01,quiz_5_08_01_1,,,
course_5,ch_5_08,les_5_08_01,topic_5_08_01_01,quiz_5_08_01_2,,,
course_5,ch_5_08,les_5_08_01,topic_5_08_01_01,quiz_5_08_01_3,,,
course_5,ch_5_08,les_5_08_01,topic_5_08_01_01,quiz_5_08_01_4,,,
course_5,ch_5_08,les_5_08_01,topic_5_08_01_01,quiz_5_08_01_5,,,
course_5,ch_5_08,les_5_08_02,topic_5_08_02_01,quiz_5_08_02_1,,,
course_5,ch_5_08,les_5_08_02,topic_5_08_02_01,quiz_5_08_02_2,,,
course_5,ch_5_08,les_5_08_02,topic_5_08_02_01,quiz_5_08_02_3,,,
course_5,ch_5_08,les_5_08_02,topic_5_08_02_01,quiz_5_08_02_4,,,
course_5,ch_5_08,les_5_08_02,topic_5_08_02_01,quiz_5_08_02_5,,,
course_5,ch_5_08,les_5_08_03,topic_5_08_03_01,quiz_5_08_03_1,,,
course_5,ch_5_08,les_5_08_03,topic_5_08_03_01,quiz_5_08_03_2,,,
course_5,ch_5_08,les_5_08_03,topic_5_08_03_01,quiz_5_08_03_3,,,
course_5,ch_5_08,les_5_08_03,topic_5_08_03_01,quiz_5_08_03_4,,,
course_5,ch_5_08,les_5_08_03,topic_5_08_03_01,quiz_5_08_03_5,,,
course_5,ch_5_08,les_5_08_04,topic_5_08_04_01,quiz_5_08_04_1,,,
course_5,ch_5_08,les_5_08_04,topic_5_08_04_01,quiz_5_08_04_2,,,
course_5,ch_5_08,les_5_08_04,topic_5_08_04_01,quiz_5_08_04_3,,,
course_5,ch_5_08,les_5_08_04,topic_5_08_04_01,quiz_5_08_04_4,,,
course_5,ch_5_08,les_5_08_04,topic_5_08_04_01,quiz_5_08_04_5,,,
course_5,ch_5_08,les_5_08_05,topic_5_08_05_01,quiz_5_08_05_1,,,
course_5,ch_5_08,les_5_08_05,topic_5_08_05_01,quiz_5_08_05_2,,,
course_5,ch_5_08,les_5_08_05,topic_5_08_05_01,quiz_5_08_05_3,,,
course_5,ch_5_08,les_5_08_05,topic_5_08_05_01,quiz_5_08_05_4,,,
course_5,ch_5_08,les_5_08_05,topic_5_08_05_01,quiz_5_08_05_5,,,
course_5,ch_5_08,les_5_08_06,topic_5_08_06_01,quiz_5_08_06_1,,,
course_5,ch_5_08,les_5_08_06,topic_5_08_06_01,quiz_5_08_06_2,,,
course_5,ch_5_08,les_5_08_06,topic_5_08_06_01,quiz_5_08_06_3,,,
course_5,ch_5_08,les_5_08_06,topic_5_08_06_01,quiz_5_08_06_4,,,
course_5,ch_5_08,les_5_08_06,topic_5_08_06_01,quiz_5_08_06_5,,,
course_5,ch_5_08,les_5_08_07,topic_5_08_07_01,quiz_5_08_07_1,,,
course_5,ch_5_08,les_5_08_07,topic_5_08_07_01,quiz_5_08_07_2,,,
course_5,ch_5_08,les_5_08_07,topic_5_08_07_01,quiz_5_08_07_3,,,
course_5,ch_5_08,les_5_08_07,topic_5_08_07_01,quiz_5_08_07_4,,,
course_5,ch_5_08,les_5_08_07,topic_5_08_07_01,quiz_5_08_07_5,,,
course_5,ch_5_08,les_5_08_08,topic_5_08_08_01,quiz_5_08_08_1,,,
course_5,ch_5_08,les_5_08_08,topic_5_08_08_01,quiz_5_08_08_2,,,
course_5,ch_5_08,les_5_08_08,topic_5_08_08_01,quiz_5_08_08_3,,,
course_5,ch_5_08,les_5_08_08,topic_5_08_08_01,quiz_5_08_08_4,,,
course_5,ch_5_08,les_5_08_08,topic_5_08_08_01,quiz_5_08_08_5,,,
course_5,ch_5_08,les_5_08_09,topic_5_08_09_01,quiz_5_08_09_1,,,
course_5,ch_5_08,les_5_08_09,topic_5_08_09_01,quiz_5_08_09_2,,,
course_5,ch_5_08,les_5_08_09,topic_5_08_09_01,quiz_5_08_09_3,,,
course_5,ch_5_08,les_5_08_09,topic_5_08_09_01,quiz_5_08_09_4,,,
course_5,ch_5_08,les_5_08_09,topic_5_08_09_01,quiz_5_08_09_5,,,
course_5,ch_5_08,les_5_08_10,topic_5_08_10_01,quiz_5_08_10_1,,,
course_5,ch_5_08,les_5_08_10,topic_5_08_10_01,quiz_5_08_10_2,,,
course_5,ch_5_08,les_5_08_10,topic_5_08_10_01,quiz_5_08_10_3,,,
course_5,ch_5_08,les_5_08_10,topic_5_08_10_01,quiz_5_08_10_4,,,
course_5,ch_5_08,les_5_08_10,topic_5_08_10_01,quiz_5_08_10_5,,,
course_5,ch_5_09,les_5_09_01,topic_5_09_01_01,quiz_5_09_01_1,,,
course_5,ch_5_09,les_5_09_01,topic_5_09_01_01,quiz_5_09_01_2,,,
course_5,ch_5_09,les_5_09_01,topic_5_09_01_01,quiz_5_09_01_3,,,
course_5,ch_5_09,les_5_09_01,topic_5_09_01_01,quiz_5_09_01_4,,,
course_5,ch_5_09,les_5_09_01,topic_5_09_01_01,quiz_5_09_01_5,,,
course_5,ch_5_09,les_5_09_02,topic_5_09_02_01,quiz_5_09_02_1,,,
course_5,ch_5_09,les_5_09_02,topic_5_09_02_01,quiz_5_09_02_2,,,
course_5,ch_5_09,les_5_09_02,topic_5_09_02_01,quiz_5_09_02_3,,,
course_5,ch_5_09,les_5_09_02,topic_5_09_02_01,quiz_5_09_02_4,,,
course_5,ch_5_09,les_5_09_02,topic_5_09_02_01,quiz_5_09_02_5,,,
course_5,ch_5_09,les_5_09_03,topic_5_09_03_01,quiz_5_09_03_1,,,
course_5,ch_5_09,les_5_09_03,topic_5_09_03_01,quiz_5_09_03_2,,,
course_5,ch_5_09,les_5_09_03,topic_5_09_03_01,quiz_5_09_03_3,,,
course_5,ch_5_09,les_5_09_03,topic_5_09_03_01,quiz_5_09_03_4,,,
course_5,ch_5_09,les_5_09_03,topic_5_09_03_01,quiz_5_09_03_5,,,
course_5,ch_5_09,les_5_09_04,topic_5_09_04_01,quiz_5_09_04_1,,,
course_5,ch_5_09,les_5_09_04,topic_5_09_04_01,quiz_5_09_04_2,,,
course_5,ch_5_09,les_5_09_04,topic_5_09_04_01,quiz_5_09_04_3,,,
course_5,ch_5_09,les_5_09_04,topic_5_09_04_01,quiz_5_09_04_4,,,
course_5,ch_5_09,les_5_09_04,topic_5_09_04_01,quiz_5_09_04_5,,,
course_5,ch_5_09,les_5_09_05,topic_5_09_05_01,quiz_5_09_05_1,,,
course_5,ch_5_09,les_5_09_05,topic_5_09_05_01,quiz_5_09_05_2,,,
course_5,ch_5_09,les_5_09_05,topic_5_09_05_01,quiz_5_09_05_3,,,
course_5,ch_5_09,les_5_09_05,topic_5_09_05_01,quiz_5_09_05_4,,,
course_5,ch_5_09,les_5_09_05,topic_5_09_05_01,quiz_5_09_05_5,,,
course_5,ch_5_09,les_5_09_06,topic_5_09_06_01,quiz_5_09_06_1,,,
course_5,ch_5_09,les_5_09_06,topic_5_09_06_01,quiz_5_09_06_2,,,
course_5,ch_5_09,les_5_09_06,topic_5_09_06_01,quiz_5_09_06_3,,,
course_5,ch_5_09,les_5_09_06,topic_5_09_06_01,quiz_5_09_06_4,,,
course_5,ch_5_09,les_5_09_06,topic_5_09_06_01,quiz_5_09_06_5,,,
course_5,ch_5_09,les_5_09_07,topic_5_09_07_01,quiz_5_09_07_1,,,
course_5,ch_5_09,les_5_09_07,topic_5_09_07_01,quiz_5_09_07_2,,,
course_5,ch_5_09,les_5_09_07,topic_5_09_07_01,quiz_5_09_07_3,,,
course_5,ch_5_09,les_5_09_07,topic_5_09_07_01,quiz_5_09_07_4,,,
course_5,ch_5_09,les_5_09_07,topic_5_09_07_01,quiz_5_09_07_5,,,
course_5,ch_5_09,les_5_09_08,topic_5_09_08_01,quiz_5_09_08_1,,,
course_5,ch_5_09,les_5_09_08,topic_5_09_08_01,quiz_5_09_08_2,,,
course_5,ch_5_09,les_5_09_08,topic_5_09_08_01,quiz_5_09_08_3,,,
course_5,ch_5_09,les_5_09_08,topic_5_09_08_01,quiz_5_09_08_4,,,
course_5,ch_5_09,les_5_09_08,topic_5_09_08_01,quiz_5_09_08_5,,,
course_5,ch_5_09,les_5_09_09,topic_5_09_09_01,quiz_5_09_09_1,,,
course_5,ch_5_09,les_5_09_09,topic_5_09_09_01,quiz_5_09_09_2,,,
course_5,ch_5_09,les_5_09_09,topic_5_09_09_01,quiz_5_09_09_3,,,
course_5,ch_5_09,les_5_09_09,topic_5_09_09_01,quiz_5_09_09_4,,,
course_5,ch_5_09,les_5_09_09,topic_5_09_09_01,quiz_5_09_09_5,,,
course_5,ch_5_09,les_5_09_10,topic_5_09_10_01,quiz_5_09_10_1,,,
course_5,ch_5_09,les_5_09_10,topic_5_09_10_01,quiz_5_09_10_2,,,
course_5,ch_5_09,les_5_09_10,topic_5_09_10_01,quiz_5_09_10_3,,,
course_5,ch_5_09,les_5_09_10,topic_5_09_10_01,quiz_5_09_10_4,,,
course_5,ch_5_09,les_5_09_10,topic_5_09_10_01,quiz_5_09_10_5,,,
course_5,ch_5_10,les_5_10_01,topic_5_10_01_01,quiz_5_10_01_1,,,
course_5,ch_5_10,les_5_10_01,topic_5_10_01_01,quiz_5_10_01_2,,,
course_5,ch_5_10,les_5_10_01,topic_5_10_01_01,quiz_5_10_01_3,,,
course_5,ch_5_10,les_5_10_01,topic_5_10_01_01,quiz_5_10_01_4,,,
course_5,ch_5_10,les_5_10_01,topic_5_10_01_01,quiz_5_10_01_5,,,
course_5,ch_5_10,les_5_10_02,topic_5_10_02_01,quiz_5_10_02_1,,,
course_5,ch_5_10,les_5_10_02,topic_5_10_02_01,quiz_5_10_02_2,,,
course_5,ch_5_10,les_5_10_02,topic_5_10_02_01,quiz_5_10_02_3,,,
course_5,ch_5_10,les_5_10_02,topic_5_10_02_01,quiz_5_10_02_4,,,
course_5,ch_5_10,les_5_10_02,topic_5_10_02_01,quiz_5_10_02_5,,,
course_5,ch_5_10,les_5_10_03,topic_5_10_03_01,quiz_5_10_03_1,,,
course_5,ch_5_10,les_5_10_03,topic_5_10_03_01,quiz_5_10_03_2,,,
course_5,ch_5_10,les_5_10_03,topic_5_10_03_01,quiz_5_10_03_3,,,
course_5,ch_5_10,les_5_10_03,topic_5_10_03_01,quiz_5_10_03_4,,,
course_5,ch_5_10,les_5_10_03,topic_5_10_03_01,quiz_5_10_03_5,,,
course_5,ch_5_10,les_5_10_04,topic_5_10_04_01,quiz_5_10_04_1,,,
course_5,ch_5_10,les_5_10_04,topic_5_10_04_01,quiz_5_10_04_2,,,
course_5,ch_5_10,les_5_10_04,topic_5_10_04_01,quiz_5_10_04_3,,,
course_5,ch_5_10,les_5_10_04,topic_5_10_04_01,quiz_5_10_04_4,,,
course_5,ch_5_10,les_5_10_04,topic_5_10_04_01,quiz_5_10_04_5,,,
course_5,ch_5_10,les_5_10_05,topic_5_10_05_01,quiz_5_10_05_1,,,
course_5,ch_5_10,les_5_10_05,topic_5_10_05_01,quiz_5_10_05_2,,,
course_5,ch_5_10,les_5_10_05,topic_5_10_05_01,quiz_5_10_05_3,,,
course_5,ch_5_10,les_5_10_05,topic_5_10_05_01,quiz_5_10_05_4,,,
course_5,ch_5_10,les_5_10_05,topic_5_10_05_01,quiz_5_10_05_5,,,
course_5,ch_5_10,les_5_10_06,topic_5_10_06_01,quiz_5_10_06_1,,,
course_5,ch_5_10,les_5_10_06,topic_5_10_06_01,quiz_5_10_06_2,,,
course_5,ch_5_10,les_5_10_06,topic_5_10_06_01,quiz_5_10_06_3,,,
course_5,ch_5_10,les_5_10_06,topic_5_10_06_01,quiz_5_10_06_4,,,
course_5,ch_5_10,les_5_10_06,topic_5_10_06_01,quiz_5_10_06_5,,,
course_5,ch_5_10,les_5_10_07,topic_5_10_07_01,quiz_5_10_07_1,,,
course_5,ch_5_10,les_5_10_07,topic_5_10_07_01,quiz_5_10_07_2,,,
course_5,ch_5_10,les_5_10_07,topic_5_10_07_01,quiz_5_10_07_3,,,
course_5,ch_5_10,les_5_10_07,topic_5_10_07_01,quiz_5_10_07_4,,,
course_5,ch_5_10,les_5_10_07,topic_5_10_07_01,quiz_5_10_07_5,,,
course_5,ch_5_10,les_5_10_08,topic_5_10_08_01,quiz_5_10_08_1,,,
course_5,ch_5_10,les_5_10_08,topic_5_10_08_01,quiz_5_10_08_2,,,
course_5,ch_5_10,les_5_10_08,topic_5_10_08_01,quiz_5_10_08_3,,,
course_5,ch_5_10,les_5_10_08,topic_5_10_08_01,quiz_5_10_08_4,,,
course_5,ch_5_10,les_5_10_08,topic_5_10_08_01,quiz_5_10_08_5,,,
course_5,ch_5_10,les_5_10_09,topic_5_10_09_01,quiz_5_10_09_1,,,
course_5,ch_5_10,les_5_10_09,topic_5_10_09_01,quiz_5_10_09_2,,,
course_5,ch_5_10,les_5_10_09,topic_5_10_09_01,quiz_5_10_09_3,,,
course_5,ch_5_10,les_5_10_09,topic_5_10_09_01,quiz_5_10_09_4,,,
course_5,ch_5_10,les_5_10_09,topic_5_10_09_01,quiz_5_10_09_5,,,
course_5,ch_5_10,les_5_10_10,topic_5_10_10_01,quiz_5_10_10_1,,,
course_5,ch_5_10,les_5_10_10,topic_5_10_10_01,quiz_5_10_10_2,,,
course_5,ch_5_10,les_5_10_10,topic_5_10_10_01,quiz_5_10_10_3,,,
course_5,ch_5_10,les_5_10_10,topic_5_10_10_01,quiz_5_10_10_4,,,
course_5,ch_5_10,les_5_10_10,topic_5_10_10_01,quiz_5_10_10_5,,,
course_5,ch_5_11,les_5_11_01,topic_5_11_01_01,quiz_5_11_01_1,,,
course_5,ch_5_11,les_5_11_01,topic_5_11_01_01,quiz_5_11_01_2,,,
course_5,ch_5_11,les_5_11_01,topic_5_11_01_01,quiz_5_11_01_3,,,
course_5,ch_5_11,les_5_11_01,topic_5_11_01_01,quiz_5_11_01_4,,,
course_5,ch_5_11,les_5_11_01,topic_5_11_01_01,quiz_5_11_01_5,,,
course_5,ch_5_11,les_5_11_02,topic_5_11_02_01,quiz_5_11_02_1,,,
course_5,ch_5_11,les_5_11_02,topic_5_11_02_01,quiz_5_11_02_2,,,
course_5,ch_5_11,les_5_11_02,topic_5_11_02_01,quiz_5_11_02_3,,,
course_5,ch_5_11,les_5_11_02,topic_5_11_02_01,quiz_5_11_02_4,,,
course_5,ch_5_11,les_5_11_02,topic_5_11_02_01,quiz_5_11_02_5,,,
course_5,ch_5_11,les_5_11_03,topic_5_11_03_01,quiz_5_11_03_1,,,
course_5,ch_5_11,les_5_11_03,topic_5_11_03_01,quiz_5_11_03_2,,,
course_5,ch_5_11,les_5_11_03,topic_5_11_03_01,quiz_5_11_03_3,,,
course_5,ch_5_11,les_5_11_03,topic_5_11_03_01,quiz_5_11_03_4,,,
course_5,ch_5_11,les_5_11_03,topic_5_11_03_01,quiz_5_11_03_5,,,
course_5,ch_5_11,les_5_11_04,topic_5_11_04_01,quiz_5_11_04_1,,,
course_5,ch_5_11,les_5_11_04,topic_5_11_04_01,quiz_5_11_04_2,,,
course_5,ch_5_11,les_5_11_04,topic_5_11_04_01,quiz_5_11_04_3,,,
course_5,ch_5_11,les_5_11_04,topic_5_11_04_01,quiz_5_11_04_4,,,
course_5,ch_5_11,les_5_11_04,topic_5_11_04_01,quiz_5_11_04_5,,,
course_5,ch_5_11,les_5_11_05,topic_5_11_05_01,quiz_5_11_05_1,,,
course_5,ch_5_11,les_5_11_05,topic_5_11_05_01,quiz_5_11_05_2,,,
course_5,ch_5_11,les_5_11_05,topic_5_11_05_01,quiz_5_11_05_3,,,
course_5,ch_5_11,les_5_11_05,topic_5_11_05_01,quiz_5_11_05_4,,,
course_5,ch_5_11,les_5_11_05,topic_5_11_05_01,quiz_5_11_05_5,,,
course_5,ch_5_11,les_5_11_06,topic_5_11_06_01,quiz_5_11_06_1,,,
course_5,ch_5_11,les_5_11_06,topic_5_11_06_01,quiz_5_11_06_2,,,
course_5,ch_5_11,les_5_11_06,topic_5_11_06_01,quiz_5_11_06_3,,,
course_5,ch_5_11,les_5_11_06,topic_5_11_06_01,quiz_5_11_06_4,,,
course_5,ch_5_11,les_5_11_06,topic_5_11_06_01,quiz_5_11_06_5,,,
course_5,ch_5_11,les_5_11_07,topic_5_11_07_01,quiz_5_11_07_1,,,
course_5,ch_5_11,les_5_11_07,topic_5_11_07_01,quiz_5_11_07_2,,,
course_5,ch_5_11,les_5_11_07,topic_5_11_07_01,quiz_5_11_07_3,,,
course_5,ch_5_11,les_5_11_07,topic_5_11_07_01,quiz_5_11_07_4,,,
course_5,ch_5_11,les_5_11_07,topic_5_11_07_01,quiz_5_11_07_5,,,
course_5,ch_5_11,les_5_11_08,topic_5_11_08_01,quiz_5_11_08_1,,,
course_5,ch_5_11,les_5_11_08,topic_5_11_08_01,quiz_5_11_08_2,,,
course_5,ch_5_11,les_5_11_08,topic_5_11_08_01,quiz_5_11_08_3,,,
course_5,ch_5_11,les_5_11_08,topic_5_11_08_01,quiz_5_11_08_4,,,
course_5,ch_5_11,les_5_11_08,topic_5_11_08_01,quiz_5_11_08_5,,,
course_5,ch_5_11,les_5_11_09,topic_5_11_09_01,quiz_5_11_09_1,,,
course_5,ch_5_11,les_5_11_09,topic_5_11_09_01,quiz_5_11_09_2,,,
course_5,ch_5_11,les_5_11_09,topic_5_11_09_01,quiz_5_11_09_3,,,
course_5,ch_5_11,les_5_11_09,topic_5_11_09_01,quiz_5_11_09_4,,,
course_5,ch_5_11,les_5_11_09,topic_5_11_09_01,quiz_5_11_09_5,,,
course_5,ch_5_11,les_5_11_10,topic_5_11_10_01,quiz_5_11_10_1,,,
course_5,ch_5_11,les_5_11_10,topic_5_11_10_01,quiz_5_11_10_2,,,
course_5,ch_5_11,les_5_11_10,topic_5_11_10_01,quiz_5_11_10_3,,,
course_5,ch_5_11,les_5_11_10,topic_5_11_10_01,quiz_5_11_10_4,,,
course_5,ch_5_11,les_5_11_10,topic_5_11_10_01,quiz_5_11_10_5,,,
course_5,ch_5_12,les_5_12_01,topic_5_12_01_01,quiz_5_12_01_1,,,
course_5,ch_5_12,les_5_12_01,topic_5_12_01_01,quiz_5_12_01_2,,,
course_5,ch_5_12,les_5_12_01,topic_5_12_01_01,quiz_5_12_01_3,,,
course_5,ch_5_12,les_5_12_01,topic_5_12_01_01,quiz_5_12_01_4,,,
course_5,ch_5_12,les_5_12_01,topic_5_12_01_01,quiz_5_12_01_5,,,
course_5,ch_5_12,les_5_12_02,topic_5_12_02_01,quiz_5_12_02_1,,,
course_5,ch_5_12,les_5_12_02,topic_5_12_02_01,quiz_5_12_02_2,,,
course_5,ch_5_12,les_5_12_02,topic_5_12_02_01,quiz_5_12_02_3,,,
course_5,ch_5_12,les_5_12_02,topic_5_12_02_01,quiz_5_12_02_4,,,
course_5,ch_5_12,les_5_12_02,topic_5_12_02_01,quiz_5_12_02_5,,,
course_5,ch_5_12,les_5_12_03,topic_5_12_03_01,quiz_5_12_03_1,,,
course_5,ch_5_12,les_5_12_03,topic_5_12_03_01,quiz_5_12_03_2,,,
course_5,ch_5_12,les_5_12_03,topic_5_12_03_01,quiz_5_12_03_3,,,
course_5,ch_5_12,les_5_12_03,topic_5_12_03_01,quiz_5_12_03_4,,,
course_5,ch_5_12,les_5_12_03,topic_5_12_03_01,quiz_5_12_03_5,,,
course_5,ch_5_12,les_5_12_04,topic_5_12_04_01,quiz_5_12_04_1,,,
course_5,ch_5_12,les_5_12_04,topic_5_12_04_01,quiz_5_12_04_2,,,
course_5,ch_5_12,les_5_12_04,topic_5_12_04_01,quiz_5_12_04_3,,,
course_5,ch_5_12,les_5_12_04,topic_5_12_04_01,quiz_5_12_04_4,,,
course_5,ch_5_12,les_5_12_04,topic_5_12_04_01,quiz_5_12_04_5,,,
course_5,ch_5_12,les_5_12_05,topic_5_12_05_01,quiz_5_12_05_1,,,
course_5,ch_5_12,les_5_12_05,topic_5_12_05_01,quiz_5_12_05_2,,,
course_5,ch_5_12,les_5_12_05,topic_5_12_05_01,quiz_5_12_05_3,,,
course_5,ch_5_12,les_5_12_05,topic_5_12_05_01,quiz_5_12_05_4,,,
course_5,ch_5_12,les_5_12_05,topic_5_12_05_01,quiz_5_12_05_5,,,
course_5,ch_5_12,les_5_12_06,topic_5_12_06_01,quiz_5_12_06_1,,,
course_5,ch_5_12,les_5_12_06,topic_5_12_06_01,quiz_5_12_06_2,,,
course_5,ch_5_12,les_5_12_06,topic_5_12_06_01,quiz_5_12_06_3,,,
course_5,ch_5_12,les_5_12_06,topic_5_12_06_01,quiz_5_12_06_4,,,
course_5,ch_5_12,les_5_12_06,topic_5_12_06_01,quiz_5_12_06_5,,,
course_5,ch_5_12,les_5_12_07,topic_5_12_07_01,quiz_5_12_07_1,,,
course_5,ch_5_12,les_5_12_07,topic_5_12_07_01,quiz_5_12_07_2,,,
course_5,ch_5_12,les_5_12_07,topic_5_12_07_01,quiz_5_12_07_3,,,
course_5,ch_5_12,les_5_12_07,topic_5_12_07_01,quiz_5_12_07_4,,,
course_5,ch_5_12,les_5_12_07,topic_5_12_07_01,quiz_5_12_07_5,,,
course_5,ch_5_12,les_5_12_08,topic_5_12_08_01,quiz_5_12_08_1,,,
course_5,ch_5_12,les_5_12_08,topic_5_12_08_01,quiz_5_12_08_2,,,
course_5,ch_5_12,les_5_12_08,topic_5_12_08_01,quiz_5_12_08_3,,,
course_5,ch_5_12,les_5_12_08,topic_5_12_08_01,quiz_5_12_08_4,,,
course_5,ch_5_12,les_5_12_08,topic_5_12_08_01,quiz_5_12_08_5,,,
course_5,ch_5_12,les_5_12_09,topic_5_12_09_01,quiz_5_12_09_1,,,
course_5,ch_5_12,les_5_12_09,topic_5_12_09_01,quiz_5_12_09_2,,,
course_5,ch_5_12,les_5_12_09,topic_5_12_09_01,quiz_5_12_09_3,,,
course_5,ch_5_12,les_5_12_09,topic_5_12_09_01,quiz_5_12_09_4,,,
course_5,ch_5_12,les_5_12_09,topic_5_12_09_01,quiz_5_12_09_5,,,
course_5,ch_5_12,les_5_12_10,topic_5_12_10_01,quiz_5_12_10_1,,,
course_5,ch_5_12,les_5_12_10,topic_5_12_10_01,quiz_5_12_10_2,,,
course_5,ch_5_12,les_5_12_10,topic_5_12_10_01,quiz_5_12_10_3,,,
course_5,ch_5_12,les_5_12_10,topic_5_12_10_01,quiz_5_12_10_4,,,
course_5,ch_5_12,les_5_12_10,topic_5_12_10_01,quiz_5_12_10_5,,,
,,,,,,,
,,,,,,,
,,,,,,,
course_6,ch_6_01,les_6_01_01,topic_6_01_01_01,quiz_6_01_01_1,,,
course_6,ch_6_01,les_6_01_01,topic_6_01_01_01,quiz_6_01_01_2,,,
course_6,ch_6_01,les_6_01_01,topic_6_01_01_01,quiz_6_01_01_3,,,
course_6,ch_6_01,les_6_01_01,topic_6_01_01_01,quiz_6_01_01_4,,,
course_6,ch_6_01,les_6_01_01,topic_6_01_01_01,quiz_6_01_01_5,,,
course_6,ch_6_01,les_6_01_02,topic_6_01_02_01,quiz_6_01_02_1,,,
course_6,ch_6_01,les_6_01_02,topic_6_01_02_01,quiz_6_01_02_2,,,
course_6,ch_6_01,les_6_01_02,topic_6_01_02_01,quiz_6_01_02_3,,,
course_6,ch_6_01,les_6_01_02,topic_6_01_02_01,quiz_6_01_02_4,,,
course_6,ch_6_01,les_6_01_02,topic_6_01_02_01,quiz_6_01_02_5,,,
course_6,ch_6_01,les_6_01_03,topic_6_01_03_01,quiz_6_01_03_1,,,
course_6,ch_6_01,les_6_01_03,topic_6_01_03_01,quiz_6_01_03_2,,,
course_6,ch_6_01,les_6_01_03,topic_6_01_03_01,quiz_6_01_03_3,,,
course_6,ch_6_01,les_6_01_03,topic_6_01_03_01,quiz_6_01_03_4,,,
course_6,ch_6_01,les_6_01_03,topic_6_01_03_01,quiz_6_01_03_5,,,
course_6,ch_6_01,les_6_01_04,topic_6_01_04_01,quiz_6_01_04_1,,,
course_6,ch_6_01,les_6_01_04,topic_6_01_04_01,quiz_6_01_04_2,,,
course_6,ch_6_01,les_6_01_04,topic_6_01_04_01,quiz_6_01_04_3,,,
course_6,ch_6_01,les_6_01_04,topic_6_01_04_01,quiz_6_01_04_4,,,
course_6,ch_6_01,les_6_01_04,topic_6_01_04_01,quiz_6_01_04_5,,,
course_6,ch_6_01,les_6_01_05,topic_6_01_05_01,quiz_6_01_05_1,,,
course_6,ch_6_01,les_6_01_05,topic_6_01_05_01,quiz_6_01_05_2,,,
course_6,ch_6_01,les_6_01_05,topic_6_01_05_01,quiz_6_01_05_3,,,
course_6,ch_6_01,les_6_01_05,topic_6_01_05_01,quiz_6_01_05_4,,,
course_6,ch_6_01,les_6_01_05,topic_6_01_05_01,quiz_6_01_05_5,,,
course_6,ch_6_01,les_6_01_06,topic_6_01_06_01,quiz_6_01_06_1,,,
course_6,ch_6_01,les_6_01_06,topic_6_01_06_01,quiz_6_01_06_2,,,
course_6,ch_6_01,les_6_01_06,topic_6_01_06_01,quiz_6_01_06_3,,,
course_6,ch_6_01,les_6_01_06,topic_6_01_06_01,quiz_6_01_06_4,,,
course_6,ch_6_01,les_6_01_06,topic_6_01_06_01,quiz_6_01_06_5,,,
course_6,ch_6_01,les_6_01_07,topic_6_01_07_01,quiz_6_01_07_1,,,
course_6,ch_6_01,les_6_01_07,topic_6_01_07_01,quiz_6_01_07_2,,,
course_6,ch_6_01,les_6_01_07,topic_6_01_07_01,quiz_6_01_07_3,,,
course_6,ch_6_01,les_6_01_07,topic_6_01_07_01,quiz_6_01_07_4,,,
course_6,ch_6_01,les_6_01_07,topic_6_01_07_01,quiz_6_01_07_5,,,
course_6,ch_6_01,les_6_01_08,topic_6_01_08_01,quiz_6_01_08_1,,,
course_6,ch_6_01,les_6_01_08,topic_6_01_08_01,quiz_6_01_08_2,,,
course_6,ch_6_01,les_6_01_08,topic_6_01_08_01,quiz_6_01_08_3,,,
course_6,ch_6_01,les_6_01_08,topic_6_01_08_01,quiz_6_01_08_4,,,
course_6,ch_6_01,les_6_01_08,topic_6_01_08_01,quiz_6_01_08_5,,,
course_6,ch_6_01,les_6_01_09,topic_6_01_09_01,quiz_6_01_09_1,,,
course_6,ch_6_01,les_6_01_09,topic_6_01_09_01,quiz_6_01_09_2,,,
course_6,ch_6_01,les_6_01_09,topic_6_01_09_01,quiz_6_01_09_3,,,
course_6,ch_6_01,les_6_01_09,topic_6_01_09_01,quiz_6_01_09_4,,,
course_6,ch_6_01,les_6_01_09,topic_6_01_09_01,quiz_6_01_09_5,,,
course_6,ch_6_01,les_6_01_10,topic_6_01_10_01,quiz_6_01_10_1,,,
course_6,ch_6_01,les_6_01_10,topic_6_01_10_01,quiz_6_01_10_2,,,
course_6,ch_6_01,les_6_01_10,topic_6_01_10_01,quiz_6_01_10_3,,,
course_6,ch_6_01,les_6_01_10,topic_6_01_10_01,quiz_6_01_10_4,,,
course_6,ch_6_01,les_6_01_10,topic_6_01_10_01,quiz_6_01_10_5,,,
course_6,ch_6_02,les_6_02_01,topic_6_02_01_01,quiz_6_02_01_1,,,
course_6,ch_6_02,les_6_02_01,topic_6_02_01_01,quiz_6_02_01_2,,,
course_6,ch_6_02,les_6_02_01,topic_6_02_01_01,quiz_6_02_01_3,,,
course_6,ch_6_02,les_6_02_01,topic_6_02_01_01,quiz_6_02_01_4,,,
course_6,ch_6_02,les_6_02_01,topic_6_02_01_01,quiz_6_02_01_5,,,
course_6,ch_6_02,les_6_02_02,topic_6_02_02_01,quiz_6_02_02_1,,,
course_6,ch_6_02,les_6_02_02,topic_6_02_02_01,quiz_6_02_02_2,,,
course_6,ch_6_02,les_6_02_02,topic_6_02_02_01,quiz_6_02_02_3,,,
course_6,ch_6_02,les_6_02_02,topic_6_02_02_01,quiz_6_02_02_4,,,
course_6,ch_6_02,les_6_02_02,topic_6_02_02_01,quiz_6_02_02_5,,,
course_6,ch_6_02,les_6_02_03,topic_6_02_03_01,quiz_6_02_03_1,,,
course_6,ch_6_02,les_6_02_03,topic_6_02_03_01,quiz_6_02_03_2,,,
course_6,ch_6_02,les_6_02_03,topic_6_02_03_01,quiz_6_02_03_3,,,
course_6,ch_6_02,les_6_02_03,topic_6_02_03_01,quiz_6_02_03_4,,,
course_6,ch_6_02,les_6_02_03,topic_6_02_03_01,quiz_6_02_03_5,,,
course_6,ch_6_02,les_6_02_04,topic_6_02_04_01,quiz_6_02_04_1,,,
course_6,ch_6_02,les_6_02_04,topic_6_02_04_01,quiz_6_02_04_2,,,
course_6,ch_6_02,les_6_02_04,topic_6_02_04_01,quiz_6_02_04_3,,,
course_6,ch_6_02,les_6_02_04,topic_6_02_04_01,quiz_6_02_04_4,,,
course_6,ch_6_02,les_6_02_04,topic_6_02_04_01,quiz_6_02_04_5,,,
course_6,ch_6_02,les_6_02_05,topic_6_02_05_01,quiz_6_02_05_1,,,
course_6,ch_6_02,les_6_02_05,topic_6_02_05_01,quiz_6_02_05_2,,,
course_6,ch_6_02,les_6_02_05,topic_6_02_05_01,quiz_6_02_05_3,,,
course_6,ch_6_02,les_6_02_05,topic_6_02_05_01,quiz_6_02_05_4,,,
course_6,ch_6_02,les_6_02_05,topic_6_02_05_01,quiz_6_02_05_5,,,
course_6,ch_6_02,les_6_02_06,topic_6_02_06_01,quiz_6_02_06_1,,,
course_6,ch_6_02,les_6_02_06,topic_6_02_06_01,quiz_6_02_06_2,,,
course_6,ch_6_02,les_6_02_06,topic_6_02_06_01,quiz_6_02_06_3,,,
course_6,ch_6_02,les_6_02_06,topic_6_02_06_01,quiz_6_02_06_4,,,
course_6,ch_6_02,les_6_02_06,topic_6_02_06_01,quiz_6_02_06_5,,,
course_6,ch_6_02,les_6_02_07,topic_6_02_07_01,quiz_6_02_07_1,,,
course_6,ch_6_02,les_6_02_07,topic_6_02_07_01,quiz_6_02_07_2,,,
course_6,ch_6_02,les_6_02_07,topic_6_02_07_01,quiz_6_02_07_3,,,
course_6,ch_6_02,les_6_02_07,topic_6_02_07_01,quiz_6_02_07_4,,,
course_6,ch_6_02,les_6_02_07,topic_6_02_07_01,quiz_6_02_07_5,,,
course_6,ch_6_02,les_6_02_08,topic_6_02_08_01,quiz_6_02_08_1,,,
course_6,ch_6_02,les_6_02_08,topic_6_02_08_01,quiz_6_02_08_2,,,
course_6,ch_6_02,les_6_02_08,topic_6_02_08_01,quiz_6_02_08_3,,,
course_6,ch_6_02,les_6_02_08,topic_6_02_08_01,quiz_6_02_08_4,,,
course_6,ch_6_02,les_6_02_08,topic_6_02_08_01,quiz_6_02_08_5,,,
course_6,ch_6_02,les_6_02_09,topic_6_02_09_01,quiz_6_02_09_1,,,
course_6,ch_6_02,les_6_02_09,topic_6_02_09_01,quiz_6_02_09_2,,,
course_6,ch_6_02,les_6_02_09,topic_6_02_09_01,quiz_6_02_09_3,,,
course_6,ch_6_02,les_6_02_09,topic_6_02_09_01,quiz_6_02_09_4,,,
course_6,ch_6_02,les_6_02_09,topic_6_02_09_01,quiz_6_02_09_5,,,
course_6,ch_6_02,les_6_02_10,topic_6_02_10_01,quiz_6_02_10_1,,,
course_6,ch_6_02,les_6_02_10,topic_6_02_10_01,quiz_6_02_10_2,,,
course_6,ch_6_02,les_6_02_10,topic_6_02_10_01,quiz_6_02_10_3,,,
course_6,ch_6_02,les_6_02_10,topic_6_02_10_01,quiz_6_02_10_4,,,
course_6,ch_6_02,les_6_02_10,topic_6_02_10_01,quiz_6_02_10_5,,,
course_6,ch_6_03,les_6_03_01,topic_6_03_01_01,quiz_6_03_01_1,,,
course_6,ch_6_03,les_6_03_01,topic_6_03_01_01,quiz_6_03_01_2,,,
course_6,ch_6_03,les_6_03_01,topic_6_03_01_01,quiz_6_03_01_3,,,
course_6,ch_6_03,les_6_03_01,topic_6_03_01_01,quiz_6_03_01_4,,,
course_6,ch_6_03,les_6_03_01,topic_6_03_01_01,quiz_6_03_01_5,,,
course_6,ch_6_03,les_6_03_02,topic_6_03_02_01,quiz_6_03_02_1,,,
course_6,ch_6_03,les_6_03_02,topic_6_03_02_01,quiz_6_03_02_2,,,
course_6,ch_6_03,les_6_03_02,topic_6_03_02_01,quiz_6_03_02_3,,,
course_6,ch_6_03,les_6_03_02,topic_6_03_02_01,quiz_6_03_02_4,,,
course_6,ch_6_03,les_6_03_02,topic_6_03_02_01,quiz_6_03_02_5,,,
course_6,ch_6_03,les_6_03_03,topic_6_03_03_01,quiz_6_03_03_1,,,
course_6,ch_6_03,les_6_03_03,topic_6_03_03_01,quiz_6_03_03_2,,,
course_6,ch_6_03,les_6_03_03,topic_6_03_03_01,quiz_6_03_03_3,,,
course_6,ch_6_03,les_6_03_03,topic_6_03_03_01,quiz_6_03_03_4,,,
course_6,ch_6_03,les_6_03_03,topic_6_03_03_01,quiz_6_03_03_5,,,
course_6,ch_6_03,les_6_03_04,topic_6_03_04_01,quiz_6_03_04_1,,,
course_6,ch_6_03,les_6_03_04,topic_6_03_04_01,quiz_6_03_04_2,,,
course_6,ch_6_03,les_6_03_04,topic_6_03_04_01,quiz_6_03_04_3,,,
course_6,ch_6_03,les_6_03_04,topic_6_03_04_01,quiz_6_03_04_4,,,
course_6,ch_6_03,les_6_03_04,topic_6_03_04_01,quiz_6_03_04_5,,,
course_6,ch_6_03,les_6_03_05,topic_6_03_05_01,quiz_6_03_05_1,,,
course_6,ch_6_03,les_6_03_05,topic_6_03_05_01,quiz_6_03_05_2,,,
course_6,ch_6_03,les_6_03_05,topic_6_03_05_01,quiz_6_03_05_3,,,
course_6,ch_6_03,les_6_03_05,topic_6_03_05_01,quiz_6_03_05_4,,,
course_6,ch_6_03,les_6_03_05,topic_6_03_05_01,quiz_6_03_05_5,,,
course_6,ch_6_03,les_6_03_06,topic_6_03_06_01,quiz_6_03_06_1,,,
course_6,ch_6_03,les_6_03_06,topic_6_03_06_01,quiz_6_03_06_2,,,
course_6,ch_6_03,les_6_03_06,topic_6_03_06_01,quiz_6_03_06_3,,,
course_6,ch_6_03,les_6_03_06,topic_6_03_06_01,quiz_6_03_06_4,,,
course_6,ch_6_03,les_6_03_06,topic_6_03_06_01,quiz_6_03_06_5,,,
course_6,ch_6_03,les_6_03_07,topic_6_03_07_01,quiz_6_03_07_1,,,
course_6,ch_6_03,les_6_03_07,topic_6_03_07_01,quiz_6_03_07_2,,,
course_6,ch_6_03,les_6_03_07,topic_6_03_07_01,quiz_6_03_07_3,,,
course_6,ch_6_03,les_6_03_07,topic_6_03_07_01,quiz_6_03_07_4,,,
course_6,ch_6_03,les_6_03_07,topic_6_03_07_01,quiz_6_03_07_5,,,
course_6,ch_6_03,les_6_03_08,topic_6_03_08_01,quiz_6_03_08_1,,,
course_6,ch_6_03,les_6_03_08,topic_6_03_08_01,quiz_6_03_08_2,,,
course_6,ch_6_03,les_6_03_08,topic_6_03_08_01,quiz_6_03_08_3,,,
course_6,ch_6_03,les_6_03_08,topic_6_03_08_01,quiz_6_03_08_4,,,
course_6,ch_6_03,les_6_03_08,topic_6_03_08_01,quiz_6_03_08_5,,,
course_6,ch_6_03,les_6_03_09,topic_6_03_09_01,quiz_6_03_09_1,,,
course_6,ch_6_03,les_6_03_09,topic_6_03_09_01,quiz_6_03_09_2,,,
course_6,ch_6_03,les_6_03_09,topic_6_03_09_01,quiz_6_03_09_3,,,
course_6,ch_6_03,les_6_03_09,topic_6_03_09_01,quiz_6_03_09_4,,,
course_6,ch_6_03,les_6_03_09,topic_6_03_09_01,quiz_6_03_09_5,,,
course_6,ch_6_03,les_6_03_10,topic_6_03_10_01,quiz_6_03_10_1,,,
course_6,ch_6_03,les_6_03_10,topic_6_03_10_01,quiz_6_03_10_2,,,
course_6,ch_6_03,les_6_03_10,topic_6_03_10_01,quiz_6_03_10_3,,,
course_6,ch_6_03,les_6_03_10,topic_6_03_10_01,quiz_6_03_10_4,,,
course_6,ch_6_03,les_6_03_10,topic_6_03_10_01,quiz_6_03_10_5,,,
course_6,ch_6_04,les_6_04_01,topic_6_04_01_01,quiz_6_04_01_1,,,
course_6,ch_6_04,les_6_04_01,topic_6_04_01_01,quiz_6_04_01_2,,,
course_6,ch_6_04,les_6_04_01,topic_6_04_01_01,quiz_6_04_01_3,,,
course_6,ch_6_04,les_6_04_01,topic_6_04_01_01,quiz_6_04_01_4,,,
course_6,ch_6_04,les_6_04_01,topic_6_04_01_01,quiz_6_04_01_5,,,
course_6,ch_6_04,les_6_04_02,topic_6_04_02_01,quiz_6_04_02_1,,,
course_6,ch_6_04,les_6_04_02,topic_6_04_02_01,quiz_6_04_02_2,,,
course_6,ch_6_04,les_6_04_02,topic_6_04_02_01,quiz_6_04_02_3,,,
course_6,ch_6_04,les_6_04_02,topic_6_04_02_01,quiz_6_04_02_4,,,
course_6,ch_6_04,les_6_04_02,topic_6_04_02_01,quiz_6_04_02_5,,,
course_6,ch_6_04,les_6_04_03,topic_6_04_03_01,quiz_6_04_03_1,,,
course_6,ch_6_04,les_6_04_03,topic_6_04_03_01,quiz_6_04_03_2,,,
course_6,ch_6_04,les_6_04_03,topic_6_04_03_01,quiz_6_04_03_3,,,
course_6,ch_6_04,les_6_04_03,topic_6_04_03_01,quiz_6_04_03_4,,,
course_6,ch_6_04,les_6_04_03,topic_6_04_03_01,quiz_6_04_03_5,,,
course_6,ch_6_04,les_6_04_04,topic_6_04_04_01,quiz_6_04_04_1,,,
course_6,ch_6_04,les_6_04_04,topic_6_04_04_01,quiz_6_04_04_2,,,
course_6,ch_6_04,les_6_04_04,topic_6_04_04_01,quiz_6_04_04_3,,,
course_6,ch_6_04,les_6_04_04,topic_6_04_04_01,quiz_6_04_04_4,,,
course_6,ch_6_04,les_6_04_04,topic_6_04_04_01,quiz_6_04_04_5,,,
course_6,ch_6_04,les_6_04_05,topic_6_04_05_01,quiz_6_04_05_1,,,
course_6,ch_6_04,les_6_04_05,topic_6_04_05_01,quiz_6_04_05_2,,,
course_6,ch_6_04,les_6_04_05,topic_6_04_05_01,quiz_6_04_05_3,,,
course_6,ch_6_04,les_6_04_05,topic_6_04_05_01,quiz_6_04_05_4,,,
course_6,ch_6_04,les_6_04_05,topic_6_04_05_01,quiz_6_04_05_5,,,
course_6,ch_6_04,les_6_04_06,topic_6_04_06_01,quiz_6_04_06_1,,,
course_6,ch_6_04,les_6_04_06,topic_6_04_06_01,quiz_6_04_06_2,,,
course_6,ch_6_04,les_6_04_06,topic_6_04_06_01,quiz_6_04_06_3,,,
course_6,ch_6_04,les_6_04_06,topic_6_04_06_01,quiz_6_04_06_4,,,
course_6,ch_6_04,les_6_04_06,topic_6_04_06_01,quiz_6_04_06_5,,,
course_6,ch_6_04,les_6_04_07,topic_6_04_07_01,quiz_6_04_07_1,,,
course_6,ch_6_04,les_6_04_07,topic_6_04_07_01,quiz_6_04_07_2,,,
course_6,ch_6_04,les_6_04_07,topic_6_04_07_01,quiz_6_04_07_3,,,
course_6,ch_6_04,les_6_04_07,topic_6_04_07_01,quiz_6_04_07_4,,,
course_6,ch_6_04,les_6_04_07,topic_6_04_07_01,quiz_6_04_07_5,,,
course_6,ch_6_04,les_6_04_08,topic_6_04_08_01,quiz_6_04_08_1,,,
course_6,ch_6_04,les_6_04_08,topic_6_04_08_01,quiz_6_04_08_2,,,
course_6,ch_6_04,les_6_04_08,topic_6_04_08_01,quiz_6_04_08_3,,,
course_6,ch_6_04,les_6_04_08,topic_6_04_08_01,quiz_6_04_08_4,,,
course_6,ch_6_04,les_6_04_08,topic_6_04_08_01,quiz_6_04_08_5,,,
course_6,ch_6_04,les_6_04_09,topic_6_04_09_01,quiz_6_04_09_1,,,
course_6,ch_6_04,les_6_04_09,topic_6_04_09_01,quiz_6_04_09_2,,,
course_6,ch_6_04,les_6_04_09,topic_6_04_09_01,quiz_6_04_09_3,,,
course_6,ch_6_04,les_6_04_09,topic_6_04_09_01,quiz_6_04_09_4,,,
course_6,ch_6_04,les_6_04_09,topic_6_04_09_01,quiz_6_04_09_5,,,
course_6,ch_6_04,les_6_04_10,topic_6_04_10_01,quiz_6_04_10_1,,,
course_6,ch_6_04,les_6_04_10,topic_6_04_10_01,quiz_6_04_10_2,,,
course_6,ch_6_04,les_6_04_10,topic_6_04_10_01,quiz_6_04_10_3,,,
course_6,ch_6_04,les_6_04_10,topic_6_04_10_01,quiz_6_04_10_4,,,
course_6,ch_6_04,les_6_04_10,topic_6_04_10_01,quiz_6_04_10_5,,,
course_6,ch_6_05,les_6_05_01,topic_6_05_01_01,quiz_6_05_01_1,,,
course_6,ch_6_05,les_6_05_01,topic_6_05_01_01,quiz_6_05_01_2,,,
course_6,ch_6_05,les_6_05_01,topic_6_05_01_01,quiz_6_05_01_3,,,
course_6,ch_6_05,les_6_05_01,topic_6_05_01_01,quiz_6_05_01_4,,,
course_6,ch_6_05,les_6_05_01,topic_6_05_01_01,quiz_6_05_01_5,,,
course_6,ch_6_05,les_6_05_02,topic_6_05_02_01,quiz_6_05_02_1,,,
course_6,ch_6_05,les_6_05_02,topic_6_05_02_01,quiz_6_05_02_2,,,
course_6,ch_6_05,les_6_05_02,topic_6_05_02_01,quiz_6_05_02_3,,,
course_6,ch_6_05,les_6_05_02,topic_6_05_02_01,quiz_6_05_02_4,,,
course_6,ch_6_05,les_6_05_02,topic_6_05_02_01,quiz_6_05_02_5,,,
course_6,ch_6_05,les_6_05_03,topic_6_05_03_01,quiz_6_05_03_1,,,
course_6,ch_6_05,les_6_05_03,topic_6_05_03_01,quiz_6_05_03_2,,,
course_6,ch_6_05,les_6_05_03,topic_6_05_03_01,quiz_6_05_03_3,,,
course_6,ch_6_05,les_6_05_03,topic_6_05_03_01,quiz_6_05_03_4,,,
course_6,ch_6_05,les_6_05_03,topic_6_05_03_01,quiz_6_05_03_5,,,
course_6,ch_6_05,les_6_05_04,topic_6_05_04_01,quiz_6_05_04_1,,,
course_6,ch_6_05,les_6_05_04,topic_6_05_04_01,quiz_6_05_04_2,,,
course_6,ch_6_05,les_6_05_04,topic_6_05_04_01,quiz_6_05_04_3,,,
course_6,ch_6_05,les_6_05_04,topic_6_05_04_01,quiz_6_05_04_4,,,
course_6,ch_6_05,les_6_05_04,topic_6_05_04_01,quiz_6_05_04_5,,,
course_6,ch_6_05,les_6_05_05,topic_6_05_05_01,quiz_6_05_05_1,,,
course_6,ch_6_05,les_6_05_05,topic_6_05_05_01,quiz_6_05_05_2,,,
course_6,ch_6_05,les_6_05_05,topic_6_05_05_01,quiz_6_05_05_3,,,
course_6,ch_6_05,les_6_05_05,topic_6_05_05_01,quiz_6_05_05_4,,,
course_6,ch_6_05,les_6_05_05,topic_6_05_05_01,quiz_6_05_05_5,,,
course_6,ch_6_05,les_6_05_06,topic_6_05_06_01,quiz_6_05_06_1,,,
course_6,ch_6_05,les_6_05_06,topic_6_05_06_01,quiz_6_05_06_2,,,
course_6,ch_6_05,les_6_05_06,topic_6_05_06_01,quiz_6_05_06_3,,,
course_6,ch_6_05,les_6_05_06,topic_6_05_06_01,quiz_6_05_06_4,,,
course_6,ch_6_05,les_6_05_06,topic_6_05_06_01,quiz_6_05_06_5,,,
course_6,ch_6_05,les_6_05_07,topic_6_05_07_01,quiz_6_05_07_1,,,
course_6,ch_6_05,les_6_05_07,topic_6_05_07_01,quiz_6_05_07_2,,,
course_6,ch_6_05,les_6_05_07,topic_6_05_07_01,quiz_6_05_07_3,,,
course_6,ch_6_05,les_6_05_07,topic_6_05_07_01,quiz_6_05_07_4,,,
course_6,ch_6_05,les_6_05_07,topic_6_05_07_01,quiz_6_05_07_5,,,
course_6,ch_6_05,les_6_05_08,topic_6_05_08_01,quiz_6_05_08_1,,,
course_6,ch_6_05,les_6_05_08,topic_6_05_08_01,quiz_6_05_08_2,,,
course_6,ch_6_05,les_6_05_08,topic_6_05_08_01,quiz_6_05_08_3,,,
course_6,ch_6_05,les_6_05_08,topic_6_05_08_01,quiz_6_05_08_4,,,
course_6,ch_6_05,les_6_05_08,topic_6_05_08_01,quiz_6_05_08_5,,,
course_6,ch_6_05,les_6_05_09,topic_6_05_09_01,quiz_6_05_09_1,,,
course_6,ch_6_05,les_6_05_09,topic_6_05_09_01,quiz_6_05_09_2,,,
course_6,ch_6_05,les_6_05_09,topic_6_05_09_01,quiz_6_05_09_3,,,
course_6,ch_6_05,les_6_05_09,topic_6_05_09_01,quiz_6_05_09_4,,,
course_6,ch_6_05,les_6_05_09,topic_6_05_09_01,quiz_6_05_09_5,,,
course_6,ch_6_05,les_6_05_10,topic_6_05_10_01,quiz_6_05_10_1,,,
course_6,ch_6_05,les_6_05_10,topic_6_05_10_01,quiz_6_05_10_2,,,
course_6,ch_6_05,les_6_05_10,topic_6_05_10_01,quiz_6_05_10_3,,,
course_6,ch_6_05,les_6_05_10,topic_6_05_10_01,quiz_6_05_10_4,,,
course_6,ch_6_05,les_6_05_10,topic_6_05_10_01,quiz_6_05_10_5,,,
course_6,ch_6_06,les_6_06_01,topic_6_06_01_01,quiz_6_06_01_1,,,
course_6,ch_6_06,les_6_06_01,topic_6_06_01_01,quiz_6_06_01_2,,,
course_6,ch_6_06,les_6_06_01,topic_6_06_01_01,quiz_6_06_01_3,,,
course_6,ch_6_06,les_6_06_01,topic_6_06_01_01,quiz_6_06_01_4,,,
course_6,ch_6_06,les_6_06_01,topic_6_06_01_01,quiz_6_06_01_5,,,
course_6,ch_6_06,les_6_06_02,topic_6_06_02_01,quiz_6_06_02_1,,,
course_6,ch_6_06,les_6_06_02,topic_6_06_02_01,quiz_6_06_02_2,,,
course_6,ch_6_06,les_6_06_02,topic_6_06_02_01,quiz_6_06_02_3,,,
course_6,ch_6_06,les_6_06_02,topic_6_06_02_01,quiz_6_06_02_4,,,
course_6,ch_6_06,les_6_06_02,topic_6_06_02_01,quiz_6_06_02_5,,,
course_6,ch_6_06,les_6_06_03,topic_6_06_03_01,quiz_6_06_03_1,,,
course_6,ch_6_06,les_6_06_03,topic_6_06_03_01,quiz_6_06_03_2,,,
course_6,ch_6_06,les_6_06_03,topic_6_06_03_01,quiz_6_06_03_3,,,
course_6,ch_6_06,les_6_06_03,topic_6_06_03_01,quiz_6_06_03_4,,,
course_6,ch_6_06,les_6_06_03,topic_6_06_03_01,quiz_6_06_03_5,,,
course_6,ch_6_06,les_6_06_04,topic_6_06_04_01,quiz_6_06_04_1,,,
course_6,ch_6_06,les_6_06_04,topic_6_06_04_01,quiz_6_06_04_2,,,
course_6,ch_6_06,les_6_06_04,topic_6_06_04_01,quiz_6_06_04_3,,,
course_6,ch_6_06,les_6_06_04,topic_6_06_04_01,quiz_6_06_04_4,,,
course_6,ch_6_06,les_6_06_04,topic_6_06_04_01,quiz_6_06_04_5,,,
course_6,ch_6_06,les_6_06_05,topic_6_06_05_01,quiz_6_06_05_1,,,
course_6,ch_6_06,les_6_06_05,topic_6_06_05_01,quiz_6_06_05_2,,,
course_6,ch_6_06,les_6_06_05,topic_6_06_05_01,quiz_6_06_05_3,,,
course_6,ch_6_06,les_6_06_05,topic_6_06_05_01,quiz_6_06_05_4,,,
course_6,ch_6_06,les_6_06_05,topic_6_06_05_01,quiz_6_06_05_5,,,
course_6,ch_6_06,les_6_06_06,topic_6_06_06_01,quiz_6_06_06_1,,,
course_6,ch_6_06,les_6_06_06,topic_6_06_06_01,quiz_6_06_06_2,,,
course_6,ch_6_06,les_6_06_06,topic_6_06_06_01,quiz_6_06_06_3,,,
course_6,ch_6_06,les_6_06_06,topic_6_06_06_01,quiz_6_06_06_4,,,
course_6,ch_6_06,les_6_06_06,topic_6_06_06_01,quiz_6_06_06_5,,,
course_6,ch_6_06,les_6_06_07,topic_6_06_07_01,quiz_6_06_07_1,,,
course_6,ch_6_06,les_6_06_07,topic_6_06_07_01,quiz_6_06_07_2,,,
course_6,ch_6_06,les_6_06_07,topic_6_06_07_01,quiz_6_06_07_3,,,
course_6,ch_6_06,les_6_06_07,topic_6_06_07_01,quiz_6_06_07_4,,,
course_6,ch_6_06,les_6_06_07,topic_6_06_07_01,quiz_6_06_07_5,,,
course_6,ch_6_06,les_6_06_08,topic_6_06_08_01,quiz_6_06_08_1,,,
course_6,ch_6_06,les_6_06_08,topic_6_06_08_01,quiz_6_06_08_2,,,
course_6,ch_6_06,les_6_06_08,topic_6_06_08_01,quiz_6_06_08_3,,,
course_6,ch_6_06,les_6_06_08,topic_6_06_08_01,quiz_6_06_08_4,,,
course_6,ch_6_06,les_6_06_08,topic_6_06_08_01,quiz_6_06_08_5,,,
course_6,ch_6_06,les_6_06_09,topic_6_06_09_01,quiz_6_06_09_1,,,
course_6,ch_6_06,les_6_06_09,topic_6_06_09_01,quiz_6_06_09_2,,,
course_6,ch_6_06,les_6_06_09,topic_6_06_09_01,quiz_6_06_09_3,,,
course_6,ch_6_06,les_6_06_09,topic_6_06_09_01,quiz_6_06_09_4,,,
course_6,ch_6_06,les_6_06_09,topic_6_06_09_01,quiz_6_06_09_5,,,
course_6,ch_6_06,les_6_06_10,topic_6_06_10_01,quiz_6_06_10_1,,,
course_6,ch_6_06,les_6_06_10,topic_6_06_10_01,quiz_6_06_10_2,,,
course_6,ch_6_06,les_6_06_10,topic_6_06_10_01,quiz_6_06_10_3,,,
course_6,ch_6_06,les_6_06_10,topic_6_06_10_01,quiz_6_06_10_4,,,
course_6,ch_6_06,les_6_06_10,topic_6_06_10_01,quiz_6_06_10_5,,,
course_6,ch_6_07,les_6_07_01,topic_6_07_01_01,quiz_6_07_01_1,,,
course_6,ch_6_07,les_6_07_01,topic_6_07_01_01,quiz_6_07_01_2,,,
course_6,ch_6_07,les_6_07_01,topic_6_07_01_01,quiz_6_07_01_3,,,
course_6,ch_6_07,les_6_07_01,topic_6_07_01_01,quiz_6_07_01_4,,,
course_6,ch_6_07,les_6_07_01,topic_6_07_01_01,quiz_6_07_01_5,,,
course_6,ch_6_07,les_6_07_02,topic_6_07_02_01,quiz_6_07_02_1,,,
course_6,ch_6_07,les_6_07_02,topic_6_07_02_01,quiz_6_07_02_2,,,
course_6,ch_6_07,les_6_07_02,topic_6_07_02_01,quiz_6_07_02_3,,,
course_6,ch_6_07,les_6_07_02,topic_6_07_02_01,quiz_6_07_02_4,,,
course_6,ch_6_07,les_6_07_02,topic_6_07_02_01,quiz_6_07_02_5,,,
course_6,ch_6_07,les_6_07_03,topic_6_07_03_01,quiz_6_07_03_1,,,
course_6,ch_6_07,les_6_07_03,topic_6_07_03_01,quiz_6_07_03_2,,,
course_6,ch_6_07,les_6_07_03,topic_6_07_03_01,quiz_6_07_03_3,,,
course_6,ch_6_07,les_6_07_03,topic_6_07_03_01,quiz_6_07_03_4,,,
course_6,ch_6_07,les_6_07_03,topic_6_07_03_01,quiz_6_07_03_5,,,
course_6,ch_6_07,les_6_07_04,topic_6_07_04_01,quiz_6_07_04_1,,,
course_6,ch_6_07,les_6_07_04,topic_6_07_04_01,quiz_6_07_04_2,,,
course_6,ch_6_07,les_6_07_04,topic_6_07_04_01,quiz_6_07_04_3,,,
course_6,ch_6_07,les_6_07_04,topic_6_07_04_01,quiz_6_07_04_4,,,
course_6,ch_6_07,les_6_07_04,topic_6_07_04_01,quiz_6_07_04_5,,,
course_6,ch_6_07,les_6_07_05,topic_6_07_05_01,quiz_6_07_05_1,,,
course_6,ch_6_07,les_6_07_05,topic_6_07_05_01,quiz_6_07_05_2,,,
course_6,ch_6_07,les_6_07_05,topic_6_07_05_01,quiz_6_07_05_3,,,
course_6,ch_6_07,les_6_07_05,topic_6_07_05_01,quiz_6_07_05_4,,,
course_6,ch_6_07,les_6_07_05,topic_6_07_05_01,quiz_6_07_05_5,,,
course_6,ch_6_07,les_6_07_06,topic_6_07_06_01,quiz_6_07_06_1,,,
course_6,ch_6_07,les_6_07_06,topic_6_07_06_01,quiz_6_07_06_2,,,
course_6,ch_6_07,les_6_07_06,topic_6_07_06_01,quiz_6_07_06_3,,,
course_6,ch_6_07,les_6_07_06,topic_6_07_06_01,quiz_6_07_06_4,,,
course_6,ch_6_07,les_6_07_06,topic_6_07_06_01,quiz_6_07_06_5,,,
course_6,ch_6_07,les_6_07_07,topic_6_07_07_01,quiz_6_07_07_1,,,
course_6,ch_6_07,les_6_07_07,topic_6_07_07_01,quiz_6_07_07_2,,,
course_6,ch_6_07,les_6_07_07,topic_6_07_07_01,quiz_6_07_07_3,,,
course_6,ch_6_07,les_6_07_07,topic_6_07_07_01,quiz_6_07_07_4,,,
course_6,ch_6_07,les_6_07_07,topic_6_07_07_01,quiz_6_07_07_5,,,
course_6,ch_6_07,les_6_07_08,topic_6_07_08_01,quiz_6_07_08_1,,,
course_6,ch_6_07,les_6_07_08,topic_6_07_08_01,quiz_6_07_08_2,,,
course_6,ch_6_07,les_6_07_08,topic_6_07_08_01,quiz_6_07_08_3,,,
course_6,ch_6_07,les_6_07_08,topic_6_07_08_01,quiz_6_07_08_4,,,
course_6,ch_6_07,les_6_07_08,topic_6_07_08_01,quiz_6_07_08_5,,,
course_6,ch_6_07,les_6_07_09,topic_6_07_09_01,quiz_6_07_09_1,,,
course_6,ch_6_07,les_6_07_09,topic_6_07_09_01,quiz_6_07_09_2,,,
course_6,ch_6_07,les_6_07_09,topic_6_07_09_01,quiz_6_07_09_3,,,
course_6,ch_6_07,les_6_07_09,topic_6_07_09_01,quiz_6_07_09_4,,,
course_6,ch_6_07,les_6_07_09,topic_6_07_09_01,quiz_6_07_09_5,,,
course_6,ch_6_07,les_6_07_10,topic_6_07_10_01,quiz_6_07_10_1,,,
course_6,ch_6_07,les_6_07_10,topic_6_07_10_01,quiz_6_07_10_2,,,
course_6,ch_6_07,les_6_07_10,topic_6_07_10_01,quiz_6_07_10_3,,,
course_6,ch_6_07,les_6_07_10,topic_6_07_10_01,quiz_6_07_10_4,,,
course_6,ch_6_07,les_6_07_10,topic_6_07_10_01,quiz_6_07_10_5,,,
course_6,ch_6_08,les_6_08_01,topic_6_08_01_01,quiz_6_08_01_1,,,
course_6,ch_6_08,les_6_08_01,topic_6_08_01_01,quiz_6_08_01_2,,,
course_6,ch_6_08,les_6_08_01,topic_6_08_01_01,quiz_6_08_01_3,,,
course_6,ch_6_08,les_6_08_01,topic_6_08_01_01,quiz_6_08_01_4,,,
course_6,ch_6_08,les_6_08_01,topic_6_08_01_01,quiz_6_08_01_5,,,
course_6,ch_6_08,les_6_08_02,topic_6_08_02_01,quiz_6_08_02_1,,,
course_6,ch_6_08,les_6_08_02,topic_6_08_02_01,quiz_6_08_02_2,,,
course_6,ch_6_08,les_6_08_02,topic_6_08_02_01,quiz_6_08_02_3,,,
course_6,ch_6_08,les_6_08_02,topic_6_08_02_01,quiz_6_08_02_4,,,
course_6,ch_6_08,les_6_08_02,topic_6_08_02_01,quiz_6_08_02_5,,,
course_6,ch_6_08,les_6_08_03,topic_6_08_03_01,quiz_6_08_03_1,,,
course_6,ch_6_08,les_6_08_03,topic_6_08_03_01,quiz_6_08_03_2,,,
course_6,ch_6_08,les_6_08_03,topic_6_08_03_01,quiz_6_08_03_3,,,
course_6,ch_6_08,les_6_08_03,topic_6_08_03_01,quiz_6_08_03_4,,,
course_6,ch_6_08,les_6_08_03,topic_6_08_03_01,quiz_6_08_03_5,,,
course_6,ch_6_08,les_6_08_04,topic_6_08_04_01,quiz_6_08_04_1,,,
course_6,ch_6_08,les_6_08_04,topic_6_08_04_01,quiz_6_08_04_2,,,
course_6,ch_6_08,les_6_08_04,topic_6_08_04_01,quiz_6_08_04_3,,,
course_6,ch_6_08,les_6_08_04,topic_6_08_04_01,quiz_6_08_04_4,,,
course_6,ch_6_08,les_6_08_04,topic_6_08_04_01,quiz_6_08_04_5,,,
course_6,ch_6_08,les_6_08_05,topic_6_08_05_01,quiz_6_08_05_1,,,
course_6,ch_6_08,les_6_08_05,topic_6_08_05_01,quiz_6_08_05_2,,,
course_6,ch_6_08,les_6_08_05,topic_6_08_05_01,quiz_6_08_05_3,,,
course_6,ch_6_08,les_6_08_05,topic_6_08_05_01,quiz_6_08_05_4,,,
course_6,ch_6_08,les_6_08_05,topic_6_08_05_01,quiz_6_08_05_5,,,
course_6,ch_6_08,les_6_08_06,topic_6_08_06_01,quiz_6_08_06_1,,,
course_6,ch_6_08,les_6_08_06,topic_6_08_06_01,quiz_6_08_06_2,,,
course_6,ch_6_08,les_6_08_06,topic_6_08_06_01,quiz_6_08_06_3,,,
course_6,ch_6_08,les_6_08_06,topic_6_08_06_01,quiz_6_08_06_4,,,
course_6,ch_6_08,les_6_08_06,topic_6_08_06_01,quiz_6_08_06_5,,,
course_6,ch_6_08,les_6_08_07,topic_6_08_07_01,quiz_6_08_07_1,,,
course_6,ch_6_08,les_6_08_07,topic_6_08_07_01,quiz_6_08_07_2,,,
course_6,ch_6_08,les_6_08_07,topic_6_08_07_01,quiz_6_08_07_3,,,
course_6,ch_6_08,les_6_08_07,topic_6_08_07_01,quiz_6_08_07_4,,,
course_6,ch_6_08,les_6_08_07,topic_6_08_07_01,quiz_6_08_07_5,,,
course_6,ch_6_08,les_6_08_08,topic_6_08_08_01,quiz_6_08_08_1,,,
course_6,ch_6_08,les_6_08_08,topic_6_08_08_01,quiz_6_08_08_2,,,
course_6,ch_6_08,les_6_08_08,topic_6_08_08_01,quiz_6_08_08_3,,,
course_6,ch_6_08,les_6_08_08,topic_6_08_08_01,quiz_6_08_08_4,,,
course_6,ch_6_08,les_6_08_08,topic_6_08_08_01,quiz_6_08_08_5,,,
course_6,ch_6_08,les_6_08_09,topic_6_08_09_01,quiz_6_08_09_1,,,
course_6,ch_6_08,les_6_08_09,topic_6_08_09_01,quiz_6_08_09_2,,,
course_6,ch_6_08,les_6_08_09,topic_6_08_09_01,quiz_6_08_09_3,,,
course_6,ch_6_08,les_6_08_09,topic_6_08_09_01,quiz_6_08_09_4,,,
course_6,ch_6_08,les_6_08_09,topic_6_08_09_01,quiz_6_08_09_5,,,
course_6,ch_6_08,les_6_08_10,topic_6_08_10_01,quiz_6_08_10_1,,,
course_6,ch_6_08,les_6_08_10,topic_6_08_10_01,quiz_6_08_10_2,,,
course_6,ch_6_08,les_6_08_10,topic_6_08_10_01,quiz_6_08_10_3,,,
course_6,ch_6_08,les_6_08_10,topic_6_08_10_01,quiz_6_08_10_4,,,
course_6,ch_6_08,les_6_08_10,topic_6_08_10_01,quiz_6_08_10_5,,,
course_6,ch_6_09,les_6_09_01,topic_6_09_01_01,quiz_6_09_01_1,,,
course_6,ch_6_09,les_6_09_01,topic_6_09_01_01,quiz_6_09_01_2,,,
course_6,ch_6_09,les_6_09_01,topic_6_09_01_01,quiz_6_09_01_3,,,
course_6,ch_6_09,les_6_09_01,topic_6_09_01_01,quiz_6_09_01_4,,,
course_6,ch_6_09,les_6_09_01,topic_6_09_01_01,quiz_6_09_01_5,,,
course_6,ch_6_09,les_6_09_02,topic_6_09_02_01,quiz_6_09_02_1,,,
course_6,ch_6_09,les_6_09_02,topic_6_09_02_01,quiz_6_09_02_2,,,
course_6,ch_6_09,les_6_09_02,topic_6_09_02_01,quiz_6_09_02_3,,,
course_6,ch_6_09,les_6_09_02,topic_6_09_02_01,quiz_6_09_02_4,,,
course_6,ch_6_09,les_6_09_02,topic_6_09_02_01,quiz_6_09_02_5,,,
course_6,ch_6_09,les_6_09_03,topic_6_09_03_01,quiz_6_09_03_1,,,
course_6,ch_6_09,les_6_09_03,topic_6_09_03_01,quiz_6_09_03_2,,,
course_6,ch_6_09,les_6_09_03,topic_6_09_03_01,quiz_6_09_03_3,,,
course_6,ch_6_09,les_6_09_03,topic_6_09_03_01,quiz_6_09_03_4,,,
course_6,ch_6_09,les_6_09_03,topic_6_09_03_01,quiz_6_09_03_5,,,
course_6,ch_6_09,les_6_09_04,topic_6_09_04_01,quiz_6_09_04_1,,,
course_6,ch_6_09,les_6_09_04,topic_6_09_04_01,quiz_6_09_04_2,,,
course_6,ch_6_09,les_6_09_04,topic_6_09_04_01,quiz_6_09_04_3,,,
course_6,ch_6_09,les_6_09_04,topic_6_09_04_01,quiz_6_09_04_4,,,
course_6,ch_6_09,les_6_09_04,topic_6_09_04_01,quiz_6_09_04_5,,,
course_6,ch_6_09,les_6_09_05,topic_6_09_05_01,quiz_6_09_05_1,,,
course_6,ch_6_09,les_6_09_05,topic_6_09_05_01,quiz_6_09_05_2,,,
course_6,ch_6_09,les_6_09_05,topic_6_09_05_01,quiz_6_09_05_3,,,
course_6,ch_6_09,les_6_09_05,topic_6_09_05_01,quiz_6_09_05_4,,,
course_6,ch_6_09,les_6_09_05,topic_6_09_05_01,quiz_6_09_05_5,,,
course_6,ch_6_09,les_6_09_06,topic_6_09_06_01,quiz_6_09_06_1,,,
course_6,ch_6_09,les_6_09_06,topic_6_09_06_01,quiz_6_09_06_2,,,
course_6,ch_6_09,les_6_09_06,topic_6_09_06_01,quiz_6_09_06_3,,,
course_6,ch_6_09,les_6_09_06,topic_6_09_06_01,quiz_6_09_06_4,,,
course_6,ch_6_09,les_6_09_06,topic_6_09_06_01,quiz_6_09_06_5,,,
course_6,ch_6_09,les_6_09_07,topic_6_09_07_01,quiz_6_09_07_1,,,
course_6,ch_6_09,les_6_09_07,topic_6_09_07_01,quiz_6_09_07_2,,,
course_6,ch_6_09,les_6_09_07,topic_6_09_07_01,quiz_6_09_07_3,,,
course_6,ch_6_09,les_6_09_07,topic_6_09_07_01,quiz_6_09_07_4,,,
course_6,ch_6_09,les_6_09_07,topic_6_09_07_01,quiz_6_09_07_5,,,
course_6,ch_6_09,les_6_09_08,topic_6_09_08_01,quiz_6_09_08_1,,,
course_6,ch_6_09,les_6_09_08,topic_6_09_08_01,quiz_6_09_08_2,,,
course_6,ch_6_09,les_6_09_08,topic_6_09_08_01,quiz_6_09_08_3,,,
course_6,ch_6_09,les_6_09_08,topic_6_09_08_01,quiz_6_09_08_4,,,
course_6,ch_6_09,les_6_09_08,topic_6_09_08_01,quiz_6_09_08_5,,,
course_6,ch_6_09,les_6_09_09,topic_6_09_09_01,quiz_6_09_09_1,,,
course_6,ch_6_09,les_6_09_09,topic_6_09_09_01,quiz_6_09_09_2,,,
course_6,ch_6_09,les_6_09_09,topic_6_09_09_01,quiz_6_09_09_3,,,
course_6,ch_6_09,les_6_09_09,topic_6_09_09_01,quiz_6_09_09_4,,,
course_6,ch_6_09,les_6_09_09,topic_6_09_09_01,quiz_6_09_09_5,,,
course_6,ch_6_09,les_6_09_10,topic_6_09_10_01,quiz_6_09_10_1,,,
course_6,ch_6_09,les_6_09_10,topic_6_09_10_01,quiz_6_09_10_2,,,
course_6,ch_6_09,les_6_09_10,topic_6_09_10_01,quiz_6_09_10_3,,,
course_6,ch_6_09,les_6_09_10,topic_6_09_10_01,quiz_6_09_10_4,,,
course_6,ch_6_09,les_6_09_10,topic_6_09_10_01,quiz_6_09_10_5,,,
course_6,ch_6_10,les_6_10_01,topic_6_10_01_01,quiz_6_10_01_1,,,
course_6,ch_6_10,les_6_10_01,topic_6_10_01_01,quiz_6_10_01_2,,,
course_6,ch_6_10,les_6_10_01,topic_6_10_01_01,quiz_6_10_01_3,,,
course_6,ch_6_10,les_6_10_01,topic_6_10_01_01,quiz_6_10_01_4,,,
course_6,ch_6_10,les_6_10_01,topic_6_10_01_01,quiz_6_10_01_5,,,
course_6,ch_6_10,les_6_10_02,topic_6_10_02_01,quiz_6_10_02_1,,,
course_6,ch_6_10,les_6_10_02,topic_6_10_02_01,quiz_6_10_02_2,,,
course_6,ch_6_10,les_6_10_02,topic_6_10_02_01,quiz_6_10_02_3,,,
course_6,ch_6_10,les_6_10_02,topic_6_10_02_01,quiz_6_10_02_4,,,
course_6,ch_6_10,les_6_10_02,topic_6_10_02_01,quiz_6_10_02_5,,,
course_6,ch_6_10,les_6_10_03,topic_6_10_03_01,quiz_6_10_03_1,,,
course_6,ch_6_10,les_6_10_03,topic_6_10_03_01,quiz_6_10_03_2,,,
course_6,ch_6_10,les_6_10_03,topic_6_10_03_01,quiz_6_10_03_3,,,
course_6,ch_6_10,les_6_10_03,topic_6_10_03_01,quiz_6_10_03_4,,,
course_6,ch_6_10,les_6_10_03,topic_6_10_03_01,quiz_6_10_03_5,,,
course_6,ch_6_10,les_6_10_04,topic_6_10_04_01,quiz_6_10_04_1,,,
course_6,ch_6_10,les_6_10_04,topic_6_10_04_01,quiz_6_10_04_2,,,
course_6,ch_6_10,les_6_10_04,topic_6_10_04_01,quiz_6_10_04_3,,,
course_6,ch_6_10,les_6_10_04,topic_6_10_04_01,quiz_6_10_04_4,,,
course_6,ch_6_10,les_6_10_04,topic_6_10_04_01,quiz_6_10_04_5,,,
course_6,ch_6_10,les_6_10_05,topic_6_10_05_01,quiz_6_10_05_1,,,
course_6,ch_6_10,les_6_10_05,topic_6_10_05_01,quiz_6_10_05_2,,,
course_6,ch_6_10,les_6_10_05,topic_6_10_05_01,quiz_6_10_05_3,,,
course_6,ch_6_10,les_6_10_05,topic_6_10_05_01,quiz_6_10_05_4,,,
course_6,ch_6_10,les_6_10_05,topic_6_10_05_01,quiz_6_10_05_5,,,
course_6,ch_6_10,les_6_10_06,topic_6_10_06_01,quiz_6_10_06_1,,,
course_6,ch_6_10,les_6_10_06,topic_6_10_06_01,quiz_6_10_06_2,,,
course_6,ch_6_10,les_6_10_06,topic_6_10_06_01,quiz_6_10_06_3,,,
course_6,ch_6_10,les_6_10_06,topic_6_10_06_01,quiz_6_10_06_4,,,
course_6,ch_6_10,les_6_10_06,topic_6_10_06_01,quiz_6_10_06_5,,,
course_6,ch_6_10,les_6_10_07,topic_6_10_07_01,quiz_6_10_07_1,,,
course_6,ch_6_10,les_6_10_07,topic_6_10_07_01,quiz_6_10_07_2,,,
course_6,ch_6_10,les_6_10_07,topic_6_10_07_01,quiz_6_10_07_3,,,
course_6,ch_6_10,les_6_10_07,topic_6_10_07_01,quiz_6_10_07_4,,,
course_6,ch_6_10,les_6_10_07,topic_6_10_07_01,quiz_6_10_07_5,,,
course_6,ch_6_10,les_6_10_08,topic_6_10_08_01,quiz_6_10_08_1,,,
course_6,ch_6_10,les_6_10_08,topic_6_10_08_01,quiz_6_10_08_2,,,
course_6,ch_6_10,les_6_10_08,topic_6_10_08_01,quiz_6_10_08_3,,,
course_6,ch_6_10,les_6_10_08,topic_6_10_08_01,quiz_6_10_08_4,,,
course_6,ch_6_10,les_6_10_08,topic_6_10_08_01,quiz_6_10_08_5,,,
course_6,ch_6_10,les_6_10_09,topic_6_10_09_01,quiz_6_10_09_1,,,
course_6,ch_6_10,les_6_10_09,topic_6_10_09_01,quiz_6_10_09_2,,,
course_6,ch_6_10,les_6_10_09,topic_6_10_09_01,quiz_6_10_09_3,,,
course_6,ch_6_10,les_6_10_09,topic_6_10_09_01,quiz_6_10_09_4,,,
course_6,ch_6_10,les_6_10_09,topic_6_10_09_01,quiz_6_10_09_5,,,
course_6,ch_6_10,les_6_10_10,topic_6_10_10_01,quiz_6_10_10_1,,,
course_6,ch_6_10,les_6_10_10,topic_6_10_10_01,quiz_6_10_10_2,,,
course_6,ch_6_10,les_6_10_10,topic_6_10_10_01,quiz_6_10_10_3,,,
course_6,ch_6_10,les_6_10_10,topic_6_10_10_01,quiz_6_10_10_4,,,
course_6,ch_6_10,les_6_10_10,topic_6_10_10_01,quiz_6_10_10_5,,,
course_6,ch_6_11,les_6_11_01,topic_6_11_01_01,quiz_6_11_01_1,,,
course_6,ch_6_11,les_6_11_01,topic_6_11_01_01,quiz_6_11_01_2,,,
course_6,ch_6_11,les_6_11_01,topic_6_11_01_01,quiz_6_11_01_3,,,
course_6,ch_6_11,les_6_11_01,topic_6_11_01_01,quiz_6_11_01_4,,,
course_6,ch_6_11,les_6_11_01,topic_6_11_01_01,quiz_6_11_01_5,,,
course_6,ch_6_11,les_6_11_02,topic_6_11_02_01,quiz_6_11_02_1,,,
course_6,ch_6_11,les_6_11_02,topic_6_11_02_01,quiz_6_11_02_2,,,
course_6,ch_6_11,les_6_11_02,topic_6_11_02_01,quiz_6_11_02_3,,,
course_6,ch_6_11,les_6_11_02,topic_6_11_02_01,quiz_6_11_02_4,,,
course_6,ch_6_11,les_6_11_02,topic_6_11_02_01,quiz_6_11_02_5,,,
course_6,ch_6_11,les_6_11_03,topic_6_11_03_01,quiz_6_11_03_1,,,
course_6,ch_6_11,les_6_11_03,topic_6_11_03_01,quiz_6_11_03_2,,,
course_6,ch_6_11,les_6_11_03,topic_6_11_03_01,quiz_6_11_03_3,,,
course_6,ch_6_11,les_6_11_03,topic_6_11_03_01,quiz_6_11_03_4,,,
course_6,ch_6_11,les_6_11_03,topic_6_11_03_01,quiz_6_11_03_5,,,
course_6,ch_6_11,les_6_11_04,topic_6_11_04_01,quiz_6_11_04_1,,,
course_6,ch_6_11,les_6_11_04,topic_6_11_04_01,quiz_6_11_04_2,,,
course_6,ch_6_11,les_6_11_04,topic_6_11_04_01,quiz_6_11_04_3,,,
course_6,ch_6_11,les_6_11_04,topic_6_11_04_01,quiz_6_11_04_4,,,
course_6,ch_6_11,les_6_11_04,topic_6_11_04_01,quiz_6_11_04_5,,,
course_6,ch_6_11,les_6_11_05,topic_6_11_05_01,quiz_6_11_05_1,,,
course_6,ch_6_11,les_6_11_05,topic_6_11_05_01,quiz_6_11_05_2,,,
course_6,ch_6_11,les_6_11_05,topic_6_11_05_01,quiz_6_11_05_3,,,
course_6,ch_6_11,les_6_11_05,topic_6_11_05_01,quiz_6_11_05_4,,,
course_6,ch_6_11,les_6_11_05,topic_6_11_05_01,quiz_6_11_05_5,,,
course_6,ch_6_11,les_6_11_06,topic_6_11_06_01,quiz_6_11_06_1,,,
course_6,ch_6_11,les_6_11_06,topic_6_11_06_01,quiz_6_11_06_2,,,
course_6,ch_6_11,les_6_11_06,topic_6_11_06_01,quiz_6_11_06_3,,,
course_6,ch_6_11,les_6_11_06,topic_6_11_06_01,quiz_6_11_06_4,,,
course_6,ch_6_11,les_6_11_06,topic_6_11_06_01,quiz_6_11_06_5,,,
course_6,ch_6_11,les_6_11_07,topic_6_11_07_01,quiz_6_11_07_1,,,
course_6,ch_6_11,les_6_11_07,topic_6_11_07_01,quiz_6_11_07_2,,,
course_6,ch_6_11,les_6_11_07,topic_6_11_07_01,quiz_6_11_07_3,,,
course_6,ch_6_11,les_6_11_07,topic_6_11_07_01,quiz_6_11_07_4,,,
course_6,ch_6_11,les_6_11_07,topic_6_11_07_01,quiz_6_11_07_5,,,
course_6,ch_6_11,les_6_11_08,topic_6_11_08_01,quiz_6_11_08_1,,,
course_6,ch_6_11,les_6_11_08,topic_6_11_08_01,quiz_6_11_08_2,,,
course_6,ch_6_11,les_6_11_08,topic_6_11_08_01,quiz_6_11_08_3,,,
course_6,ch_6_11,les_6_11_08,topic_6_11_08_01,quiz_6_11_08_4,,,
course_6,ch_6_11,les_6_11_08,topic_6_11_08_01,quiz_6_11_08_5,,,
course_6,ch_6_11,les_6_11_09,topic_6_11_09_01,quiz_6_11_09_1,,,
course_6,ch_6_11,les_6_11_09,topic_6_11_09_01,quiz_6_11_09_2,,,
course_6,ch_6_11,les_6_11_09,topic_6_11_09_01,quiz_6_11_09_3,,,
course_6,ch_6_11,les_6_11_09,topic_6_11_09_01,quiz_6_11_09_4,,,
course_6,ch_6_11,les_6_11_09,topic_6_11_09_01,quiz_6_11_09_5,,,
course_6,ch_6_11,les_6_11_10,topic_6_11_10_01,quiz_6_11_10_1,,,
course_6,ch_6_11,les_6_11_10,topic_6_11_10_01,quiz_6_11_10_2,,,
course_6,ch_6_11,les_6_11_10,topic_6_11_10_01,quiz_6_11_10_3,,,
course_6,ch_6_11,les_6_11_10,topic_6_11_10_01,quiz_6_11_10_4,,,
course_6,ch_6_11,les_6_11_10,topic_6_11_10_01,quiz_6_11_10_5,,,
course_6,ch_6_12,les_6_12_01,topic_6_12_01_01,quiz_6_12_01_1,,,
course_6,ch_6_12,les_6_12_01,topic_6_12_01_01,quiz_6_12_01_2,,,
course_6,ch_6_12,les_6_12_01,topic_6_12_01_01,quiz_6_12_01_3,,,
course_6,ch_6_12,les_6_12_01,topic_6_12_01_01,quiz_6_12_01_4,,,
course_6,ch_6_12,les_6_12_01,topic_6_12_01_01,quiz_6_12_01_5,,,
course_6,ch_6_12,les_6_12_02,topic_6_12_02_01,quiz_6_12_02_1,,,
course_6,ch_6_12,les_6_12_02,topic_6_12_02_01,quiz_6_12_02_2,,,
course_6,ch_6_12,les_6_12_02,topic_6_12_02_01,quiz_6_12_02_3,,,
course_6,ch_6_12,les_6_12_02,topic_6_12_02_01,quiz_6_12_02_4,,,
course_6,ch_6_12,les_6_12_02,topic_6_12_02_01,quiz_6_12_02_5,,,
course_6,ch_6_12,les_6_12_03,topic_6_12_03_01,quiz_6_12_03_1,,,
course_6,ch_6_12,les_6_12_03,topic_6_12_03_01,quiz_6_12_03_2,,,
course_6,ch_6_12,les_6_12_03,topic_6_12_03_01,quiz_6_12_03_3,,,
course_6,ch_6_12,les_6_12_03,topic_6_12_03_01,quiz_6_12_03_4,,,
course_6,ch_6_12,les_6_12_03,topic_6_12_03_01,quiz_6_12_03_5,,,
course_6,ch_6_12,les_6_12_04,topic_6_12_04_01,quiz_6_12_04_1,,,
course_6,ch_6_12,les_6_12_04,topic_6_12_04_01,quiz_6_12_04_2,,,
course_6,ch_6_12,les_6_12_04,topic_6_12_04_01,quiz_6_12_04_3,,,
course_6,ch_6_12,les_6_12_04,topic_6_12_04_01,quiz_6_12_04_4,,,
course_6,ch_6_12,les_6_12_04,topic_6_12_04_01,quiz_6_12_04_5,,,
course_6,ch_6_12,les_6_12_05,topic_6_12_05_01,quiz_6_12_05_1,,,
course_6,ch_6_12,les_6_12_05,topic_6_12_05_01,quiz_6_12_05_2,,,
course_6,ch_6_12,les_6_12_05,topic_6_12_05_01,quiz_6_12_05_3,,,
course_6,ch_6_12,les_6_12_05,topic_6_12_05_01,quiz_6_12_05_4,,,
course_6,ch_6_12,les_6_12_05,topic_6_12_05_01,quiz_6_12_05_5,,,
course_6,ch_6_12,les_6_12_06,topic_6_12_06_01,quiz_6_12_06_1,,,
course_6,ch_6_12,les_6_12_06,topic_6_12_06_01,quiz_6_12_06_2,,,
course_6,ch_6_12,les_6_12_06,topic_6_12_06_01,quiz_6_12_06_3,,,
course_6,ch_6_12,les_6_12_06,topic_6_12_06_01,quiz_6_12_06_4,,,
course_6,ch_6_12,les_6_12_06,topic_6_12_06_01,quiz_6_12_06_5,,,
course_6,ch_6_12,les_6_12_07,topic_6_12_07_01,quiz_6_12_07_1,,,
course_6,ch_6_12,les_6_12_07,topic_6_12_07_01,quiz_6_12_07_2,,,
course_6,ch_6_12,les_6_12_07,topic_6_12_07_01,quiz_6_12_07_3,,,
course_6,ch_6_12,les_6_12_07,topic_6_12_07_01,quiz_6_12_07_4,,,
course_6,ch_6_12,les_6_12_07,topic_6_12_07_01,quiz_6_12_07_5,,,
course_6,ch_6_12,les_6_12_08,topic_6_12_08_01,quiz_6_12_08_1,,,
course_6,ch_6_12,les_6_12_08,topic_6_12_08_01,quiz_6_12_08_2,,,
course_6,ch_6_12,les_6_12_08,topic_6_12_08_01,quiz_6_12_08_3,,,
course_6,ch_6_12,les_6_12_08,topic_6_12_08_01,quiz_6_12_08_4,,,
course_6,ch_6_12,les_6_12_08,topic_6_12_08_01,quiz_6_12_08_5,,,
course_6,ch_6_12,les_6_12_09,topic_6_12_09_01,quiz_6_12_09_1,,,
course_6,ch_6_12,les_6_12_09,topic_6_12_09_01,quiz_6_12_09_2,,,
course_6,ch_6_12,les_6_12_09,topic_6_12_09_01,quiz_6_12_09_3,,,
course_6,ch_6_12,les_6_12_09,topic_6_12_09_01,quiz_6_12_09_4,,,
course_6,ch_6_12,les_6_12_09,topic_6_12_09_01,quiz_6_12_09_5,,,
course_6,ch_6_12,les_6_12_10,topic_6_12_10_01,quiz_6_12_10_1,,,
course_6,ch_6_12,les_6_12_10,topic_6_12_10_01,quiz_6_12_10_2,,,
course_6,ch_6_12,les_6_12_10,topic_6_12_10_01,quiz_6_12_10_3,,,
course_6,ch_6_12,les_6_12_10,topic_6_12_10_01,quiz_6_12_10_4,,,
course_6,ch_6_12,les_6_12_10,topic_6_12_10_01,quiz_6_12_10_5,,,
,,,,,,,
,,,,,,,
,,,,,,,
course_7,ch_7_01,les_7_01_01,topic_7_01_01_1,quiz_7_01_01_1,Which of the following best describes source documents in a clinical trial context?,"A) Copies of case report forms (CRFs) |
B) Original records where trial data is first captured |
C) Digital platforms like Medidata or Viva |
D) Audit reports from regulatory authorities",B
course_7,ch_7_01,les_7_01_01,topic_7_01_01_1,quiz_7_01_01_2,What are some common documentation errors highlighted that can lead to audit findings?,"A) Proper signatures and timely entries |
B) Backdating, missing signatures, whiteouts, and mismatched CRF entries |
C) Use of electronic data capture systems |
D) Accurate source-to-CRF data matching",B
course_7,ch_7_01,les_7_01_01,topic_7_01_01_1,quiz_7_01_01_3,Which of the following can cause issues during monitoring visits or audits related to subject informed consent forms (ICFs)?,"A) Subject signs but does not date the form |
B) Investigator signs on the same day as the visit |
C) Using the latest version of the ICF |
D) Having legible signatures and dates",A
course_7,ch_7_01,les_7_01_01,topic_7_01_01_1,quiz_7_01_01_4,Which of the following is NOT a recommended practice when making corrections in clinical trial documentation?,"A) Using a single-line strikethrough |
B) Initialing and dating the correction |
C) Providing a reason for the correction |
D) Erasing the original entry completely",D
course_7,ch_7_01,les_7_01_01,topic_7_01_01_1,quiz_7_01_01_5,What is the primary role of the Clinical Research Coordinator (CRC) in managing study documentation?,"A) To monitor the study remotely and verify data accuracy
B) To record source data accurately and perform initial CRF data entry
C) To provide training to the study team on protocol compliance
D) To audit the study site for regulatory compliance",B
